ID	BioCyc	BiGG	KEGG	CAS	PubChem	3DMET	ChEBI	PDB-CCD	KNApSAcK	LIPID MAPS	LipidBank	Name	Traditional Name	IUPAC Name	Category	Subcategory	Empirical Formula	SMILES	Charge	Hydrophobic	Molecular Weight	van der Walls Volume	pKa	pI	logP	logD	Lower	Upper	Reactions	Comments
A23CMP	CPD-3707	23camp	C02353		5400	B01564	27844	ACK				2',3'-Cyclic AMP	4-(6-aminopurin-9-yl)-6-(hydroxymethyl)-2-oxo-tetrahydro-1,3,5,2$l^{5}-furo[3,4-d][1,3,2$l^{5}]dioxaphosphol-2-olate	4-(6-amino-9H-purin-9-yl)-6-(hydroxymethyl)-2-oxo-tetrahydro-2H-1,3,5,2$l^{5}-furo[3,4-d][1,3,2$l^{5}]dioxaphosphol-2-olate	cyclic ribonucleotide monophosphate		C10H11N5O6P1	NC1=NC=NC2=C1N=CN2C1OC(CO)C2OP([O-])(=O)OC12	-1	N	328	239		4.0	-4.1	-3.7			CpdB3	
A3MP	CPD-3706	3amp	C01367	84-21-9	4566	B01442	28931	3AM	C00019350			3'-AMP	[5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] phosphate	[5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] phosphate	nucleoside 3'-phosphate 		C10H12N5O7P1	NC1=NC=NC2=C1N=CN2C1OC(CO)C(OP([O-])([O-])=O)C1O	-2	N	345	256		3.8	-5.2	-5.9			CpdB3	
AC	ACET	ac	C00033	64-19-7	3335	B00009	15366	ACY	C00001176	LMFA01010002	DFA0002	acetate	acetate	acetate	carboxy acid		C2H3O2	C([O-])(=O)C	-1	N	59	54			-0.2	-2.8			AckA, TX_ACUP	
ACAL	ACETALD	acald	C00084	75-07-0	3384	B01155	15343	ACE	C00007392			acetaldehyde	acetaldehyde	acetaldehyde			C2H4O1	[CH](C)=O	0	N	44	47			-0.4	-0.4			DeoC, GlyA4, PhnX, TX_ACAL	
ACCOA	ACETYL-COA	accoa	C00024	72-89-9	2093	B04621	15351	ACO	C00007259			Acetyl-CoA	{3-[(2-{[2-(acetylsulfanyl)ethyl]carbamoyl}ethyl)carbamoyl]-3-hydroxy-2,2-dimethylpropyl} ({[5-(6-aminopurin-9-yl)-4-hydroxy-3-(phosphonatooxy)oxolan-2-yl]methyl phosphonato}oxy)phosphonate	{3-[(2-{[2-(acetylsulfanyl)ethyl]carbamoyl}ethyl)carbamoyl]-3-hydroxy-2,2-dimethylpropyl} ({[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonatooxy)oxolan-2-yl]methyl phosphonato}oxy)phosphonate	vitamin	CoA derivative	C23H34N7O17P3S1	CC(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP([O-])(=O)OP([O-])(=O)OCC1OC(C(O)C1OP([O-])([O-])=O)N1C=NC2=C1N=CN=C2N	-4	N	806	621		2.1	-7.2	-12.0			AceE, Pta	
acetamide	ACETAMIDE		C06244		8144445		27856					acetamide 	acetamide	acetamide	damaging agent		C2H5N1O1	CC(=O)N	0	N	59	58		7.7	-1.0	-1.0			DNADamage_AD_carbamoylmethyl6AD_acetamide	
acriflavine			C11273		156632		383703					Acriflavine	3,6-diamino-10-methylacridin-10-ium	3,6-diamino-10-methylacridin-10-ium	antibiotic	acridine	C14H14N3	C[N+]1=C2C=C(C=CC2=CC3=C1C=C(C=C3)N)N	1	N	224	206			-2.8	-2.8			TX_NormM_acriflavine	DNA intercalator [PUB_0847].
ACTP	ACETYL-P	actp	C00227		3527	B00063	15350	UVW	C00019559			Acetyl phosphate	acetyl phosphate	(acetyloxy)phosphonate			C2H3O5P1	CC(=O)OP([O-])([O-])=O	-2	N	138	96			-0.9	-4.2			AckA, Pta	
AD	ADENINE	ade	C00147	73-24-5	3447	B00041	16708	ADE	C00001490			adenine	adenine	7H-purin-6-amine	nucleobase		C5H5N5	C1=NC2=C(N1)C(=NC=N2)N	0	N	135	107		7.8	-0.6	-0.6			Apt, DeoD2, DeoD5, DNADamage_AD_carbamoylmethyl6AD_acetamide, DNADamage_AD_e1AD_DES, DNADamage_AD_e1AD_EMS, DNADamage_AD_e1AD_ENU, DNADamage_AD_e3AD_DES, DNADamage_AD_e3AD_EMS, DNADamage_AD_e3AD_ENU, DNADamage_AD_e6AD_DES, DNADamage_AD_e6AD_EMS, DNADamage_AD_e6AD_ENU, DNADamage_AD_e7AD_DES, DNADamage_AD_e7AD_EMS, DNADamage_AD_e7AD_ENU, DNADamage_AD_epsilon1N6AD_chloroethylene_oxide, DNADamage_AD_FAPyAD_hydroxyl_radical, DNADamage_AD_m1AD_MMS, DNADamage_AD_m1AD_MMSO4, DNADamage_AD_m1AD_MNNG, DNADamage_AD_m1AD_MNU, DNADamage_AD_m3AD_MMS, DNADamage_AD_m3AD_MMSO4, DNADamage_AD_m3AD_MNNG, DNADamage_AD_m3AD_MNU, DNADamage_AD_m6AD_CH3, DNADamage_AD_m7AD_MMS, DNADamage_AD_m7AD_MMSO4, DNADamage_AD_m7AD_MNNG, DNADamage_AD_m7AD_MNU, DNADamage_AD_n2AD_NH3, DNADamage_AD_oxo2AD_hydroxyl_radical, DNADamage_AD_oxo8AD_hydroxyl_radical, DNADamage_SpontaneousBaseDeamination_adenine, DNADamage_SpontaneousBaseLoss_adenine, DNA_RM_EcoD_Methylation, DNA_RM_MunI_Methylation, TX_AD, YicP	
ADN	ADENOSINE	adn	C00212	58-61-7	3512	B01189	16335	ADN	C00007444			adenosine	adenosine	2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol	ribonucleoside		C10H13N5O4	C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O	0	N	267	216		8.8	-2.1	-2.1			AHCYSs, DeoD5, UshA_AMP	
ADP	ADP	adp	C00008	20398-34-9	3310	B01130	16761	ADP	C00019353			ADP	[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (phosphonatooxy)phosphonate	[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (phosphonatooxy)phosphonate	ribonucleotide diphosphate		C10H12N5O10P2	NC1=NC=NC2=C1N=CN2C1OC(COP([O-])(=O)OP([O-])([O-])=O)C(O)C1O	-3	N	424	299		2.7	-5.6	-7.6			AckA, Adk1, Adk2, Adk3, Adk4, ArcC, AtpA, ATPHs_DNAReplication_Helicase, ATPHs_DNASupercoiling_gyrase, ATPHs_DNASupercoiling_topoisomeraseIV, ATPHs_ProteinTranslocation_SecA, CholK, CmkA1, CmkA2, CmkB3, CoaE, Dak1, Dck, Dgk1, DnaA_reactivation, DNA_RM_EcoD_Restriction, FruK1, FruK2, FthC, FTHFS, GlpK, Gmk1, Gmk2, HR_junctionMigration, HR_strandExchange, MG502_Amidotransferase, MG_070_MONOMER_MODIFICATION_001, MG_070_MONOMER_MODIFICATION_002, MG_070_MONOMER_MODIFICATION_003, MG_070_MONOMER_MODIFICATION_004, MG_070_MONOMER_MODIFICATION_005, MG_166_MONOMER_MODIFICATION_001, MG_217_MONOMER_MODIFICATION_001, MG_273_MONOMER_MODIFICATION_001, MG_274_MONOMER_MODIFICATION_001, MG_282_MONOMER_MODIFICATION_001, MG_305_MONOMER_MODIFICATION_001, MG_305_MONOMER_MODIFICATION_002, MG_317_MONOMER_MODIFICATION_001, MG_317_MONOMER_MODIFICATION_002, MG_317_MONOMER_MODIFICATION_003, MG_317_MONOMER_MODIFICATION_004, MG_317_MONOMER_MODIFICATION_005, MG_328_MONOMER_MODIFICATION_001, MG_342_MONOMER_MODIFICATION_001, MG_377_MONOMER_MODIFICATION_001, MG_377_MONOMER_MODIFICATION_002, MG_377_MONOMER_MODIFICATION_003, MG_377_MONOMER_MODIFICATION_004, MG_377_MONOMER_MODIFICATION_005, MG_377_MONOMER_MODIFICATION_006, MG_377_MONOMER_MODIFICATION_007, MG_377_MONOMER_MODIFICATION_008, MG_377_MONOMER_MODIFICATION_009, MG_377_MONOMER_MODIFICATION_010, MG_377_MONOMER_MODIFICATION_011, MG_392_MONOMER_MODIFICATION_001, MG_392_MONOMER_MODIFICATION_002, MG_401_MONOMER_MODIFICATION_001, MG_401_MONOMER_MODIFICATION_002, MG_401_MONOMER_MODIFICATION_003, MG_401_MONOMER_MODIFICATION_004, MG_401_MONOMER_MODIFICATION_005, MG_401_MONOMER_MODIFICATION_006, MG_401_MONOMER_MODIFICATION_007, MG_401_MONOMER_MODIFICATION_008, MG_401_MONOMER_MODIFICATION_009, MG_407_MONOMER_MODIFICATION_001, MG_407_MONOMER_MODIFICATION_002, MG_407_MONOMER_MODIFICATION_003, MG_427_MONOMER_MODIFICATION_001, MG_427_MONOMER_MODIFICATION_002, MG_438_MONOMER_MODIFICATION_001, MG_438_MONOMER_MODIFICATION_002, MG_438_MONOMER_MODIFICATION_003, MG_438_MONOMER_MODIFICATION_004, MG_438_MONOMER_MODIFICATION_005, MG_438_MONOMER_MODIFICATION_006, MG_438_MONOMER_MODIFICATION_007, MG_438_MONOMER_MODIFICATION_008, MG_438_MONOMER_MODIFICATION_009, MG_451_MONOMER_MODIFICATION_001, MG_451_MONOMER_MODIFICATION_002, MG_451_MONOMER_MODIFICATION_003, MG_460_MONOMER_MODIFICATION_001, MG_460_MONOMER_MODIFICATION_002, MG_460_MONOMER_MODIFICATION_003, MG_491_MONOMER_MODIFICATION_001, NadK, NADR2, NER_DNAExcision, NER_DNAIncision, NrdEF_ADP, PcbX, PfkA1, Pgk1, PncB, ProteinDegradation_FtsH_ALA, ProteinDegradation_FtsH_ARG, ProteinDegradation_FtsH_ASN, ProteinDegradation_FtsH_ASP, ProteinDegradation_FtsH_CYS, ProteinDegradation_FtsH_GLN, ProteinDegradation_FtsH_GLU, ProteinDegradation_FtsH_GLY, ProteinDegradation_FtsH_HIS, ProteinDegradation_FtsH_ILE, ProteinDegradation_FtsH_LEU, ProteinDegradation_FtsH_LYS, ProteinDegradation_FtsH_MET, ProteinDegradation_FtsH_PHE, ProteinDegradation_FtsH_PRO, ProteinDegradation_FtsH_SER, ProteinDegradation_FtsH_THR, ProteinDegradation_FtsH_TRP, ProteinDegradation_FtsH_TYR, ProteinDegradation_FtsH_VAL, ProteinDegradation_Lon_ALA, ProteinDegradation_Lon_ARG, ProteinDegradation_Lon_ASN, ProteinDegradation_Lon_ASP, ProteinDegradation_Lon_CYS, ProteinDegradation_Lon_GLN, ProteinDegradation_Lon_GLU, ProteinDegradation_Lon_GLY, ProteinDegradation_Lon_HIS, ProteinDegradation_Lon_ILE, ProteinDegradation_Lon_LEU, ProteinDegradation_Lon_LYS, ProteinDegradation_Lon_MET, ProteinDegradation_Lon_PHE, ProteinDegradation_Lon_PRO, ProteinDegradation_Lon_SER, ProteinDegradation_Lon_THR, ProteinDegradation_Lon_TRP, ProteinDegradation_Lon_TYR, ProteinDegradation_Lon_VAL, PYDXK, Pyk_ADP, RibF1, RNACleavage_DeaD_AMP, RNACleavage_DeaD_CMP, RNACleavage_DeaD_GMP, RNACleavage_DeaD_UMP, Tdk1, Tdk2, ThiL, Tmk, TX_Cbi_Co, TX_Cbi_Ni, TX_GL, TX_GL3P, TX_GLNHPQ, TX_MdlB_doxorubicin, TX_MGTA_CA, TX_MGTA_CU, TX_MGTA_FE2, TX_MGTA_FE3, TX_MGTA_MG, TX_MGTA_MN, TX_MGTA_MOBD, TX_MGTA_ZN, TX_OppB_Ala, TX_OppB_Arg, TX_OppB_Asn, TX_OppB_Asp, TX_OppB_Cys, TX_OppB_Gln, TX_OppB_Glu, TX_OppB_Gly, TX_OppB_His, TX_OppB_Ile, TX_OppB_Leu, TX_OppB_Lys, TX_OppB_Met, TX_OppB_Phe, TX_OppB_Pro, TX_OppB_Ser, TX_OppB_Thr, TX_OppB_Trp, TX_OppB_Tyr, TX_OppB_Val, TX_PHNT, TX_PIUP1, TX_RIBUP, TX_SalX_nisin, TX_SO4, TX_SPMDUP1, TX_SPRDUP2, TX_SunT_nisin	
AEPP			C03557		6353	B00598	15573					2-aminoethylphosphonate	(2-aminoethyl)phosphonic acid	(2-aminoethyl)phosphonic acid			C2H8N1O3P1	C(CP(=O)(O)O)N	0	N	125	102		4.7	-3.1	-2.9			PhnW, TX_PHNT	
AHCYS	ADENOSYL-HOMO-CYS	ahcys	C00021	979-92-0	3323	B01134	25246222	SAH	C00007230			S-Adenosyl-L-homocysteine	2-aminio-4-({[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfanyl)butanoate	4-({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfanyl)-2-azaniumylbutanoate			C14H20N6O5S1	NC1=NC=NC2=C1N=CN2C1OC(CSCCC([NH3+])C([O-])=O)C(O)C1O	0	N	384	317		7.3	-4.2	-4.2			AHCYSs, DNA_RM_EcoD_Methylation, DNA_RM_MunI_Methylation, HCYSMT, MG471_MODIFICATION_001, MG472_MODIFICATION_001, MG484_MODIFICATION_001, MG484_MODIFICATION_002, MG485_MODIFICATION_001, MG486_MODIFICATION_001, MG487_MODIFICATION_001, MG488_MODIFICATION_001, MG490_MODIFICATION_001, MG492_MODIFICATION_001, MG497_MODIFICATION_001, MG501_MODIFICATION_001, MG504_MODIFICATION_001, MG508_MODIFICATION_001, MG509_MODIFICATION_001, MG510_MODIFICATION_001, MG511_MODIFICATION_001, MG512_MODIFICATION_001, MG514_MODIFICATION_001, MG519_MODIFICATION_001, MG519_MODIFICATION_002, MG523_MODIFICATION_001, MGrrnA16S_MODIFICATION_001, MGrrnA16S_MODIFICATION_003, MGrrnA16S_MODIFICATION_004, MGrrnA16S_MODIFICATION_005, MGrrnA16S_MODIFICATION_006, MGrrnA23S_MODIFICATION_004, MGrrnA23S_MODIFICATION_006	"Byproduct of DNA, RNA, and protein methylation by S-Adenosyl-L-methionine (AMET).
"
AHL_3OC12	CPD-10783		C11840		14002		607680					N-(3-Oxododecanoyl)homoserine lactone	3-oxo-N-(2-oxooxolan-3-yl)dodecanamide	3-oxo-N-(2-oxooxolan-3-yl)dodecanamide			C16H27N1O4	CCCCCCCCCC(=O)CC(=O)NC1CCOC1=O	0	N	297	298		3.8	3.0	3.0				P. aeruginosa LasR (LuxR homolog) agonist [PUB_0209]
AHL_3OC6	CPD-10780		C11839		14001		116841					N-(3-Oxohexanoyl)homoserine lactone	3-oxo-N-(2-oxooxolan-3-yl)hexanamide	3-oxo-N-(2-oxooxolan-3-yl)hexanamide			C10H15N1O4	CCCC(CC(=O)NC1CCOC1=O)=O	0	N	213	196		3.8	0.3	0.3				V. fischeri LuxR agonist [PUB_0209]
AKG	2-KETOGLUTARATE	akg	C00026	328-50-7	3328	B00008	30915	AKG	C00000769			2-Oxoglutarate	α-ketoglutarate	2-oxopentanedioate			C5H4O5	[O-]C(=O)CCC(=O)C([O-])=O	-2	N	144	115			-0.1	-6.7			AspC1, AspC2, AspC3, TX_AKG	
ALA	L-ALPHA-ALANINE	ala-L	C00041	56-41-7	3343	B00011	16977	ALA	C00001332			L-alanine	alanine	2-aminopropanoic acid	amino acid		C3H7N1O2	C(=O)(O)C(C)N	0	N	89	85		6.0	-3.0	-3.0			Apts_Ala, CsdA, GlyA2, MG471_Aminoacylation, MG_0004_Aminoacylation, PeptidylTRNAHs_ALA, ProteinDegradation_FtsH_ALA, ProteinDegradation_Lon_ALA, ProteinPolymerization_ALA	
AlaAla					6197512							L-alanyl-L-alanine	ala-ala	2-(2-aminopropanamido)propanoic acid	dipeptide		C6H12N2O3	CC(C(=O)NC(C)C(=O)O)N	0	N	160	150		6.2	-3.8	-3.8			Apts_Ala, ProteinDegradation_FtsH_ALA, ProteinDegradation_Lon_ALA, ProteinPolymerization_ALA, TX_OppB_Ala	
AMET	S-ADENOSYLMETHIONINE	29908-03-0,	C00019	29908-03-0	3321	B04620		SAM	C00007347			S-Adenosyl-L-methionine	2-aminio-4-({[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)sulfaniumyl)butanoate	4-({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)sulfaniumyl)-2-azaniumylbutanoate	vitamin	non-standard amino acid	C15H23N6O5S1	C[S+](CCC([NH3+])C([O-])=O)CC1OC(C(O)C1O)N1C=NC2=C1N=CN=C2N	1	N	399	337		7.3	-5.4	-5.4			DNA_RM_EcoD_Methylation, DNA_RM_MunI_Methylation, HCYSMT, MetK, MG471_MODIFICATION_001, MG472_MODIFICATION_001, MG484_MODIFICATION_001, MG484_MODIFICATION_002, MG485_MODIFICATION_001, MG486_MODIFICATION_001, MG487_MODIFICATION_001, MG488_MODIFICATION_001, MG490_MODIFICATION_001, MG492_MODIFICATION_001, MG497_MODIFICATION_001, MG501_MODIFICATION_001, MG504_MODIFICATION_001, MG508_MODIFICATION_001, MG509_MODIFICATION_001, MG510_MODIFICATION_001, MG511_MODIFICATION_001, MG512_MODIFICATION_001, MG514_MODIFICATION_001, MG519_MODIFICATION_001, MG519_MODIFICATION_002, MG523_MODIFICATION_001, MGrrnA16S_MODIFICATION_001, MGrrnA16S_MODIFICATION_003, MGrrnA16S_MODIFICATION_004, MGrrnA16S_MODIFICATION_005, MGrrnA16S_MODIFICATION_006, MGrrnA23S_MODIFICATION_004, MGrrnA23S_MODIFICATION_006	Methyl donor to DNA, RNA, protein.
aminodimethylaniline	CPD0-1148		C04203		6876		15783					N,N'-dimethyl-p-phenylenediamine	1-N,1-N-dimethylbenzene-1,4-diamine	1-N,1-N-dimethylbenzene-1,4-diamine			C8H12N2	CN(C)C1=CC=C(C=C1)N	0	N	136	140			1.3	1.1			AzoR	
AMP	AMP	amp	C00020	61-19-8	3322	B01133	16027	A	C00019347			AMP	[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	ribonucleotide monophosphate		C10H12N5O7P1	NC1=NC=NC2=C1N=CN2C1OC(COP([O-])([O-])=O)C(O)C1O	-2	N	345	256		3.9	-5.2	-5.6			Aas1, Aas2, Aas3, Aas4, Aas5, Aas6, Aas7, Adk1, Adk2, Adk3, Apt, BPNT, DNALigation, DNAPrimerPolymerization_ATP, DNA_ligation_repair, HinT_AMP_Lysine_MG132, HinT_AMP_Mor_MG132, HinT_AMP_NH2_MG132, MG471_Aminoacylation, MG471_MODIFICATION_003, MG472_Aminoacylation, MG472_MODIFICATION_002, MG475_Aminoacylation, MG475_MODIFICATION_001, MG479_Aminoacylation, MG479_MODIFICATION_001, MG483_Aminoacylation, MG483_MODIFICATION_002, MG484_Aminoacylation, MG484_MODIFICATION_003, MG485_Aminoacylation, MG485_MODIFICATION_002, MG486_Aminoacylation, MG486_MODIFICATION_002, MG486_MODIFICATION_004, MG487_Aminoacylation, MG487_MODIFICATION_002, MG488_Aminoacylation, MG488_MODIFICATION_003, MG489_Aminoacylation, MG489_MODIFICATION_001, MG490_Aminoacylation, MG490_MODIFICATION_002, MG492_Aminoacylation, MG492_MODIFICATION_002, MG493_Aminoacylation, MG493_MODIFICATION_001, MG495_Aminoacylation, MG495_MODIFICATION_002, MG496_Aminoacylation, MG496_MODIFICATION_001, MG497_Aminoacylation, MG497_MODIFICATION_002, MG499_Aminoacylation, MG499_MODIFICATION_001, MG500_Aminoacylation, MG500_MODIFICATION_002, MG501_Aminoacylation, MG501_MODIFICATION_002, MG501_MODIFICATION_005, MG502_Aminoacylation, MG502_MODIFICATION_001, MG502_MODIFICATION_004, MG503_Aminoacylation, MG503_MODIFICATION_002, MG504_Aminoacylation, MG504_MODIFICATION_003, MG506_Aminoacylation, MG506_MODIFICATION_001, MG507_Aminoacylation, MG507_MODIFICATION_001, MG508_Aminoacylation, MG508_MODIFICATION_003, MG509_Aminoacylation, MG509_MODIFICATION_003, MG510_Aminoacylation, MG510_MODIFICATION_003, MG511_Aminoacylation, MG511_MODIFICATION_002, MG512_Aminoacylation, MG512_MODIFICATION_003, MG513_Aminoacylation, MG513_MODIFICATION_001, MG513_MODIFICATION_003, MG514_Aminoacylation, MG514_MODIFICATION_002, MG518_Aminoacylation, MG518_MODIFICATION_002, MG519_Aminoacylation, MG519_MODIFICATION_003, MG520_Aminoacylation, MG520_MODIFICATION_001, MG523_Aminoacylation, MG523_MODIFICATION_002, MGrrnA16S_MODIFICATION_003, MGrrnA16S_MODIFICATION_005, MG_0004_Aminoacylation, MG_272_MONOMER_MODIFICATION_001, NadE, PeptidylTRNAHs_ALA, PeptidylTRNAHs_ARG, PeptidylTRNAHs_ASN, PeptidylTRNAHs_ASP, PeptidylTRNAHs_CYS, PeptidylTRNAHs_FMET, PeptidylTRNAHs_GLN, PeptidylTRNAHs_GLU, PeptidylTRNAHs_GLY, PeptidylTRNAHs_HIS, PeptidylTRNAHs_ILE, PeptidylTRNAHs_LEU, PeptidylTRNAHs_LYS, PeptidylTRNAHs_MET, PeptidylTRNAHs_PHE, PeptidylTRNAHs_PRO, PeptidylTRNAHs_SER, PeptidylTRNAHs_THR, PeptidylTRNAHs_TRP, PeptidylTRNAHs_TYR, PeptidylTRNAHs_VAL, PrsA, RelA1, RelA2, RNACleavage_DeaD_AMP, RNACleavage_RNAseIII_AMP, RNACleavage_RNAseJ_AMP, RNACleavage_RNAseP_AMP, RNACleavage_RNAseR_AMP, RNACleavage_RsgA_AMP, RnaPolymerization_ATP, TMDPK, UshA_AMP	
AMP_ALA					85239785							L-alanyl-AMP					C13H17N6O8P1	CC(N)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	416								PeptidylTRNAHs_ALA	
AMP_ARG												L-Arginyl-AMP					C16H26N9O8P1	NC(=[NH2+])NCCCC([NH3+])C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-1	N	503								PeptidylTRNAHs_ARG	
AMP_ASN												L-Asparagyl-AMP					C14H18N7O9P1	NC(CC(N)=O)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	459								PeptidylTRNAHs_ASN	
AMP_ASP												L-Aspartyl-AMP					C14H16N6O10P1	NC(CC([O-])=O)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-3	N	459								PeptidylTRNAHs_ASP	
AMP_CYS												L-Cysteinyl-AMP					C13H17N6O8P1S1	NC(CS)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	448								PeptidylTRNAHs_CYS	
AMP_FMET												N-Formyl-L-methionine-AMP					C16H21N6O9P1S1	CSCCC(NC=O)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-3	N	504								PeptidylTRNAHs_FMET	
AMP_GLN												L-glutaminyl-AMP					C15H20N7O9P1	NC(CCC(N)=O)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	473								PeptidylTRNAHs_GLN	
AMP_GLU	CPD-9993				57389065							L-Glutamatyl-AMP					C15H19N6O10P1	NC1=NC=NC2=C1N=CN2C1OC(COP([O-])([O-])=O)C(OC(=O)C([NH3+])CCC([O-])=O)C1O	-3	N	474								PeptidylTRNAHs_GLU	
AMP_GLY												glycyl-AMP					C12H15N6O8P1	NCC(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	402								PeptidylTRNAHs_GLY	
AMP_HIS												L-Histidyl-AMP					C16H19N8O8P1	NC(CC1=CNC=N1)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	482								PeptidylTRNAHs_HIS	
AMP_ILE												L-Isoleucyl-AMP					C16H23N6O8P1	CCC(C)C(N)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	458								PeptidylTRNAHs_ILE	
AMP_LEU												L-Leucyl-AMP					C16H23N6O8P1	CC(C)CC(N)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	458								PeptidylTRNAHs_LEU	
AMP_LYS					85239786							L-Lysyl-AMP					C16H25N7O8P1	NC(CCCC[NH3+])C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-1	N	474								PeptidylTRNAHs_LYS	
AMP_Lysine												AMP-Lysine	[(5-aminio-5-carboxypentyl)amino]({[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinate	{[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[(5-azaniumyl-5-carboxypentyl)amino]phosphinate	modified ribonucleotide monophosphate		C16H26N7O8P1	NC1=NC=NC2=C1N=CN2C1OC(COP([O-])(=O)NCCCCC([NH3+])C(O)=O)C(O)C1O	-1	N	475	389		4.3	-6.8	-7.4			HinT_AMP_Lysine_MG132	
AMP_MET												L-Methionyl-AMP					C15H21N6O8P1S1	CSCCC(N)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	476								PeptidylTRNAHs_MET	
AMP_Mor												AMP-morpholidate	[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl morpholin-4-ium-4-phosphonate	[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl morpholin-4-ium-4-phosphonate	modified ribonucleotide monophosphate		C14H21N6O7P1	NC1=NC=NC2=C1N=CN2C1OC(COP([O-])(=O)[NH+]2CCOCC2)C(O)C1O	-1	N	416	332		4.2	-4.6	-4.9			HinT_AMP_Mor_MG132	
AMP_NH2												AMP-NH2	aminio({[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinate	{[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(azaniumyl)phosphinate	modified ribonucleotide monophosphate		C10H15N6O6P1	NC1=NC=NC2=C1N=CN2C1OC(COP([NH3+])([O-])=O)C(O)C1O	-1	N	346	264		4.3	-4.6	-5.2			HinT_AMP_NH2_MG132	
AMP_PHE												L-phenylalanyl-AMP					C19H21N6O8P1	NC(CC1=CC=CC=C1)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	492								PeptidylTRNAHs_PHE	
AMP_PRO												L-Prolyl-AMP					C15H19N6O8P1	NC1=NC=NC2=C1N=CN2C1OC(COP([O-])([O-])=O)C(OC(=O)C2CCCN2)C1O	-2	N	442								PeptidylTRNAHs_PRO	
AMP_SER	SERYL-AMP				3172							L-Seryl-AMP					C13H17N6O9P1	NC(CO)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	432								PeptidylTRNAHs_SER	
AMP_THR	CPD-9994				57389934							L-Threonyl-AMP					C14H19N6O9P1	CC(O)C(N)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	446								PeptidylTRNAHs_THR	
AMP_TRP												L-tryptophanyl-AMP					C21H22N7O8P1	NC(CC1=CNC2=C1C=CC=C2)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	531								PeptidylTRNAHs_TRP	
AMP_TYR												L-tyrosyl-AMP					C19H21N6O9P1	NC(CC1=CC=C(O)C=C1)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	508								PeptidylTRNAHs_TYR	
AMP_VAL												L-Valyl-AMP					C15H21N6O8P1	CC(C)C(N)C(=O)OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CN=C2N	-2	N	444								PeptidylTRNAHs_VAL	
anthranilate			C00108		3408		30754					2-aminobenzoic acid	anthranilate	2-aminobenzoate	antibiotic		C7H6N1O2	NC1=CC=CC=C1C([O-])=O	-1	N	136	118		3.3	1.5	-1.0			AzoR	
ApAp												Ap-Ap	5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 5-(6-aminopurin-9-yl)-4-hydroxy-2-[(phosphonatooxy)methyl]oxolan-3-yl phosphate	5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-[(phosphonatooxy)methyl]oxolan-3-yl phosphate			C20H23N10O13P2	NC1=NC=NC2=C1N=CN2C1OC(COP([O-])(=O)OC2C(COP([O-])([O-])=O)OC(C2O)N2C=NC3=C2N=CN=C3N)C(O)C1O	-3	N	673								DNAPrimerPolymerization_ATP, RNACleavage_DeaD_AMP, RNACleavage_RNAseIII_AMP, RNACleavage_RNAseJ_AMP, RNACleavage_RNAseP_AMP, RNACleavage_RNAseR_AMP, RNACleavage_RsgA_AMP, RnaPolymerization_ATP	
ARG	ARG	arg-L	C00062	74-79-3	3362	B01143	16467	ARG	C00001340			L-Arginine	argininium	5-{[amino(iminiumyl)methyl]amino}-2-azaniumylpentanoate	amino acid		C6H15N4O2	NC(=[NH2+])NCCCC([NH3+])C([O-])=O	1	N	175	165	2.2	10.8	-4.3	-6.0			Adi, Apts_Arg, MG492_Aminoacylation, MG495_Aminoacylation, MG497_Aminoacylation, MG523_Aminoacylation, PeptidylTRNAHs_ARG, ProteinDegradation_FtsH_ARG, ProteinDegradation_Lon_ARG, ProteinPolymerization_ARG	
ArgArg				15483-27-9 	77638054							L-arginyl-L-arginine	2-(2-aminio-5-{[amino(iminio)methyl]amino}pentanamido)-5-{[amino(iminio)methyl]amino}pentanoate	5-{[amino(iminiumyl)methyl]amino}-2-(5-{[amino(iminiumyl)methyl]amino}-2-azaniumylpentanamido)pentanoate	dipeptide		C12H28N8O3	NC(=[NH2+])NCCCC([NH3+])C(=O)NC(CCCNC(N)=[NH2+])C([O-])=O	2	N	332	310		12.1	-6.3	-9.1			Apts_Arg, ProteinDegradation_FtsH_ARG, ProteinDegradation_Lon_ARG, ProteinPolymerization_ARG, TX_OppB_Arg	
ASN	ASN	asn-L	C00152	70-47-3	3452	B00043	17196	ASN	C00001341			L-Asparagine	asparagine	2-amino-3-carbamoylpropanoic acid	amino acid		C4H8N2O3	C(=O)(O)C(N)CC(N)=O	0	N	132	115	2.0	5.2	-4.4	-4.4			Apts_Asn, MG514_Aminoacylation, PeptidylTRNAHs_ASN, ProteinDegradation_FtsH_ASN, ProteinDegradation_Lon_ASN, ProteinPolymerization_ASN	
AsnAsn					28724627							L-asparaginyl-L-asparagine	2-(2-amino-3-carbamoylpropanamido)-3-carbamoylpropanoic acid	2-(2-amino-3-carbamoylpropanamido)-3-carbamoylpropanoic acid	dipeptide		C8H14N4O5	C(C(C(=O)NC(CC(=O)N)C(=O)O)N)C(=O)N	0	N	246	210		5.5	-6.7	-6.9			Apts_Asn, ProteinDegradation_FtsH_ASN, ProteinDegradation_Lon_ASN, ProteinPolymerization_ASN, TX_OppB_Asn	
ASP	L-ASPARTATE	asp-L	C00049	56-84-8	3351	B00015	17053	ASP	C00001342			L-Aspartate	3-amino-3-carboxypropanoate	3-amino-3-carboxypropanoate	amino acid		C4H6N1O4	NC(CC([O-])=O)C(O)=O	-1	N	132	110		3.4	-3.6	-5.7			Apts_Asp, AspC1, MG489_Aminoacylation, PeptidylTRNAHs_ASP, ProteinDegradation_FtsH_ASP, ProteinDegradation_Lon_ASP, ProteinPolymerization_ASP	
AspAsp					10306892							L-aspartyl-L-aspartic Acid	3-amino-3-[(1-carboxy-2-carboxylatoethyl)carbamoyl]propanoate	3-amino-3-[(1-carboxy-2-carboxylatoethyl)carbamoyl]propanoate	dipeptide		C8H10N2O7	NC(CC([O-])=O)C(=O)NC(CC([O-])=O)C(O)=O	-2	N	246	200		3.2	-5.2	-10.4			Apts_Asp, ProteinDegradation_FtsH_ASP, ProteinDegradation_Lon_ASP, ProteinPolymerization_ASP, TX_OppB_Asp	
ATP	ATP	atp	C00002	56-65-5	3304	B01125	15422	ATP	C00001491			ATP	({[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	ribonucleotide triphosphate		C10H12N5O13P3	NC1=NC=NC2=C1N=CN2C1OC(COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)C(O)C1O	-3	N	503	341		2.3	-6.4	-10.4			Aas1, Aas2, Aas3, Aas4, Aas5, Aas6, Aas7, AckA, Adk1, Adk4, ArcC, AtpA, ATPHs_ChromosomeCondensation_SMC, ATPHs_DNAReplication_Helicase, ATPHs_DNASupercoiling_gyrase, ATPHs_DNASupercoiling_topoisomeraseIV, ATPHs_ProteinTranslocation_SecA, CholK, CmkA1, CmkA2, CmkB3, CoaE, Dak1, Dck, Dgk1, diadenylate_cyclase, DnaA_activation, DnaA_reactivation, DNAPrimerPolymerization_ATP, DNA_RM_EcoD_Restriction, FruK1, FruK2, FthC, FTHFS, GlpK, Gmk1, Gmk2, HR_junctionMigration, HR_strandExchange, LplA, MetK, MG471_Aminoacylation, MG471_MODIFICATION_003, MG472_Aminoacylation, MG472_MODIFICATION_002, MG475_Aminoacylation, MG475_MODIFICATION_001, MG479_Aminoacylation, MG479_MODIFICATION_001, MG483_Aminoacylation, MG483_MODIFICATION_002, MG484_Aminoacylation, MG484_MODIFICATION_003, MG485_Aminoacylation, MG485_MODIFICATION_002, MG486_Aminoacylation, MG486_MODIFICATION_002, MG486_MODIFICATION_004, MG487_Aminoacylation, MG487_MODIFICATION_002, MG488_Aminoacylation, MG488_MODIFICATION_003, MG489_Aminoacylation, MG489_MODIFICATION_001, MG490_Aminoacylation, MG490_MODIFICATION_002, MG492_Aminoacylation, MG492_MODIFICATION_002, MG493_Aminoacylation, MG493_MODIFICATION_001, MG495_Aminoacylation, MG495_MODIFICATION_002, MG496_Aminoacylation, MG496_MODIFICATION_001, MG497_Aminoacylation, MG497_MODIFICATION_002, MG499_Aminoacylation, MG499_MODIFICATION_001, MG500_Aminoacylation, MG500_MODIFICATION_002, MG501_Aminoacylation, MG501_MODIFICATION_002, MG501_MODIFICATION_005, MG502_Amidotransferase, MG502_Aminoacylation, MG502_MODIFICATION_001, MG502_MODIFICATION_004, MG503_Aminoacylation, MG503_MODIFICATION_002, MG504_Aminoacylation, MG504_MODIFICATION_003, MG506_Aminoacylation, MG506_MODIFICATION_001, MG507_Aminoacylation, MG507_MODIFICATION_001, MG508_Aminoacylation, MG508_MODIFICATION_003, MG509_Aminoacylation, MG509_MODIFICATION_003, MG510_Aminoacylation, MG510_MODIFICATION_003, MG511_Aminoacylation, MG511_MODIFICATION_002, MG512_Aminoacylation, MG512_MODIFICATION_003, MG513_Aminoacylation, MG513_MODIFICATION_001, MG513_MODIFICATION_003, MG514_Aminoacylation, MG514_MODIFICATION_002, MG518_Aminoacylation, MG518_MODIFICATION_002, MG519_Aminoacylation, MG519_MODIFICATION_003, MG520_Aminoacylation, MG520_MODIFICATION_001, MG523_Aminoacylation, MG523_MODIFICATION_002, MG_0004_Aminoacylation, MG_070_MONOMER_MODIFICATION_001, MG_070_MONOMER_MODIFICATION_002, MG_070_MONOMER_MODIFICATION_003, MG_070_MONOMER_MODIFICATION_004, MG_070_MONOMER_MODIFICATION_005, MG_166_MONOMER_MODIFICATION_001, MG_217_MONOMER_MODIFICATION_001, MG_273_MONOMER_MODIFICATION_001, MG_274_MONOMER_MODIFICATION_001, MG_282_MONOMER_MODIFICATION_001, MG_305_MONOMER_MODIFICATION_001, MG_305_MONOMER_MODIFICATION_002, MG_317_MONOMER_MODIFICATION_001, MG_317_MONOMER_MODIFICATION_002, MG_317_MONOMER_MODIFICATION_003, MG_317_MONOMER_MODIFICATION_004, MG_317_MONOMER_MODIFICATION_005, MG_328_MONOMER_MODIFICATION_001, MG_342_MONOMER_MODIFICATION_001, MG_377_MONOMER_MODIFICATION_001, MG_377_MONOMER_MODIFICATION_002, MG_377_MONOMER_MODIFICATION_003, MG_377_MONOMER_MODIFICATION_004, MG_377_MONOMER_MODIFICATION_005, MG_377_MONOMER_MODIFICATION_006, MG_377_MONOMER_MODIFICATION_007, MG_377_MONOMER_MODIFICATION_008, MG_377_MONOMER_MODIFICATION_009, MG_377_MONOMER_MODIFICATION_010, MG_377_MONOMER_MODIFICATION_011, MG_392_MONOMER_MODIFICATION_001, MG_392_MONOMER_MODIFICATION_002, MG_401_MONOMER_MODIFICATION_001, MG_401_MONOMER_MODIFICATION_002, MG_401_MONOMER_MODIFICATION_003, MG_401_MONOMER_MODIFICATION_004, MG_401_MONOMER_MODIFICATION_005, MG_401_MONOMER_MODIFICATION_006, MG_401_MONOMER_MODIFICATION_007, MG_401_MONOMER_MODIFICATION_008, MG_401_MONOMER_MODIFICATION_009, MG_407_MONOMER_MODIFICATION_001, MG_407_MONOMER_MODIFICATION_002, MG_407_MONOMER_MODIFICATION_003, MG_427_MONOMER_MODIFICATION_001, MG_427_MONOMER_MODIFICATION_002, MG_438_MONOMER_MODIFICATION_001, MG_438_MONOMER_MODIFICATION_002, MG_438_MONOMER_MODIFICATION_003, MG_438_MONOMER_MODIFICATION_004, MG_438_MONOMER_MODIFICATION_005, MG_438_MONOMER_MODIFICATION_006, MG_438_MONOMER_MODIFICATION_007, MG_438_MONOMER_MODIFICATION_008, MG_438_MONOMER_MODIFICATION_009, MG_451_MONOMER_MODIFICATION_001, MG_451_MONOMER_MODIFICATION_002, MG_451_MONOMER_MODIFICATION_003, MG_460_MONOMER_MODIFICATION_001, MG_460_MONOMER_MODIFICATION_002, MG_460_MONOMER_MODIFICATION_003, MG_491_MONOMER_MODIFICATION_001, NADD1, NADD2, NadE, NadK, NADR1, NADR2, NER_DNAExcision, NER_DNAIncision, PcbX, PfkA1, Pgk1, PncB, ProteinDegradation_FtsH_ALA, ProteinDegradation_FtsH_ARG, ProteinDegradation_FtsH_ASN, ProteinDegradation_FtsH_ASP, ProteinDegradation_FtsH_CYS, ProteinDegradation_FtsH_GLN, ProteinDegradation_FtsH_GLU, ProteinDegradation_FtsH_GLY, ProteinDegradation_FtsH_HIS, ProteinDegradation_FtsH_ILE, ProteinDegradation_FtsH_LEU, ProteinDegradation_FtsH_LYS, ProteinDegradation_FtsH_MET, ProteinDegradation_FtsH_PHE, ProteinDegradation_FtsH_PRO, ProteinDegradation_FtsH_SER, ProteinDegradation_FtsH_THR, ProteinDegradation_FtsH_TRP, ProteinDegradation_FtsH_TYR, ProteinDegradation_FtsH_VAL, ProteinDegradation_Lon_ALA, ProteinDegradation_Lon_ARG, ProteinDegradation_Lon_ASN, ProteinDegradation_Lon_ASP, ProteinDegradation_Lon_CYS, ProteinDegradation_Lon_GLN, ProteinDegradation_Lon_GLU, ProteinDegradation_Lon_GLY, ProteinDegradation_Lon_HIS, ProteinDegradation_Lon_ILE, ProteinDegradation_Lon_LEU, ProteinDegradation_Lon_LYS, ProteinDegradation_Lon_MET, ProteinDegradation_Lon_PHE, ProteinDegradation_Lon_PRO, ProteinDegradation_Lon_SER, ProteinDegradation_Lon_THR, ProteinDegradation_Lon_TRP, ProteinDegradation_Lon_TYR, ProteinDegradation_Lon_VAL, PrsA, PYDXK, Pyk_ADP, RelA1, RelA2, RibF1, RibF2, RNACleavage_DeaD_AMP, RNACleavage_DeaD_CMP, RNACleavage_DeaD_GMP, RNACleavage_DeaD_UMP, RnaPolymerization_ATP, Tdk1, Tdk2, ThiL, TMDPK, Tmk, TX_Cbi_Co, TX_Cbi_Ni, TX_GL, TX_GL3P, TX_GLNHPQ, TX_MdlB_doxorubicin, TX_MGTA_CA, TX_MGTA_CU, TX_MGTA_FE2, TX_MGTA_FE3, TX_MGTA_MG, TX_MGTA_MN, TX_MGTA_MOBD, TX_MGTA_ZN, TX_OppB_Ala, TX_OppB_Arg, TX_OppB_Asn, TX_OppB_Asp, TX_OppB_Cys, TX_OppB_Gln, TX_OppB_Glu, TX_OppB_Gly, TX_OppB_His, TX_OppB_Ile, TX_OppB_Leu, TX_OppB_Lys, TX_OppB_Met, TX_OppB_Phe, TX_OppB_Pro, TX_OppB_Ser, TX_OppB_Thr, TX_OppB_Trp, TX_OppB_Tyr, TX_OppB_Val, TX_PHNT, TX_PIUP1, TX_RIBUP, TX_SalX_nisin, TX_SO4, TX_SPMDUP1, TX_SPRDUP2, TX_SunT_nisin	
aza6dT				13410-30-5	9400071							6-aza-2'-deoxythymidine	2-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-methyl-4H-1,2,4-triazine-3,5-dione	2-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-methyl-2,3,4,5-tetrahydro-1,2,4-triazine-3,5-dione	modified deoxyribonucleoside		C9H13N3O5	CC1=NN(C(=O)NC1=O)C2CC(C(O2)CO)O	0	N	243	201		2.5	-1.5	-1.6			TX_aza6dT, UshA_aza6dTMP	
aza6dTMP												6-aza-2'-deoxythymidine monophosphate	[3-hydroxy-5-(6-methyl-3,5-dioxo-4H-1,2,4-triazin-2-yl)oxolan-2-yl]methyl phosphate	[3-hydroxy-5-(6-methyl-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazin-2-yl)oxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C9H12N3O8P1	CC1=NN(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)NC1=O	-2	N	321	242			-1.6	-5.1			UshA_aza6dTMP	
aza6THY					8193699							6-aza-thymine	6-azathymine	6-methyl-2,3,4,5-tetrahydro-1,2,4-triazine-3,5-dione	modified nucleobase		C4H5N3O2	CC1=NNC(=O)NC1=O	0	N	127	101		1.4	-0.9	-0.9				
aza8AD					56229750							8-aza-adenine	3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine	3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine	modified nucleobase		C4H4N6	NC1=NC=NC2=C1N=NN2	0	N	136	103		6.9	-0.5	-1.4				
aza8dA					85351322		151803					8-aza-2'-deoxyadenosine	5-{7-amino-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl}-2-(hydroxymethyl)oxolan-3-ol	5-{7-amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl}-2-(hydroxymethyl)oxolan-3-ol	modified deoxyribonucleoside		C9H12N6O3	C1C(C(OC1N2C3=C(C(=NC=N3)N)N=N2)CO)O	0	N	252	203		9.0	-1.3	-1.3			TX_aza8dA, UshA_aza8dAMP	
aza8dAMP												8-aza-2'-deoxyadenosine monophosphate	(5-{7-amino-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl}-3-hydroxyoxolan-2-yl)methyl phosphate	(5-{7-amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl}-3-hydroxyoxolan-2-yl)methyl phosphate	modified deoxyribonucleotide monophosphate		C9H11N6O6P1	NC1=NC=NC2=C1N=NN2C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	330	243		2.7	-4.2	-4.7			UshA_aza8dAMP	
azithromycin			C06838	83905-01-5	46507743		2955					azithromycin			antibiotic	macrolide	C38H72N2O12	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)C(C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O	0	N	749									Binds to the 50S subunit of the 70S bacterial ribosomes, inhibiting RNA-dependent protein synthesis [PUB_0847].
benzalkonium			C08037		87249495		545858					Benzalkonium	benzyldimethyltridecylazanium	benzyldimethyltridecylazanium	antibiotic		C22H40N1	CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1	1	N	319	371			3.1	3.1			TX_NormM_benzalkonium	
berberine			C00757		4019		16118					Berberine	16,17-dimethoxy-5,7-dioxa-13$l^{5}-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{15,20}]henicosa-1(13),2,4(8),9,14,16,18,20-octaen-13-ylium	16,17-dimethoxy-5,7-dioxa-13$l^{5}-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{15,20}]henicosa-1(13),2,4(8),9,14,16,18,20-octaen-13-ylium	antibiotic		C20H18N1O4	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	1	N	336	293			-1.3	-1.3			TX_NormM_berberine	
BUT				107-92-6	264							butyric acid, butanoic acid	butyric acid	butanoic acid			C4H8O2	O=C(O)CCC	-1	Y	88	90			0.9	-1.4			LIPASE_DIBUTYRIN_MG310, LIPASE_DIBUTYRIN_MG327, LIPASE_DIBUTYRIN_MG344, LIPASE_MONOBUTYRIN_MG310, LIPASE_MONOBUTYRIN_MG327, LIPASE_MONOBUTYRIN_MG344, LIPASE_TRIBUTYRIN_MG310, LIPASE_TRIBUTYRIN_MG327, LIPASE_TRIBUTYRIN_MG344	
butylene_glycol					85096732		52682					1,2-Butylene glycol	1,2-butanediol	butane-1,2-diol	damaging agent		C4H10O2	CCC(CO)O	0	N	90	96		5.7	-0.3	-0.3			DNADamage_hm5U_dhpURA_butylene_glycol	
C23CMP	CPD-3713	23ccmp	C02354		5401	B01565						2',3'-Cyclic CMP	4-(4-amino-2-oxopyrimidin-1-yl)-6-(hydroxymethyl)-2-oxo-tetrahydro-1,3,5,2$l^{5}-furo[3,4-d][1,3,2$l^{5}]dioxaphosphol-2-olate	4-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-6-(hydroxymethyl)-2-oxo-tetrahydro-2H-1,3,5,2$l^{5}-furo[3,4-d][1,3,2$l^{5}]dioxaphosphol-2-olate	cyclic ribonucleotide monophosphate		C9H11N3O7P1	C1(=CC(N)=NC(=O)N1C3(OC(CO)C2(OP(=O)([O-])OC23)))	-1	N	304	224		1.2	-2.3	-4.4			CpdB2	
C3MP	CPD-3711	3cmp	C05822	63-37-6	8117	B01898	53013	C3P				3'-CMP	[5-(4-amino-2-oxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] phosphate	[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] phosphate	nucleoside 3'-phosphate 		C9H12N3O8P1	NC1=NC(=O)N(C=C1)C1OC(CO)C(OP([O-])([O-])=O)C1O	-2	N	321	241		0.7	-3.5	-6.6			CpdB2	
c5dU				14599-46-3	75707699							5-Carbouy-2'-deoxyuridine	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxo-3H-pyrimidine-5-carboxylic acid	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid	modified deoxyribonucleoside		C10H12N2O7	C1C(C(OC1N2C=C(C(=O)NC2=O)C(=O)O)CO)O	-1	N	272	217		0.0	-1.9	-5.4			TX_c5dU, UshA_c5dUMP	
c5dUMP												5-Carbouy-2'-deoxyuridine monophosphate	[5-(5-carboxy-2,4-dioxo-3H-pyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(5-carboxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C10H11N2O10P1	OC1CC(OC1COP([O-])([O-])=O)N1C=C(C(O)=O)C(=O)NC1=O	-3	N	350	257			-2.0	-8.8			UshA_c5dUMP	
c5URA			C03030		8144603		17477					5-Carbouyuracil	steviolbioside	2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid	modified nucleobase		C5H4N2O4	N1C=C(C(=O)NC1=O)C(=O)O	-1	N	156	117			-1.3	-4.7			DNADamage_f5URA_c5URA_hydroxyl_radical	
CA	CA+2	ca2	C00076	7440-70-2	3376		29108	CA				calcium ion	ca(2+)	calcium	ion		Ca1	[Ca++]	2	N	40	34			-0.6	-0.6			TX_MGTA_CA	
CAP		cbp	C00169		3469	B00050	17672	CP	C00007513			carbamoyl phosphate	(carbamoyloxy)phosphonate	(carbamoyloxy)phosphonate			C1H2N1O5P1	NC(=O)OP([O-])([O-])=O	-2	N	139	90			-1.2	-4.7			ArcC, ArgF, TX_CAP	
carbamoylmethyl6AD					85884570							N6-carbamoylmethyladenine	2-(9H-purin-6-ylamino)acetamide	2-(9H-purin-6-ylamino)acetamide	modified nucleobase		C7H8N6O1	NC(=O)CNC1=NC=NC2=C1N=CN2	0	N	192	155		7.5	-1.6	-1.6			DNADamage_AD_carbamoylmethyl6AD_acetamide	formed by E. coli Mu phage mom gene product [PUB_0478]; converts adenosine in consensus sequence [CG]A[GC]NPy [PUB_0478]; modification protects against host nucleases [PUB_0478];
carbamoylmethyl6dA					54051794							N6-carbamoylmethyl-2'-deoxyadenosine	2-({9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl}amino)acetamide	2-({9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}amino)acetamide	modified deoxyribonucleoside		C12H16N6O4	C1C(C(OC1N2C=NC3=C2N=CN=C3NCC(=O)N)CO)O	0	N	308	255		9.2	-2.2	-2.2			TX_carbamoylmethyl6dA, UshA_carbamoylmethyl6dAMP	formed by E. coli Mu phage mom gene product [PUB_0478]; converts adenosine in consensus sequence [CG]A[GC]NPy [PUB_0478]; modification protects against host nucleases [PUB_0478];
carbamoylmethyl6dAMP												N6-carbamoylmethyl-2'-deoxyadenosine monophosphate	(5-{6-[(carbamoylmethyl)amino]purin-9-yl}-3-hydroxyoxolan-2-yl)methyl phosphate	(5-{6-[(carbamoylmethyl)amino]-9H-purin-9-yl}-3-hydroxyoxolan-2-yl)methyl phosphate	modified deoxyribonucleotide monophosphate		C12H15N6O7P1	NC(=O)CNC1=NC=NC2=C1N=CN2C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	386	295		3.8	-5.3	-5.7			UshA_carbamoylmethyl6dAMP	
CDP	CDP	cdp	C00112	63-38-7	3412	B01162	17239	CDP				CDP	[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (phosphonatooxy)phosphonate	[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (phosphonatooxy)phosphonate	ribonucleotide diphosphate		C9H12N3O11P2	NC1=NC(=O)N(C=C1)C1OC(COP([O-])(=O)OP([O-])([O-])=O)C(O)C1O	-3	N	400	284		1.2	-3.6	-8.3			CmkA2, NrdEF_CDP, Pyk_CDP	
CDPDG120		cdpdddecg	C00269		3567					LMGP13010000		CDP-1,2-didodecanoylglycerol	[2,3-bis(dodecanoyloxy)propyl] ({[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	[2,3-bis(dodecanoyloxy)propyl] ({[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	lipid	glycerophospholipid, CDP-diacyl glycerol	C36H63N3O15P2	CCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OP([O-])(=O)OCC1OC(C(O)C1O)N1C=CC(N)=NC1=O)OC(=O)CCCCCCCCCCC	-2	Y	840	769		1.3	5.7	1.3			CdsA1	
CDPDG140		cdpdtdecg	C00269		3567					LMGP13010000		CDP-1,2-ditetradecanoylglycerol	[2,3-bis(tetradecanoyloxy)propyl] ({[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	[2,3-bis(tetradecanoyloxy)propyl] ({[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	lipid	glycerophospholipid, CDP-diacyl glycerol	C40H71N3O15P2	CCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OP([O-])(=O)OCC1OC(C(O)C1O)N1C=CC(N)=NC1=O)OC(=O)CCCCCCCCCCCCC	-2	Y	896	836		1.3	7.5	3.0			CdsA2	
CDPDG141		cdpdtdec7eg	C00269		3567					LMGP13010000		CDP-1,2-ditetradec-7-enoylglycerol	[2,3-bis(tetradec-7-enoyloxy)propyl] ({[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	[2,3-bis(tetradec-7-enoyloxy)propyl] ({[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	lipid	glycerophospholipid, CDP-diacyl glycerol	C40H67N3O15P2	CCCCCCC=CCCCCCC(=O)OCC(COP([O-])(=O)OP([O-])(=O)OCC1OC(C(O)C1O)N1C=CC(N)=NC1=O)OC(=O)CCCCCC=CCCCCCC	-2	Y	892	822		1.3	6.8	2.3			CdsA3	
CDPDG160		cdpdhdecg	C00269		3567					LMGP13010000		CDP-1,2-dihexadecanoylglycerol	[2,3-bis(hexadecanoyloxy)propyl] ({[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	[2,3-bis(hexadecanoyloxy)propyl] ({[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	lipid	glycerophospholipid, CDP-diacyl glycerol	C44H79N3O15P2	CCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OP([O-])(=O)OCC1OC(C(O)C1O)N1C=CC(N)=NC1=O)OC(=O)CCCCCCCCCCCCCCC	-2	Y	952	906		1.3	9.3	4.8			CdsA4, PgsA1	
CDPDG161		cdpdhdec9eg	C00269		3567					LMGP13010000		CDP-1,2-dihexadec-9-enoylglycerol	[2,3-bis(hexadec-9-enoyloxy)propyl] ({[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	[2,3-bis(hexadec-9-enoyloxy)propyl] ({[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	lipid	glycerophospholipid, CDP-diacyl glycerol	C44H75N3O15P2	CCCCCCC=CCCCCCCCC(=O)OCC(COP([O-])(=O)OP([O-])(=O)OCC1OC(C(O)C1O)N1C=CC(N)=NC1=O)OC(=O)CCCCCCCC=CCCCCCC	-2	Y	948	890		1.3	8.6	4.1			CdsA5, PgsA2	
CDPDG180		cdpdodecg	C00269		3567					LMGP13010000		CDP-1,2-dioctadecanoylglycerol	[2,3-bis(octadecanoyloxy)propyl] ({[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	[2,3-bis(octadecanoyloxy)propyl] ({[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	lipid	glycerophospholipid, CDP-diacyl glycerol	C48H87N3O15P2	CCCCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OP([O-])(=O)OCC1OC(C(O)C1O)N1C=CC(N)=NC1=O)OC(=O)CCCCCCCCCCCCCCCCC	-2	Y	1008	972		1.3	11.1	6.6			CdsA6	
CDPDG181		cdpdodec11eg	C00269		3567					LMGP13010000		CDP-1,2-dioctadec-11-enoylglycerol	[2,3-bis(octadec-11-enoyloxy)propyl] ({[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	[2,3-bis(octadec-11-enoyloxy)propyl] ({[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	lipid	glycerophospholipid, CDP-diacyl glycerol	C48H83N3O15P2	CCCCCCC=CCCCCCCCCCC(=O)OCC(COP([O-])(=O)OP([O-])(=O)OCC1OC(C(O)C1O)N1C=CC(N)=NC1=O)OC(=O)CCCCCCCCCC=CCCCCCC	-2	Y	1004	958		1.3	10.3	5.9			CdsA7, PgsA3	
cephalosporin_C					46505733		15776					cephalosporin C			antibiotic	beta-lactam	C16H22N3O8S1	CC(=O)OCC1=C(N2[C@@H](SC1)[C@H](NC(=O)CCC[C@H]([NH3+])C(O)=O)C2=O)C(O)=O	1	N	416									Inhibits cell wall synthesis [PUB_0847].
Ceramide16				24696-26-2	7850623					LMSP02010004		Ceramide (d18:1/16:0)	N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide	N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide	lipid	sphingolipid, ceramide	C34H67N1O3	[H][C@@](O)(\C=C\CCCCCCCCCCCCC)[C@]([H])(CO)NC(=O)CCCCCCCCCCCCCCC	0	Y	538	612		7.0	10.9	10.9			glycosyltransferase_Ceramide16_GalCer16, glycosyltransferase_Ceramide16_GlcCer16	
CH3				2229-07-4	8146637		29309					Methyl radical	(CH)(.)	methyl	alkylating agent	methylation	C1H3	[CH3]	0	N	15	26			0.8	0.8			DNADamage_AD_m6AD_CH3, DNADamage_CSN_m4CSN_CH3, DNADamage_CSN_m5CSN_CH3, DNADamage_GN_m8GN_CH3	
CH3OH				67-56-1								methanol	methanol	methanol	alcohol		C1H4O1	CO	0	N	32	37		6.7	-0.5	-0.5			LIPASE_METHYL_OCDCEA_MG310, LIPASE_METHYL_OCDCEA_MG327, LIPASE_METHYL_OCDCEA_MG344	
chloramphenicol			C00918	56-75-7	46505318							chloramphenicol			antibiotic		C11H12Cl2N2O5	OCC(NC(=O)C(Cl)Cl)C(O)C1=CC=C(C=C1)[N+]([O-])=O	0	N	323									Binds L16 protein of the 50S ribosomal subunit and inhibits amino acid transfer to growing peptide chains [PUB_0847].
chloroacetaldehyde	CHLOROACETALDEHYDE		C06754		8975		27871					chloroacetaldehyde	chloroacetaldehyde	2-chloroacetaldehyde	reactive oxygen species		C2H3Cl1O1	C(C=O)Cl	0	N	78	62			0.2	0.2			vinyl_chloride_activation_2	
chloroethylene_oxide					8146713		29129					chloroethylene oxide	chloroethylene oxide	2-chlorooxirane	reactive oxygen species		C2H3Cl1O1	C1C(O1)Cl	0	N	78	57			0.8	0.8			DNADamage_AD_epsilon1N6AD_chloroethylene_oxide, DNADamage_CSN_epsilon3N4CSN_chloroethylene_oxide, DNADamage_GN_epsilon1N2GN_chloroethylene_oxide, DNADamage_GN_epsilonN23GN_chloroethylene_oxide, DNADamage_GN_oxoethyl7GN_chloroethylene_oxide, vinyl_chloride_activation_1, vinyl_chloride_activation_2	
CHOL	CHOLINE	chol	C00114	62-49-7	3414	B00031	15354	CHT	C00007298			choline	choline	(2-hydroxyethyl)trimethylazanium			C5H14N1O1	C[N+](C)(C)CCO	1	N	104	122		5.4	-4.7	-4.7			CholK, GlpQ1, MG385r1	
CHP					7683015							cumene hydroperoxide	cumene hydroperoxide	2-phenylpropane-2-peroxol			C9H12O2	CC(C)(C1=CC=CC=C1)OO	0	N	152	151		3.7	2.3	2.3			Ohr_CHP, OsmC_CHP	
ciprofloxacin			C05349                      	85721-33-1	87350446		100241					ciprofloxacin	cipro	1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid	antibiotic	fluoroquinolone	C17H18F1N3O3	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O	0	N	331	283		7.4	-1.4	-1.4			TX_NormM_ciprofloxacin	Inhibits topoisomerase II/DNA gyrase and topoisomerase IV [PUB_0847].
CITR		citr-L	C00327	372-75-8	3621	B01217	16349	CIR	C00001348			L-citrulline	citrulline	2-amino-5-(carbamoylamino)pentanoic acid			C6H13N3O3	C(CC(C(=O)O)N)CNC(=O)N	0	N	175	161		5.8	-4.1	-4.1			Adi, ArgF	
CL	CL-	cl	C00698	16887-00-6	312		17996	CL				chloride ion	cl(-)	chloride	ion		Cl1	[Cl-]	-1	N	35	22			0.6	0.8			DNADamage_AD_epsilon1N6AD_chloroethylene_oxide, DNADamage_CSN_epsilon3N4CSN_chloroethylene_oxide, DNADamage_GN_epsilon1N2GN_chloroethylene_oxide, DNADamage_GN_epsilonN23GN_chloroethylene_oxide, DNADamage_GN_oxoethyl7GN_chloroethylene_oxide, TX_CL	
CL160		clpn160	C05980		8259					LMGP12010000		cardiolipin (tetrahexadecanoyl, n-C16:0)	1-({[3-({[2,3-bis(hexadecanoyloxy)propyl] phosphonato}oxy)-2-hydroxypropyl] phosphonato}oxy)-3-(hexadecanoyloxy)propan-2-yl hexadecanoate	1-({[3-({[2,3-bis(hexadecanoyloxy)propyl] phosphonato}oxy)-2-hydroxypropyl] phosphonato}oxy)-3-(hexadecanoyloxy)propan-2-yl hexadecanoate	lipid	glycerophospholipid, cardiolipin	C73H140O17P2	CCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC	-2	Y	1352	1409			23.7	19.0			Cls1	
CL161		clpn161	C05980		8259					LMGP12010000		cardiolipin (tetrahexadec-9-enoyl, n-C16:1)	1-({[3-({[2,3-bis(hexadec-9-enoyloxy)propyl] phosphonato}oxy)-2-hydroxypropyl] phosphonato}oxy)-3-(hexadec-9-enoyloxy)propan-2-yl hexadec-9-enoate	1-({[3-({[2,3-bis(hexadec-9-enoyloxy)propyl] phosphonato}oxy)-2-hydroxypropyl] phosphonato}oxy)-3-(hexadec-9-enoyloxy)propan-2-yl hexadec-9-enoate	lipid	glycerophospholipid, cardiolipin	C73H132O17P2	CCCCCCC=CCCCCCCCC(=O)OCC(COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC	-2	Y	1344	1377			22.3	17.5			Cls2	
CL181		clpn181	C05980		8259					LMGP12010000		cardiolipin (tetraoctadec-11-enoyl, n-C18:1)	1-({[3-({[2,3-bis(octadec-11-enoyloxy)propyl] phosphonato}oxy)-2-hydroxypropyl] phosphonato}oxy)-3-(octadec-11-enoyloxy)propan-2-yl octadec-11-enoate	1-({[3-({[2,3-bis(octadec-11-enoyloxy)propyl] phosphonato}oxy)-2-hydroxypropyl] phosphonato}oxy)-3-(octadec-11-enoyloxy)propan-2-yl octadec-11-enoate	lipid	glycerophospholipid, cardiolipin	C81H148O17P2	CCCCCCC=CCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC	-2	Y	1456	1515			25.8	21.1			Cls3	
clarithromycin			C06912	81103-11-9	99313627		3732					clarithromycin			antibiotic	macrolide	C38H69N1O13	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC	0	N	748									Binds 23 S rRNA of 50S ribosomal subunit, blocking translocation of aminoacyl-tRNA and polypeptide synthesis [PUB_0847].
clindamycin			C06914	18323-44-9	46506073		3745					clindamycin			antibiotic	lincosamide	C18H33Cl1N2O5S1	CCC[C@@H]1C[C@H](N(C)C1)C(=O)NC(C(C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O	0	N	425									Binds 23S rRNA of the 50S ribosomal subunit [PUB_0847].
cmnm5s2U				78173-95-2	24536988							5-carboxymethylaminomethyl-2-thiouridine	[({1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxo-2-sulfanylidene-3H-pyrimidin-5-yl}methyl)amino]acetic acid	2-[({1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxo-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-5-yl}methyl)amino]acetic acid			C12H17N3O7S1	OCC1OC(C(O)C1O)N1C=C(CNCC(O)=O)C(=O)NC1=S	0	N	347	282		4.5	-5.2	-5.3			TX_cmnm5s2U, UshA_cmnm5s2UMP	
cmnm5s2UMP												5-carboxymethylaminomethyl-2-thiouridine monophosphate	[5-(5-{[(carboxymethyl)amino]methyl}-4-oxo-2-sulfanylidene-3H-pyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	[5-(5-{[(carboxymethyl)amino]methyl}-4-oxo-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	modified ribonucleotide monophosphate		C12H16N3O10P1S1	OC1C(O)C(OC1COP([O-])([O-])=O)N1C=C(CNCC(O)=O)C(=O)NC1=S	-2	N	425	322		1.3	-5.9	-8.8			MG501_MODIFICATION_003, MG502_MODIFICATION_002, MG513_MODIFICATION_002, UshA_cmnm5s2UMP	
CMP	CMP	cmp	C00055	63-37-6	3357	B01141	17361					CMP	[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	ribonucleotide monophosphate		C9H12N3O8P1	NC1=NC(=O)N(C=C1)C1OC(COP([O-])([O-])=O)C(O)C1O	-2	N	321	241		0.9	-3.3	-6.3			CmkA2, DNAPrimerPolymerization_CTP, MG486_MODIFICATION_002, PgsA1, PgsA2, PgsA3, RNACleavage_DeaD_CMP, RNACleavage_RNAseIII_CMP, RNACleavage_RNAseJ_CMP, RNACleavage_RNAseP_CMP, RNACleavage_RNAseR_CMP, RNACleavage_RsgA_CMP, RnaPolymerization_CTP, Udk2	
CO	CO+2		C00175	7440-48-4	3475		27638	3CO				cobalt ion	co(2+)	cobalt(2+) ion	ion		Co1	[Co++]	2	N	59	34			0.2	0.2			TX_Cbi_Co	
CO2	CARBON-DIOXIDE	co2	C00011	124-38-9	3313	B01131	16526	CO2				carbon dioxide	[CO2]	methanedione	gas		C1O2	C(=O)=O	0	N	44	33			-0.3	-0.3			AceE, ArcC, DNADamage_DHURA_ho5Hydantoin_hydroxyl_radical, PcbX, Ppc, TX_CO2	
COA	CO-A	coa	C00010	85-61-0	3312	B04618	15346	COA	C00007258			coenzyme A	[3-hydroxy-2,2-dimethyl-3-({2-[(2-sulfanylethyl)carbamoyl]ethyl}carbamoyl)propyl] ({[5-(6-aminopurin-9-yl)-4-hydroxy-3-(phosphonatooxy)oxolan-2-yl]methyl phosphonato}oxy)phosphonate	[3-hydroxy-2,2-dimethyl-3-({2-[(2-sulfanylethyl)carbamoyl]ethyl}carbamoyl)propyl] ({[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonatooxy)oxolan-2-yl]methyl phosphonato}oxy)phosphonate	vitamin		C21H32N7O16P3S1	CC(C)(COP([O-])(=O)OP([O-])(=O)OCC1OC(C(O)C1OP([O-])([O-])=O)N1C=NC2=C1N=CN=C2N)C(O)C(=O)NCCC(=O)NCCS	-4	N	764	584		2.1	-7.0	-11.8			AceE, AcpS, CoaE, Pta, TX_COA	
CpCp												Cp-Cp	5-(4-amino-2-oxopyrimidin-1-yl)-2-[(hydrogen phosphonatooxy)methyl]-4-hydroxyoxolan-3-yl [5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-2-[(hydrogen phosphonatooxy)methyl]-4-hydroxyoxolan-3-yl [5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate			C18H23N6O15P2	NC1=NC(=O)N(C=C1)C1OC(COP([O-])(=O)OC2C(COP(O)([O-])=O)OC(C2O)N2C=CC(N)=NC2=O)C(O)C1O	-3	N	625								DNAPrimerPolymerization_CTP, RNACleavage_DeaD_CMP, RNACleavage_RNAseIII_CMP, RNACleavage_RNAseJ_CMP, RNACleavage_RNAseP_CMP, RNACleavage_RNAseR_CMP, RNACleavage_RsgA_CMP, RnaPolymerization_CTP	
crystalViolet			D01046		87324702		604234					Crystal violet	gentian violet	4-{bis[4-(dimethylamino)phenyl]methylidene}-N,N-dimethylcyclohexa-2,5-dien-1-iminium	antibiotic	phenylpropene	C25H30N3	CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C	1	N	373	372			1.4	1.4			TX_NormM_crystalViolet	
CSN	CYTOSINE	csn	C00380	71-30-7	3670	B00097	116552	CYT	C00001498			cytosine	4-amino-3H-pyrimidin-2-one	6-amino-1,2-dihydropyrimidin-2-one	nucleobase		C4H5N3O1	C1=C(NC(=O)N=C1)N	0	N	111	92		12.4	-1.1	-1.1			DNADamage_CSNCSN_CSN64CSN_UVB_radiation, DNADamage_CSNCSN_cyclobutane_CSNCSN_UVB_radiation, DNADamage_CSNTHY_CSN64THY_UVB_radiation, DNADamage_CSNTHY_cyclobutane_CSNTHY_UVB_radiation, DNADamage_CSN_CSN_GLYC_hydroxyl_radical, DNADamage_CSN_e3CSN_DES, DNADamage_CSN_e3CSN_EMS, DNADamage_CSN_e3CSN_ENU, DNADamage_CSN_epsilon3N4CSN_chloroethylene_oxide, DNADamage_CSN_ho5CSN_hydroxyl_radical, DNADamage_CSN_m3CSN_MMS, DNADamage_CSN_m3CSN_MMSO4, DNADamage_CSN_m3CSN_MNNG, DNADamage_CSN_m3CSN_MNU, DNADamage_CSN_m4CSN_CH3, DNADamage_CSN_m5CSN_CH3, DNADamage_CSN_O2eCSN_DES, DNADamage_CSN_O2eCSN_EMS, DNADamage_CSN_O2eCSN_ENU, DNADamage_CSN_O2mCSN_MNNG, DNADamage_CSN_O2mCSN_MNU, DNADamage_SpontaneousBaseDeamination_cytosine, DNADamage_SpontaneousBaseLoss_cytosine, DNADamage_THYCSN_cyclobutane_THYCSN_UVB_radiation, DNADamage_THYCSN_THY64CSN_UVB_radiation	
CSN64CSN												cytosine-[6,4]-cytosine	4-(5,6-diamino-2-oxo-4,5-dihydro-3H-pyrimidin-4-yl)-1H-pyrimidin-2-one	4-(5,6-diamino-2-oxo-2,3,4,5-tetrahydropyrimidin-4-yl)-1,2-dihydropyrimidin-2-one	modified nucleobase		C8H10N6O2	N1C=CC(=NC1=O)C2NC(N=C(C2N)N)=O	1	N	222	180		10.9	-3.0	-3.7			DNADamage_CSN64CSN_CSN64CSN_dewar_UVB_radiation, DNADamage_CSNCSN_CSN64CSN_UVB_radiation	
CSN64CSN_dewar												cytosine-[6,4]-cytosine dewar product	6-(5,6-diamino-2-oxo-4,5-dihydro-3H-pyrimidin-4-yl)-1,3-diazabicyclo[2.2.0]hex-4-en-2-one	6-(5,6-diamino-2-oxo-2,3,4,5-tetrahydropyrimidin-4-yl)-1,3-diazabicyclo[2.2.0]hex-4-en-2-one	modified nucleobase		C8H10N6O2	N2C1=CC(N1C2=O)C3NC(N=C(C3N)N)=O	1	N	222	173		9.1	-2.8	-3.5			DNADamage_CSN64CSN_CSN64CSN_dewar_UVB_radiation	
CSN64THY												cytosine-[6,4]-thymine	4-amino-5-hydroxy-6-(5-methyl-2-oxo-3,4-dihydro-1H-pyrimidin-4-yl)-5H-pyrimidin-2-one	4-amino-5-hydroxy-6-(5-methyl-2-oxo-1,2,3,4-tetrahydropyrimidin-4-yl)-2,5-dihydropyrimidin-2-one	modified nucleobase		C9H11N5O3	CC1=CNC(=O)NC1C1=NC(=O)N=C(N)C1O	0	N	237	191		11.2	-2.3	-2.3			DNADamage_CSN64THY_CSN64THY_dewar_UVB_radiation, DNADamage_CSNTHY_CSN64THY_UVB_radiation	
CSN64THY_dewar												cytosine-[6,4]-thymine dewar product	5-amino-5-methyl-6-{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-1,3-diazinane-2,4-dione	5-amino-5-methyl-6-{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-1,3-diazinane-2,4-dione	modified nucleobase		C9H11N5O3	N2C1=CC(N1C2=O)C3C(C)(C(NC(N3)=O)=O)N	0	N	237	187		7.5	-2.0	-2.0			DNADamage_CSN64THY_CSN64THY_dewar_UVB_radiation	
CSN_GLYC				13484-98-5	8146715		29127					cytosine glycol	cytosine glycol	4-amino-5,6-dihydroxy-1,2,5,6-tetrahydropyrimidin-2-one	modified nucleobase		C4H7N3O3	N1C(C(C(=NC1=O)N)O)O	0	N	145	115		6.3	-2.7	-2.7			DNADamage_CSN_CSN_GLYC_hydroxyl_radical	
CTP	CTP	ctp	C00063	65-47-4	3363	B01144	17677	CTP	C00019639			CTP	({[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	({[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	ribonucleotide triphosphate		C9H12N3O14P3	NC1=NC(=O)N(C=C1)C1OC(COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)C(O)C1O	-4	N	479	327		0.7	-4.4	-11.1			CdsA1, CdsA2, CdsA3, CdsA4, CdsA5, CdsA6, CdsA7, DNAPrimerPolymerization_CTP, Pyk_CDP, RnaPolymerization_CTP	
CU	CU+2	cu2	C00070	7440-50-8	27099		28694	CU				cupric ion	cu(2+)	copper(2+) ion	ion		Cu1	[Cu++]	2	N	64	11			0.2	0.2			TX_MGTA_CU	
cyclobutane_CSNCSN												cyclobutane cytosine dimer	4,5-diamino-1,4a,4b,8,8a,8b-hexahydro-1,3,6,8-tetraazabiphenylene-2,7-dione	4,5-diamino-1,2,4a,4b,7,8,8a,8b-octahydro-1,3,6,8-tetraazabiphenylene-2,7-dione	modified nucleobase		C8H10N6O2	N1C2C(C(=NC1=O)N)C3C2NC(N=C3N)=O	0	N	222	173		7.4	-3.5	-3.5			DNADamage_CSNCSN_cyclobutane_CSNCSN_UVB_radiation	
cyclobutane_CSNTHY												cyclobutane cytosine thymine 	5-amino-4a-methyl-1,3,4b,8,8a,8b-hexahydro-1,3,6,8-tetraazabiphenylene-2,4,7-trione	5-amino-4a-methyl-1,2,3,4,4a,4b,7,8,8a,8b-decahydro-1,3,6,8-tetraazabiphenylene-2,4,7-trione	modified nucleobase		C9H11N5O3	N1C2C(C(=NC1=O)N)C3(C)C2NC(=O)NC3=O	0	N	237	188		5.9	-2.6	-2.6			DNADamage_CSNTHY_cyclobutane_CSNTHY_UVB_radiation	
cyclobutane_dCdC												cyclobutane 2'-deoxycytidine dimer	4,5-diamino-1,8-bis[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4a,4b,8a,8b-tetrahydro-1,3,6,8-tetraazabiphenylene-2,7-dione	4,5-diamino-1,8-bis[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4a,4b,7,8,8a,8b-octahydro-1,3,6,8-tetraazabiphenylene-2,7-dione	modified deoxyribonucleoside		C18H26N6O8	C1C(C(OC1N2C3C(C(=NC2=O)N)C5C3N(C4OC(C(C4)O)CO)C(N=C5N)=O)CO)O	0	N	454	374		8.1	-4.8	-4.8			TX_cyclobutane_dCdC, UshA_cyclobutane_dCMPdCMP	
cyclobutane_dCdT												cyclobutane 2'-deoxycytidine 2'-deoxythymidine 	5-amino-1,8-bis[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4a-methyl-3,4b,8a,8b-tetrahydro-1,3,6,8-tetraazabiphenylene-2,4,7-trione	5-amino-1,8-bis[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4a-methyl-1,2,3,4,4a,4b,7,8,8a,8b-decahydro-1,3,6,8-tetraazabiphenylene-2,4,7-trione	modified deoxyribonucleoside		C19H27N5O9	C1C(C(OC1N2C3C(C(=NC2=O)N)C4(C)C3N(C(=O)NC4=O)C5CC(C(O5)CO)O)CO)O	0	N	469	389		7.0	-3.9	-3.9			TX_cyclobutane_dCdT, UshA_cyclobutane_dCMPdTMP	
cyclobutane_dCMPdCMP												cyclobutane 2'-deoxycytidine monophosphate dimer	[5-(4,5-diamino-8-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-2,7-dioxo-4a,4b,8a,8b-tetrahydro-1,3,6,8-tetraazabiphenylen-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(4,5-diamino-8-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-2,7-dioxo-1,2,4a,4b,7,8,8a,8b-octahydro-1,3,6,8-tetraazabiphenylen-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C18H24N6O14P2	NC1=NC(=O)N(C2C3C(C12)C(N)=NC(=O)N3C1CC(O)C(COP([O-])([O-])=O)O1)C1CC(O)C(COP([O-])([O-])=O)O1	-4	N	610	454		1.8	-8.0	-11.8			UshA_cyclobutane_dCMPdCMP	
cyclobutane_dCMPdTMP												cyclobutane 2'-deoxycytidine monophosphate 2'-deoxythymidine monophosphate	[5-(4-amino-8-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-4b-methyl-2,5,7-trioxo-4a,6,8a,8b-tetrahydro-1,3,6,8-tetraazabiphenylen-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(4-amino-8-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-4b-methyl-2,5,7-trioxo-1,2,4a,4b,5,6,7,8,8a,8b-decahydro-1,3,6,8-tetraazabiphenylen-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C19H25N5O15P2	CC12C(C3C1C(N)=NC(=O)N3C1CC(O)C(COP([O-])([O-])=O)O1)N(C1CC(O)C(COP([O-])([O-])=O)O1)C(=O)NC2=O	-4	N	625	469		1.0	-6.0	-10.8			UshA_cyclobutane_dCMPdTMP	
cyclobutane_dTdC												cyclobutane 2'-deoxythymidine 2'-deoxycytidine	5-amino-1,8-bis[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4a-methyl-3,4b,8a,8b-tetrahydro-1,3,6,8-tetraazabiphenylene-2,4,7-trione	5-amino-1,8-bis[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4a-methyl-1,2,3,4,4a,4b,7,8,8a,8b-decahydro-1,3,6,8-tetraazabiphenylene-2,4,7-trione	modified deoxyribonucleoside		C19H27N5O9	CC14C(N(C(=O)NC1=O)C2CC(C(O2)CO)O)C5N(C3OC(C(C3)O)CO)C(N=C(C45)N)=O	0	N	469	389		7.0	-3.9	-3.9			TX_cyclobutane_dTdC, UshA_cyclobutane_dTMPdCMP	
cyclobutane_dTdT					10254580							cyclobutane 2'-deoxythymidine dimer	1,8-bis[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4a,4b-dimethyl-tetrahydro-1,3,6,8-tetraazabiphenylene-2,4,5,7-tetrone	1,8-bis[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4a,4b-dimethyl-dodecahydro-1,3,6,8-tetraazabiphenylene-2,4,5,7-tetrone	modified deoxyribonucleoside		C20H28N4O10	CC12C(C3C1(C(=O)NC(=O)N3C4CC(C(O4)CO)O)C)N(C(=O)NC2=O)C5CC(C(O5)CO)O	0	N	484	404		4.4	-3.0	-3.0			TX_cyclobutane_dTdT, UshA_cyclobutane_dTMPdTMP	
cyclobutane_dTMPdCMP												cyclobutane 2'-deoxythymidine monophosphate 2'-deoxycytidine monophosphate	[5-(4-amino-8-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-4b-methyl-2,5,7-trioxo-4a,6,8a,8b-tetrahydro-1,3,6,8-tetraazabiphenylen-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(4-amino-8-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-4b-methyl-2,5,7-trioxo-1,2,4a,4b,5,6,7,8,8a,8b-decahydro-1,3,6,8-tetraazabiphenylen-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C19H25N5O15P2	CC12C(C3C1C(N)=NC(=O)N3C1CC(O)C(COP([O-])([O-])=O)O1)N(C1CC(O)C(COP([O-])([O-])=O)O1)C(=O)NC2=O	-4	N	625	469		1.0	-6.0	-10.8			UshA_cyclobutane_dTMPdCMP	
cyclobutane_dTMPdTMP												cyclobutane 2'-deoxythymidine monophosphate dimer	[3-hydroxy-5-(8-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-4a,4b-dimethyl-2,4,5,7-tetraoxo-tetrahydro-1,3,6,8-tetraazabiphenylen-1-yl)oxolan-2-yl]methyl phosphate	[3-hydroxy-5-(8-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-4a,4b-dimethyl-2,4,5,7-tetraoxo-dodecahydro-1,3,6,8-tetraazabiphenylen-1-yl)oxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C20H26N4O16P2	CC12C(C3N(C4CC(O)C(COP([O-])([O-])=O)O4)C(=O)NC(=O)C13C)N(C1CC(O)C(COP([O-])([O-])=O)O1)C(=O)NC2=O	-4	N	640	485		1.0	-3.2	-9.9			UshA_cyclobutane_dTMPdTMP	
cyclobutane_THYCSN												cyclobutane thymine cytosine	5-amino-4a-methyl-1,3,4b,8,8a,8b-hexahydro-1,3,6,8-tetraazabiphenylene-2,4,7-trione	5-amino-4a-methyl-1,2,3,4,4a,4b,7,8,8a,8b-decahydro-1,3,6,8-tetraazabiphenylene-2,4,7-trione	modified nucleobase		C9H11N5O3	CC12C(NC(=O)NC1=O)C3NC(N=C(C23)N)=O	0	N	237	188		5.9	-2.6	-2.6			DNADamage_THYCSN_cyclobutane_THYCSN_UVB_radiation	
cyclobutane_THYTHY					24610583							cyclobutane thymine dimer	4a,4b-dimethyl-hexahydro-1,3,6,8-tetraazabiphenylene-2,4,5,7-tetrone	4a,4b-dimethyl-dodecahydro-1,3,6,8-tetraazabiphenylene-2,4,5,7-tetrone	modified nucleobase		C10H12N4O4	CC13C(C2C1(C(=O)NC(=O)N2)C)NC(=O)NC3=O	0	N	252	203			-1.6	-1.7			DNADamage_THYTHY_cyclobutane_THYTHY_UVB_radiation	
cyclodA				117182-88-4	9471068							8,5'-cyclo-2'-deoxyadenosine	7-amino-15-oxa-2,4,6,9-tetraazatetracyclo[10.2.1.0^{2,10}.0^{3,8}]pentadeca-3(8),4,6,9-tetraene-11,13-diol	7-amino-15-oxa-2,4,6,9-tetraazatetracyclo[10.2.1.0^{2,10}.0^{3,8}]pentadeca-3(8),4,6,9-tetraene-11,13-diol	modified deoxyribonucleoside		C10H11N5O3	C1C(C2C(C3=NC4=C(N3C1O2)N=CN=C4N)O)O	0	N	249	196		8.7	-1.1	-1.2			DNADamage_DA_cyclodA_UVB_radiation, TX_cyclodA, UshA_cyclodAMP	3 lesions per 10^7 bases [PUB_0479];
cyclodAMP												8,5'-cyclo-2'-deoxyadenosine monophosphate	{7-amino-13-hydroxy-15-oxa-2,4,6,9-tetraazatetracyclo[10.2.1.0^{2,10}.0^{3,8}]pentadeca-3(8),4,6,9-tetraen-11-yl} phosphate	{7-amino-13-hydroxy-15-oxa-2,4,6,9-tetraazatetracyclo[10.2.1.0^{2,10}.0^{3,8}]pentadeca-3(8),4,6,9-tetraen-11-yl} phosphate	modified deoxyribonucleotide monophosphate		C10H10N5O6P1	NC1=NC=NC2=C1N=C1C(OP([O-])([O-])=O)C3OC(CC3O)N21	-2	N	327	236		3.3	-4.5	-4.7			UshA_cyclodAMP	
cyclodG				104504-22-5	50378233							8,5'-cyclo-2'-deoxyguanosine	5-amino-11,13-dihydroxy-15-oxa-2,4,6,9-tetraazatetracyclo[10.2.1.0^{2,10}.0^{3,8}]pentadeca-3(8),5,9-trien-7-one	5-amino-11,13-dihydroxy-15-oxa-2,4,6,9-tetraazatetracyclo[10.2.1.0^{2,10}.0^{3,8}]pentadeca-3(8),5,9-trien-7-one	modified deoxyribonucleoside		C10H11N5O4	C1C(C2C(C3=NC4=C(N3C1O2)NC(=NC4=O)N)O)O	0	N	265	204		10.1	-1.3	-1.3			DNADamage_DG_cyclodG_UVB_radiation, TX_cyclodG, UshA_cyclodGMP	
cyclodGMP												8,5'-cyclo-2'-deoxyguanosine monophosphate	{5-amino-13-hydroxy-7-oxo-15-oxa-2,4,6,9-tetraazatetracyclo[10.2.1.0^{2,10}.0^{3,8}]pentadeca-3(8),5,9-trien-11-yl} phosphate	{5-amino-13-hydroxy-7-oxo-15-oxa-2,4,6,9-tetraazatetracyclo[10.2.1.0^{2,10}.0^{3,8}]pentadeca-3(8),5,9-trien-11-yl} phosphate	modified deoxyribonucleotide monophosphate		C10H10N5O7P1	NC1=NC(=O)C2=C(N1)N1C3CC(O)C(O3)C(OP([O-])([O-])=O)C1=N2	-2	N	343	244		5.9	-1.9	-4.9			UshA_cyclodGMP	
CYS	CYS	cys-L	C00097	52-90-4	3397	B01159	17561	CYS	C00001351			L-Cysteine	cysteine	2-amino-3-sulfanylpropanoic acid	amino acid		C3H7N1O2S1	C(S)C(N)C(=O)O	0	N	121	103		5.7	-2.9	-2.9			Apts_Cys, MG471_MODIFICATION_003, MG472_MODIFICATION_002, MG475_MODIFICATION_001, MG479_MODIFICATION_001, MG483_Aminoacylation, MG483_MODIFICATION_002, MG484_MODIFICATION_003, MG485_MODIFICATION_002, MG486_MODIFICATION_004, MG487_MODIFICATION_002, MG488_MODIFICATION_003, MG489_MODIFICATION_001, MG490_MODIFICATION_002, MG492_MODIFICATION_002, MG493_MODIFICATION_001, MG495_MODIFICATION_002, MG496_MODIFICATION_001, MG497_MODIFICATION_002, MG499_MODIFICATION_001, MG500_MODIFICATION_002, MG501_MODIFICATION_002, MG501_MODIFICATION_005, MG502_MODIFICATION_001, MG502_MODIFICATION_004, MG503_MODIFICATION_002, MG504_MODIFICATION_003, MG506_MODIFICATION_001, MG507_MODIFICATION_001, MG508_MODIFICATION_003, MG509_MODIFICATION_003, MG510_MODIFICATION_003, MG511_MODIFICATION_002, MG512_MODIFICATION_003, MG513_MODIFICATION_001, MG513_MODIFICATION_003, MG514_MODIFICATION_002, MG518_MODIFICATION_002, MG519_MODIFICATION_003, MG520_MODIFICATION_001, MG523_MODIFICATION_002, PeptidylTRNAHs_CYS, ProLipoproteinDiacylglycerylTransferase, ProteinDegradation_FtsH_CYS, ProteinDegradation_Lon_CYS, ProteinPolymerization_CYS	
CysCys					10251455							L-cysteinyl-L-cysteine	2-(2-amino-3-sulfanylpropanamido)-3-sulfanylpropanoic acid	2-(2-amino-3-sulfanylpropanamido)-3-sulfanylpropanoic acid	dipeptide		C6H12N2O3S2	C(C(C(=O)NC(CS)C(=O)O)N)S	0	N	224	187		6.0	-3.7	-3.8			Apts_Cys, ProteinDegradation_FtsH_CYS, ProteinDegradation_Lon_CYS, ProteinPolymerization_CYS, TX_OppB_Cys	
CYTD	CYTIDINE	cytd	C00475	65-46-3	3758	B01256	17562	CTN				cytidine	cytidine	4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one	ribonucleoside		C9H13N3O5	C1(OC(C(C(O)1)O)CO)(N2(C=CC(N)=NC2=O))	0	N	243	201		6.6	-2.8	-2.8			Cdd1, TX_CYTD, Udk2	
c_di_AMP												Cyclic-di-adenylate	 8,17-bis(6-aminopurin-9-yl)-9,18-dihydroxy-3,12- dioxo-2,4,7,11,13,16-hexaoxa-3$l^{5},12$l^{5}- diphosphatricyclo[13.3.0.0^{6,10}]octadecane-3,12- bis(olate)	 8,17-bis(6-amino-9H-purin-9-yl)-9,18-dihydroxy- 3,12-dioxo-2,4,7,11,13,16-hexaoxa-3$l^{5},12$l^{5}- diphosphatricyclo[13.3.0.0^{6,10}]octadecane-3,12- bis(olate)			C20H22N10O12P2	NC1=NC=NC2=C1N=CN2C1OC2COP([O-])(=O)[O-]C3C(COP([O-])(=O)[O-]C2C1O)OC(C3O)N1C=NC2=C1N=CN=C2N	-2	N	656	480		4.0	-8.1	-7.4			diadenylate_cyclase	c-di-AMP may act as second messenger, similar to c-di-GMP to regulate Spo0A [PUB_0512]. c-di-AMP may secreted and trigger a host response [PUB_0683].
DA		dad-2	C00559	958-09-8	3839	B01287	17256	3D1	C00019281			deoxyadenosine	adenosine, 2'-deoxy-	5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol	deoxyribonucleoside		C10H13N5O3	C1C(C(OC1N2C=NC3=C2N=CN=C3N)CO)O	0	N	251	207		9.4	-1.2	-1.2			Dak1, DeoD2, DNADamage_DA_cyclodA_UVB_radiation, TX_DA	
DADP	DADP	dadp	C00206		3506	B01188	16174	DAT				dADP	({[5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	({[5-(6-amino-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	deoxyribonucleotide diphosphate		C10H12N5O9P2	C(C3(C(CC(N2(C1(=C(C(=NC=N1)N)N=C2)))O3)O))OP(OP([O-])([O-])=O)([O-])=O	-3	N	408	290		2.7	-4.7	-6.7			Adk4, Gmk3, Gmk4, NrdEF_ADP, PfkA3, Pgk3, Pyk_DADP	
DAG160			C00641									Diacylglycerol (n-16:0)	1-hydroxy-3-(tetradecanoyloxy)propan-2-yl octadec-9-enoate	diradylglycerol	lipid	diacylglycerol	C35H66O5	CCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCCCCCCCC	0	Y	567	631		5.8	11.6	11.6			glycosyltransferase_DAG160_GalDAG160, glycosyltransferase_DAG160_GlcDAG160, glycosyltransferase_PG160_DAG160	
DAG161			C00641									Diacylglycerol (n-16:1)	1-(hexadec-9-enoyloxy)-3-hydroxypropan-2-yl hexadec-9-enoate	diradylglycerol	lipid	diacylglycerol	C35H64O5	CCCCCCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCCCCCC	0	Y	565	623		5.8	11.3	11.3			glycosyltransferase_DAG161_GalDAG161, glycosyltransferase_DAG161_GlcDAG161, glycosyltransferase_PG161_DAG161	
DAG181			C00641									Diacylglycerol (n-18:1)	1-hydroxy-3-(octadec-11-enoyloxy)propan-2-yl octadec-11-enoate	diradylglycerol	lipid	diacylglycerol	C39H72O5	CCCCCCC=CCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCC=CCCCCCC	0	Y	621	691		5.8	13.1	13.1			glycosyltransferase_DAG181_GalDAG181, glycosyltransferase_DAG181_GlcDAG181, glycosyltransferase_PG181_DAG181	
DALA		ala-D	C00133	338-69-2	3433	B00036	15570	DAL	C00019654			D-alanine	alanine	2-aminopropanoic acid	amino acid		C3H7N1O2	CC(C(=O)O)N	0	N	89	85		6.0	-3.0	-3.0			GlyA1	
DAMP		damp	C00360	653-63-4	3651	B01226	17713	D5M				dAMP	[5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(6-amino-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	deoxyribonucleotide monophosphate		C10H12N5O6P1	NC1=NC=NC2=C1N=CN2C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	329	248		3.8	-4.3	-4.7			Adk4, Dak1, DNADamage_SpontaneousBaseLoss_adenine, DNAPolymerization_dATP, DNAProcessiveCleavage_dAMP, DNA_polymerization_dATP_repair, HR_DNAResection_dAMP, TatD_dAMP, TX_ComEC_dApdAp	
dApdAp												dAp-dAp	[5-(6-aminopurin-9-yl)-2-[(phosphonatooxy)methyl]oxolan-3-yl] [5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(6-amino-9H-purin-9-yl)-2-[(phosphonatooxy)methyl]oxolan-3-yl] [5-(6-amino-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	dideoxynucleotide		C20H23N10O11P2	NC1=NC=NC2=C1N=CN2C1CC(O)C(COP([O-])(=O)OC2CC(OC2COP([O-])([O-])=O)N2C=NC3=C2N=CN=C3N)O1	-3	N	641	479		3.9	-7.4	-7.5			DNAPolymerization_dATP, DNAProcessiveCleavage_dAMP, DNA_polymerization_dATP_repair, HR_DNAResection_dAMP, TatD_dAMP, TX_ComEC_dApdAp	
DATP	DATP	datp	C00131	1927-31-7	3431	B01169	16284	2OA				dATP	({[5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	({[5-(6-amino-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	deoxyribonucleotide triphosphate		C10H12N5O12P3	NC1=NC=NC2=C1N=CN2C1CC(O)C(COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)O1	-4	N	487	333		2.3	-5.6	-9.5			DNAPolymerization_dATP, DNA_polymerization_dATP_repair, Gmk3, Gmk4, PfkA3, Pgk3, Pyk_DADP	
DC	DEOXYCYTIDINE	dcyt	C00881	951-77-9	4137	B01347	15698	DCZ				deoxycytidine	4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one	deoxyribonucleoside		C9H13N3O4	C1C(C(OC1N2C=CC(=NC2=O)N)CO)O	0	N	227	193		7.6	-1.9	-1.9			Cdd2, Dck, UshA_dCMP	
dC64dC												2'-deoxycytidine-[6,4]-2'-deoxycytidine	4-{5,6-diamino-3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-4,5-dihydropyrimidin-4-yl}-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	4-{5,6-diamino-3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-2,3,4,5-tetrahydropyrimidin-4-yl}-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one	modified deoxyribonucleoside		C18H26N6O8	C1C(C(OC1N2C=CC(=NC2=O)C4N(C3OC(C(C3)O)CO)C(N=C(C4N)N)=O)CO)O	1	N	454	381		10.6	-4.2	-5.0			TX_dC64dC, UshA_dCMP64dCMP	
dC64dC_dewar												2'-deoxycytidine-[6,4]-2'-deoxycytidine dewar product	6-{5,6-diamino-3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-4,5-dihydropyrimidin-4-yl}-3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazabicyclo[2.2.0]hex-4-en-2-one	6-{5,6-diamino-3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-2,3,4,5-tetrahydropyrimidin-4-yl}-3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazabicyclo[2.2.0]hex-4-en-2-one	modified deoxyribonucleoside		C18H26N6O8	C1C(C(OC1N3C2=CC(N2C3=O)C5N(C4OC(C(C4)O)CO)C(N=C(C5N)N)=O)CO)O	1	N	454	373		10.6	-4.1	-4.8			TX_dC64dC_dewar, UshA_dCMP64dCMP_dewar	
dC64dT												2'-deoxycytidine-[6,4]-2'-deoxythymidine	4-amino-5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-{1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-oxo-3,4-dihydropyrimidin-4-yl}-2-oxo-5H-1$l^{5},3-pyrimidin-1-ylium	4-amino-5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-{1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-oxo-1,2,3,4-tetrahydropyrimidin-4-yl}-2-oxo-2,5-dihydro-1$l^{5},3-pyrimidin-1-ylium	modified deoxyribonucleoside		C19H28N5O9	CC1=CN(C2CC(O)C(CO)O2)C(=O)NC1C1=[N+](C2CC(O)C(CO)O2)C(=O)N=C(N)C1O	0	N	470	395		2.8	-6.9	-6.8			TX_dC64dT, UshA_dCMP64dTMP	
dC64dT_dewar												2'-deoxycytidine-[6,4]-2'-deoxythymidine dewar product	5-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-{3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-5-methyl-1,3-diazinane-2,4-dione	5-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-{3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-5-methyl-1,3-diazinane-2,4-dione	modified deoxyribonucleoside		C19H27N5O9	C1C(C(OC1N3C2=CC(N2C3=O)C4C(C)(C(NC(N4C5CC(C(O5)CO)O)=O)=O)N)CO)O	0	N	469	389		8.8	-3.3	-3.3			TX_dC64dT_dewar, UshA_dCMP64dTMP_dewar	
DCDP	DCDP	dcdp	C00705		3972	B01317		YYY				dCDP	({[5-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	({[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	deoxyribonucleotide diphosphate		C9H12N3O10P2	C2(N(C1(CC(C(O1)COP(OP(=O)([O-])[O-])([O-])=O)O))C(N=C(C=2)N)=O)	-3	N	384	275		1.5	-3.0	-7.4			CmkA1, DcdK, NrdEF_CDP, Pyk_DCDP	
DCMP	DCMP	dcmp	C00239	1032-65-1	3538	B01198	15918	DC				dCMP	[5-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	deoxyribonucleotide monophosphate		C9H12N3O7P1	C2(N(C1(OC(C(C1)O)COP([O-])([O-])=O))C(N=C(C=2)N)=O)	-2	N	305	233		1.3	-2.7	-5.4			CmkA1, DcdK, Dck, DNADamage_SpontaneousBaseLoss_cytosine, DNAPolymerization_dCTP, DNAProcessiveCleavage_dCMP, DNA_polymerization_dCTP_repair, HR_DNAResection_dCMP, TatD_dCMP, TX_ComEC_dCpdCp, UshA_dCMP	
dCMP64dCMP												2'-deoxycytidine monophosphate-[6,4]-2'-deoxycytidine monophosphate	{5-[4,5-diamino-6-(1-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-2-oxopyrimidin-4-yl)-2-oxo-5,6-dihydropyrimidin-1-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	{5-[4,5-diamino-6-(1-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-2-oxo-1,2-dihydropyrimidin-4-yl)-2-oxo-1,2,5,6-tetrahydropyrimidin-1-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C18H24N6O14P2	NC1C(N(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)N=C1N)C1=NC(=O)N(C=C1)C1CC(O)C(COP([O-])([O-])=O)O1	-3	N	610	461		1.6	-8.6	-10.7			UshA_dCMP64dCMP	
dCMP64dCMP_dewar												2'-deoxycytidine monophosphate-[6,4]-2'-deoxycytidine monophosphate dewar product	{5-[6-(5,6-diamino-3-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-2-oxo-4,5-dihydropyrimidin-4-yl)-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-3-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	{5-[6-(5,6-diamino-3-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-2-oxo-2,3,4,5-tetrahydropyrimidin-4-yl)-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-3-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C18H24N6O14P2	NC1C(C2C=C3N2C(=O)N3C2CC(O)C(COP([O-])([O-])=O)O2)N(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)N=C1N	-3	N	610	454		1.6	-8.5	-10.6			UshA_dCMP64dCMP_dewar	
dCMP64dTMP												2'-deoxycytidine monophosphate-[6,4]-2'-deoxythymidine monophosphate	4-amino-5-hydroxy-1-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-6-(1-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-5-methyl-2-oxo-3,4-dihydropyrimidin-4-yl)-2-oxo-5H-1$l^{5},3-pyrimidin-1-ylium	4-amino-5-hydroxy-1-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-6-(1-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-5-methyl-2-oxo-1,2,3,4-tetrahydropyrimidin-4-yl)-2-oxo-2,5-dihydro-1$l^{5},3-pyrimidin-1-ylium	modified deoxyribonucleotide monophosphate		C19H26N5O15P2	CC1=CN(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)NC1C1=[N+](C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)N=C(N)C1O	-4	N	626	477		0.9	-7.2	-7.7			UshA_dCMP64dTMP	
dCMP64dTMP_dewar												2'-deoxycytidine monophosphate-[6,4]-2'-deoxythymidine monophosphate dewar product	{5-[6-(5-amino-3-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-5-methyl-2,6-dioxo-1,3-diazinan-4-yl)-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-3-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	{5-[6-(5-amino-3-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-5-methyl-2,6-dioxo-1,3-diazinan-4-yl)-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-3-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C19H25N5O15P2	CC1(N)C(C2C=C3N2C(=O)N3C2CC(O)C(COP([O-])([O-])=O)O2)N(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)NC1=O	-4	N	625	469		1.6	-6.9	-10.1			UshA_dCMP64dTMP_dewar	
dCMP_GLYC												2-'deoxycytidine monophosphate glycol	[5-(4-amino-5,6-dihydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(4-amino-5,6-dihydroxy-2-oxo-1,2,5,6-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C9H14N3O9P1	NC1=NC(=O)N(C2CC(O)C(COP([O-])([O-])=O)O2)C(O)C1O	-2	N	339	256		1.5	-4.3	-6.8			UshA_dCMP_GLYC	
dCpdCp												dCp-dCp	[5-(4-amino-2-oxopyrimidin-1-yl)-2-[(phosphonatooxy)methyl]oxolan-3-yl] [5-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-2-[(phosphonatooxy)methyl]oxolan-3-yl] [5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	dideoxynucleotide		C18H23N6O13P2	NC1=NC(=O)N(C=C1)C1CC(O)C(COP([O-])(=O)OC2CC(OC2COP([O-])([O-])=O)N2C=CC(N)=NC2=O)O1	-3	N	593	449		1.2	-4.2	-8.9			DNAPolymerization_dCTP, DNAProcessiveCleavage_dCMP, DNA_polymerization_dCTP_repair, HR_DNAResection_dCMP, TatD_dCMP, TX_ComEC_dCpdCp	
DCTP	DCTP	dctp	C00458	2056-98-6	3742	B01248	16311	DCP				dCTP	({[5-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	({[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	deoxyribonucleotide triphosphate		C9H12N3O13P3	C2(N(C1(OC(C(C1)O)COP(OP(OP([O-])([O-])=O)([O-])=O)([O-])=O))C(N=C(C=2)N)=O)	-4	N	463	318		1.1	-3.8	-10.2			DcdK, DNAPolymerization_dCTP, DNA_polymerization_dCTP_repair, Pyk_DCDP	
dC_GLYC					40937372							2-'deoxycytidine glycol	4-amino-5,6-dihydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5,6-dihydropyrimidin-2-one	4-amino-5,6-dihydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,5,6-tetrahydropyrimidin-2-one	modified deoxyribonucleoside		C9H15N3O6	C1C(C(OC1N2C(C(C(=NC2=O)N)O)O)CO)O	0	N	261	216		6.8	-3.3	-3.3			TX_dC_GLYC, UshA_dCMP_GLYC	
DDCA		ddca	C02679	143-07-7	5649	B00483	30805	DAO	C00001221	LMFA01010012	DFA0012	Dodecanoate (n-C12:0)	laurate	dodecanoate	fatty acyl		C12H23O2	CCCCCCCCCCCC(=O)[O-]	-1	N	199	223			4.5	2.3			Aas1, LIPASE_TRILAURIN_MG310, LIPASE_TRILAURIN_MG327, LIPASE_TRILAURIN_MG344, TX_DDCA	
DDECG3P		1ddecg3p	C00681		3950		16975			LMGP10050000		1-dodecanoyl-sn-glycerol 3-phosphate	2-hydroxy-3-(phosphonatooxy)propyl dodecanoate	2-hydroxy-3-(phosphonatooxy)propyl dodecanoate	lipid	glycerophospholipid	C15H29O7P1	CCCCCCCCCCCC(=O)OCC(O)COP([O-])([O-])=O	-2	N	352	334			3.2	0.1			PlsC1, PlsX1	
ddRibose5P												dideoxyribose 5'-phosphate	[(2S,5R)-5-hydroxyoxolan-2-yl]methyl phosphate	[(2S,5R)-5-hydroxyoxolan-2-yl]methyl phosphate	carbohydrate	sugar phosphate	C5H9O6P1	O[C@H]1CC[C@@H](COP([O-])([O-])=O)O1	-2	N	196	151			-0.8	-4.1				
DEN			C14422		11533729		34873					diethyl nitrosamine	DANA	diethyl(nitroso)amine	alkylating agent	ethylation	C4H10N2O1	CCN(CC)N=O	0	N	102	107			0.8	0.8				DNA methylating agent [PUB_0467]
deoxyG6P	2-DEOXYGLUCOSE-6-PHOSPHATE		C06369		57391093							2-deoxy-glucose-6-phosphate	[(2,3,4-trihydroxy-6-oxohexyl)oxy]phosphonic acid	[(2,3,4-trihydroxy-6-oxohexyl)oxy]phosphonic acid	carbohydrate	sugar phosphate	C6H13O8P1	OC(COP(O)(O)=O)C(O)C(O)CC=O	-2	N	244	195			-3.0	-6.1			YbiV_deoxyG6P	
deoxyGLC	2-DEOXY-D-GLUCOSE		C00586		1947		15866					2-deoxy-glucose	6-(hydroxymethyl)oxane-2,4,5-triol	6-(hydroxymethyl)oxane-2,4,5-triol	deoxy sugar		C6H12O5	C(O)C1(OC(O)CC(O)C(O)1)	0	N	164	146		4.7	-2.0	-2.0			YbiV_deoxyG6P	
DES			C14706		85562736		371217					diethyl sulfate	diethyl sulfate	diethyl sulfate	alkylating agent	ethylation	C4H10O4S1	CCOS(=O)(=O)OCC	0	N	154	133			0.6	0.6			DNADamage_AD_e1AD_DES, DNADamage_AD_e3AD_DES, DNADamage_AD_e6AD_DES, DNADamage_AD_e7AD_DES, DNADamage_CSN_e3CSN_DES, DNADamage_CSN_O2eCSN_DES, DNADamage_GN_e1GN_DES, DNADamage_GN_e3GN_DES, DNADamage_GN_e7GN_DES, DNADamage_GN_O6eGN_DES, DNADamage_THY_e3THY_DES, DNADamage_THY_O2eTHY_DES, DNADamage_THY_O4eTHY_DES	SN2 DNA methylating agent [PUB_0467]
DG		dgsn	C00330	961-07-9	3624	B01219	17172	GNG				deoxyguanosine	2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one	2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-one	deoxyribonucleoside		C10H13N5O4	C1C(C(OC1N2C=NC3=C2NC(=NC3=O)N)CO)O	0	N	267	215		10.8	-1.3	-1.4			DeoD3, Dgk1, DNADamage_DG_cyclodG_UVB_radiation	
DGDP	DGDP	dgdp	C00361		3652	B01227	28862	DGI	C00019355			dGDP	[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl (phosphonatooxy)phosphonate	[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl (phosphonatooxy)phosphonate	deoxyribonucleotide diphosphate		C10H12N5O10P2	C(OP(=O)([O-])OP(=O)([O-])[O-])C1(OC(CC(O)1)N3(C=NC2(C(=O)NC(N)=NC=23)))	-3	N	424	298		1.5	-2.9	-7.3			Gmk2, Gmk4, NrdEF_GDP, Pgk5, Pyk_DGDP	
DGMP		dgmp	C00362	902-04-5	3653	B01228	16192	DG	C00019356			dGMP	[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	deoxyribonucleotide monophosphate		C10H12N5O7P1	C(OP(=O)([O-])[O-])C1(OC(CC(O)1)N3(C=NC2(C(=O)NC(N)=NC=23)))	-2	N	345	255		1.5	-2.7	-5.3			Dgk1, DNADamage_SpontaneousBaseLoss_guanine, DNAPolymerization_dGTP, DNAProcessiveCleavage_dGMP, DNA_polymerization_dGTP_repair, Gmk2, Gmk4, HR_DNAResection_dGMP, TatD_dGMP, TX_ComEC_dGpdGp	
dGpdGp												dGp-dGp	[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[(phosphonatooxy)methyl]oxolan-3-yl] [5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-2-[(phosphonatooxy)methyl]oxolan-3-yl] [5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	dideoxynucleotide		C20H23N10O13P2	NC1=NC2=C(N=CN2C2CC(O)C(COP([O-])(=O)OC3CC(OC3COP([O-])([O-])=O)N3C=NC4=C3N=C(N)NC4=O)O2)C(=O)N1	-3	N	673	494		1.4	-4.2	-8.7			DNAPolymerization_dGTP, DNAProcessiveCleavage_dGMP, DNA_polymerization_dGTP_repair, HR_DNAResection_dGMP, TatD_dGMP, TX_ComEC_dGpdGp	
DGTP	DGTP	dgtp	C00286	2564-35-4	3581	B01207	16497	DGT	C00019346			dGTP	({[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	({[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	deoxyribonucleotide triphosphate		C10H12N5O13P3	C(OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])C1(OC(CC(O)1)N3(C=NC2(C(=O)NC(N)=NC=23)))	-4	N	503	340		1.2	-3.8	-10.1			DNAPolymerization_dGTP, DNA_polymerization_dGTP_repair, Pgk5, Pyk_DGDP	
DHA		dha	C00184	96-26-4	3484	B00055	16016	2HA				Dihydroxyacetone	dihydroxyacetone	1,3-dihydroxypropan-2-one			C3H6O3	C(C(=O)CO)O	0	N	90	81		5.2	-1.5	-1.5			DhaK	
DHdT				5627-00-9	10255868							5,6-dihydro-2'-deoxythymidine	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,3-diazinane-2,4-dione	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,3-diazinane-2,4-dione	modified deoxyribonucleoside		C10H16N2O5	CC1CN(C(=O)NC1=O)C2CC(C(O2)CO)O	0	N	244	213		4.4	-1.3	-1.3			TX_DHdT, UshA_DHdTMP	recognized by endonuclease III, FPG, UNG [PUB_0473]
DHdTMP												5,6-dihydro-2'-deoxythymidine monophosphate	[3-hydroxy-5-(5-methyl-2,4-dioxo-1,3-diazinan-1-yl)oxolan-2-yl]methyl phosphate	[3-hydroxy-5-(5-methyl-2,4-dioxo-1,3-diazinan-1-yl)oxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C10H15N2O8P1	CC1CN(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)NC1=O	-2	N	322	253			-1.5	-4.8			UshA_DHdTMP	
DHdU												5,6-dihydroxy-2'-deoxyuridine	5,6-dihydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrimidine-2,4-dione	5,6-dihydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified deoxyribonucleoside		C9H12N2O7	C1C(C(OC1N2C(=C(C(=O)NC2=O)O)O)CO)O	0	N	260	206		2.6	-1.6	-1.7			TX_DHdU, UshA_DHdUMP	
DHdUMP												5,6-dihydroxy-2'-deoxyuridine monophosphate	[5-(5,6-dihydroxy-2,4-dioxo-3H-pyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(5,6-dihydroxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C9H11N2O10P1	OC1CC(OC1COP([O-])([O-])=O)N1C(=O)NC(=O)C(O)=C1O	-2	N	338	246			-1.8	-5.1			UshA_DHdUMP	
DHF	DIHYDROFOLATE	dhf	C00415	4033-27-6	3705	B01240	15633	DHF	C00007248			dihydrofolate	2-[(4-{[(2-amino-4-oxo-7,8-dihydro-1H-pteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioate	2-[(4-{[(2-amino-4-oxo-1,4,7,8-tetrahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioate	vitamin	folate	C19H19N7O6	NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)NC(CCC([O-])=O)C([O-])=O)=N2)N1	-2	N	441	363		4.3	-1.8	-7.9			DhfR1, ThyA	
dhpdU												5'-dihydroxypentyl-2'-deoxyuridine	5-(4,5-dihydroxypentyl)-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrimidine-2,4-dione	5-(4,5-dihydroxypentyl)-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified deoxyribonucleoside		C14H22N2O7	C1=C(C(N(C(N1C2OC(C(C2)O)CO)=O)[H])=O)CCCC(O)CO	0	N	330	291		3.7	-1.9	-1.9			TX_dhpdU, UshA_dhpdUMP	occurs in bacteriophage DNA [PUB_0477]; in bacteriophage SP15 up to 60% thymidine replaced by dhpdU [PUB_0478];
dhpdUMP												5'-dihydroxypentyl-2'-deoxyuridine monophosphate	{5-[5-(4,5-dihydroxypentyl)-2,4-dioxo-3H-pyrimidin-1-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	{5-[5-(4,5-dihydroxypentyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C14H21N2O10P1	[H]N1C(=O)N(C=C(CCCC(O)CO)C1=O)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	408	331			-2.0	-5.3			UshA_dhpdUMP	
dhpURA					24612588							5'-dihydroxypentyluracil	5-(4,5-dihydroxypentyl)-1,3-dihydropyrimidine-2,4-dione	5-(4,5-dihydroxypentyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified nucleobase		C9H14N2O4	C1=C(C(N(C(N1)=O)[H])=O)CCCC(O)CO	0	N	214	191		3.6	-1.2	-1.2			DNADamage_hm5U_dhpURA_butylene_glycol	occurs in bacteriophage DNA [PUB_0477]; in bacteriophage SP15 up to 60% thymidine replaced by dhpdU [PUB_0478];
DHTHY	DIHYDRO-THYMINE		C00906		8144506		27468					5,6-dihydrothymine	5,6-dihydrothymine	5-methyl-1,3-diazinane-2,4-dione	modified nucleobase		C5H8N2O2	CC1CNC(=O)NC1=O	0	N	128	112			-0.7	-0.7			DNADamage_THY_DHTHY_hydrogen_radical	recognized by endonuclease III, FPG, UNG [PUB_0473]
DHURA				42608-53-7 	8191706							5,6-dihydroxyuracil; dialuric acid	5,6-dihydroxy-1,3-dihydropyrimidine-2,4-dione	5,6-dihydroxy-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified nucleobase		C4H4N2O4	N1C(=C(C(=O)NC1=O)O)O	0	N	144	106			-1.0	-1.0			DNADamage_DHURA_ho5Hydantoin_hydroxyl_radical, DNADamage_URA_DHURA_hydroxyl_radical	
diacylglycerolCys					23741369							S-diacylglycerol cysteine 	2-amino-3-{[2,3-bis(hexadecanoyloxy)propyl]sulfanyl}propanoic acid	2-amino-3-{[2,3-bis(hexadecanoyloxy)propyl]sulfanyl}propanoic acid			C38H73N1O6S1	CCCCCCCCCCCCCCCC(=O)OCC(CSCC(N)C(O)=O)OC(=O)CCCCCCCCCCCCCCC	0	N	672	721		5.4	9.7	9.7			ProLipoproteinDiacylglycerylTransferase, TX_diacylglycerolCys	
DIBUTYRIN												dibutyrin	2-hydroxy-1-[(2-oxopentyl)oxy]ethyl butanoate	2-hydroxy-1-[(2-oxopentyl)oxy]ethyl butanoate			C11H20O5	CCCC(=O)COC(CO)OC(=O)CCC	0	Y	232	229		5.3	1.6	1.6			LIPASE_DIBUTYRIN_MG310, LIPASE_DIBUTYRIN_MG327, LIPASE_DIBUTYRIN_MG344	
difloxacin			C11234		103163868							difloxacin			antibiotic	fluoroquinolone	C21H19F2N3O3	CN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F	0	N	399									Inhibits topoisomerase II/DNA gyrase and topoisomerase IV [PUB_0847].
dINS	DEOXYINOSINE	din	C05512	890-38-0	2620	B01869	28997	2ND				2'-deoxyinosine	9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one	9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-one	modified deoxyribonucleoside		C10H12N4O4	C1C(C(OC1N2C=NC3=C2NC=NC3=O)CO)O	-1	N	252	204		10.4	-1.1	-1.5			DeoD1, TX_dINS, UshA_dINSMP	
dINSMP					38399292							2'-deoxyinosine monophosphate	[3-hydroxy-5-(6-oxo-3H-purin-9-yl)oxolan-2-yl]methyl phosphate	[3-hydroxy-5-(6-oxo-6,9-dihydro-3H-purin-9-yl)oxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C10H11N4O7P1	OC1CC(OC1COP([O-])([O-])=O)N1C=NC2=C1NC=NC2=O	-3	N	330	244		3.5	-1.2	-4.9			UshA_dINSMP	
DMBA					8158944							dimethylbenzyl alcohol	2-phenyl isopropanol	2-phenylpropan-2-ol			C9H12O1	CC(C)(C1=CC=CC=C1)O	0	N	136	142		5.8	1.9	1.9			Ohr_CHP, OsmC_CHP	
DMN			C14704		14717781		35807					dimethyl nitrosamine	dimethylnitrosamine	dimethyl(nitroso)amine	alkylating agent	ethylation	C2H6N2O1	CN(C)N=O	0	N	74	73			0.0	0.0				DNA methylating agent [PUB_0467]
DNAD	DEAMIDO-NAD	dnad	C00857	6450-77-7	2609	B01343	18304	NXX				Deamino-NAD+	1-[5-({[({[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphinato]oxy}methyl)-3,4-dihydroxyoxolan-2-yl]-1$l^{5}-pyridin-1-ylium-3-carboxylate	1-[5-({[({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphinato]oxy}methyl)-3,4-dihydroxyoxolan-2-yl]-1$l^{5}-pyridin-1-ylium-3-carboxylate			C21H27N6O15P2	C(C5(C=CC=[N+](C1(C(C(O)C(O1)COP(=O)([O-])OP([O-])(OCC4(C(O)C(O)C(N2(C3(C(N=C2)=C(N=CN=3)N)))O4))=O)O))C=5))([O-])=O	-2	N	662	497		2.4	-10.1	-12.4				
doxorubicin			C01661		11533222		28748					Doxorubicin	adriamycin	10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione			C27H29N1O11	CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	1	N	544	464		9.1	0.9	-0.5			TX_MdlB_doxorubicin, TX_NormM_doxorubicin	
DPCOA	DEPHOSPHO-COA	dpcoa	C00882		4138	B04743	15468	COD				dephospho-CoA	[3-hydroxy-2,2-dimethyl-3-({2-[(2-sulfanylethyl)carbamoyl]ethyl}carbamoyl)propyl] ({[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	[3-hydroxy-2,2-dimethyl-3-({2-[(2-sulfanylethyl)carbamoyl]ethyl}carbamoyl)propyl] ({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	CoA derivative		C21H33N7O13P2S1	CC(C)(COP([O-])(=O)OP([O-])(=O)OCC1OC(C(O)C1O)N1C=NC2=C1N=CN=C2N)C(O)C(=O)NCCC(=O)NCCS	-2	N	686	544		2.9	-6.1	-8.0			CoaE	
DPG	DPG	13dpg	C00236	38168-82-0	3535	B01197	16001		C00019552			3-Phospho-D-glyceroyl phosphate	{[2-hydroxy-3-(phosphonatooxy)propanoyl]oxy}phosphonate	{[2-hydroxy-3-(phosphonatooxy)propanoyl]oxy}phosphonate	glycerate		C3H4O10P2	OC(COP([O-])([O-])=O)C(=O)OP([O-])([O-])=O	-4	N	262	170			-2.3	-8.9			GapA, Pgk1, Pgk2, Pgk3, Pgk4, Pgk5	
DR1P	DEOXY-RIBOSE-1P	2dr1p	C00672		3941	B04713	28542					2-Deoxy-D-ribose 1-phosphate	[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl] phosphate	[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl] phosphate	carbohydrate	sugar phosphate	C5H9O7P1	OCC1OC(CC1O)OP([O-])([O-])=O	-2	N	212	160			-1.5	-4.7			DeoD1, DeoD2, DeoD3, DeoD8, Pdp1, Pdp2	
DR5P	DEOXY-RIBOSE-5P	2dr5p	C00673		3942	B04714	16132					2-Deoxy-D-ribose 5-phosphate	(3,5-dihydroxyoxolan-2-yl)methyl phosphate	(3,5-dihydroxyoxolan-2-yl)methyl phosphate	carbohydrate	sugar phosphate	C5H9O7P1	OC1CC(O)C(COP([O-])([O-])=O)O1	-2	N	212	160			-1.5	-4.9			AP_endonuclease, AP_lyase, DeoC, deoxyribosephosphodiesterase, DNADamage_GammaRadiationInducedStrandBreak, DNADamage_SpontaneousAbasicSiteStrandBreak, DNADamage_SpontaneousBaseLoss_adenine, DNADamage_SpontaneousBaseLoss_cytosine, DNADamage_SpontaneousBaseLoss_guanine, DNADamage_SpontaneousBaseLoss_thymine, DNALigation, DNA_ligation_repair, DNA_RM_EcoD_Restriction, DNA_RM_MunI_Restriction, dRiboseP_lyase, HR_junctionResolution, MutM_FAPyAD, MutM_FAPyGN, MutM_oxo8AD, MutM_oxo8GN, NER_DNAIncision, Ung_ho5URA, Ung_URA	
dRibose5P_ddRibose5P												deoxyribose 5'-phosphate - dideoxyribose 5'-phosphate	5-(hydroxymethyl)-4-({[(5-hydroxyoxolan-2-yl)methoxy]phospho}oxy)oxolan-2-ol	5-(hydroxymethyl)-4-({[(5-hydroxyoxolan-2-yl)methoxy]phospho}oxy)oxolan-2-ol	carbohydrate	sugar phosphate	C10H17O12P2	O[C@@H]1CC[C@@H](CO[P@@]([O-])(=O)O[C@H]2C[C@@H](O)O[C@@H]2COP([O-])([O-])=O)O1	-3	N	391	294			-1.5	-7.2				
dRibose5P_dRibose5P												2-Deoxy-D-ribose 5-phosphate dimer	(3,5-dihydroxyoxolan-2-yl)methyl {5-hydroxy-2- [(phosphonatooxy)methyl]oxolan-3-yl} phosphate	(3,5-dihydroxyoxolan-2-yl)methyl {5-hydroxy-2- [(phosphonatooxy)methyl]oxolan-3-yl} phosphate			C10H17O13P2	OC1CC(O)C(COP([O-])(=O)OC2CC(O)OC2COP([O-])([O-])=O)O1	-3	N	407	303			-9.3	-7.9			AP_endonuclease, AP_lyase, deoxyribosephosphodiesterase, DNADamage_GammaRadiationInducedStrandBreak, DNADamage_SpontaneousAbasicSiteStrandBreak, DNALigation, DNA_ligation_repair, DNA_RM_EcoD_Restriction, DNA_RM_MunI_Restriction, dRiboseP_lyase, HR_junctionResolution, NER_DNAIncision	
DT	THYMIDINE	thymd	C00214	50-89-5	3514	B01191	17748	THM	C00019698			thymidine	thymidine	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione	deoxyribonucleoside		C10H14N2O5	CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O	0	N	242	206		3.5	-1.1	-1.1			Pdp2, Tdk2, UshA_dTMP	
dT64dC												2'-deoxythymidine-[6,4]-2'-deoxycytidine	5-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-{1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl}-5-methyl-1,3-diazinane-2,4-dione	5-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-{1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}-5-methyl-1,3-diazinane-2,4-dione	modified deoxyribonucleoside		C19H27N5O9	C1C(C(OC1N2C=CC(=NC2=O)C3C(C)(C(NC(N3C4CC(C(O4)CO)O)=O)=O)N)CO)O	0	N	469	396		8.8	-3.4	-3.4			TX_dT64dC, UshA_dTMP64dCMP	
dT64dC_dewar												2'-deoxythymidine-[6,4]-2'-deoxycytidine dewar product	5-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-{3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-5-methyl-1,3-diazinane-2,4-dione	5-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-{3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-5-methyl-1,3-diazinane-2,4-dione	modified deoxyribonucleoside		C19H27N5O9	C1C(C(OC1N3C2=CC(N2C3=O)C4C(C)(C(NC(N4C5CC(C(O5)CO)O)=O)=O)N)CO)O	0	N	469	389		8.8	-3.3	-3.3			TX_dT64dC_dewar, UshA_dTMP64dCMP_dewar	
dT64dT												2'-deoxythymidine-[6,4]-2'-deoxythymidine	5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-{1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl}-5-methyl-1,3-diazinane-2,4-dione	5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-{1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl}-5-methyl-1,3-diazinane-2,4-dione	modified deoxyribonucleoside		C20H28N4O10	CC1(C(N(C(=O)NC1=O)C2CC(C(O2)CO)O)C3=NC(=O)N(C=C3C)C4CC(C(O4)CO)O)O	0	N	484	409		4.4	-2.9	-2.9			TX_dT64dT, UshA_dTMP64dTMP	
dT64dT_dewar												2'-deoxythymidine-[6,4]-2'-deoxythymidine dewar product	5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-{3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-5-methyl-1,3-diazinane-2,4-dione	5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-{3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-5-methyl-1,3-diazinane-2,4-dione	modified deoxyribonucleoside		C20H28N4O10	CC2=C1N(C(=O)N1C2C3C(C)(C(NC(N3C4CC(C(O4)CO)O)=O)=O)O)C5CC(C(O5)CO)O	0	N	484	402		4.4	-2.9	-2.9			TX_dT64dT_dewar, UshA_dTMP64dTMP_dewar	
DTDP	TDP	dtdp	C00363		3654	B01229	18075		C00019696			dTDP	[3-hydroxy-5-(5-methyl-2,4-dioxo-3H-pyrimidin-1-yl)oxolan-2-yl]methyl (phosphonatooxy)phosphonate	[3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methyl (phosphonatooxy)phosphonate	deoxyribonucleotide diphosphate		C10H13N2O11P2	CC1(=CN(C(=O)NC(=O)1)C2(CC(O)C(COP(=O)([O-])OP(=O)([O-])[O-])O2))	-3	N	399	289			-1.7	-6.6			Pyk_DTDP, Tmk	
DTMP	TMP	dtmp	C00364	365-07-1	3655	B01230	17013	DT	C00019637			dTMP	[3-hydroxy-5-(5-methyl-2,4-dioxo-3H-pyrimidin-1-yl)oxolan-2-yl]methyl phosphate	[3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methyl phosphate	deoxyribonucleotide monophosphate		C10H13N2O8P1	CC1(=CN(C(=O)NC(=O)1)C2(CC(O)C(COP(=O)([O-])[O-])O2))	-2	N	320	246			-1.2	-4.6			DNADamage_SpontaneousBaseLoss_thymine, DNAPolymerization_dTTP, DNAProcessiveCleavage_dTMP, DNA_polymerization_dTTP_repair, HR_DNAResection_dTMP, TatD_dTMP, Tdk2, ThyA, Tmk, TX_ComEC_dTpdTp, UshA_dTMP	
dTMP64dCMP												2'-deoxythymidine monophosphate-[6,4]-2'-deoxycytidine monophosphate	{5-[5-amino-6-(1-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-2-oxopyrimidin-4-yl)-5-methyl-2,4-dioxo-1,3-diazinan-1-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	{5-[5-amino-6-(1-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-2-oxo-1,2-dihydropyrimidin-4-yl)-5-methyl-2,4-dioxo-1,3-diazinan-1-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C19H25N5O15P2	CC1(N)C(N(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)NC1=O)C1=NC(=O)N(C=C1)C1CC(O)C(COP([O-])([O-])=O)O1	-4	N	625	476		1.6	-7.0	-10.3			UshA_dTMP64dCMP	
dTMP64dCMP_dewar												2'-deoxythymidine monophosphate-[6,4]-2'-deoxycytidine monophosphate dewar product	{5-[6-(5-amino-3-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-5-methyl-2,6-dioxo-1,3-diazinan-4-yl)-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-3-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	{5-[6-(5-amino-3-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-5-methyl-2,6-dioxo-1,3-diazinan-4-yl)-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-3-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C19H25N5O15P2	CC1(N)C(C2C=C3N2C(=O)N3C2CC(O)C(COP([O-])([O-])=O)O2)N(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)NC1=O	-4	N	625	469		1.6	-6.9	-10.1			UshA_dTMP64dCMP_dewar	
dTMP64dTMP												2'-deoxythymidine monophosphate-[6,4]-2'-deoxythymidine monophosphate	{3-hydroxy-5-[4-(5-hydroxy-3-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-5-methyl-2,6-dioxo-1,3-diazinan-4-yl)-5-methyl-2-oxopyrimidin-1-yl]oxolan-2-yl}methyl phosphate	{3-hydroxy-5-[4-(5-hydroxy-3-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-5-methyl-2,6-dioxo-1,3-diazinan-4-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl]oxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C20H26N4O16P2	CC1=CN(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)N=C1C1N(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)NC(=O)C1(C)O	-4	N	640	491			-3.1	-9.8			UshA_dTMP64dTMP	
dTMP64dTMP_dewar												2'-deoxythymidine monophosphate-[6,4]-2'-deoxythymidine monophosphate dewar product	{3-hydroxy-5-[5-hydroxy-6-(3-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-5-methyl-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl)-5-methyl-2,4-dioxo-1,3-diazinan-1-yl]oxolan-2-yl}methyl phosphate	{3-hydroxy-5-[5-hydroxy-6-(3-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-5-methyl-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl)-5-methyl-2,4-dioxo-1,3-diazinan-1-yl]oxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C20H26N4O16P2	CC1=C2N(C1C1N(C3CC(O)C(COP([O-])([O-])=O)O3)C(=O)NC(=O)C1(C)O)C(=O)N2C1CC(O)C(COP([O-])([O-])=O)O1	-4	N	640	482			-3.2	-9.9			UshA_dTMP64dTMP_dewar	
dTMP_GLYC				6168-31-	52369065							2'-deoxythymidine monophosphate glycol	[5-(5,6-dihydroxy-5-methyl-2,4-dioxo-1,3-diazinan-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(5,6-dihydroxy-5-methyl-2,4-dioxo-1,3-diazinan-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C10H15N2O10P1	CC1(O)C(O)N(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)NC1=O	-2	N	354	271			-2.6	-6.0			UshA_dTMP_GLY	
dTpdTp												dTp-dTp	[3-hydroxy-5-(5-methyl-2,4-dioxo-3H-pyrimidin-1-yl)oxolan-2-yl]methyl [5-(5-methyl-2,4-dioxo-3H-pyrimidin-1-yl)-2-[(phosphonatooxy)methyl]oxolan-3-yl] phosphate	[3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methyl [5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-2-[(phosphonatooxy)methyl]oxolan-3-yl] phosphate	dideoxynucleotide		C20H25N4O15P2	CC1=CN(C2CC(O)C(COP([O-])(=O)OC3CC(OC3COP([O-])([O-])=O)N3C=C(C)C(=O)NC3=O)O2)C(=O)NC1=O	-3	N	623	476			-1.6	-7.3			DNAPolymerization_dTTP, DNAProcessiveCleavage_dTMP, DNA_polymerization_dTTP_repair, HR_DNAResection_dTMP, TatD_dTMP, TX_ComEC_dTpdTp	
DTTP	TTP	dttp	C00459		3743	B01249	18077	TTP	C00019695			dTTP	({[3-hydroxy-5-(5-methyl-2,4-dioxo-3H-pyrimidin-1-yl)oxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	({[3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	deoxyribonucleotide triphosphate		C10H13N2O14P3	CC1(=CN(C(=O)NC(=O)1)C2(CC(O)C(COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O2))	-4	N	478	331			-2.1	-9.4			DNAPolymerization_dTTP, DNA_polymerization_dTTP_repair, Pyk_DTDP	
dT_GLYC					49978348							2'-deoxythymidine glycol	5,6-dihydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,3-diazinane-2,4-dione	5,6-dihydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,3-diazinane-2,4-dione	modified deoxyribonucleoside		C10H16N2O7	CC1(C(N(C(=O)NC1=O)C2CC(C(O2)CO)O)O)O	0	N	276	230		4.1	-2.5	-2.5			TX_dT_GLYC, UshA_dTMP_GLY	recognized by endonuclease III, FPG, UNG [PUB_0473]
DU	DEOXYURIDINE	duri	C00526	951-78-0	3809	B01281	16450	DUR	C00019697			deoxyuridine	uridine, 2'-deoxy-	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified deoxyribonucleoside		C9H12N2O5	C1C(C(OC1N2C=CC(=O)NC2=O)CO)O	0	N	228	189		3.4	-1.5	-1.5			Cdd2, DeoD8, Pdp1, Tdk1, UshA_dUMP	recognized by endonuclease III, FPG, UNG [PUB_0473]
DUDP	DUDP	dudp	C01346		4551	B01441	28850	DUD				dUDP	[5-(2,4-dioxo-3H-pyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl (phosphonatooxy)phosphonate	[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl (phosphonatooxy)phosphonate	modified deoxyribonucleotide diphosphate		C9H11N2O11P2	C1(=CC(=O)NC(=O)N1C2(CC(O)C(COP(=O)([O-])OP(=O)([O-])[O-])O2))	-3	N	385	272			-2.1	-7.0			NrdEF_UDP, Pyk_DUDP	
DUMP	DUMP	dump	C00365	964-26-1	3656	B01231	17622	DU	C00019282			dUMP	[5-(2,4-dioxo-3H-pyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C9H11N2O8P1	C1(=CC(=O)NC(=O)N1C2(CC(O)C(COP(=O)([O-])[O-])O2))	-2	N	306	229			-1.6	-5.0			Tdk1, ThyA, Ung_URA, UshA_dUMP	
DUTP	DUTP	dutp	C00460		3744	B01250	17625	DUT	C00019636			dUTP	({[5-(2,4-dioxo-3H-pyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	({[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	modified deoxyribonucleotide triphosphate		C9H11N2O14P3	C1(=CC(=O)NC(=O)N1C2(CC(O)C(COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O2))	-4	N	464	314			-2.5	-9.8			Pyk_DUDP	
dXAN				29049-22-7	8189652							2'-deoxyxanthosine	9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-dihydropurine-2,6-dione	9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,3,6,9-tetrahydro-1H-purine-2,6-dione	modified deoxyribonucleoside		C10H12N4O5	C1C(C(OC1N2C=NC3=C2NC(=O)NC3=O)CO)O	0	N	268	211		3.6	-0.9	-0.9			TX_dXAN, UshA_dXANMP	
dXANMP	CPD0-1468				57393982							2'-deoxyxanthosine monophosphate	[5-(2,6-dioxo-1,3-dihydropurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C10H11N4O8P1	OC1CC(OC1COP([O-])([O-])=O)N1C=NC2=C1NC(=O)NC2=O	-2	N	346	252			-1.0	-4.4			UshA_dXANMP	
e1AD												1-ethyladenine	6-amino-1-ethyl-9H-purin-1-ium	6-amino-1-ethyl-9H-purin-1-ium	modified nucleobase	ethylation	C7H10N5	CC[N+]1=C(N)C2=C(NC=N2)N=C1	1	N	164	144		6.6	-5.1	-5.1			DNADamage_AD_e1AD_DES, DNADamage_AD_e1AD_EMS, DNADamage_AD_e1AD_ENU	
e1dA												1-ethyl-2'-deoxyadenosine	6-amino-1-ethyl-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-1-ium	6-amino-1-ethyl-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-1-ium	modified deoxyribonucleoside	ethylation	C12H18N5O3	CC[N+]1=C(N)C2=C(N=C1)N(C=N2)C1CC(O)C(CO)O1	1	N	280	244		8.5	-5.8	-5.8			TX_e1dA, UshA_e1dAMP	
e1dAMP												1-ethyl-2'-deoxyadenosine monophosphate	6-amino-1-ethyl-9-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}purin-1-ium	6-amino-1-ethyl-9-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-9H-purin-1-ium	modified deoxyribonucleotide monophosphate	ethylation	C12H17N5O6P1	CC[N+]1=C(N)C2=C(N=C1)N(C=N2)C1CC(O)C(COP([O-])([O-])=O)O1	-1	N	358	284		2.2	-7.4	-9.0			UshA_e1dAMP	
e1dG												1-ethyl-2'-deoxyguanosine	2-amino-1-ethyl-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-one	2-amino-1-ethyl-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one	modified deoxyribonucleoside	ethylation	C12H17N5O4	CCN1C(=O)C2=C(N=C1N)N(C=N2)C1CC(O)C(CO)O1	0	N	295	250		7.9	-1.2	-1.2			TX_e1dG, UshA_e1dGMP	
e1dGMP												1-ethyl-2'-deoxyguanosine monophosphate	[5-(2-amino-1-ethyl-6-oxopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2-amino-1-ethyl-6-oxo-6,9-dihydro-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	ethylation	C12H16N5O7P1	CCN1C(=O)C2=C(N=C1N)N(C=N2)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	373	290		1.5	-2.2	-4.7			UshA_e1dGMP	
e1GN												1-ethylguanine	2-amino-1-ethyl-9H-purin-6-one	2-amino-1-ethyl-6,9-dihydro-1H-purin-6-one	modified nucleobase	ethylation	C7H9N5O1	CCN1C(=O)C2=C(NC=N2)N=C1N	0	N	179	149		6.4	-0.6	-0.6			DNADamage_GN_e1GN_DES, DNADamage_GN_e1GN_EMS, DNADamage_GN_e1GN_ENU	
e3AD				43003-87-8	24462545							3-ethyladenine	3-ethyl-9H-purin-6-imine	3-ethyl-6,9-dihydro-3H-purin-6-imine	modified nucleobase	ethylation	C7H9N5	CCN1C=NC(=N)C2=C1NC=N2	0	N	163	141		8.3	-0.6	-0.6			DNADamage_AD_e3AD_DES, DNADamage_AD_e3AD_EMS, DNADamage_AD_e3AD_ENU	
e3CSN												3-ethylcytosine	4-(ethylamino)-1H-pyrimidin-2-one	4-(ethylamino)-1,2-dihydropyrimidin-2-one	modified nucleobase	ethylation	C6H9N3O1	CCNC1=NC(=O)NC=C1	0	N	139	126		12.5	-0.6	-0.6			DNADamage_CSN_e3CSN_DES, DNADamage_CSN_e3CSN_EMS, DNADamage_CSN_e3CSN_ENU	
e3dA												3-ethyl-2'-deoxyadenosine	5-(3-ethyl-6-iminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol	5-(3-ethyl-6-imino-6,9-dihydro-3H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol	modified deoxyribonucleoside	ethylation	C12H17N5O3	C(N1C=NC(=N)C2=C1[N](C=N2)C3CC(C(O3)CO)O)C	0	N	279	241		8.9	-1.3	-1.3			TX_e3dA, UshA_e3dAMP	
e3dAMP												3-ethyl-2'-deoxyadenosine monophosphate	[5-(3-ethyl-6-iminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(3-ethyl-6-imino-6,9-dihydro-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	ethylation	C12H16N5O6P1	CCN1C=NC(=N)C2=C1N(C=N2)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	357	281		2.7	-4.2	-4.7			UshA_e3dAMP	
e3dC					85555081		363482					3-ethyl-2'-deoxycytidine	4-(ethylamino)-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	4-(ethylamino)-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one	modified deoxyribonucleoside	ethylation	C11H17N3O4	CCNC1=NC(=O)N(C=C1)C2CC(C(O2)CO)O	0	N	255	227		7.6	-1.3	-1.3			TX_e3dC, UshA_e3dCMP	
e3dCMP												3-ethyl-2'-deoxycytidine monophosphate	{5-[4-(ethylamino)-2-oxopyrimidin-1-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	{5-[4-(ethylamino)-2-oxo-1,2-dihydropyrimidin-1-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate	ethylation	C11H16N3O7P1	CCNC1=NC(=O)N(C=C1)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	333	267		1.1	-2.0	-4.7			UshA_e3dCMP	
e3dG												3-ethyl-2'-deoxyguanosine	2-amino-3-ethyl-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-one	2-amino-3-ethyl-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-one	modified deoxyribonucleoside	ethylation	C12H17N5O4	CCN1C2=C(N=CN2C2CC(O)C(CO)O2)C(=O)N=C1N	0	N	295	250		7.1	-1.6	-1.6			TX_e3dG, UshA_e3dGMP	
e3dGMP												3-ethyl-2'-deoxyguanosine monophosphate	[5-(2-amino-3-ethyl-6-oxopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2-amino-3-ethyl-6-oxo-6,9-dihydro-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	ethylation	C12H16N5O7P1	CCN1C2=C(N=CN2C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)N=C1N	-2	N	373	290		1.4	-2.0	-5.0			UshA_e3dGMP	
e3dT				21473-40-5	24518675							3'-ethyl-2'-deoxythymidine	3-ethyl-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione	3-ethyl-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified deoxyribonucleoside	ethylation	C12H18N2O5	CCN1C(=O)C(=CN(C1=O)C2CC(C(O2)CO)O)C	0	N	270	241		5.5	-0.5	-0.5			TX_e3dT, UshA_e3dTMP	
e3dTMP												3'-ethyl-2'-deoxythymidine monophosphate	[5-(3-ethyl-5-methyl-2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(3-ethyl-5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	ethylation	C12H17N2O8P1	CCN1C(=O)N(C=C(C)C1=O)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	348	281			-0.7	-4.0			UshA_e3dTMP	
e3GN												3-ethylguanine	2-amino-3-ethyl-7H-purin-6-one	2-amino-3-ethyl-6,7-dihydro-3H-purin-6-one	modified nucleobase	ethylation	C7H9N5O1	CCN1C2=C(NC=N2)C(=O)N=C1N	0	N	179	149		5.2	-0.9	-0.9			DNADamage_GN_e3GN_DES, DNADamage_GN_e3GN_EMS, DNADamage_GN_e3GN_ENU	
e3THY					54576237							3'-ethylthymine	3-ethyl-5-methyl-1H-pyrimidine-2,4-dione	3-ethyl-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified nucleobase	ethylation	C7H10N2O2	CCN1C(=O)C(=CNC1=O)C	0	N	154	140		3.5	0.1	0.1			DNADamage_THY_e3THY_DES, DNADamage_THY_e3THY_EMS, DNADamage_THY_e3THY_ENU	
e4CSN					41610900							4-ethylcytosine	4-amino-4-ethyl-1,3-dihydropyrimidin-2-one	4-amino-4-ethyl-1,2,3,4-tetrahydropyrimidin-2-one	modified nucleobase	ethylation	C6H11N3O1	N1C=CC(NC1=O)(N)CC	1	N	141	132		10.5	-0.4	-1.2				
e4dC												4-ethyl-2'-deoxycytidine	4-amino-4-ethyl-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrimidin-2-one	4-amino-4-ethyl-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidin-2-one	modified deoxyribonucleoside	ethylation	C11H19N3O4	C1C(C(OC1N2C=CC(NC2=O)(N)CC)CO)O	1	N	257	232		10.4	-1.0	-1.9			TX_e4dC, UshA_e4dCMP	
e4dCMP												4-ethyl-2'-deoxycytidine monophosphate	[5-(4-amino-4-ethyl-2-oxo-3H-pyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(4-amino-4-ethyl-2-oxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	ethylation	C11H18N3O7P1	CCC1(N)NC(=O)N(C=C1)C1CC(O)C(COP([O-])([O-])=O)O1	-1	N	335	272		3.6	-5.4	-5.3			UshA_e4dCMP	
E4P	ERYTHROSE-4P	e4p	C00279	585-18-2	3574	B04660	48153		C00007472			D-Erythrose 4-phosphate	2,3-dihydroxy-4-(phosphonatooxy)butanal	2,3-dihydroxy-4-(phosphonatooxy)butanal	carbohydrate	sugar phosphate	C4H7O7P1	OC(COP([O-])([O-])=O)C(O)C=O	-2	N	198	147			-2.4	-5.6			TalA, Tkt2	
e5CSN					46170859							5-ethylcytosine	4-amino-5-ethyl-1H-pyrimidin-2-one	4-amino-5-ethyl-1,2-dihydropyrimidin-2-one	modified nucleobase	ethylation	C6H9N3O1	CCC1=CNC(=O)N=C1N	0	N	139	126		12.6	-0.4	-0.4				
e5dC					8668654							5-ethyl-2'-deoxycytidine	4-amino-5-ethyl-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	4-amino-5-ethyl-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one	modified deoxyribonucleoside	ethylation	C11H17N3O4	CCC1=CN(C(=O)N=C1N)C2CC(C(O2)CO)O	0	N	255	226		7.8	-1.1	-1.1			TX_e5dC, UshA_e5dCMP	
e5dCMP												5-ethyl-2'-deoxycytidine monophosphate	[5-(4-amino-5-ethyl-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(4-amino-5-ethyl-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	ethylation	C11H16N3O7P1	CCC1=CN(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)N=C1N	-2	N	333	266		1.5	-2.0	-4.5			UshA_e5dCMP	
e6AD												6-ethyladenine	N-ethyl-9H-purin-6-amine	adenine,N6-ethyl	modified nucleobase	ethylation	C7H9N5	CCNC1=NC=NC2=C1N=CN2	0	N	163	142		7.6	0.1	0.1			DNADamage_AD_e6AD_DES, DNADamage_AD_e6AD_EMS, DNADamage_AD_e6AD_ENU	
e6dA					85333496		133709					6-ethyl-2'-deoxyadenosine	5-[6-(ethylamino)-9H-purin-9-yl]-2-(hydroxymethyl)oxolan-3-ol	5-[6-(ethylamino)purin-9-yl]-2-(hydroxymethyl)oxolan-3-ol	modified deoxyribonucleoside	ethylation	C12H17N5O3	CCNC1=NC=NC2=C1N=CN2C1CC(O)C(CO)O1	0	N	279	242		9.4	-0.5	-0.5			TX_e6dA, UshA_e6dAMP	
e6dAMP												6-ethyl-2'-deoxyadenosine monophosphate	{5-[6-(ethylamino)-9H-purin-9-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	{5-[6-(ethylamino)purin-9-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate	ethylation	C12H16N5O6P1	CCNC1=NC=NC2=C1N=CN2C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	357	282		3.8	-3.6	-4.0			UshA_e6dAMP	
e7AD												7-ethyladenine	7-ethylpurin-6-amine	7-ethyl-7H-purin-6-amine	modified nucleobase	ethylation	C7H9N5	CCN1C=NC2=C1C(N)=NC=N2	0	N	163	142		13.1	0.0				DNADamage_AD_e7AD_DES, DNADamage_AD_e7AD_EMS, DNADamage_AD_e7AD_ENU	
e7dA												7-ethyl-2'-deoxyadenosine	6-amino-7-ethyl-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,7,9$l^{5}-purin-9-ylium	6-amino-7-ethyl-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7H-1,3,7,9$l^{5}-purin-9-ylium	modified deoxyribonucleoside	ethylation	C12H18N5O3	CCN1C=[N+](C2CC(O)C(CO)O2)C2=C1C(N)=NC=N2	1	N	280	244		5.8	-4.7	-4.7			TX_e7dA, UshA_e7dAMP	
e7dAMP												7-ethyl-2'-deoxyadenosine monophosphate	6-amino-7-ethyl-9-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-1,3,7,9$l^{5}-purin-9-ylium	6-amino-7-ethyl-9-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-7H-1,3,7,9$l^{5}-purin-9-ylium	modified deoxyribonucleotide monophosphate	ethylation	C12H17N5O6P1	CCN1C=[N+](C2CC(O)C(COP([O-])([O-])=O)O2)C2=C1C(N)=NC=N2	-1	N	358	284			-4.9	-7.3			UshA_e7dAMP	
e7dG												7-ethyl-2'-deoxyguanosine	2-amino-7-ethyl-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-1,3,7,9$l^{5}-purin-9-ylium	2-amino-7-ethyl-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-6,7-dihydro-3H-1,3,7,9$l^{5}-purin-9-ylium	modified deoxyribonucleoside	ethylation	C12H18N5O4	C([N]1C=[N+](C2=C1C(=O)N=C(N2)N)C3CC(C(O3)CO)O)C	1	N	296	252		3.0	-4.9	-5.0			TX_e7dG, UshA_e7dGMP	
e7dGMP												7-ethyl-2'-deoxyguanosine monophosphate	2-amino-7-ethyl-9-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-6-oxo-3H-1,3,7,9$l^{5}-purin-9-ylium	2-amino-7-ethyl-9-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-6-oxo-6,7-dihydro-3H-1,3,7,9$l^{5}-purin-9-ylium	modified deoxyribonucleotide monophosphate	ethylation	C12H17N5O7P1	CCN1C=[N+](C2CC(O)C(COP([O-])([O-])=O)O2)C2=C1C(=O)N=C(N)N2	-1	N	374	292			-5.1	-7.6			UshA_e7dGMP	
e7GN												7-ethylguanine	2-amino-7-ethyl-3H-purin-6-one	2-amino-7-ethyl-6,7-dihydro-3H-purin-6-one	modified nucleobase	ethylation	C7H9N5O1	CCN1C=NC2=C1C(=O)N=C(N)N2	0	N	179	149		12.1	0.0	0.0			DNADamage_GN_e7GN_DES, DNADamage_GN_e7GN_EMS, DNADamage_GN_e7GN_ENU	
e8dG												8-ethyl-2'-deoxyguanosine	2-amino-8-ethyl-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-3H-purin-6-one	2-amino-8-ethyl-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,7,8,9-tetrahydro-3H-purin-6-one	modified deoxyribonucleoside	ethylation	C12H19N5O4	N1C(N(C2=C1C(=O)N=C(N2)N)C3CC(C(O3)CO)O)CC	0	N	297	255		11.8	-1.3	-1.4			TX_e8dG, UshA_e8dGMP	
e8dGMP												8-ethyl-2'-deoxyguanosine monophosphate	[5-(2-amino-8-ethyl-6-oxo-7,8-dihydro-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2-amino-8-ethyl-6-oxo-6,7,8,9-tetrahydro-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	ethylation	C12H18N5O7P1	CCC1NC2=C(NC(N)=NC2=O)N1C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	375	294		6.1	-5.2	-4.8			UshA_e8dGMP	
e8GN												8-ethylguanine	2-amino-8-ethyl-3,7,8,9-tetrahydropurin-6-one	2-amino-8-ethyl-6,7,8,9-tetrahydro-3H-purin-6-one	modified nucleobase	ethylation	C7H11N5O1	N1C(NC2=C1C(=O)N=C(N2)N)CC	0	N	181	154		12.5	-0.8	-0.9				
EMS					85497932		305656					ethyl methanesulfonate	ethyl methanesulfonate	ethyl methanesulfonate	alkylating agent	ethylation	C3H8O3S1	CCOS(=O)(=O)C	0	N	124	107			-0.2	-0.2			DNADamage_AD_e1AD_EMS, DNADamage_AD_e3AD_EMS, DNADamage_AD_e6AD_EMS, DNADamage_AD_e7AD_EMS, DNADamage_CSN_e3CSN_EMS, DNADamage_CSN_O2eCSN_EMS, DNADamage_GN_e1GN_EMS, DNADamage_GN_e3GN_EMS, DNADamage_GN_e7GN_EMS, DNADamage_GN_O6eGN_EMS, DNADamage_THY_e3THY_EMS, DNADamage_THY_O2eTHY_EMS, DNADamage_THY_O4eTHY_EMS	SN1/SN2 DNA methylating agent [PUB_0467]
ENNG					24599990							ethyl-N'-nitro-N-nitrosoguanidine	1-ethyl-2-nitro-1-nitrosoguanidine	1-ethyl-2-nitro-1-nitrosoguanidine	alkylating agent	ethylation	C3H7N5O3	CCN(C(=N[N+](=O)[O-])N)N=O	0	N	161	127			-0.1	-0.1				SN1 DNA methylating agent [PUB_0467]
enoxacin			C06979		85356621		157175					Enoxacin	enoxacin	1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid	antibiotic	fluoroquinolone	C15H17F1N4O3	CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O	0	N	320	273		7.2	-1.7	-1.7			TX_NormM_enoxacin	Inhibits topoisomerase II/DNA gyrase and topoisomerase IV [PUB_0847].
ENU					85240160		23995					ethyl nitrosourea	1-ethyl-1-nitrosourea	1-ethyl-1-nitrosourea	alkylating agent	ethylation	C3H7N3O2	CCN(C(=O)N)N=O	0	N	117	102			-0.2	-0.2			DNADamage_AD_e1AD_ENU, DNADamage_AD_e3AD_ENU, DNADamage_AD_e6AD_ENU, DNADamage_AD_e7AD_ENU, DNADamage_CSN_e3CSN_ENU, DNADamage_CSN_O2eCSN_ENU, DNADamage_GN_e1GN_ENU, DNADamage_GN_e3GN_ENU, DNADamage_GN_e7GN_ENU, DNADamage_GN_O6eGN_ENU, DNADamage_THY_e3THY_ENU, DNADamage_THY_O2eTHY_ENU, DNADamage_THY_O4eTHY_ENU	SN1 DNA methylating agent [PUB_0467]
epsilon1N2dG				108929-11-9	75846477							1,N2-etheno-2'-deoxyguanosine	3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4H-imidazo[1,2-a]purin-9-one	3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,4H,9H-imidazo[1,2-a]purin-9-one	modified deoxyribonucleoside		C12H13N5O4	C1C(C(OC1N2C=NC3=C2NC4=NC=CN4C3=O)CO)O	0	N	291	231		6.4	0.2	0.2			TX_epsilon1N2dG, UshA_epsilon1N2dGMP	
epsilon1N2dGMP												1,N2-etheno-2'-deoxyguanosine monophosphate	(3-hydroxy-5-{9-oxo-4H-imidazo[1,2-a]purin-3-yl}oxolan-2-yl)methyl phosphate	(3-hydroxy-5-{9-oxo-3H,4H,9H-imidazo[1,2-a]purin-3-yl}oxolan-2-yl)methyl phosphate	modified deoxyribonucleotide monophosphate		C12H12N5O7P1	OC1CC(OC1COP([O-])([O-])=O)N1C=NC2=C1NC1=NC=CN1C2=O	-2	N	369	272		1.5	-0.9	-3.3			UshA_epsilon1N2dGMP	
epsilon1N2GN				56287-13-9	24506279							1,N2-etheno-guanine	3H,4H-imidazo[1,2-a]purin-9-one	3H,4H,9H-imidazo[1,2-a]purin-9-one	modified nucleobase		C7H5N5O1	O=C1N2C=CN=C2NC2=C1N=CN2	0	N	175	131		6.8	0.8	0.8			DNADamage_GN_epsilon1N2GN_chloroethylene_oxide	
epsilon1N6AD	CPD0-1927				8146699		29146					1,N6-etheno-adenine	3H-imidazo[2,1-f]purine	3H-imidazo[2,1-f]purine	modified nucleobase		C7H5N5	N1C=NC2=C1N=CN1C=CN=C21	0	N	159	124		7.0	-0.8	-0.8			DNADamage_AD_epsilon1N6AD_chloroethylene_oxide	
epsilon1N6dA					24894542							1,N6-etheno-2'-deoxyadenosine	2-(hydroxymethyl)-5-{imidazo[2,1-f]purin-3-yl}oxolan-3-ol	2-(hydroxymethyl)-5-{3H-imidazo[2,1-f]purin-3-yl}oxolan-3-ol	modified deoxyribonucleoside		C12H13N5O3	C1C(C(OC1N2C=NC3=C2N=CN4C3=NC=C4)CO)O	0	N	275	224		9.4	-1.4	-1.5			TX_epsilon1N6dA, UshA_epsilon1N6dAMP	
epsilon1N6dAMP												1,N6-etheno-2'-deoxyadenosine monophosphate	(3-hydroxy-5-{imidazo[2,1-f]purin-3-yl}oxolan-2-yl)methyl phosphate	(3-hydroxy-5-{3H-imidazo[2,1-f]purin-3-yl}oxolan-2-yl)methyl phosphate	modified deoxyribonucleotide monophosphate		C12H12N5O6P1	OC1CC(OC1COP([O-])([O-])=O)N1C=NC2=C1N=CN1C=CN=C21	-2	N	353	264		3.3	-4.2	-4.9			UshA_epsilon1N6dAMP	
epsilon3N4CSN	CPD0-1931				87254954		551784					3,N4-etheno-cytosine	6H-imidazo[1,2-c]pyrimidin-5-one	5H,6H-imidazo[1,2-c]pyrimidin-5-one	modified nucleobase		C6H5N3O1	N2C=CC1=NC=C[N]1C2=O	0	N	135	109		5.5	-0.1	-0.1			DNADamage_CSN_epsilon3N4CSN_chloroethylene_oxide	
epsilon3N4dC				68498-26-0	10234429							3,N4-etheno-2'-deoxycytidine	6-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[1,2-c]pyrimidin-5-one	6-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5H,6H-imidazo[1,2-c]pyrimidin-5-one	modified deoxyribonucleoside		C11H13N3O4	C1C(C(OC1N2C=CC3=NC=CN3C2=O)CO)O	0	N	251	209		6.9	-0.7	-0.7			TX_epsilon3N4dC, UshA_epsilon3N4dCMP	
epsilon3N4dCMP												3,N4-etheno-2'-deoxycytidine monophosphate	(3-hydroxy-5-{5-oxoimidazo[1,2-c]pyrimidin-6-yl}oxolan-2-yl)methyl phosphate	(3-hydroxy-5-{5-oxo-5H,6H-imidazo[1,2-c]pyrimidin-6-yl}oxolan-2-yl)methyl phosphate	modified deoxyribonucleotide monophosphate		C11H12N3O7P1	OC1CC(OC1COP([O-])([O-])=O)N1C=CC2=NC=CN2C1=O	-2	N	329	249		0.6	-1.1	-4.2			UshA_epsilon3N4dCMP	
epsilonN23dG				121055-53-6 	78853880							N2,3-etheno-2'-deoxyguanosine	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5H-imidazo[2,1-b]purin-4-one	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H,4H,5H-imidazo[2,1-b]purin-4-one	modified deoxyribonucleoside		C12H13N5O4	C1C(C(OC1N2C=NC3=C2N4C=CN=C4NC3=O)CO)O	0	N	291	232		5.7	-1.8	-1.8			TX_epsilonN23dG, UshA_epsilonN23dGMP	
epsilonN23dGMP												N2,3-etheno-2'-deoxyguanosine monophosphate	(3-hydroxy-5-{4-oxo-5H-imidazo[2,1-b]purin-1-yl}oxolan-2-yl)methyl phosphate	(3-hydroxy-5-{4-oxo-1H,4H,5H-imidazo[2,1-b]purin-1-yl}oxolan-2-yl)methyl phosphate	modified deoxyribonucleotide monophosphate		C12H12N5O7P1	OC1CC(OC1COP([O-])([O-])=O)N1C=NC2=C1N1C=CN=C1NC2=O	-2	N	369	272		1.5	-3.2	-5.4			UshA_epsilonN23dGMP	
epsilonN23GN				56287-13-9	24520287							N2,3-etheno-guanine	1H,5H-imidazo[2,1-b]purin-4-one	1H,4H,5H-imidazo[2,1-b]purin-4-one	modified nucleobase		C7H5N5O1	O=C1NC2=NC=CN2C2=C1N=CN2	0	N	175	131		6.0	-1.0	-1.0			DNADamage_GN_epsilonN23GN_chloroethylene_oxide	
erythromycin			C01912	114-07-8	46508487		48923					erythromycin			antibiotic	macrolide	C37H67N1O13	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	0	N	734									Binds 50 S ribosomal subunit near the P site so that binding of tRNA to the donor site is blocked [PUB_0847]. Also prevents translocation of peptides from the A to P site [PUB_0847].
ES					8153734							ethylsulfate	ethyl sulfate	ethoxysulfonic acid	alkylating agent	ethylation	C2H6O4S1	CCOS(=O)(=O)O	-1	N	126	99			-0.1	-2.5			DNADamage_AD_e1AD_DES, DNADamage_AD_e3AD_DES, DNADamage_AD_e6AD_DES, DNADamage_AD_e7AD_DES, DNADamage_CSN_e3CSN_DES, DNADamage_CSN_O2eCSN_DES, DNADamage_GN_e1GN_DES, DNADamage_GN_e3GN_DES, DNADamage_GN_e7GN_DES, DNADamage_GN_O6eGN_DES, DNADamage_THY_e3THY_DES, DNADamage_THY_O2eTHY_DES, DNADamage_THY_O4eTHY_DES	byproduct of DNA ethylation by DES
ethidium			C11161		29214985		42478					Ethidium	ethidium	3,8-diamino-5-ethyl-6-phenylphenanthridin-5-ium	antibiotic		C21H20N3	CC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N)N	1	N	314	294			-0.9	-0.9			TX_NormM_ethidium	DNA intercalator [PUB_0847].
ethyl_nitrosamine					10250262							ethyl nitrosamine	ethyl(nitroso)amine	ethyl(nitroso)amine	alkylating byproduct	ethylation	C2H6N2O1	CCNN=O	0	N	74	72		0.3	0.2	-0.9				byproduct of DNA ethylation by DEN
ETN		etha	C00189	141-43-5	3489	B01183	16000	ETA	C00007279			ethanolamine	ethanolamine	2-aminoethan-1-ol			C2H7N1O1	C(O)CN	1	N	61	66	9.5	12.6	-1.3	-3.6			GlpQ2, MG385r2	
F1P	FRU1P	f1p	C02976		5887							D-Fructose 1-phosphate	[2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl phosphate	[2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl phosphate	carbohydrate	sugar phosphate	C6H11O9P1	OCC1OC(O)(COP([O-])([O-])=O)C(O)C1O	-2	N	258	194			-2.9	-6.3			FruK1, TX_FRUPTS	
f5dU					85638942		448445					5-formyl-2'-deoxyuridine	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxo-3H-pyrimidine-5-carbaldehyde	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde	modified deoxyribonucleoside		C10H12N2O6	C1C(C(OC1N2C=C(C(=O)NC2=O)C=O)CO)O	0	N	256	208		3.1	-2.1	-2.1			TX_f5dU, UshA_f5dUMP	
f5dUMP												5-formyl-2'-deoxyuridine monophosphate	[5-(5-formyl-2,4-dioxo-3H-pyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(5-formyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C10H11N2O9P1	OC1CC(OC1COP([O-])([O-])=O)N1C=C(C=O)C(=O)NC1=O	-2	N	334	249			-2.2	-5.6			UshA_f5dUMP	
f5URA					8880738							5-formyluracil	2,4-dioxo-1,3-dihydropyrimidine-5-carbaldehyde	2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde	modified nucleobase		C5H4N2O3	N1C=C(C(=O)NC1=O)C=O	0	N	140	108			-1.4	-1.4			DNADamage_f5URA_c5URA_hydroxyl_radical, DNADamage_hm5URA_f5URA_hydroxyl_radical	
F6P	FRUCTOSE-6P	f6p	C00085	643-13-0	3385	B04628	15946		C00007305			D-Fructose 6-phosphate	[3,4,5-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl phosphate	[3,4,5-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl phosphate	carbohydrate	sugar phosphate	C6H11O9P1	OCC1(O)OC(COP([O-])([O-])=O)C(O)C1O	-2	N	258	194			-2.9	-6.2			PfkA1, PfkA2, PfkA3, PfkA4, PfkA5, Pgi, TalA, Tkt2, YbiV_F6P	
FAD	FAD	fad	C00016	146-14-5	3318	B04619	16238	FAD	C00001500			flavin adenine dinucleotide, oxidized	(5-{7,8-dimethyl-2,4-dioxo-3H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl) ({[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	(5-{7,8-dimethyl-2,4-dioxo-2H,3H,4H,10H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl) ({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	vitamin	redox electron carrier	C27H31N9O15P2	CC1=C(C)C=C2N(CC(O)C(O)C(O)COP([O-])(=O)OP([O-])(=O)OCC3OC(C(O)C3O)N3C=NC4=C(N)N=CN=C34)C3=NC(=O)NC(=O)C3=NC2=C1	-2	N	784	604		2.9	-5.5	-7.8			Fre1, Fre2, GpsA, RibF2	
FADH2	FADH2	fadh2	C01352		4556		17877					flavin adenine dinucleotide, reduced	(5-{7,8-dimethyl-2,4-dioxo-1H,3H,5H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl) ({[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	(5-{7,8-dimethyl-2,4-dioxo-1H,2H,3H,4H,5H,10H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl) ({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	vitamin	redox electron carrier	C27H33N9O15P2	CC1=CC2=C(C=C1C)N(CC(O)C(O)C(O)COP([O-])(=O)OP([O-])(=O)OCC1OC(C(O)C1O)N1C=NC3=C1N=CN=C3N)C1=C(N2)C(=O)NC(=O)N1	-2	N	786	609		2.9	-5.6	-7.5			Fre1, Fre2, GpsA	
FALD	FORMALDEHYDE	fald	C00067 	50-00-0	2710	B00018	16842	FOR				formaldehyde	formaldehyde	formaldehyde			C1H2O1	C=O	0	N	30	31			-0.5	-0.5			TX_FALD	
FAPyAD					10236558							4,6-diamino-5-N-formamidopyrimidine	N-(4,6-diaminopyrimidin-5-yl)formamide	N-(4,6-diaminopyrimidin-5-yl)formamide	modified nucleobase		C5H7N5O1	NC1=C(NC=O)C(=NC=N1)N	0	N	153	126		9.4	-1.2	-1.4			DNADamage_AD_FAPyAD_hydroxyl_radical, MutM_FAPyAD	28.5 lesions per 10^6 bases [PUB_0479]; 
FAPydA												N4-(2-Deoxy-alpha,beta-D-erythro-pentofuranosyl)-4,6-diamino-5-formamidopyrimidine	N-(4-amino-6-{[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]amino}pyrimidin-5-yl)formamide	N-(4-amino-6-{[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]amino}pyrimidin-5-yl)formamide	modified deoxyribonucleoside		C10H15N5O4	C1C(C(OC1NC2=C(NC=O)C(=NC=N2)N)CO)O	0	N	269	227		9.1	-1.8	-1.9			TX_FAPydA, UshA_FAPydAMP	28.5 lesions per 10^6 bases [PUB_0479]; 
FAPydAMP												N4-(2-Deoxy-alpha,beta-D-erythro-pentofuranosyl)-4,6-diamino-5-formamidopyrimidine monophosphate	{5-[(6-amino-5-formamidopyrimidin-4-yl)amino]-3-hydroxyoxolan-2-yl}methyl phosphate	{5-[(6-amino-5-formamidopyrimidin-4-yl)amino]-3-hydroxyoxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C10H14N5O7P1	NC1=NC=NC(NC2CC(O)C(COP([O-])([O-])=O)O2)=C1NC=O	-2	N	347	267		3.5	-5.7	-5.4			MutM_FAPyAD, UshA_FAPydAMP	
FAPydG												N6-(2-Deoxy-α,β-d-erythro-pentofuranosyl)-2,6-diamino-4-hydroxy-5-formamidopyrimidine	N-(2-amino-4-{[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]amino}-6-oxo-3H-pyrimidin-5-yl)formamide	N-(2-amino-6-{[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]amino}-4-oxo-1,4-dihydropyrimidin-5-yl)formamide	modified deoxyribonucleoside		C10H15N5O5	C1C(C(OC1NC2=C(NC=O)C(N=C(N2)N)=O)CO)O	0	N	285	234		11.3	-3.2	-3.2			TX_FAPydG, UshA_FAPydGMP	78.5 lesions per 10^6 bases [PUB_0479]; recognized by endonuclease III, FPG, UNG [PUB_0473]
FAPydGMP												N6-(2-Deoxy-α,β-d-erythro-pentofuranosyl)-2,6-diamino-4-hydroxy-5-formamidopyrimidine monophosphate	{5-[(2-amino-5-formamido-6-oxo-3H-pyrimidin-4-yl)amino]-3-hydroxyoxolan-2-yl}methyl phosphate	{5-[(2-amino-5-formamido-6-oxo-3,6-dihydropyrimidin-4-yl)amino]-3-hydroxyoxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C10H14N5O8P1	NC1=NC(=O)C(NC=O)=C(NC2CC(O)C(COP([O-])([O-])=O)O2)N1	-2	N	363	274		3.6	-6.3	-6.7			MutM_FAPyGN, UshA_FAPydGMP	
FAPyGN				51093-31-3	75523584							2,6-diamino-4-hydroxy-5-formamidopyrimidine	N-(2,4-diamino-6-oxo-3H-pyrimidin-5-yl)formamide	N-(2,6-diamino-4-oxo-1,4-dihydropyrimidin-5-yl)formamide	modified nucleobase		C5H7N5O2	NC1=C(NC=O)C(N=C(N1)N)=O	0	N	169	134		11.5	-2.7	-2.8			DNADamage_GN_FAPyGN_hydroxyl_radical, MutM_FAPyGN	78.5 lesions per 10^6 bases [PUB_0479]; recognized by endonuclease III, FPG, UNG [PUB_0473]
FDP	FRUCTOSE-16-DIPHOSPHATE	fdp	C00354	488-69-7	3647	B04673	16905	AFP	C00007386			D-Fructose 1,6-bisphosphate	{3,4,5-trihydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}methyl phosphate	{3,4,5-trihydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}methyl phosphate	carbohydrate	sugar phosphate	C6H10O12P2	OC1C(COP([O-])([O-])=O)OC(O)(COP([O-])([O-])=O)C1O	-4	N	336	234			-3.0	-9.8			Fba, FruK1, PfkA1, PfkA2, PfkA3, PfkA4, PfkA5	
FE2		fe2										ferrous iron	iron(2+)	iron(2+) ion	ion		Fe1	[Fe++]	2	N	56	34			-0.8	-0.8			Fre2, TX_MGTA_FE2	
FE3		fe3										ferric iron	fe(3+)	iron(3+) ion	ion		Fe1	[Fe+++]	3	N	56	34			-0.8	-0.8			Fre2, TX_MGTA_FE3	
FMET				4289-98-9	6033	B01634	16552	FME				N-Formyl-L-methionine	2-formamido-4-(methylsulfanyl)butanoic acid	2-formamido-4-(methylsulfanyl)butanoic acid	modified amino acid		C6H11N1O3S1	CSCCC(C(=O)O)NC=O	-1	N	177	157		1.5	-0.2	-3.2			FMETHs, MG488_Formyltransferase, PeptidylTRNAHs_FMET	
fMetMet												N-Formyl-L-methionyl-L-methionine					C11H20N2O4S2	CSCCC(N)C(=O)N(C=O)C(CCSC)C(O)=O	-1	N	308								Deformylation	
FMN	FMN	fmn	C00061	146-17-8	3361	B04626	17621		C00019686			flavin mononucleotide, oxidized	7,8-dimethyl-10-[2,3,4-trihydroxy-5-(phosphonatooxy)pentyl]-3H-benzo[g]pteridine-2,4-dione	7,8-dimethyl-10-[2,3,4-trihydroxy-5-(phosphonatooxy)pentyl]-2H,3H,4H,10H-benzo[g]pteridine-2,4-dione	vitamin	redox electron carrier	C17H19N4O9P1	CC1=C(C)C=C2N(CC(O)C(O)C(O)COP([O-])([O-])=O)C3=NC(=O)NC(=O)C3=NC2=C1	-3	N	454	361		1.1	-1.4	-4.6			Fre5, Fre6, NrdEF_maintenance, RibF1, RibF2	
FMNH2	FMNH2	fmnh2	C01847		4964		16048					flavin mononucleotide, reduced	7,8-dimethyl-10-[2,3,4-trihydroxy-5-(phosphonatooxy)pentyl]-1H,3H,5H-benzo[g]pteridine-2,4-dione	7,8-dimethyl-10-[2,3,4-trihydroxy-5-(phosphonatooxy)pentyl]-1H,2H,3H,4H,5H,10H-benzo[g]pteridine-2,4-dione	vitamin	redox electron carrier	C17H21N4O9P1	C12(N(CC(O)C(O)C(O)COP([O-])(=O)[O-])C3(=C(NC(C(=O)NC(=O)N1)=2)C=C(C)C(C)=C3))	-2	N	456	365		0.5	-1.1	-4.3			Fre5, Fre6, NrdEF_maintenance	
FOR	FORMATE	for	C00058	64-18-6	3358	B01142	15740	FMT	C00001182	LMFA01010040	DFA0001	Formate	formate	formate	carboxy acid		C1H1O2	[CH]([O-])=O	-1	N	45	37			-0.3	-3.1	0		Deformylation, FMETHs, FTHFS, TX_FOR	
FRU	FRU	fru	C00095	57-48-7	11533129		15824					D-Fructose	sorbose	1,3,4,5,6-pentahydroxyhexan-2-one	carbohydrate	sugar	C6H12O6	C(C(O)C(O)C(O)C(=O)CO)O	0	N	180	159		3.4	-3.3	-3.3			TX_FRUPTS, YbiV_F6P	
FTHF10	10-FORMYL-THF	10fthf	C00234		3533	B04652	15637		C00007251			10-formyl-tetrahydrofolate	2-[(4-{N-[(2-amino-4-oxo-5,6,7,8-tetrahydro-1H-pteridin-6-yl)methyl]formamido}phenyl)formamido]pentanedioate	2-[(4-{N-[(2-amino-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl]formamido}phenyl)formamido]pentanedioate	vitamin	folate	C20H21N7O7	NC1=NC(=O)C2=C(NCC(CN(C=O)C3=CC=C(C=C3)C(=O)NC(CCC([O-])=O)C([O-])=O)N2)N1	-2	N	471	390		4.7	-4.9	-8.9			FolD2, FthC, FTHFS, MG488_Formyltransferase	
FTHF5	5-FORMYL-THF		C03479	58-05-9	6294	B04899	15640					5-formyltetrahydrofolate	foliinic acid	2-[(4-{[(2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid	vitamin	folate	C20H23N7O7	NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)NC(CCC(O)=O)C(O)=O)N2C=O)N1	-2	N	473	395		4.4	-4.0	-8.8			METHFHYD, MG501_MODIFICATION_003, MG502_MODIFICATION_002, MG513_MODIFICATION_002	
FUC1P			C02985		5894	B04872	28319					L-fucose 1-phosphate	[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phosphonic acid	[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phosphonic acid	carbohydrate	sugar phosphate	C6H13O8P1	CC1C(C(C(C(O1)OP(=O)(O)O)O)O)O	-2	N	244	191			-2.0	-5.4			TX_UHPT2	
G1P	GLC-1-P	g1p	C00103	59-56-3	3403	B04634	16077	G1P	C00007482			D-Glucose 1-phosphate	[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate	[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate	carbohydrate	sugar phosphate	C6H11O9P1	OCC1OC(OP([O-])([O-])=O)C(O)C(O)C1O	-2	N	258	194			-3.1	-6.4			GalU1, Pgm	
G23CMP	CPD-3709	23cgmp	C06194		8444	B01992						2',3'-Cyclic GMP	4-(2-amino-6-oxo-3H-purin-9-yl)-6-(hydroxymethyl)-2-oxo-tetrahydro-1,3,5,2$l^{5}-furo[3,4-d][1,3,2$l^{5}]dioxaphosphol-2-olate	4-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-6-(hydroxymethyl)-2-oxo-tetrahydro-2H-1,3,5,2$l^{5}-furo[3,4-d][1,3,2$l^{5}]dioxaphosphol-2-olate	cyclic ribonucleotide monophosphate		C10H11N5O7P1	NC1=NC(=O)C2=C(N1)N(C=N2)C1OC(CO)C2OP([O-])(=O)OC12	-1	N	344	247		4.9	-1.4	-3.8			CpdB4	"Site specific cleavage of RNA can leave 2',3' cyclic phosphate and 5'-OH ends [PUB_0270]. Cyclic phosphate must be hydrolyzed to 3'-OH and 5'-OH must be phosphorylated to 5'-PO4 to repair RNA [PUB_0270].
"
G2P	2-PG	2pg	C00631		3904	B01295	17835	2PG				D-Glycerate 2-phosphate	3-hydroxy-2-(phosphonatooxy)propanoate	3-hydroxy-2-(phosphonatooxy)propanoate	glycerate		C3H4O7P1	OCC(OP([O-])([O-])=O)C([O-])=O	-3	N	183	128			-1.6	-8.5			Eno, GpmA	
G3MP	CPD-3708	3gmp	C06193		8443	B01991	28072	3GP				3'-GMP	[5-(2-amino-6-oxo-3H-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] phosphate	[5-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] phosphate	nucleoside 3'-phosphate 		C10H12N5O8P1	NC1=NC(=O)C2=C(N1)N(C=N2)C1OC(CO)C(OP([O-])([O-])=O)C1O	-2	N	361	264		3.2	-2.6	-6.0			CpdB4	
G3P	G3P	3pg	C00197		3497	B01185	17794	3PG				3-Phospho-D-glycerate	2-hydroxy-3-(phosphonatooxy)propanoate	2-hydroxy-3-(phosphonatooxy)propanoate	glycerate		C3H4O7P1	OC(COP([O-])([O-])=O)C([O-])=O	-3	N	183	128			-1.6	-8.1			GpmA, Pgk1, Pgk2, Pgk3, Pgk4, Pgk5	
G6P	GLC-6-P	g6p	C00092	56-73-5	3392	B04630	4170		C00007306			D-Glucose 6-phosphate	(3,4,5,6-tetrahydroxyoxan-2-yl)methyl phosphate	(3,4,5,6-tetrahydroxyoxan-2-yl)methyl phosphate	carbohydrate	sugar phosphate	C6H11O9P1	OC1OC(COP([O-])([O-])=O)C(O)C(O)C1O	-2	N	258	194			-3.1	-6.4			Pgi, Pgm, TX_GLCPTS, TX_UHPT1, YbiV_G6P	
GalCer16					85297420					LMSP0501AC01		galactosyl-β-Ceramide (d18:1/16:0)	N-[(2S,3R,4E)-3-hydroxy-1-{[(2R,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl]hexadecanamide	N-[(2S,3R,4E)-3-hydroxy-1-{[(2R,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl]hexadecanamide	lipid	sphingolipid, neutral glycosphingolipids	C40H77N1O8	[H][C@@](CO[C@@H]1OC(CO)[C@H](O)[C@H](O)C1O)(NC(=O)CCCCCCCCCCCCCCC)[C@]([H])(O)\C=C\CCCCCCCCCCCCC	0	Y	700	748		6.1	9.1	9.1			glycosyltransferase_Ceramide16_GalCer16, glycosyltransferase_GalCer16_GalGalCer16, glycosyltransferase_GalCer16_GlcGalCer16	
GalDAG160					85331175		126185					galactosyl-β-diacylglycerol(16:0/16:1(9Z))	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C41H76O10	CCCCCCCCCCCCCC(=O)OCC(COC1OC(CO)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCCCC	0	Y	729	765		4.7	9.9	9.9			glycosyltransferase_DAG160_GalDAG160, glycosyltransferase_GalDAG160_GalGalDAG160, glycosyltransferase_GalDAG160_GlcGalDAG160	
GalDAG161					36640824							galactosyl-β-diacylglycerol(16:1(9Z)/16:1(9Z))	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C41H74O10	CCCCCCC=CCCCCCCCC(=O)OCC(COC1OC(CO)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCC	0	Y	727	758		4.7	9.5	9.5			glycosyltransferase_DAG161_GalDAG161, glycosyltransferase_GalDAG161_GalGalDAG161, glycosyltransferase_GalDAG161_GlcGalDAG161	
GalDAG181												galactosyl-β-diacylglycerol(18:1(11Z)/18:1(11Z))	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C45H82O10	CCCCCCC=CCCCCCCCCCC(=O)OCC(COC1OC(CO)C(O)C(O)C1O)OC(=O)CCCCCCCCCC=CCCCCCC	0	Y	783	826		4.7	11.3	11.3			glycosyltransferase_DAG181_GalDAG181, glycosyltransferase_GalDAG181_GalGalDAG181, glycosyltransferase_GalDAG181_GlcGalDAG181	
GalGalCer16					85299228					LMSP0509AA01		galactosyl-α1-4-galactosyl-β-Ceramide (d18:1/16:0)	N-[(2S,3R,4E)-3-hydroxy-1-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}octadec-4-en-2-yl]hexadecanamide	N-[(2S,3R,4E)-3-hydroxy-1-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}octadec-4-en-2-yl]hexadecanamide	lipid	sphingolipid, neutral glycosphingolipids	C46H87N1O13	[H][C@@](COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)(NC(=O)CCCCCCCCCCCCCCC)[C@]([H])(O)\C=C\CCCCCCCCCCCCC	0	Y	862	883		5.8	7.3	7.3			glycosyltransferase_GalCer16_GalGalCer16	
GalGalDAG160												galactosyl-α1-4-galactosyl-β-diacylglycerol(16:0/16:1(9Z))	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C47H86O15	CCCCCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCCCC	0	Y	891	899		4.5	8.1	8.1			glycosyltransferase_GalDAG160_GalGalDAG160, glycosyltransferase_GalGalDAG160_GalGalGalDAG160, glycosyltransferase_GalGalDAG160_GlcGalGalDAG160	
GalGalDAG161					85596007		404948					galactosyl-α1-4-galactosyl-β-diacylglycerol(16:1(9Z)/16:1(9Z))	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C47H84O15	CCCCCCC=CCCCCCCCC(=O)OCC(COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCC	0	Y	889	892		4.5	7.7	7.7			glycosyltransferase_GalDAG161_GalGalDAG161, glycosyltransferase_GalGalDAG161_GalGalGalDAG161, glycosyltransferase_GalGalDAG161_GlcGalGalDAG161	
GalGalDAG181												galactosyl-α1-4-galactosyl-β-diacylglycerol(18:1(11Z)/18:1(11Z))	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C51H92O15	CCCCCCC=CCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCCCC=CCCCCCC	0	Y	945	959		4.5	9.5	9.5			glycosyltransferase_GalDAG181_GalGalDAG181, glycosyltransferase_GalGalDAG181_GalGalGalDAG181, glycosyltransferase_GalGalDAG181_GlcGalGalDAG181	
GalGalGalDAG160												galactosyl-α1-4-galactosyl-β1-4-galactosyl-β-diacylglycerol(16:0/16:1(9Z))	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C53H96O20	CCCCCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCCCC	0	Y	1053	1036		4.4	6.3	6.3			glycosyltransferase_GalGalDAG160_GalGalGalDAG160	
GalGalGalDAG161												galactosyl-α1-4-galactosyl-β1-4-galactosyl-β-diacylglycerol(16:1(9Z)/16:1(9Z))	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C53H94O20	CCCCCCC=CCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCC	0	Y	1051	1028		4.4	6.0	6.0			glycosyltransferase_GalGalDAG161_GalGalGalDAG161	
GalGalGalDAG181												galactosyl-α1-4-galactosyl-β1-4-galactosyl-β-diacylglycerol(18:1(11Z)/18:1(11Z))	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C57H102O20	CCCCCCC=CCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCCCC=CCCCCCC	0	Y	1107	1096		4.4	7.8	7.8			glycosyltransferase_GalGalDAG181_GalGalGalDAG181	
GalGalGlcCer16					85297436					LMSP0502AA01		galactosyl-α1-4-galactosyl-β1-4-glucosyl-β-Ceramide (d18:1/16:0)	N-[(2S,3R,4E)-1-{[(2R,4R,5S)-5-{[(2S,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide	N-[(2S,3R,4E)-1-{[(2R,4R,5S)-5-{[(2S,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide	lipid	glycerolipid, glycosyldiradylglycerol	C52H97N1O18	[H][C@@](CO[C@@H]1OC(CO)[C@@H](O[C@@H]2OC(CO)[C@H](O[C@@H]3OC(CO)[C@H](O)[C@H](O)C3O)[C@H](O)C2O)[C@H](O)C1O)(NC(=O)CCCCCCCCCCCCCCC)[C@]([H])(O)\C=C\CCCCCCCCCCCCC	0	Y	1024	1018		5.8	5.6	5.6			glycosyltransferase_GalGlcCer16_GalGalGlcCer16	
GalGalGlcDAG160												galactosyl-α1-4-galactosyl-β1-4-glucosyl-β-diacylglycerol(16:0/16:1(9Z))	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C53H96O20	CCCCCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCCCC	0	Y	1053	1036		4.4	6.3	6.3			glycosyltransferase_GalGlcDAG160_GalGalGlcDAG160	
GalGalGlcDAG161												galactosyl-α1-4-galactosyl-β1-4-glucosyl-β-diacylglycerol(16:1(9Z)/16:1(9Z))	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C53H94O20	CCCCCCC=CCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCC	0	Y	1051	1028		4.4	6.0	6.0			glycosyltransferase_GalGlcDAG161_GalGalGlcDAG161	
GalGalGlcDAG181												galactosyl-α1-4-galactosyl-β1-4-glucosyl-β-diacylglycerol(18:1(11Z)/18:1(11Z))	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C57H102O20	CCCCCCC=CCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCCCC=CCCCCCC	0	Y	1107	1096		4.4	7.8	7.8			glycosyltransferase_GalGlcDAG181_GalGalGlcDAG181	
GalGlcCer16					85297412					LMSP0501AB03		galactosyl-β1-4-glucosyl-β-Ceramide (d18:1/16:0)	N-[(2S,3R,4E)-1-{[(2R,4R,5S)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide	N-[(2S,3R,4E)-1-{[(2R,4R,5S)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide	lipid	glycerolipid, glycosyldiradylglycerol	C46H87N1O13	[H][C@@](CO[C@@H]1OC(CO)[C@@H](O[C@@H]2OC(CO)[C@H](O)[C@H](O)C2O)[C@H](O)C1O)(NC(=O)CCCCCCCCCCCCCCC)[C@]([H])(O)\C=C\CCCCCCCCCCCCC	0	Y	862	883		5.9	7.3	7.3			glycosyltransferase_GalGlcCer16_GalGalGlcCer16, glycosyltransferase_GlcCer16_GalGlcCer16	
GalGlcDAG160												galactosyl-β1-4-glucosyl-β-diacylglycerol(16:0/16:1(9Z))	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C47H86O15	CCCCCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCCCC	0	Y	891	899		4.5	8.1	8.1			glycosyltransferase_GalGlcDAG160_GalGalGlcDAG160, glycosyltransferase_GalGlcDAG160_GlcGalGlcDAG160, glycosyltransferase_GlcDAG160_GalGlcDAG160	
GalGlcDAG161					85596007		404948					galactosyl-β1-4-glucosyl-β-diacylglycerol(16:1(9Z)/16:1(9Z))	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C47H84O15	CCCCCCC=CCCCCCCCC(=O)OCC(COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCC	0	Y	889	892		4.5	7.7	7.7			glycosyltransferase_GalGlcDAG161_GalGalGlcDAG161, glycosyltransferase_GalGlcDAG161_GlcGalGlcDAG161, glycosyltransferase_GlcDAG161_GalGlcDAG161	
GalGlcDAG181												galactosyl-β1-4-glucosyl-β-diacylglycerol(18:1(11Z)/18:1(11Z))	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C51H92O15	CCCCCCC=CCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCCCC=CCCCCCC	0	Y	945	959		4.5	9.5	9.5			glycosyltransferase_GalGlcDAG181_GalGalGlcDAG181, glycosyltransferase_GalGlcDAG181_GlcGalGlcDAG181, glycosyltransferase_GlcDAG181_GalGlcDAG181	
GDP	GDP	gdp	C00035	146-91-8	3337	B01135	17552	GDP				GDP	[5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (phosphonatooxy)phosphonate	[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (phosphonatooxy)phosphonate	ribonucleotide diphosphate		C10H12N5O11P2	C(OP(=O)([O-])OP(=O)([O-])[O-])C1(OC(C(O)C(O)1)N3(C=NC2(C(=O)NC(N)=NC=23)))	-3	N	440	306		1.5	-3.8	-8.2			Adk2, ATPHs_ProteinTranslocation_SRP, Gmk1, Gmk3, GTPHs_ChromosomeSegregation_CobQ, GTPHs_ChromosomeSegregation_Era, GTPHs_ChromosomeSegregation_MraZ, GTPHs_ChromosomeSegregation_Obg, GTPHs_RibosomeAssembly_EngA, GTPHs_RibosomeAssembly_EngB, GTPHs_RibosomeAssembly_Era, GTPHs_RibosomeAssembly_Obg, GTPHs_RibosomeAssembly_RbfA, GTPHs_RibosomeAssembly_RbgA, NrdEF_GDP, PfkA2, Pgk2, Pyk_GDP, RelA1, RNACleavage_RsgA_AMP, RNACleavage_RsgA_CMP, RNACleavage_RsgA_GMP, RNACleavage_RsgA_UMP, Udk1, Udk2	
GDPTP	GDP-TP	gdptp	C04494		7111	B01748						Guanosine 3'-diphosphate 5'-triphosphate	[5-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-2-{[({[(phosphonatooxy)phosphinato]oxy}phosphinato)oxy]methyl}oxolan-3-yl] (phosphonatooxy)phosphonate	[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-4-hydroxy-2-{[({[(phosphonatooxy)phosphinato]oxy}phosphinato)oxy]methyl}oxolan-3-yl] (phosphonatooxy)phosphonate	modified ribonucleotide diphosphate		C10H11N5O20P5	C(OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])C1(OC(C(O)C(OP(=O)([O-])OP(=O)([O-])[O-])1)N3(C=NC2(C(=O)NC(N)=NC=23)))	-5	N	676	431		0.5	-4.2	-16.5			RelA2	
gentamicin			C00505	1403-66-3	46506523		17833					gentamicin			antibiotic	aminoglycoside	C21H43N5O7	CNC(C)C1CCC(N)C(OC2C(N)CC(N)C(OC3OCC(C)(O)C(NC)C3O)C2O)O1	0	N	478									Binds 16S rRNA and ribosomal protein S12, and interferes with decoding [PUB_0847].
GL	GLYCEROL	glyc	C00116	56-81-5	3416	B00032	17754	GOL	C00001163			glycerol	glycerol	propane-1,2,3-triol			C3H8O3	C(O)C(O)CO	0	N	92	88		5.5	-1.8	-1.8			Cls1, Cls2, Cls3, GlpK, GlpQ4, LIPASE_DIBUTYRIN_MG310, LIPASE_DIBUTYRIN_MG327, LIPASE_DIBUTYRIN_MG344, LIPASE_MONOBUTYRIN_MG310, LIPASE_MONOBUTYRIN_MG327, LIPASE_MONOBUTYRIN_MG344, LIPASE_TRIBUTYRIN_MG310, LIPASE_TRIBUTYRIN_MG327, LIPASE_TRIBUTYRIN_MG344, LIPASE_TRILAURIN_MG310, LIPASE_TRILAURIN_MG327, LIPASE_TRILAURIN_MG344, LIPASE_TRIMYRISTIN_MG310, LIPASE_TRIMYRISTIN_MG327, LIPASE_TRIMYRISTIN_MG344, LIPASE_TRIOLEIN_MG310, LIPASE_TRIOLEIN_MG327, LIPASE_TRIOLEIN_MG344, LIPASE_TRIPALMITIN_MG310, LIPASE_TRIPALMITIN_MG327, LIPASE_TRIPALMITIN_MG344, LIPASE_TRISTEARIN_MG310, LIPASE_TRISTEARIN_MG327, LIPASE_TRISTEARIN_MG344, LIPASE_TRI_HDCEA_IN_MG310, LIPASE_TRI_HDCEA_IN_MG327, LIPASE_TRI_HDCEA_IN_MG344, LIPASE_TRI_TTDCEA_IN_MG310, LIPASE_TRI_TTDCEA_IN_MG327, LIPASE_TRI_TTDCEA_IN_MG344, MG385r4, TX_GL, TX_GLUP, YbiV_GL2P, YbiV_SNGLYP	
GL2P	CPD-536	glyc2p	C02979 	3249-68-1	57392492							Glycerol 2-phosphate	2-(phosphonatooxy)propane-1,3-diol	2-(phosphonatooxy)propane-1,3-diol			C3H7O6P1	C(C(CO)OP([O-])([O-])=O)O	-2	N	170	128			-2.0	-5.4			YbiV_GL2P	
GL3P	GLYCEROL-3P	glyc3p	C00093	57-03-4	3393	B01157	15978	G3P				Glycerol 3-phosphate	3-(hydrogen phosphonatooxy)propane-1,2-diol	3-(hydrogen phosphonatooxy)propane-1,2-diol			C3H8O6P1	OCC(O)COP(O)([O-])=O	-2	N	171	131	2.15, 7.2		-2.0	-5.1			GlpK, GlpQ1, GlpQ2, GlpQ3, GlpQ4, GlpQ5, glycosyltransferase_PG160_DAG160, glycosyltransferase_PG161_DAG161, glycosyltransferase_PG181_DAG181, GpsA, MG385r1, MG385r2, MG385r3, MG385r4, MG385r5, PgsA1, PgsA2, PgsA3, PlsX1, PlsX2, PlsX3, PlsX4, PlsX5, PlsX6, PlsX7, TX_GL3P	
GLC			C00031	50-99-7	3333	B04623	4167					D-Glucose	glucose	6-(hydroxymethyl)oxane-2,3,4,5-tetrol	carbohydrate	sugar	C6H12O6	C(O)C1(C(O)C(O)C(O)C(O1)O)	0	N	180	154		4.2	-2.9	-2.9			DNADamage_hm5C_glchm5CSN_GLC, DNADamage_hm5U_glchm5URA_GLC, TX_GLCPTS, YbiV_G6P	
GlcCer16					14714483					LMSP0501AA03		glucosyl-β-Ceramide (d18:1/16:0)	N-[(2S,3R,4E)-3-hydroxy-1-{[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl]hexadecanamide	N-[(2S,3R,4E)-3-hydroxy-1-{[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl]hexadecanamide	lipid	sphingolipid, neutral glycosphingolipids	C40H77N1O8	[H][C@@](CO[C@@H]1O[C@H](CO)[C@@H](O)C(O)C1O)(NC(=O)CCCCCCCCCCCCCCC)[C@]([H])(O)\C=C\CCCCCCCCCCCCC	0	Y	700	749		6.1	9.1	9.1			glycosyltransferase_Ceramide16_GlcCer16, glycosyltransferase_GlcCer16_GalGlcCer16	
GlcDAG160					85331175		126185					glucosyl-β-diacylglycerol(16:0/16:1(9Z))	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C41H76O10	CCCCCCCCCCCCCC(=O)OCC(COC1OC(CO)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCCCC	0	Y	729	765		4.7	9.9	9.9			glycosyltransferase_DAG160_GlcDAG160, glycosyltransferase_GlcDAG160_GalGlcDAG160, glycosyltransferase_GlcDAG160_GlcGlcDAG160	
GlcDAG161					36640824							glucosyl-β-diacylglycerol(16:1(9Z)/16:1(9Z))	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C41H74O10	CCCCCCC=CCCCCCCCC(=O)OCC(COC1OC(CO)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCC	0	Y	727	758		4.7	9.5	9.5			glycosyltransferase_DAG161_GlcDAG161, glycosyltransferase_GlcDAG161_GalGlcDAG161, glycosyltransferase_GlcDAG161_GlcGlcDAG161	
GlcDAG181												glucosyl-β-diacylglycerol(18:1(11Z)/18:1(11Z))	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C45H82O10	CCCCCCC=CCCCCCCCCCC(=O)OCC(COC1OC(CO)C(O)C(O)C1O)OC(=O)CCCCCCCCCC=CCCCCCC	0	Y	783	826		4.7	11.3	11.3			glycosyltransferase_DAG181_GlcDAG181, glycosyltransferase_GlcDAG181_GalGlcDAG181, glycosyltransferase_GlcDAG181_GlcGlcDAG181	
GlcGalCer16												glucosyl-β1-4-galactosyl-β-Ceramide (d18:1/16:0)	N-[(2S,3R,4E)-3-hydroxy-1-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}octadec-4-en-2-yl]hexadecanamide	N-[(2S,3R,4E)-3-hydroxy-1-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}octadec-4-en-2-yl]hexadecanamide	lipid	neutral glycosphingolipids	C46H87N1O13	[H][C@@](COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)(NC(=O)CCCCCCCCCCCCCCC)[C@]([H])(O)\C=C\CCCCCCCCCCCCC	0	Y	862	883		5.8	7.3	7.3			glycosyltransferase_GalCer16_GlcGalCer16	
GlcGalDAG160												glucosyl-β1-4-galactosyl-β-diacylglycerol(16:0/16:1(9Z))	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C47H86O15	CCCCCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCCCC	0	Y	891	899		4.5	8.1	8.1			glycosyltransferase_GalDAG160_GlcGalDAG160	
GlcGalDAG161					85596007		404948					glucosyl-β1-4-galactosyl-β-diacylglycerol(16:1(9Z)/16:1(9Z))	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C47H84O15	CCCCCCC=CCCCCCCCC(=O)OCC(COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCC	0	Y	889	892		4.5	7.7	7.7			glycosyltransferase_GalDAG161_GlcGalDAG161	
GlcGalDAG181												glucosyl-β1-4-galactosyl-β-diacylglycerol(18:1(11Z)/18:1(11Z))	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C51H92O15	CCCCCCC=CCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCCCC=CCCCCCC	0	Y	945	959		4.5	9.5	9.5			glycosyltransferase_GalDAG181_GlcGalDAG181	
GlcGalGalDAG160												glucosyl-β1-4-galactosyl-α1-4-galactosyl-β-diacylglycerol(16:0/16:1(9Z))	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C53H96O20	CCCCCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCCCC	0	Y	1053	1036		4.4	6.3	6.3			glycosyltransferase_GalGalDAG160_GlcGalGalDAG160	
GlcGalGalDAG161												glucosyl-β1-4-galactosyl-α1-4-galactosyl-β-diacylglycerol(16:1(9Z)/16:1(9Z))	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C53H94O20	CCCCCCC=CCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCC	0	Y	1051	1028		4.4	6.0	6.0			glycosyltransferase_GalGalDAG161_GlcGalGalDAG161	
GlcGalGalDAG181												glucosyl-β1-4-galactosyl-α1-4-galactosyl-β-diacylglycerol(18:1(11Z)/18:1(11Z))	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C57H102O20	CCCCCCC=CCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCCCC=CCCCCCC	0	Y	1107	1096		4.4	7.8	7.8			glycosyltransferase_GalGalDAG181_GlcGalGalDAG181	
GlcGalGlcDAG160												glucosyl-β1-4-galactosyl-β1-4-glucosyl-β-diacylglycerol(16:0/16:1(9Z))	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C53H96O20	CCCCCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCCCC	0	Y	1053	1036		4.4	6.3	6.3			glycosyltransferase_GalGlcDAG160_GlcGalGlcDAG160	
GlcGalGlcDAG161												glucosyl-β1-4-galactosyl-β1-4-glucosyl-β-diacylglycerol(16:1(9Z)/16:1(9Z))	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C53H94O20	CCCCCCC=CCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCC	0	Y	1051	1028		4.4	6.0	6.0			glycosyltransferase_GalGlcDAG161_GlcGalGlcDAG161	
GlcGalGlcDAG181												glucosyl-β1-4-galactosyl-β1-4-glucosyl-β-diacylglycerol(18:1(11Z)/18:1(11Z))	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C57H102O20	CCCCCCC=CCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCCCC=CCCCCCC	0	Y	1107	1096		4.4	7.8	7.8			glycosyltransferase_GalGlcDAG181_GlcGalGlcDAG181	
GlcGlcDAG160												glucosyl-β1-4-glucosyl-β-diacylglycerol(16:0/16:1(9Z))	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C47H86O15	CCCCCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCCCC	0	Y	891	899		4.5	8.1	8.1			glycosyltransferase_GlcDAG160_GlcGlcDAG160, glycosyltransferase_GlcGlcDAG160_GlcGlcGlcDAG160	
GlcGlcDAG161					85596007		404948					glucosyl-β1-4-glucosyl-β-diacylglycerol(16:1(9Z)/16:1(9Z))	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C47H84O15	CCCCCCC=CCCCCCCCC(=O)OCC(COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCC	0	Y	889	892		4.5	7.7	7.7			glycosyltransferase_GlcDAG161_GlcGlcDAG161, glycosyltransferase_GlcGlcDAG161_GlcGlcGlcDAG161	
GlcGlcDAG181												glucosyl-β1-4-glucosyl-β-diacylglycerol(18:1(11Z)/18:1(11Z))	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C51H92O15	CCCCCCC=CCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCCCC=CCCCCCC	0	Y	945	959		4.5	9.5	9.5			glycosyltransferase_GlcDAG181_GlcGlcDAG181, glycosyltransferase_GlcGlcDAG181_GlcGlcGlcDAG181	
GlcGlcGlcDAG160												glucosyl-β1-4-glucosyl-β1-4-glucosyl-β-diacylglycerol(16:0/16:1(9Z))	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	1-(tetradecanoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C53H96O20	CCCCCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCCCC	0	Y	1053	1036		4.4	6.3	6.3			glycosyltransferase_GlcGlcDAG160_GlcGlcGlcDAG160	
GlcGlcGlcDAG161												glucosyl-β1-4-glucosyl-β1-4-glucosyl-β-diacylglycerol(16:1(9Z)/16:1(9Z))	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	1-(hexadec-9-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl hexadec-9-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C53H94O20	CCCCCCC=CCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCC=CCCCCCC	0	Y	1051	1028		4.4	6.0	6.0			glycosyltransferase_GlcGlcDAG161_GlcGlcGlcDAG161	
GlcGlcGlcDAG181												glucosyl-β1-4-glucosyl-β1-4-glucosyl-β-diacylglycerol(18:1(11Z)/18:1(11Z))	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	1-(octadec-11-enoyloxy)-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propan-2-yl octadec-11-enoate	lipid	glycerolipid, glycosyldiradylglycerol	C57H102O20	CCCCCCC=CCCCCCCCCCC(=O)OCC(COC1OC(COC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C(O)C1O)OC(=O)CCCCCCCCCC=CCCCCCC	0	Y	1107	1096		4.4	7.8	7.8			glycosyltransferase_GlcGlcDAG181_GlcGlcGlcDAG181	
glchm5CSN												beta-D-glucosylhydroxymethylcytosine	4-amino-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1H-pyrimidin-2-one	4-amino-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1,2-dihydropyrimidin-2-one	modified nucleobase		C11H17N3O7	N1C=C(C(=NC1=O)N)COC2C(C(C(C(O2)CO)O)O)O	0	N	303	253		10.8	-3.9	-3.9			DNADamage_hm5C_glchm5CSN_GLC	
glchm5dC					22908699							beta-D-glucosylhydroxymethyl-2'-deoxycytidine	4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)pyrimidin-2-one	4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1,2-dihydropyrimidin-2-one	modified deoxyribonucleoside		C16H25N3O10	C1C(C(OC1N2C=C(C(=NC2=O)N)COC3C(C(C(C(O3)CO)O)O)O)CO)O	0	N	419	353		5.6	-4.6	-4.6			TX_glchm5dC, UshA_glchm5dCMP	
glchm5dCMP												beta-D-glucosylhydroxymethyl-2'-deoxycytidine monophosphate	{5-[4-amino-2-oxo-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)pyrimidin-1-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	{5-[4-amino-2-oxo-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1,2-dihydropyrimidin-1-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C16H24N3O13P1	NC1=NC(=O)N(C=C1COC1OC(CO)C(O)C(O)C1O)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	497	393		0.2	-4.7	-8.0			UshA_glchm5dCMP	
glchm5dU				53910-96-6	78580619							beta-D-glucosylhydroxymethyl-2'-deoxyuridine	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3H-pyrimidine-2,4-dione	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified deoxyribonucleoside		C16H24N2O11	C1C(C(OC1N2C=C(C(=O)NC2=O)COC3C(C(C(C(O3)CO)O)O)O)CO)O	0	N	420	350		3.5	-4.2	-4.2			TX_glchm5dU, UshA_glchm5dUMP	discovered in African trypanosomes [PUB_0478]
glchm5dUMP												beta-D-glucosylhydroxymethyl-2'-deoxyuridine monophosphate	{5-[2,4-dioxo-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3H-pyrimidin-1-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	{5-[2,4-dioxo-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1,2,3,4-tetrahydropyrimidin-1-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C16H23N2O14P1	OCC1OC(OCC2=CN(C3CC(O)C(COP([O-])([O-])=O)O3)C(=O)NC2=O)C(O)C(O)C1O	-2	N	498	390			-4.3	-7.7			UshA_glchm5dUMP	
glchm5URA					34878572							beta-D-glucosylhydroxymethyluracil; base J	5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1,3-dihydropyrimidine-2,4-dione	5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified nucleobase		C11H16N2O8	N1C=C(C(=O)NC1=O)COC2C(C(C(C(O2)CO)O)O)O	0	N	304	249		3.4	-3.5	-3.5			DNADamage_hm5U_glchm5URA_GLC	discovered in African trypanosomes [PUB_0478]
GLN	GLN	gln-L	C00064	56-85-9	3364	B00017	18050	GLN	C00001359			L-glutamine	glutamine	2-amino-4-carbamoylbutanoic acid	amino acid		C5H10N2O3	C(=O)(O)C(N)CCC(N)=O	0	N	146	132	2.17, 9.13	5.7	-4.1	-4.1			Apts_Gln, GLNHs, MG502_Amidotransferase, PeptidylTRNAHs_GLN, ProteinDegradation_FtsH_GLN, ProteinDegradation_Lon_GLN, ProteinPolymerization_GLN, TX_GLNHPQ	
GlnGln												L-glutaminyl-L-glutamine	2-(2-amino-4-carbamoylbutanamido)-4-carbamoylbutanoic acid	2-(2-amino-4-carbamoylbutanamido)-4-carbamoylbutanoic acid	dipeptide		C10H18N4O5	NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O	0	N	274	244		6.0	-6.1	-6.2			Apts_Gln, ProteinDegradation_FtsH_GLN, ProteinDegradation_Lon_GLN, ProteinPolymerization_GLN, TX_OppB_Gln	
GLU	GLT	glu-L	C00025	56-86-0	3327	B00007	16015	GLU	C00001358			L-Glutamate	glutamate	2-azaniumylpentanedioate	amino acid		C5H8N1O4	C(CC(=O)[O-])C(C(=O)[O-])[NH3+]	-1	N	146	127	2.19, 4.25, 9.67	2.8	-3.4	-6.2			Apts_Glu, AspC1, AspC2, AspC3, DNADamage_hm5U_gluTHY_GLU, GLNHs, MG502_Amidotransferase, MG502_Aminoacylation, MG513_Aminoacylation, MG_166_MONOMER_MODIFICATION_001, PeptidylTRNAHs_GLU, ProteinDegradation_FtsH_GLU, ProteinDegradation_Lon_GLU, ProteinPolymerization_GLU	
gludT												a-glutamyl-2'-deoxythymidine	2-[({1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxo-3H-pyrimidin-5-yl}methyl)amino]pentanedioic acid	2-[({1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}methyl)amino]pentanedioic acid	modified deoxyribonucleoside		C15H21N3O9	C1(=CN(C(=O)NC1=O)C2CC(C(O2)CO)O)CNC(C(O)=O)CCC(O)=O	-1	N	387	325		2.5	-5.0	-8.0			TX_gludT, UshA_gludTMP	occurs in bacteriophage DNA [PUB_0477]; in bacteriophage PhiW-14 up to 50% thymidine replaced by gludT [PUB_0478];
gludTMP												a-glutamyl-2'-deoxythymidine monophosphate	[5-(5-{[(1,3-dicarboxypropyl)amino]methyl}-2,4-dioxo-3H-pyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(5-{[(1,3-dicarboxypropyl)amino]methyl}-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C15H20N3O12P1	OC1CC(OC1COP([O-])([O-])=O)N1C=C(CNC(CCC(O)=O)C(O)=O)C(=O)NC1=O	-3	N	465	365		1.2	-5.6	-11.5			UshA_gludTMP	
GluGlu			C01425	3929-61-1	4610							L-glutamyl-L-glutamic acid	4-amino-4-[(1-carboxy-3-carboxylatopropyl)carbamoyl]butanoate	4-amino-4-[(1-carboxy-3-carboxylatopropyl)carbamoyl]butanoate	dipeptide		C10H14N2O7	NC(CCC([O-])=O)C(=O)NC(CCC([O-])=O)C(O)=O	-2	N	274	234		3.6	-4.7	-10.5			Apts_Glu, ProteinDegradation_FtsH_GLU, ProteinDegradation_Lon_GLU, ProteinPolymerization_GLU, TX_OppB_Glu	
gluTHY				76567-27-6	75229612							a-glutamylthymine	2-{[(2,4-dioxo-1,3-dihydropyrimidin-5-yl)methyl]amino}pentanedioic acid	2-{[(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]amino}pentanedioic acid	modified nucleobase		C10H13N3O6	C1(=CNC(=O)NC1=O)CNC(C(O)=O)CCC(O)=O	-1	N	271	225		2.6	-4.4	-7.3			DNADamage_hm5U_gluTHY_GLU	occurs in bacteriophage DNA [PUB_0477]; in bacteriophage PhiW-14 up to 50% thymidine replaced by gludT [PUB_0478];
GLY	GLY	gly	C00037	56-40-6	3339	B01136	15428	GLY	C00001361			glycine	glycine	2-aminoacetic acid	amino acid		C2H5N1O2	C(=O)(O)CN	0	N	75	68		5.8	-3.5	-3.5			Apts_Gly, GlyA3, GlyA4, MG493_Aminoacylation, MG499_Aminoacylation, MG501_MODIFICATION_003, MG502_MODIFICATION_002, MG513_MODIFICATION_002, PeptidylTRNAHs_GLY, ProteinDegradation_FtsH_GLY, ProteinDegradation_Lon_GLY, ProteinPolymerization_GLY	
GlyGly	CPD0-1914		C02037		8143655		17201					L-glycyl-L-glycine	gly-gly	2-(2-aminoacetamido)acetic acid	dipeptide		C4H8N2O3	C(C(=O)NCC(=O)O)N	0	N	132	115		6.0	-5.0	-5.0			Apts_Gly, ProteinDegradation_FtsH_GLY, ProteinDegradation_Lon_GLY, ProteinPolymerization_GLY, TX_OppB_Gly	
Gm				2140-71-8	53801191		19229					2'-O-methylguanosine	2-amino-9-[4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-1H-purin-6-one	2-amino-9-[4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-6,9-dihydro-1H-purin-6-one	modified ribonucleoside		C11H15N5O5	C3(OC(CO)C(O)C(O(C))3)N2C=NC1=C2N=C(N)NC1=O	0	N	297	241		6.0	-2.1	-2.1			TX_Gm, UshA_GmMP	
GmMP												2'-O-methylguanosine monophosphate	[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-4-methoxyoxolan-2-yl]methyl phosphate	[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3-hydroxy-4-methoxyoxolan-2-yl]methyl phosphate	modified ribonucleotide monophosphate		C11H14N5O8P1	COC1C(O)C(COP([O-])([O-])=O)OC1N1C=NC2=C1N=C(N)NC2=O	-2	N	375	281		1.5	-3.0	-5.5			MGrrnA23S_MODIFICATION_004, UshA_GmMP	
GMP	GMP	gmp	C00144	85-32-5	3444	B01172	17345	5GP	C00019635			GMP	[5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	ribonucleotide monophosphate		C10H12N5O8P1	C(OP([O-])(=O)[O-])C1(OC(C(O)C(O)1)N3(C=NC2(C(=O)NC(N)=NC=23)))	-2	N	361	264		1.5	-3.6	-6.2			DNAPrimerPolymerization_GTP, Gmk1, Gmk3, HinT_GMP_Lysine_MG132, HinT_GMP_Mor_MG132, Hpt2, MG471_MODIFICATION_001, MG472_MODIFICATION_001, MG484_MODIFICATION_001, MG484_MODIFICATION_002, MG485_MODIFICATION_001, MG486_MODIFICATION_001, MG487_MODIFICATION_001, MG488_MODIFICATION_001, MG490_MODIFICATION_001, MG492_MODIFICATION_001, MG497_MODIFICATION_001, MG501_MODIFICATION_001, MG504_MODIFICATION_001, MG508_MODIFICATION_001, MG509_MODIFICATION_001, MG510_MODIFICATION_001, MG511_MODIFICATION_001, MG512_MODIFICATION_001, MG514_MODIFICATION_001, MG519_MODIFICATION_001, MG519_MODIFICATION_002, MG523_MODIFICATION_001, MGrrnA16S_MODIFICATION_001, MGrrnA23S_MODIFICATION_004, RNACleavage_DeaD_GMP, RNACleavage_RNAseIII_GMP, RNACleavage_RNAseJ_GMP, RNACleavage_RNAseP_GMP, RNACleavage_RNAseR_GMP, RNACleavage_RsgA_GMP, RnaPolymerization_GTP, UshA_GMP	
GMP_Lysine												GMP-lysine	[(5-amino-5-carboxypentyl)aminio]({[5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinate	[(5-amino-5-carboxypentyl)azaniumyl]({[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinate	modified ribonucleotide monophosphate		C16H26N7O9P1	NC(CCCC[NH2+]P([O-])(=O)OCC1OC(C(O)C1O)N1C=NC2=C1N=C(N)NC2=O)C(O)=O	-1	N	491	397		2.7	-5.9	-8.0			HinT_GMP_Lysine_MG132	
GMP_Mor												GMP-morpholidate	[5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl morpholin-4-ium-4-phosphonate	[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl morpholin-4-ium-4-phosphonate	modified ribonucleotide monophosphate		C14H21N6O8P1	NC1=NC2=C(N=CN2C2OC(COP([O-])(=O)[NH+]3CCOCC3)C(O)C2O)C(=O)N1	-1	N	432	339		2.2	-3.3	-5.6			HinT_GMP_Mor_MG132	
GN	GUANINE	gua	C00242	73-40-5	3541	B00067	16235	GUN	C00001501			guanine	guanine	2-amino-6,9-dihydro-1H-purin-6-one	nucleobase		C5H5N5O1	C12(N=C(NC(=O)C(N=CN1)=2)N)	0	N	151	115		5.8	-1.1	-1.1			DeoD3, DeoD6, DNADamage_GN_e1GN_DES, DNADamage_GN_e1GN_EMS, DNADamage_GN_e1GN_ENU, DNADamage_GN_e3GN_DES, DNADamage_GN_e3GN_EMS, DNADamage_GN_e3GN_ENU, DNADamage_GN_e7GN_DES, DNADamage_GN_e7GN_EMS, DNADamage_GN_e7GN_ENU, DNADamage_GN_epsilon1N2GN_chloroethylene_oxide, DNADamage_GN_epsilonN23GN_chloroethylene_oxide, DNADamage_GN_FAPyGN_hydroxyl_radical, DNADamage_GN_m1GN_MMS, DNADamage_GN_m1GN_MNU, DNADamage_GN_m3GN_MMS, DNADamage_GN_m3GN_MMSO4, DNADamage_GN_m3GN_MNNG, DNADamage_GN_m3GN_MNU, DNADamage_GN_m7GN_MMS, DNADamage_GN_m7GN_MMSO4, DNADamage_GN_m7GN_MNNG, DNADamage_GN_m7GN_MNU, DNADamage_GN_m8GN_CH3, DNADamage_GN_O6eGN_DES, DNADamage_GN_O6eGN_EMS, DNADamage_GN_O6eGN_ENU, DNADamage_GN_O6mGN_MMS, DNADamage_GN_O6mGN_MMSO4, DNADamage_GN_O6mGN_MNNG, DNADamage_GN_O6mGN_MNU, DNADamage_GN_oxo8GN_hydroxyl_radical, DNADamage_GN_oxoethyl7GN_chloroethylene_oxide, DNADamage_SpontaneousBaseDeamination_guanine, DNADamage_SpontaneousBaseLoss_guanine, Hpt2, TX_GN	
GPCH		g3pc	C00670		3939	B01306	16870	CH5				sn-Glycero-3-phosphocholine	(2-{[(2,3-dihydroxypropyl) phosphonato]oxy}ethyl)trimethylazanium	(2-{[(2,3-dihydroxypropyl) phosphonato]oxy}ethyl)trimethylazanium			C8H20N1O6P1	C[N+](C)(C)CCOP([O-])(=O)OCC(O)CO	0	N	257	233			-5.7	-4.0			GlpQ1, MG385r1	
GPE		g3pe	C01233		4454	B04786		GPE				sn-Glycero-3-phosphoethanolamine	(2-aminoethoxy)(2,3-dihydroxypropoxy)phosphinic acid	(2-aminoethoxy)(2,3-dihydroxypropoxy)phosphinic acid			C5H14N1O6P1	C(COP(=O)(O)OCC(CO)O)N	0	N	215	179		4.8	-3.7	-3.8			GlpQ2, MG385r2	
GPG		g3pg	C03274		6135							Glycerophosphoglycerol	3-{[(2,3-dihydroxypropyl) phosphonato]oxy}propane-1,2-diol	3-{[(2,3-dihydroxypropyl) phosphonato]oxy}propane-1,2-diol			C6H14O8P1	OCC(O)COP([O-])(=O)OCC(O)CO	-1	N	245	199			-2.9	-5.3			GlpQ4, MG385r4	
GpGp												Gp-Gp	[5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 5-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-2-[(phosphonatooxy)methyl]oxolan-3-yl phosphate	[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-4-hydroxy-2-[(phosphonatooxy)methyl]oxolan-3-yl phosphate			C20H23N10O15P2	NC1=NC2=C(N=CN2C2OC(COP([O-])(=O)OC3C(COP([O-])([O-])=O)OC(C3O)N3C=NC4=C3N=C(N)NC4=O)C(O)C2O)C(=O)N1	-3	N	705								DNAPrimerPolymerization_GTP, RNACleavage_DeaD_GMP, RNACleavage_RNAseIII_GMP, RNACleavage_RNAseJ_GMP, RNACleavage_RNAseP_GMP, RNACleavage_RNAseR_GMP, RNACleavage_RsgA_GMP, RnaPolymerization_GTP	
GPI		g3pi	C01225		4447		18321					sn-Glycero-3-phospho-1-inositol	6-{[(2,3-dihydroxypropoxy)phosphinato]oxy}cyclohexane-1,2,3,4,5-pentol	6-{[(2,3-dihydroxypropoxy)phosphinato]oxy}cyclohexane-1,2,3,4,5-pentol			C9H18O11P1	OCC(O)COP([O-])(=O)OC1C(O)C(O)C(O)C(O)C1O	-1	N	333	265			-4.8	-7.2			GlpQ5, MG385r5	
GPS		g3ps										Glycerophosphoserine	2-amino-3-{[(2,3-dihydroxypropyl) phosphonato]oxy}propanoic acid	2-amino-3-{[(2,3-dihydroxypropyl) phosphonato]oxy}propanoic acid			C6H13N1O8P1	NC(COP([O-])(=O)OCC(O)CO)C(O)=O	-2	N	258	205		1.8	-4.6	-7.7			GlpQ3, MG385r3	
GSN	GUANOSINE	gsn	C00387	118-00-3	3677	B01233	16750	GMP	C00019679			guanosine	guanosine	2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one	ribonucleoside		C10H13N5O5	C(C3(C(O)C(O)C(N2(C1(=C(C(=O)NC(N)=N1)N=C2)))O3))O	0	N	283	224		6.0	-2.7	-2.7			DeoD6, UshA_GMP	
GTP	GTP	gtp	C00044	86-01-1	3346	B01137	15996	GTP	C00007223			GTP	({[5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	({[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	ribonucleotide triphosphate		C10H12N5O14P3	C(OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])C1(OC(C(O)C(O)1)N3(C=NC2(C(=O)NC(N)=NC=23)))	-4	N	519	349		1.2	-4.6	-11.0			Adk2, ATPHs_ProteinTranslocation_SRP, DNAPrimerPolymerization_GTP, FtsZ_activation, GTPHs_ChromosomeSegregation_CobQ, GTPHs_ChromosomeSegregation_Era, GTPHs_ChromosomeSegregation_MraZ, GTPHs_ChromosomeSegregation_Obg, GTPHs_RibosomeAssembly_EngA, GTPHs_RibosomeAssembly_EngB, GTPHs_RibosomeAssembly_Era, GTPHs_RibosomeAssembly_Obg, GTPHs_RibosomeAssembly_RbfA, GTPHs_RibosomeAssembly_RbgA, PfkA2, Pgk2, Pyk_GDP, RelA2, RNACleavage_RsgA_AMP, RNACleavage_RsgA_CMP, RNACleavage_RsgA_GMP, RNACleavage_RsgA_UMP, RnaPolymerization_GTP, Udk1, Udk2	
H	PROTON	h	C00080		3380		15378					hydrogen ion	H(.)	hydrogen	ion		H1	[H+]	1	N	1	7							AcpS, Adi, AP_endonuclease, AP_lyase, ArcC, ArgF, AtpA, ATPHs_ChromosomeCondensation_SMC, ATPHs_DNAReplication_Helicase, ATPHs_DNASupercoiling_gyrase, ATPHs_DNASupercoiling_topoisomeraseIV, ATPHs_ProteinTranslocation_SecA, ATPHs_ProteinTranslocation_SRP, AzoR, CdsA1, CdsA2, CdsA3, CdsA4, CdsA5, CdsA6, CdsA7, CholK, CoaE, CpdB1, CpdB2, CpdB3, CpdB4, CsdA, Dak1, Dck, Deformylation, DeoD4, DeoD5, DeoD6, DeoD7, deoxyribosephosphodiesterase, Dgk1, DhfR1, DnaA_inactivation, DNADamage_AD_carbamoylmethyl6AD_acetamide, DNADamage_AD_e1AD_DES, DNADamage_AD_e1AD_EMS, DNADamage_AD_e1AD_ENU, DNADamage_AD_epsilon1N6AD_chloroethylene_oxide, DNADamage_AD_FAPyAD_hydroxyl_radical, DNADamage_AD_m1AD_MMS, DNADamage_AD_m1AD_MMSO4, DNADamage_AD_m1AD_MNNG, DNADamage_AD_m1AD_MNU, DNADamage_AD_m6AD_CH3, DNADamage_AD_n2AD_NH3, DNADamage_AD_oxo2AD_hydroxyl_radical, DNADamage_AD_oxo8AD_hydroxyl_radical, DNADamage_CSN_epsilon3N4CSN_chloroethylene_oxide, DNADamage_CSN_ho5CSN_hydroxyl_radical, DNADamage_CSN_m4CSN_CH3, DNADamage_CSN_m5CSN_CH3, DNADamage_DA_cyclodA_UVB_radiation, DNADamage_DG_cyclodG_UVB_radiation, DNADamage_DHURA_ho5Hydantoin_hydroxyl_radical, DNADamage_f5URA_c5URA_hydroxyl_radical, DNADamage_GammaRadiationInducedStrandBreak, DNADamage_GN_epsilon1N2GN_chloroethylene_oxide, DNADamage_GN_epsilonN23GN_chloroethylene_oxide, DNADamage_GN_FAPyGN_hydroxyl_radical, DNADamage_GN_m7GN_MMS, DNADamage_GN_m7GN_MMSO4, DNADamage_GN_m7GN_MNNG, DNADamage_GN_m7GN_MNU, DNADamage_GN_m8GN_CH3, DNADamage_GN_oxo8GN_hydroxyl_radical, DNADamage_hm5URA_f5URA_hydroxyl_radical, DNADamage_hm5U_gluTHY_GLU, DNADamage_hm5U_putTHY_PTRC, DNADamage_HYXN_XAN_hydroxyl_radical, DNADamage_m3CSN_hm3CSN_hydroxyl_radical, DNADamage_m5CSN_hm5CSN_hydroxyl_radical, DNADamage_SpontaneousAbasicSiteStrandBreak, DNADamage_THY_hm5URA_hydroxyl_radical, DNADamage_THY_ho5ho6THY_hydroxyl_radical, DNADamage_URA_DHURA_hydroxyl_radical, DNADamage_URA_ho5ho6URA_hydroxyl_radical, DNADamage_URA_ho5URA_hydroxyl_radical, DNALigation, DNAProcessiveCleavage_dAMP, DNAProcessiveCleavage_dCMP, DNAProcessiveCleavage_dGMP, DNAProcessiveCleavage_dTMP, DNA_ligation_repair, DNA_RM_EcoD_Methylation, DNA_RM_EcoD_Restriction, DNA_RM_MunI_Methylation, DNA_RM_MunI_Restriction, dRiboseP_lyase, FMETHs, FolD1, FolD2, Fre1, Fre2, Fre3, Fre4, Fre5, Fre6, FruK1, FruK2, FthC, FtsZ_deactivation, GalU1, GapA, GLNHs, GlpQ2, GlyA3, glycosyltransferase_Ceramide16_GalCer16, glycosyltransferase_Ceramide16_GlcCer16, glycosyltransferase_DAG160_GalDAG160, glycosyltransferase_DAG160_GlcDAG160, glycosyltransferase_DAG161_GalDAG161, glycosyltransferase_DAG161_GlcDAG161, glycosyltransferase_DAG181_GalDAG181, glycosyltransferase_DAG181_GlcDAG181, glycosyltransferase_GalCer16_GalGalCer16, glycosyltransferase_GalCer16_GlcGalCer16, glycosyltransferase_GalDAG160_GalGalDAG160, glycosyltransferase_GalDAG160_GlcGalDAG160, glycosyltransferase_GalDAG161_GalGalDAG161, glycosyltransferase_GalDAG161_GlcGalDAG161, glycosyltransferase_GalDAG181_GalGalDAG181, glycosyltransferase_GalDAG181_GlcGalDAG181, glycosyltransferase_GalGalDAG160_GalGalGalDAG160, glycosyltransferase_GalGalDAG160_GlcGalGalDAG160, glycosyltransferase_GalGalDAG161_GalGalGalDAG161, glycosyltransferase_GalGalDAG161_GlcGalGalDAG161, glycosyltransferase_GalGalDAG181_GalGalGalDAG181, glycosyltransferase_GalGalDAG181_GlcGalGalDAG181, glycosyltransferase_GalGlcCer16_GalGalGlcCer16, glycosyltransferase_GalGlcDAG160_GalGalGlcDAG160, glycosyltransferase_GalGlcDAG160_GlcGalGlcDAG160, glycosyltransferase_GalGlcDAG161_GalGalGlcDAG161, glycosyltransferase_GalGlcDAG161_GlcGalGlcDAG161, glycosyltransferase_GalGlcDAG181_GalGalGlcDAG181, glycosyltransferase_GalGlcDAG181_GlcGalGlcDAG181, glycosyltransferase_GlcCer16_GalGlcCer16, glycosyltransferase_GlcDAG160_GalGlcDAG160, glycosyltransferase_GlcDAG160_GlcGlcDAG160, glycosyltransferase_GlcDAG161_GalGlcDAG161, glycosyltransferase_GlcDAG161_GlcGlcDAG161, glycosyltransferase_GlcDAG181_GalGlcDAG181, glycosyltransferase_GlcDAG181_GlcGlcDAG181, glycosyltransferase_GlcGlcDAG160_GlcGlcGlcDAG160, glycosyltransferase_GlcGlcDAG161_GlcGlcGlcDAG161, glycosyltransferase_GlcGlcDAG181_GlcGlcGlcDAG181, glycosyltransferase_PG160_DAG160, GpsA, GTPHs_ChromosomeSegregation_CobQ, GTPHs_ChromosomeSegregation_Era, GTPHs_ChromosomeSegregation_MraZ, GTPHs_ChromosomeSegregation_Obg, GTPHs_Cytokinesis_FtsZ, GTPHs_RibosomeAssembly_EngA, GTPHs_RibosomeAssembly_EngB, GTPHs_RibosomeAssembly_Era, GTPHs_RibosomeAssembly_Obg, GTPHs_RibosomeAssembly_RbfA, GTPHs_RibosomeAssembly_RbgA, HCYSMT, HinT_AMP_Lysine_MG132, HinT_AMP_Mor_MG132, HinT_AMP_NH2_MG132, HinT_GMP_Lysine_MG132, HinT_GMP_Mor_MG132, HR_DNAResection_dAMP, HR_DNAResection_dCMP, HR_DNAResection_dGMP, HR_DNAResection_dTMP, HR_junctionMigration, HR_junctionResolution, HR_strandExchange, hydroxyl_radical_generation_1, LdhA, LIPASE_METHYL_OCDCEA_MG310, LIPASE_METHYL_OCDCEA_MG327, LIPASE_METHYL_OCDCEA_MG344, LIPASE_TRILAURIN_MG310, LIPASE_TRILAURIN_MG327, LIPASE_TRILAURIN_MG344, LIPASE_TRIMYRISTIN_MG310, LIPASE_TRIMYRISTIN_MG327, LIPASE_TRIMYRISTIN_MG344, LIPASE_TRIOLEIN_MG310, LIPASE_TRIOLEIN_MG327, LIPASE_TRIOLEIN_MG344, LIPASE_TRIPALMITIN_MG310, LIPASE_TRIPALMITIN_MG327, LIPASE_TRIPALMITIN_MG344, LIPASE_TRISTEARIN_MG310, LIPASE_TRISTEARIN_MG327, LIPASE_TRISTEARIN_MG344, LIPASE_TRI_HDCEA_IN_MG310, LIPASE_TRI_HDCEA_IN_MG327, LIPASE_TRI_HDCEA_IN_MG344, LIPASE_TRI_TTDCEA_IN_MG310, LIPASE_TRI_TTDCEA_IN_MG327, LIPASE_TRI_TTDCEA_IN_MG344, LIPASE_TWEEN80_MG310, LIPASE_TWEEN80_MG327, LIPASE_TWEEN80_MG344, LplA, Mdh, METHFHYD, MetS, MG385r2, MG471_MODIFICATION_003, MG472_MODIFICATION_002, MG475_MODIFICATION_001, MG479_MODIFICATION_001, MG483_MODIFICATION_002, MG484_MODIFICATION_001, MG484_MODIFICATION_003, MG485_MODIFICATION_002, MG486_MODIFICATION_002, MG486_MODIFICATION_004, MG487_MODIFICATION_001, MG487_MODIFICATION_002, MG488_MODIFICATION_003, MG489_MODIFICATION_001, MG490_MODIFICATION_002, MG492_MODIFICATION_002, MG493_MODIFICATION_001, MG495_MODIFICATION_002, MG496_MODIFICATION_001, MG497_MODIFICATION_002, MG499_MODIFICATION_001, MG500_MODIFICATION_002, MG501_MODIFICATION_002, MG501_MODIFICATION_005, MG502_Amidotransferase, MG502_MODIFICATION_001, MG502_MODIFICATION_004, MG503_MODIFICATION_002, MG504_MODIFICATION_003, MG506_MODIFICATION_001, MG507_MODIFICATION_001, MG508_MODIFICATION_001, MG508_MODIFICATION_003, MG509_MODIFICATION_003, MG510_MODIFICATION_003, MG511_MODIFICATION_002, MG512_MODIFICATION_003, MG513_MODIFICATION_001, MG513_MODIFICATION_003, MG514_MODIFICATION_002, MG518_MODIFICATION_002, MG519_MODIFICATION_001, MG519_MODIFICATION_003, MG520_MODIFICATION_001, MG523_MODIFICATION_002, MGrrnA16S_MODIFICATION_001, MGrrnA16S_MODIFICATION_003, MGrrnA16S_MODIFICATION_004, MGrrnA16S_MODIFICATION_005, MGrrnA16S_MODIFICATION_006, MGrrnA23S_MODIFICATION_004, MGrrnA23S_MODIFICATION_006, MG_070_MONOMER_MODIFICATION_001, MG_070_MONOMER_MODIFICATION_002, MG_070_MONOMER_MODIFICATION_003, MG_070_MONOMER_MODIFICATION_004, MG_070_MONOMER_MODIFICATION_005, MG_166_MONOMER_MODIFICATION_001, MG_217_MONOMER_MODIFICATION_001, MG_272_MONOMER_MODIFICATION_001, MG_273_MONOMER_MODIFICATION_001, MG_274_MONOMER_MODIFICATION_001, MG_282_MONOMER_MODIFICATION_001, MG_305_MONOMER_MODIFICATION_001, MG_305_MONOMER_MODIFICATION_002, MG_317_MONOMER_MODIFICATION_001, MG_317_MONOMER_MODIFICATION_002, MG_317_MONOMER_MODIFICATION_003, MG_317_MONOMER_MODIFICATION_004, MG_317_MONOMER_MODIFICATION_005, MG_328_MONOMER_MODIFICATION_001, MG_342_MONOMER_MODIFICATION_001, MG_377_MONOMER_MODIFICATION_001, MG_377_MONOMER_MODIFICATION_002, MG_377_MONOMER_MODIFICATION_003, MG_377_MONOMER_MODIFICATION_004, MG_377_MONOMER_MODIFICATION_005, MG_377_MONOMER_MODIFICATION_006, MG_377_MONOMER_MODIFICATION_007, MG_377_MONOMER_MODIFICATION_008, MG_377_MONOMER_MODIFICATION_009, MG_377_MONOMER_MODIFICATION_010, MG_377_MONOMER_MODIFICATION_011, MG_392_MONOMER_MODIFICATION_001, MG_392_MONOMER_MODIFICATION_002, MG_401_MONOMER_MODIFICATION_001, MG_401_MONOMER_MODIFICATION_002, MG_401_MONOMER_MODIFICATION_003, MG_401_MONOMER_MODIFICATION_004, MG_401_MONOMER_MODIFICATION_005, MG_401_MONOMER_MODIFICATION_006, MG_401_MONOMER_MODIFICATION_007, MG_401_MONOMER_MODIFICATION_008, MG_401_MONOMER_MODIFICATION_009, MG_407_MONOMER_MODIFICATION_001, MG_407_MONOMER_MODIFICATION_002, MG_407_MONOMER_MODIFICATION_003, MG_427_MONOMER_MODIFICATION_001, MG_427_MONOMER_MODIFICATION_002, MG_438_MONOMER_MODIFICATION_001, MG_438_MONOMER_MODIFICATION_002, MG_438_MONOMER_MODIFICATION_003, MG_438_MONOMER_MODIFICATION_004, MG_438_MONOMER_MODIFICATION_005, MG_438_MONOMER_MODIFICATION_006, MG_438_MONOMER_MODIFICATION_007, MG_438_MONOMER_MODIFICATION_008, MG_438_MONOMER_MODIFICATION_009, MG_451_MONOMER_MODIFICATION_001, MG_451_MONOMER_MODIFICATION_002, MG_451_MONOMER_MODIFICATION_003, MG_460_MONOMER_MODIFICATION_001, MG_460_MONOMER_MODIFICATION_002, MG_460_MONOMER_MODIFICATION_003, MG_491_MONOMER_MODIFICATION_001, NADD1, NADD2, NadE, NADR1, NER_DNAExcision, NER_DNAIncision, NH3eq, NOX, PcbX, Pdp3, PeptidylTRNAHs_ARG, PeptidylTRNAHs_GLU, PfkA1, PfkA2, PfkA3, PfkA4, PfkA5, PgsA1, PgsA2, PgsA3, PhnW, PhnX, PlsC4, PlsC5, PlsX1, PlsX2, PlsX3, PlsX4, PlsX5, PlsX6, PlsX7, PncB, Ppa, Ppc, ProLipoproteinDiacylglycerylTransferase, ProteinDegradation_FtsH_ALA, ProteinDegradation_FtsH_ARG, ProteinDegradation_FtsH_ASN, ProteinDegradation_FtsH_ASP, ProteinDegradation_FtsH_CYS, ProteinDegradation_FtsH_GLN, ProteinDegradation_FtsH_GLU, ProteinDegradation_FtsH_GLY, ProteinDegradation_FtsH_HIS, ProteinDegradation_FtsH_ILE, ProteinDegradation_FtsH_LEU, ProteinDegradation_FtsH_LYS, ProteinDegradation_FtsH_MET, ProteinDegradation_FtsH_PHE, ProteinDegradation_FtsH_PRO, ProteinDegradation_FtsH_SER, ProteinDegradation_FtsH_THR, ProteinDegradation_FtsH_TRP, ProteinDegradation_FtsH_TYR, ProteinDegradation_FtsH_VAL, ProteinDegradation_Lon_ALA, ProteinDegradation_Lon_ARG, ProteinDegradation_Lon_ASN, ProteinDegradation_Lon_ASP, ProteinDegradation_Lon_CYS, ProteinDegradation_Lon_GLN, ProteinDegradation_Lon_GLU, ProteinDegradation_Lon_GLY, ProteinDegradation_Lon_HIS, ProteinDegradation_Lon_ILE, ProteinDegradation_Lon_LEU, ProteinDegradation_Lon_LYS, ProteinDegradation_Lon_MET, ProteinDegradation_Lon_PHE, ProteinDegradation_Lon_PRO, ProteinDegradation_Lon_SER, ProteinDegradation_Lon_THR, ProteinDegradation_Lon_TRP, ProteinDegradation_Lon_TYR, ProteinDegradation_Lon_VAL, PrsA, PYDXK, Pyk_ADP, Pyk_CDP, Pyk_DADP, Pyk_DCDP, Pyk_DGDP, Pyk_DTDP, Pyk_DUDP, Pyk_GDP, Pyk_IDP, Pyk_TDP, Pyk_UDP, RelA1, RelA2, RibF1, RibF2, RNACleavage_DeaD_AMP, RNACleavage_DeaD_CMP, RNACleavage_DeaD_GMP, RNACleavage_DeaD_UMP, RNACleavage_RNAseIII_AMP, RNACleavage_RNAseIII_CMP, RNACleavage_RNAseIII_GMP, RNACleavage_RNAseIII_UMP, RNACleavage_RNAseJ_AMP, RNACleavage_RNAseJ_CMP, RNACleavage_RNAseJ_GMP, RNACleavage_RNAseJ_UMP, RNACleavage_RNAseP_AMP, RNACleavage_RNAseP_CMP, RNACleavage_RNAseP_GMP, RNACleavage_RNAseP_UMP, RNACleavage_RNAseR_AMP, RNACleavage_RNAseR_CMP, RNACleavage_RNAseR_GMP, RNACleavage_RNAseR_UMP, RNACleavage_RsgA_AMP, RNACleavage_RsgA_CMP, RNACleavage_RsgA_GMP, RNACleavage_RsgA_UMP, SNGLYPOr, TatD_dAMP, TatD_dCMP, TatD_dGMP, TatD_dTMP, Tdk1, Tdk2, ThyA, TMDPK, TrxB, TXTHM, TX_ACUP, TX_AD, TX_AKG, TX_AROP11, TX_AROP12, TX_AROP13, TX_AROP21, TX_AROP22, TX_AROP23, TX_Cbi_Co, TX_Cbi_Ni, TX_CL, TX_ComEC_dApdAp, TX_ComEC_dCpdCp, TX_ComEC_dGpdGp, TX_ComEC_dTpdTp, TX_CYTD, TX_DA, TX_GL, TX_GL3P, TX_GLNHPQ, TX_GN, TX_MdlB_doxorubicin, TX_MGTA_CA, TX_MGTA_CU, TX_MGTA_FE2, TX_MGTA_FE3, TX_MGTA_MG, TX_MGTA_MN, TX_MGTA_MOBD, TX_MGTA_ZN, TX_NAUP2, TX_OppB_Ala, TX_OppB_Arg, TX_OppB_Asn, TX_OppB_Asp, TX_OppB_Cys, TX_OppB_Gln, TX_OppB_Glu, TX_OppB_Gly, TX_OppB_His, TX_OppB_Ile, TX_OppB_Leu, TX_OppB_Lys, TX_OppB_Met, TX_OppB_Phe, TX_OppB_Pro, TX_OppB_Ser, TX_OppB_Thr, TX_OppB_Trp, TX_OppB_Tyr, TX_OppB_Val, TX_PHNT, TX_PIUP1, TX_RIBUP, TX_SalX_nisin, TX_SO4, TX_SPMDUP1, TX_SPRDUP2, TX_SunT_nisin, TX_THY, TX_TRK, TX_URA, Udk1, Udk2, vinyl_chloride_activation_1, YbiV_deoxyG6P, YbiV_SBT6P	
H2O	WATER	h2o	C00001	7732-18-5	3303	B01124	15377	HOH				water	((18)O)water	water			H2O1	[OH2]	0	N	18	20		7.0	-0.9	-0.9			Adi, AHCYSs, Apts_Ala, Apts_Arg, Apts_Asn, Apts_Asp, Apts_Cys, Apts_Gln, Apts_Glu, Apts_Gly, Apts_His, Apts_Ile, Apts_Leu, Apts_Lys, Apts_Met, Apts_Phe, Apts_Pro, Apts_Ser, Apts_Thr, Apts_Trp, Apts_Tyr, Apts_Val, AP_endonuclease, AP_lyase, AtpA, ATPHs_ChromosomeCondensation_SMC, ATPHs_DNAReplication_Helicase, ATPHs_DNASupercoiling_gyrase, ATPHs_DNASupercoiling_topoisomeraseIV, ATPHs_ProteinTranslocation_SecA, ATPHs_ProteinTranslocation_SRP, BPNT, Cdd1, Cdd2, CpdB1, CpdB2, CpdB3, CpdB4, Deformylation, deoxyribosephosphodiesterase, DnaA_inactivation, DNADamage_DHURA_ho5Hydantoin_hydroxyl_radical, DNADamage_GammaRadiationInducedStrandBreak, DNADamage_hm5C_glchm5CSN_GLC, DNADamage_hm5URA_f5URA_hydroxyl_radical, DNADamage_hm5U_dhpURA_butylene_glycol, DNADamage_hm5U_glchm5URA_GLC, DNADamage_hm5U_gluTHY_GLU, DNADamage_hm5U_putTHY_PTRC, DNADamage_SpontaneousAbasicSiteStrandBreak, DNADamage_SpontaneousBaseDeamination_adenine, DNADamage_SpontaneousBaseDeamination_cytosine, DNADamage_SpontaneousBaseDeamination_guanine, DNADamage_SpontaneousBaseDeamination_m5C, DNADamage_SpontaneousBaseLoss_adenine, DNADamage_SpontaneousBaseLoss_cytosine, DNADamage_SpontaneousBaseLoss_guanine, DNADamage_SpontaneousBaseLoss_thymine, DNAProcessiveCleavage_dAMP, DNAProcessiveCleavage_dCMP, DNAProcessiveCleavage_dGMP, DNAProcessiveCleavage_dTMP, DNA_RM_EcoD_Restriction, DNA_RM_MunI_Restriction, dRiboseP_lyase, Eno, FMETHs, FolD2, FtsZ_deactivation, GLNHs, GlpQ1, GlpQ2, GlpQ3, GlpQ4, GlpQ5, GlyA3, glycosyltransferase_PG160_DAG160, glycosyltransferase_PG161_DAG161, glycosyltransferase_PG181_DAG181, GTPHs_ChromosomeSegregation_CobQ, GTPHs_ChromosomeSegregation_Era, GTPHs_ChromosomeSegregation_MraZ, GTPHs_ChromosomeSegregation_Obg, GTPHs_Cytokinesis_FtsZ, GTPHs_RibosomeAssembly_EngA, GTPHs_RibosomeAssembly_EngB, GTPHs_RibosomeAssembly_Era, GTPHs_RibosomeAssembly_Obg, GTPHs_RibosomeAssembly_RbfA, GTPHs_RibosomeAssembly_RbgA, HinT_AMP_Lysine_MG132, HinT_AMP_Mor_MG132, HinT_AMP_NH2_MG132, HinT_GMP_Lysine_MG132, HinT_GMP_Mor_MG132, HR_DNAResection_dAMP, HR_DNAResection_dCMP, HR_DNAResection_dGMP, HR_DNAResection_dTMP, HR_junctionMigration, HR_junctionResolution, HR_strandExchange, hydroxyl_radical_generation_1, hydroxyl_radical_generation_2, LIPASE_DIBUTYRIN_MG310, LIPASE_DIBUTYRIN_MG327, LIPASE_DIBUTYRIN_MG344, LIPASE_METHYL_OCDCEA_MG310, LIPASE_METHYL_OCDCEA_MG327, LIPASE_METHYL_OCDCEA_MG344, LIPASE_MONOBUTYRIN_MG310, LIPASE_MONOBUTYRIN_MG327, LIPASE_MONOBUTYRIN_MG344, LIPASE_TRIBUTYRIN_MG310, LIPASE_TRIBUTYRIN_MG327, LIPASE_TRIBUTYRIN_MG344, LIPASE_TRILAURIN_MG310, LIPASE_TRILAURIN_MG327, LIPASE_TRILAURIN_MG344, LIPASE_TRIMYRISTIN_MG310, LIPASE_TRIMYRISTIN_MG327, LIPASE_TRIMYRISTIN_MG344, LIPASE_TRIOLEIN_MG310, LIPASE_TRIOLEIN_MG327, LIPASE_TRIOLEIN_MG344, LIPASE_TRIPALMITIN_MG310, LIPASE_TRIPALMITIN_MG327, LIPASE_TRIPALMITIN_MG344, LIPASE_TRISTEARIN_MG310, LIPASE_TRISTEARIN_MG327, LIPASE_TRISTEARIN_MG344, LIPASE_TRI_HDCEA_IN_MG310, LIPASE_TRI_HDCEA_IN_MG327, LIPASE_TRI_HDCEA_IN_MG344, LIPASE_TRI_TTDCEA_IN_MG310, LIPASE_TRI_TTDCEA_IN_MG327, LIPASE_TRI_TTDCEA_IN_MG344, LIPASE_TWEEN80_MG310, LIPASE_TWEEN80_MG327, LIPASE_TWEEN80_MG344, LIPOYLLYSHs, METHFHYD, MetK, MG385r1, MG385r2, MG385r3, MG385r4, MG385r5, MG471_MODIFICATION_003, MG472_MODIFICATION_002, MG475_MODIFICATION_001, MG479_MODIFICATION_001, MG483_MODIFICATION_002, MG484_MODIFICATION_003, MG485_MODIFICATION_002, MG486_MODIFICATION_004, MG487_MODIFICATION_002, MG488_MODIFICATION_003, MG489_MODIFICATION_001, MG490_MODIFICATION_002, MG492_MODIFICATION_002, MG493_MODIFICATION_001, MG495_MODIFICATION_002, MG496_MODIFICATION_001, MG497_MODIFICATION_002, MG499_MODIFICATION_001, MG500_MODIFICATION_002, MG501_MODIFICATION_002, MG501_MODIFICATION_003, MG501_MODIFICATION_005, MG502_Amidotransferase, MG502_MODIFICATION_001, MG502_MODIFICATION_002, MG502_MODIFICATION_004, MG503_MODIFICATION_002, MG504_MODIFICATION_003, MG506_MODIFICATION_001, MG507_MODIFICATION_001, MG508_MODIFICATION_003, MG509_MODIFICATION_003, MG510_MODIFICATION_003, MG511_MODIFICATION_002, MG512_MODIFICATION_003, MG513_MODIFICATION_001, MG513_MODIFICATION_002, MG513_MODIFICATION_003, MG514_MODIFICATION_002, MG518_MODIFICATION_002, MG519_MODIFICATION_003, MG520_MODIFICATION_001, MG523_MODIFICATION_002, MG_166_MONOMER_MODIFICATION_001, MsrA, MsrB, MutM_FAPyAD, MutM_FAPyGN, MutM_oxo8AD, MutM_oxo8GN, NER_DNAExcision, NER_DNAIncision, NrdEF_ADP, NrdEF_CDP, NrdEF_GDP, NrdEF_maintenance, NrdEF_UDP, NTerminalMethionineClevage, Ohr_CHP, Ohr_H2O2, Ohr_tBHP, OsmC_CHP, OsmC_H2O2, OsmC_tBHP, PcbX, PeptidylTRNAHs_ALA, PeptidylTRNAHs_ARG, PeptidylTRNAHs_ASN, PeptidylTRNAHs_ASP, PeptidylTRNAHs_CYS, PeptidylTRNAHs_FMET, PeptidylTRNAHs_GLN, PeptidylTRNAHs_GLU, PeptidylTRNAHs_GLY, PeptidylTRNAHs_HIS, PeptidylTRNAHs_ILE, PeptidylTRNAHs_LEU, PeptidylTRNAHs_LYS, PeptidylTRNAHs_MET, PeptidylTRNAHs_PHE, PeptidylTRNAHs_PRO, PeptidylTRNAHs_SER, PeptidylTRNAHs_THR, PeptidylTRNAHs_TRP, PeptidylTRNAHs_TYR, PeptidylTRNAHs_VAL, PgpA1, PgpA2, PgpA3, PhnW, PhnX, PncB, Ppa, Ppc, ProteinDegradation_FtsH_ALA, ProteinDegradation_FtsH_ARG, ProteinDegradation_FtsH_ASN, ProteinDegradation_FtsH_ASP, ProteinDegradation_FtsH_CYS, ProteinDegradation_FtsH_GLN, ProteinDegradation_FtsH_GLU, ProteinDegradation_FtsH_GLY, ProteinDegradation_FtsH_HIS, ProteinDegradation_FtsH_ILE, ProteinDegradation_FtsH_LEU, ProteinDegradation_FtsH_LYS, ProteinDegradation_FtsH_MET, ProteinDegradation_FtsH_PHE, ProteinDegradation_FtsH_PRO, ProteinDegradation_FtsH_SER, ProteinDegradation_FtsH_THR, ProteinDegradation_FtsH_TRP, ProteinDegradation_FtsH_TYR, ProteinDegradation_FtsH_VAL, ProteinDegradation_Lon_ALA, ProteinDegradation_Lon_ARG, ProteinDegradation_Lon_ASN, ProteinDegradation_Lon_ASP, ProteinDegradation_Lon_CYS, ProteinDegradation_Lon_GLN, ProteinDegradation_Lon_GLU, ProteinDegradation_Lon_GLY, ProteinDegradation_Lon_HIS, ProteinDegradation_Lon_ILE, ProteinDegradation_Lon_LEU, ProteinDegradation_Lon_LYS, ProteinDegradation_Lon_MET, ProteinDegradation_Lon_PHE, ProteinDegradation_Lon_PRO, ProteinDegradation_Lon_SER, ProteinDegradation_Lon_THR, ProteinDegradation_Lon_TRP, ProteinDegradation_Lon_TYR, ProteinDegradation_Lon_VAL, ProteinPolymerization_ALA, ProteinPolymerization_ARG, ProteinPolymerization_ASN, ProteinPolymerization_ASP, ProteinPolymerization_CYS, ProteinPolymerization_GLN, ProteinPolymerization_GLU, ProteinPolymerization_GLY, ProteinPolymerization_HIS, ProteinPolymerization_ILE, ProteinPolymerization_LEU, ProteinPolymerization_LYS, ProteinPolymerization_MET, ProteinPolymerization_PHE, ProteinPolymerization_PRO, ProteinPolymerization_SER, ProteinPolymerization_THR, ProteinPolymerization_TRP, ProteinPolymerization_TYR, ProteinPolymerization_VAL, pSERpp, pTHRpp, pTYRpp, RNACleavage_DeaD_AMP, RNACleavage_DeaD_CMP, RNACleavage_DeaD_GMP, RNACleavage_DeaD_UMP, RNACleavage_RNAseIII_AMP, RNACleavage_RNAseIII_CMP, RNACleavage_RNAseIII_GMP, RNACleavage_RNAseIII_UMP, RNACleavage_RNAseJ_AMP, RNACleavage_RNAseJ_CMP, RNACleavage_RNAseJ_GMP, RNACleavage_RNAseJ_UMP, RNACleavage_RNAseP_AMP, RNACleavage_RNAseP_CMP, RNACleavage_RNAseP_GMP, RNACleavage_RNAseP_UMP, RNACleavage_RNAseR_AMP, RNACleavage_RNAseR_CMP, RNACleavage_RNAseR_GMP, RNACleavage_RNAseR_UMP, RNACleavage_RsgA_AMP, RNACleavage_RsgA_CMP, RNACleavage_RsgA_GMP, RNACleavage_RsgA_UMP, TatD_dAMP, TatD_dCMP, TatD_dGMP, TatD_dTMP, TX_Cbi_Co, TX_Cbi_Ni, TX_ComEC_dApdAp, TX_ComEC_dCpdCp, TX_ComEC_dGpdGp, TX_ComEC_dTpdTp, TX_GL, TX_GL3P, TX_GLNHPQ, TX_H2O, TX_MdlB_doxorubicin, TX_MGTA_CA, TX_MGTA_CU, TX_MGTA_FE2, TX_MGTA_FE3, TX_MGTA_MG, TX_MGTA_MN, TX_MGTA_MOBD, TX_MGTA_ZN, TX_OppB_Ala, TX_OppB_Arg, TX_OppB_Asn, TX_OppB_Asp, TX_OppB_Cys, TX_OppB_Gln, TX_OppB_Glu, TX_OppB_Gly, TX_OppB_His, TX_OppB_Ile, TX_OppB_Leu, TX_OppB_Lys, TX_OppB_Met, TX_OppB_Phe, TX_OppB_Pro, TX_OppB_Ser, TX_OppB_Thr, TX_OppB_Trp, TX_OppB_Tyr, TX_OppB_Val, TX_PHNT, TX_PIUP1, TX_RIBUP, TX_SalX_nisin, TX_SO4, TX_SPMDUP1, TX_SPRDUP2, TX_SunT_nisin, Ung_ho5URA, Ung_URA, UshA_AMP, UshA_aza6dTMP, UshA_aza8dAMP, UshA_c5dUMP, UshA_carbamoylmethyl6dAMP, UshA_cmnm5s2UMP, UshA_cyclobutane_dCMPdCMP, UshA_cyclobutane_dCMPdTMP, UshA_cyclobutane_dTMPdCMP, UshA_cyclobutane_dTMPdTMP, UshA_cyclodAMP, UshA_cyclodGMP, UshA_dCMP, UshA_dCMP64dCMP, UshA_dCMP64dCMP_dewar, UshA_dCMP64dTMP, UshA_dCMP64dTMP_dewar, UshA_dCMP_GLYC, UshA_DHdTMP, UshA_DHdUMP, UshA_dhpdUMP, UshA_dINSMP, UshA_dTMP, UshA_dTMP64dCMP, UshA_dTMP64dCMP_dewar, UshA_dTMP64dTMP, UshA_dTMP64dTMP_dewar, UshA_dTMP_GLY, UshA_dUMP, UshA_dXANMP, UshA_e1dAMP, UshA_e1dGMP, UshA_e3dAMP, UshA_e3dCMP, UshA_e3dGMP, UshA_e3dTMP, UshA_e4dCMP, UshA_e5dCMP, UshA_e6dAMP, UshA_e7dAMP, UshA_e7dGMP, UshA_e8dGMP, UshA_epsilon1N2dGMP, UshA_epsilon1N6dAMP, UshA_epsilon3N4dCMP, UshA_epsilonN23dGMP, UshA_f5dUMP, UshA_FAPydAMP, UshA_FAPydGMP, UshA_glchm5dCMP, UshA_glchm5dUMP, UshA_gludTMP, UshA_GmMP, UshA_GMP, UshA_hm3dCMP, UshA_hm5dCMP, UshA_hm5dUMP, UshA_hm5hydantoin_dRiboseMP, UshA_ho5dCMP, UshA_ho5dUMP, UshA_ho5ho6dTMP, UshA_ho5ho6dUMP, UshA_ho5hydantoin_dRiboseMP, UshA_IMP, UshA_k2CMP, UshA_m1dAMP, UshA_m1dGMP, UshA_m1GMP, UshA_m2GMP, UshA_m3dAMP, UshA_m3dCMP, UshA_m3dGMP, UshA_m3dTMP, UshA_m4dCMP, UshA_m5CMP, UshA_m5dCMP, UshA_m62AMP, UshA_m6AMP, UshA_m6dAMP, UshA_m7dAMP, UshA_m7dGMP, UshA_m7GMP, UshA_m8dGMP, UshA_n2dAMP, UshA_O2edCMP, UshA_O2edTMP, UshA_O2mdCMP, UshA_O2mdTMP, UshA_O4edTMP, UshA_O4mdTMP, UshA_O6edGMP, UshA_O6mdGMP, UshA_oxo2dAMP, UshA_oxo8dAMP, UshA_oxo8dGMP, UshA_oxoethyl7dGMP, UshA_PSIURIMP, UshA_putdTMP, UshA_s2UMP, UshA_s4UMP, UshA_UmMP, vinyl_chloride_activation_1, YbiV_deoxyG6P, YbiV_F6P, YbiV_G6P, YbiV_GL2P, YbiV_MAN6P, YbiV_R5P, YbiV_SBT6P, YbiV_SNGLYP, YicP	
H2O2		h2o2	C00027	7722-84-1	3329		16240	PEO				hydrogen peroxide	[OH(OH)]	peroxol			H2O2	OO	0	N	34	28		3.8	-0.4	-0.4			HemG, NOX, Ohr_H2O2, OsmC_H2O2, TX_H2O2	
HCYS	HOMO-CYS	hcys-L		454-28-4	2797	B01174	17588	HCS	C00001365			L-homocysteine	2-aminio-4-sulfanylbutanoate	2-azaniumyl-4-sulfanylbutanoate			C4H9N1O2S1	[NH3+]C(CCS)C([O-])=O	0	N	135	120		5.9	-2.7	-2.7			AHCYSs, HCYSMT, MetS	
HDCA		hdca	C00249	57-10-3	3548	B00071	15756	PLM	C00001233	LMFA01010001	DFA0016	Hexadecanoate (n-C16:0)	palmitate	hexadecanoate	fatty acyl		C16H31O2	CCCCCCCCCCCCCCCC(=O)[O-]	-1	N	255	291			6.3	4.0			Aas4, LIPASE_TRIPALMITIN_MG310, LIPASE_TRIPALMITIN_MG327, LIPASE_TRIPALMITIN_MG344, TX_HDCA	
HDCEA	CPD-9245	hdcea	C08362		7849924		28716			LMFA01030056	DFA0095	Hexadecenoate (n-C16:1)	hexadec-9-enoate	hexadec-9-enoate	fatty acyl		C16H29O2	C(=O)(CCCCCCCC=CCCCCCC)[O-]	-1	N	253	284			5.9	3.7			Aas5, LIPASE_TRI_HDCEA_IN_MG310, LIPASE_TRI_HDCEA_IN_MG327, LIPASE_TRI_HDCEA_IN_MG344, TX_HDCEA	
HDECEG3P		1hdecg3p	C00681		3950		16975			LMGP10050000		1-hexadecanoyl-sn-glycerol 3-phosphate	2-hydroxy-3-(phosphonatooxy)propyl hexadecanoate	2-hydroxy-3-(phosphonatooxy)propyl hexadecanoate	lipid	glycerophospholipid	C19H37O7P1	CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])([O-])=O	-2	N	408	403			5.0	1.8			PlsC5, PlsX5	
HDECG3P		1hdec9eg3p										1-hexadec-9-enoyl-sn-glycerol 3-phosphate	(2-hydroxy-2,3-dioxo-1,4,2$l^{5}-dioxaphosphinan-5-yl)methyl pentadecanoate	(2-hydroxy-2,3-dioxo-1,4,2$l^{5}-dioxaphosphinan-5-yl)methyl pentadecanoate	lipid	glycerophospholipid	C19H35O7P1	CCCCCCCCCCCCCCC(=O)OCC1COP(O)(=O)C(=O)O1	-1	N	406	391			5.1	2.8			PlsC4, PlsX4	
HIS	HIS	his-L	C00135	71-00-1	3435	B01171	15971	HIS	C00001363			L-Histidine	histidine	2-amino-3-(1H-imidazol-4-yl)propanoic acid	amino acid		C6H9N3O2	NC(CC1=CNC=N1)C(O)=O	0	N	155	135		7.7	-3.4	-3.4			Apts_His, MG518_Aminoacylation, PeptidylTRNAHs_HIS, ProteinDegradation_FtsH_HIS, ProteinDegradation_Lon_HIS, ProteinPolymerization_HIS	
HisHis					51795710							L-histidyl-L-histidine	2-[2-amino-3-(3H-imidazol-4-yl)propanamido]-3-(3H-imidazol-4-yl)propanoic acid	2-[2-amino-3-(1H-imidazol-5-yl)propanamido]-3-(1H-imidazol-5-yl)propanoic acid	dipeptide		C12H16N6O3	C1=C(NC=N1)CC(C(=O)NC(CC2=CN=CN2)C(=O)O)N	0	N	292	250		7.6	-5.3	-5.3			Apts_His, ProteinDegradation_FtsH_HIS, ProteinDegradation_Lon_HIS, ProteinPolymerization_HIS, TX_OppB_His	
hm3CSN					91848467							3'-hydroxymethylcytosine	4-[(hydroxymethyl)amino]-1H-pyrimidin-2-one	4-[(hydroxymethyl)amino]-1,2-dihydropyrimidin-2-one	modified nucleobase		C5H7N3O2	C(NC1=NC(=O)NC=C1)O	0	N	141	118		12.2	-1.5	-1.5			DNADamage_m3CSN_hm3CSN_hydroxyl_radical	
hm3dC												3'-hydroxymethyl-2'-deoxycytidine	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-[(hydroxymethyl)amino]pyrimidin-2-one	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-[(hydroxymethyl)amino]-1,2-dihydropyrimidin-2-one	modified deoxyribonucleoside		C10H15N3O5	C(NC1=NC(=O)N(C=C1)C2CC(C(O2)CO)O)O	0	N	257	219		7.2	-2.2	-2.2			TX_hm3dC, UshA_hm3dCMP	
hm3dCMP												3'-hydroxymethyl-2'-deoxycytidine monophosphate	(3-hydroxy-5-{4-[(hydroxymethyl)amino]-2-oxopyrimidin-1-yl}oxolan-2-yl)methyl phosphate	(3-hydroxy-5-{4-[(hydroxymethyl)amino]-2-oxo-1,2-dihydropyrimidin-1-yl}oxolan-2-yl)methyl phosphate	modified deoxyribonucleotide monophosphate		C10H14N3O8P1	OCNC1=NC(=O)N(C=C1)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	335	259		0.9	-2.7	-5.7			UshA_hm3dCMP	
hm5CSN					8194137							5'-hydroxymethylcytosine	4-amino-5-(hydroxymethyl)-1H-pyrimidin-2-one	4-amino-5-(hydroxymethyl)-1,2-dihydropyrimidin-2-one	modified nucleobase		C5H7N3O2	C(C1=CNC(=O)N=C1N)O	0	N	141	118		12.1	-2.1	-2.1			DNADamage_hm5C_glchm5CSN_GLC, DNADamage_m5CSN_hm5CSN_hydroxyl_radical	occurs in bacteriophage DNA [PUB_0477]; majority of m5dC in bacteria is due to action of restriction-modification systems [PUB_0478]; 100% replacement cytidine in E. coli phages T2, T4, T6 [PUB_0478]; hypermodification renders bacteriophage DNA resistant to several restriction endonucleases [PUB_078]
hm5dC				7226-77-9	10256919							5'-hydroxymethyl-2'-deoxycytidine	4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(hydroxymethyl)pyrimidin-2-one	4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(hydroxymethyl)-1,2-dihydropyrimidin-2-one	modified deoxyribonucleoside		C10H15N3O5	C(C1=CN(C(=O)N=C1N)C2CC(C(O2)CO)O)O	0	N	257	218		6.6	-2.8	-2.8			TX_hm5dC, UshA_hm5dCMP	occurs in bacteriophage DNA [PUB_0477]; majority of m5dC in bacteria is due to action of restriction-modification systems [PUB_0478]; 100% replacement cytidine in E. coli phages T2, T4, T6 [PUB_0478]; hypermodification renders bacteriophage DNA resistant to several restriction endonucleases [PUB_078]
hm5dCMP												5'-hydroxymethyl-2'-deoxycytidine monophosphate	{5-[4-amino-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	{5-[4-amino-5-(hydroxymethyl)-2-oxo-1,2-dihydropyrimidin-1-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C10H14N3O8P1	NC1=NC(=O)N(C=C1CO)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	335	258		0.3	-2.9	-6.3			UshA_hm5dCMP	
hm5dU					85661900		472579					5-hydroxymethyl-2'-deoxyuridine	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(hydroxymethyl)-3H-pyrimidine-2,4-dione	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(hydroxymethyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified deoxyribonucleoside		C10H14N2O6	C1C(C(OC1N2C=C(C(=O)NC2=O)CO)CO)O	0	N	258	215		3.5	-2.4	-2.4			TX_hm5dU, UshA_hm5dUMP	75 lesions per 10^6 bases [PUB_0479]; occurs in bacteriophage DNA [PUB_0477]; dT is completely replaced by hm5dU in some bacteriophage at the nucleotide precursor level, dCMP ==> dUMP ==> hm5dUMP ==> hm5dUTP, by dCMP deaminase, dUMP hydroxymethylase (not present in M. genitalium), deoxynucleotide monophosphate kinase, and nucleotide diphosphate kinase [PUB_0478];
hm5dUMP					80115916							5-hydroxymethyl-2'-deoxyuridine monophosphate	{3-hydroxy-5-[5-(hydroxymethyl)-2,4-dioxo-3H-pyrimidin-1-yl]oxolan-2-yl}methyl phosphate	{3-hydroxy-5-[5-(hydroxymethyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl]oxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C10H13N2O9P1	OCC1=CN(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)NC1=O	-2	N	336	255			-2.5	-5.9			UshA_hm5dUMP	
hm5hydantoin				10045-58-6	10040718							5-hydroxy-5-methylhydantoin	5-hydroxy-5-methylimidazolidine-2,4-dione	5-hydroxy-5-methylimidazolidine-2,4-dione	modified nucleobase		C4H6N2O3	CC1(C(=O)NC(=O)N1)O	0	N	130	103		1.6	-1.3	-1.5				
hm5hydantoin_dRibose				38709-56-7	24521394							2'-deoxy-3'-(5-hydroxy-5-methyl-hydantoin)-ribose	5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylimidazolidine-2,4-dione	5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylimidazolidine-2,4-dione	modified deoxyribonucleoside		C9H14N2O6	CC1(C(=O)NC(=O)N1C2CC(C(O2)CO)O)O	0	N	246	204		3.3	-1.9	-1.9			TX_hm5hydantoin_dRibose, UshA_hm5hydantoin_dRiboseMP	
hm5hydantoin_dRiboseMP												2'-deoxy-3'-(5-hydroxy-5-methyl-hydantoin)-ribose monophosphate	[3-hydroxy-5-(5-hydroxy-5-methyl-2,4-dioxoimidazolidin-1-yl)oxolan-2-yl]methyl phosphate	[3-hydroxy-5-(5-hydroxy-5-methyl-2,4-dioxoimidazolidin-1-yl)oxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C9H13N2O9P1	CC1(O)N(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)NC1=O	-2	N	324	244			-2.0	-5.4			UshA_hm5hydantoin_dRiboseMP	
hm5URA	CPD-254		C03088		8144743		16964					5-hydroxymethyluracil	5-(hydroxymethyl)-1,3-dihydropyrimidine-2,4-dione	5-(hydroxymethyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified nucleobase		C5H6N2O3	OCC1=CNC(=O)NC1=O	0	N	142	114		3.4	-1.7	-1.7			DNADamage_hm5URA_f5URA_hydroxyl_radical, DNADamage_hm5U_dhpURA_butylene_glycol, DNADamage_hm5U_glchm5URA_GLC, DNADamage_hm5U_gluTHY_GLU, DNADamage_hm5U_putTHY_PTRC, DNADamage_THY_hm5URA_hydroxyl_radical	75 lesions per 10^6 bases [PUB_0479]; occurs in bacteriophage DNA [PUB_0477]; dT is completely replaced by hm5dU in some bacteriophage at the nucleotide precursor level, dCMP ==> dUMP ==> hm5dUMP ==> hm5dUTP, by dCMP deaminase, dUMP hydroxymethylase (not present in M. genitalium), deoxynucleotide monophosphate kinase, and nucleotide diphosphate kinase [PUB_0478];
HNO2			C00088		3388		25567					nitrous acid	NH2(O)(OH)	azinic acid	reactive nitrogen species		H1N1O2	N(=O)O	-1	N	47	34			0.2	-2.2				
ho5CSN				13484-95-2	76231563							5-Hydroxycytosine	4-amino-5-hydroxy-1H-pyrimidin-2-one	4-amino-5-hydroxy-1,2-dihydropyrimidin-2-one	modified nucleobase		C4H5N3O2	N1C=C(C(=NC1=O)N)O	0	N	127	101		10.9	-1.5	-1.5			DNADamage_CSN_ho5CSN_hydroxyl_radical	36 lesions per 10^6 bases [PUB_0479]; recognized by endonuclease III, FPG, UNG [PUB_0473]
ho5dC				52278-77-0	49960128							5-Hydroxy-2'-deoxycytidine	4-amino-5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	4-amino-5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one	modified deoxyribonucleoside		C9H13N3O5	C1C(C(OC1N2C=C(C(=NC2=O)N)O)CO)O	0	N	243	201		5.0	-2.1	-2.1			TX_ho5dC, UshA_ho5dCMP	36 lesions per 10^6 bases [PUB_0479]; recognized by endonuclease III, FPG, UNG [PUB_0473]
ho5dCMP												5-Hydroxy-2'-deoxycytidine monophosphate	[5-(4-amino-5-hydroxy-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(4-amino-5-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C9H12N3O8P1	NC1=NC(=O)N(C=C1O)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	321	241			-2.3	-5.6			UshA_ho5dCMP	
ho5dU				5168-36-5								5-hydroxy-2'-deoxyuridine	5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrimidine-2,4-dione	5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified deoxyribonucleoside		C9H12N2O6	C1C(C(OC1N2C=C(C(=O)NC2=O)O)CO)O	0	N	244	198		2.8	-1.8	-1.8			TX_ho5dU, UshA_ho5dUMP	6 lesions per 10^6 bases [PUB_0479]; recognized by endonuclease III, FPG, UNG [PUB_0473]
ho5dUMP												5-hydroxy-2'-deoxyuridine monophosphate	[3-hydroxy-5-(5-hydroxy-2,4-dioxo-3H-pyrimidin-1-yl)oxolan-2-yl]methyl phosphate	[3-hydroxy-5-(5-hydroxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C9H11N2O9P1	OC1CC(OC1COP([O-])([O-])=O)N1C=C(O)C(=O)NC1=O	-2	N	322	238			-1.9	-5.3			Ung_ho5URA, UshA_ho5dUMP	
ho5ho6dT				41308-58-1	10236660							5-hydroxy-6-hydroxy-2'-deoxythymidine	5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,3-diazinane-2,4-dione	5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,3-diazinane-2,4-dione	modified deoxyribonucleoside		C10H16N2O6	CC1(CN(C(=O)NC1=O)C2CC(C(O2)CO)O)O	0	N	260	222		4.2	-2.2	-2.2			TX_ho5ho6dT, UshA_ho5ho6dTMP	
ho5ho6dTMP												5-hydroxy-6-hydroxy-2'-deoxythymidine monophosphate	[3-hydroxy-5-(5-hydroxy-5-methyl-2,4-dioxo-1,3-diazinan-1-yl)oxolan-2-yl]methyl phosphate	[3-hydroxy-5-(5-hydroxy-5-methyl-2,4-dioxo-1,3-diazinan-1-yl)oxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C10H15N2O9P1	CC1(O)CN(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)NC1=O	-2	N	338	262			-2.3	-5.6			UshA_ho5ho6dTMP	
ho5ho6dU												5-hydroxy-6-hydroxy-2'-deoxyuridine	5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazinane-2,4-dione	5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazinane-2,4-dione	modified deoxyribonucleoside		C9H14N2O6	C1C(C(OC1N2CC(C(=O)NC2=O)O)CO)O	0	N	246	205		4.3	-2.6	-2.6			TX_ho5ho6dU, UshA_ho5ho6dUMP	
ho5ho6dUMP												5-hydroxy-6-hydroxy-2'-deoxyuridine monophosphate	[3-hydroxy-5-(5-hydroxy-2,4-dioxo-1,3-diazinan-1-yl)oxolan-2-yl]methyl phosphate	[3-hydroxy-5-(5-hydroxy-2,4-dioxo-1,3-diazinan-1-yl)oxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C9H13N2O9P1	OC1CC(OC1COP([O-])([O-])=O)N1CC(O)C(=O)NC1=O	-2	N	324	245			-2.7	-6.1			UshA_ho5ho6dUMP	
ho5ho6THY				1123-21-3	24589118							5-hydroxy-6-hydroxythymine	5-hydroxy-5-methyl-1,3-diazinane-2,4-dione	5-hydroxy-5-methyl-1,3-diazinane-2,4-dione	modified nucleobase		C5H8N2O3	CC1(CNC(=O)NC1=O)O	0	N	144	121		2.5	-1.5	-1.5			DNADamage_THY_ho5ho6THY_hydroxyl_radical	
ho5ho6URA					24588982							5-hydroxy-6-hydroxyuracil	5-hydroxy-1,3-diazinane-2,4-dione	5-hydroxy-1,3-diazinane-2,4-dione	modified nucleobase		C4H6N2O3	N1CC(C(=O)NC1=O)O	0	N	130	104		2.5	-1.9	-1.9			DNADamage_URA_ho5ho6URA_hydroxyl_radical	
ho5hydantoin					8368117							5-hydroxyhydantoin	5-hydroxyimidazolidine-2,4-dione	5-hydroxyimidazolidine-2,4-dione	modified nucleobase		C3H4N2O3	C1(C(NC(N1)=O)=O)O	0	N	116	86		1.5	-1.7	-2.0			DNADamage_DHURA_ho5Hydantoin_hydroxyl_radical	
ho5hydantoin_dRibose												2'-deoxy-3'-(5-hydroxyhydantoin)-ribose	5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazolidine-2,4-dione	5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazolidine-2,4-dione	modified deoxyribonucleoside		C8H12N2O6	C1(C(NC(N1C2CC(C(O2)CO)O)=O)=O)O	0	N	232	187		3.2	-2.4	-2.4			TX_ho5hydantoin_dRibose, UshA_ho5hydantoin_dRiboseMP	
ho5hydantoin_dRiboseMP												2'-deoxy-3'-(5-hydroxyhydantoin)-ribose monophosphate	[3-hydroxy-5-(5-hydroxy-2,4-dioxoimidazolidin-1-yl)oxolan-2-yl]methyl phosphate	[3-hydroxy-5-(5-hydroxy-2,4-dioxoimidazolidin-1-yl)oxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C8H11N2O9P1	OC1CC(OC1COP([O-])([O-])=O)N1C(O)C(=O)NC1=O	-2	N	310	227			-2.5	-5.9			UshA_ho5hydantoin_dRiboseMP	
ho5URA					8146721		29115					5-hydroxyuracil	5-hydroxyuracil	5-hydroxy-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified nucleobase		C4H4N2O3	N1C=C(C(=O)NC1=O)O	0	N	128	97			-1.1	-1.1			DNADamage_URA_ho5URA_hydroxyl_radical, Ung_ho5URA	6 lesions per 10^6 bases [PUB_0479]; recognized by endonuclease III, FPG, UNG [PUB_0473]
HPHPYR		34hpp	C01179		4406	B00254	15999	ENO	C00007512			3-(4-Hydroxyphenyl)pyruvate	3-(4-hydroxyphenyl)-2-oxopropanoate	3-(4-hydroxyphenyl)-2-oxopropanoate			C9H7O4	OC1=CC=C(CC(=O)C([O-])=O)C=C1	-1	N	179	152			1.6	-1.9			AspC2	
hydride				12184-88-2	11533395		29239					hydride	hydrogenuide	hydrogenuide	damaging Agent		H1	[H-]	-1	N	1	7							hydroxyl_radical_generation_2	
hydrogen_radical					11533372		29305					hydrogen radical	H(.)	hydrogen	damaging Agent		H1	[H]	0	N	1	7							DNADamage_THY_DHTHY_hydrogen_radical	
hydroxyl_radical					8145426		29191					hydroxyl radical	(OH)(.)	oxidanyl	reactive oxygen species		H1O1	[OH]	0	N	17	17			-0.5	-0.5			DNADamage_AD_FAPyAD_hydroxyl_radical, DNADamage_AD_oxo2AD_hydroxyl_radical, DNADamage_AD_oxo8AD_hydroxyl_radical, DNADamage_CSN_CSN_GLYC_hydroxyl_radical, DNADamage_CSN_ho5CSN_hydroxyl_radical, DNADamage_f5URA_c5URA_hydroxyl_radical, DNADamage_GN_FAPyGN_hydroxyl_radical, DNADamage_GN_oxo8GN_hydroxyl_radical, DNADamage_hm5URA_f5URA_hydroxyl_radical, DNADamage_HYXN_XAN_hydroxyl_radical, DNADamage_m3CSN_hm3CSN_hydroxyl_radical, DNADamage_m5CSN_hm5CSN_hydroxyl_radical, DNADamage_THY_hm5URA_hydroxyl_radical, DNADamage_THY_ho5ho6THY_hydroxyl_radical, DNADamage_THY_THY_GLYC_hydroxyl_radical, DNADamage_URA_DHURA_hydroxyl_radical, DNADamage_URA_ho5ho6URA_hydroxyl_radical, DNADamage_URA_ho5URA_hydroxyl_radical, hydroxyl_radical_generation_1, hydroxyl_radical_generation_2	highly reactive ROS [PUB_0479]; formed by 1) interaction with ionizing radiation, 2) interaction of superoxide with HOCL, 3) interaction of superoxide with nitric oxide, and 4) splitting of H2O2 by transition metals such as iron and copper [PUB_0479];
HYXN	HYPOXANTHINE	hxan	C00262	68-94-0	3560	B00078	17368	HPA	C00001502			hypoxanthine	hypoxanthine	6,7-dihydro-1H-purin-6-one	modified nucleobase		C5H4N4O1	O=C1NC=NC2=C1NC=N2	0	N	136	104		4.4	-0.9	-0.9			DeoD1, DeoD4, DNADamage_HYXN_XAN_hydroxyl_radical, DNADamage_SpontaneousBaseDeamination_adenine, Hpt1, YicP	
IDP		idp	C00104	86-04-4	3404	B01160	17808	IDP				IDP	[3,4-dihydroxy-5-(6-oxo-3H-purin-9-yl)oxolan-2-yl]methyl (phosphonatooxy)phosphonate	[3,4-dihydroxy-5-(6-oxo-6,9-dihydro-3H-purin-9-yl)oxolan-2-yl]methyl (phosphonatooxy)phosphonate	modified ribonucleotide diphosphate		C10H11N4O11P2	OC1C(COP([O-])(=O)OP([O-])([O-])=O)OC(C1O)N1C=NC2=C1NC=NC2=O	-4	N	425	295		2.3	-2.5	-7.9			Adk3, PfkA4, Pgk4, Pyk_IDP	
ILE	ILE	ile-L	C00407	73-32-5	3697	B01236	17191	ILE	C00001374			L-Isoleucine	isoleucine	2-amino-3-methylpentanoic acid	amino acid		C6H13N1O2	C(=O)(O)C(N)C(C)CC	0	N	131	136		6.2	-1.6	-1.6			Apts_Ile, MG472_Aminoacylation, MG486_Aminoacylation, PeptidylTRNAHs_ILE, ProteinDegradation_FtsH_ILE, ProteinDegradation_Lon_ILE, ProteinPolymerization_ILE	
IleIle												L-isoleucyl-L-isoleucine	ile-ile	2-(2-amino-3-methylpentanamido)-3-methylpentanoic acid	dipeptide		C12H24N2O3	CCC(C)C(N)C(=O)NC(C(C)CC)C(O)=O	0	N	244	252		6.5	-1.2	-1.2			Apts_Ile, ProteinDegradation_FtsH_ILE, ProteinDegradation_Lon_ILE, ProteinPolymerization_ILE, TX_OppB_Ile	
IMP	IMP	imp	C00130	131-99-7	3430	B01168	17202	IMP	C00007224			IMP	[3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl phosphate	[3,4-dihydroxy-5-(6-oxo-6,9-dihydro-1H-purin-9-yl)oxolan-2-yl]methyl phosphate	modified ribonucleotide monophosphate		C10H11N4O8P1	OC1C(COP([O-])([O-])=O)OC(C1O)N1C=NC2=C1N=CNC2=O	-2	N	346	253		0.2	-2.6	-6.0			Hpt1, UshA_IMP	
INOS		inost	C00137	87-89-8	3437	B00038	17268	INS	C00001164			myo-inositol	inositol	cyclohexane-1,2,3,4,5,6-hexol			C6H12O6	C1(C(C(C(C(C1O)O)O)O)O)O	0	N	180	154		4.7	-3.8	-3.8			GlpQ5, MG385r5	
INS	INOSINE	ins	C00294	58-63-9	3588	B01208	17596	NOS	C00019692			inosine	inosine	(2R,3R,4S,5R)-2-(6-hydroxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol	modified ribonucleoside		C10H12N4O5	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2O	0	N	268	213		7.8	-1.6	-1.6			DeoD4, UshA_IMP	
ITP		itp	C00081	132-06-9	3381	B01153	16039	ITT				ITP	({[3,4-dihydroxy-5-(6-oxo-3H-purin-9-yl)oxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	({[3,4-dihydroxy-5-(6-oxo-6,9-dihydro-3H-purin-9-yl)oxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	modified ribonucleotide triphosphate		C10H11N4O14P3	OC1C(COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)OC(C1O)N1C=NC2=C1NC=NC2=O	-5	N	504	338		1.6	-2.9	-10.7			Adk3, PfkA4, Pgk4, Pyk_IDP	
K	K+	k	C00238	7440-09-7	3537		29103	K				potassium ion	[KH]	potassium	ion		K1	[K+]	1	N	39	87			0.2	0.2			TX_TRK	
k2C				116120-47-9	87326008							lysidine	2-amino-6-({4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-ylidene}amino)hexanoic acid	2-amino-6-({4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-ylidene}amino)hexanoic acid	modified amino acid		C15H25N5O6	NC(CCCCN=C1N=C(N)C=CN1C1OC(CO)C(O)C1O)C(O)=O	1	N	371	329		9.2	-5.2	-6.4			TX_k2C, UshA_k2CMP	
k2CMP												lysidine monophosphate	(5-{2-[(5-amino-5-carboxypentyl)amino]-4-iminopyrimidin-1-yl}-3,4-dihydroxyoxolan-2-yl)methyl phosphate	(5-{2-[(5-amino-5-carboxypentyl)amino]-4-imino-1,4-dihydropyrimidin-1-yl}-3,4-dihydroxyoxolan-2-yl)methyl phosphate	modified ribonucleotide monophosphate		C15H24N5O9P1	NC(CCCCNC1=NC(=N)C=CN1C1OC(COP([O-])([O-])=O)C(O)C1O)C(O)=O	-1	N	449	369		5.0	-8.6	-9.8			MG486_MODIFICATION_002, UshA_k2CMP	
LAC	D-LACTATE	lac-D	C00256	10326-41-7	3555	B00075	42111	LAC	C00019549			D-lactate	lactate	2-hydroxypropanoate	carboxy acid		C3H5O3	CC(O)C([O-])=O	-1	N	89	79		0.1	-0.5	-3.6			LdhA	
LEU	LEU	leu-L	C00123	61-90-5	3423	B00034	15603	LEU	C00001377			L-Leucine	leucine	2-amino-4-methylpentanoic acid	amino acid		C6H13N1O2	C(=O)(O)C(N)CC(C)C	0	N	131	136		6.1	-1.7	-1.7			Apts_Leu, MG500_Aminoacylation, MG508_Aminoacylation, MG519_Aminoacylation, MG520_Aminoacylation, PeptidylTRNAHs_LEU, ProteinDegradation_FtsH_LEU, ProteinDegradation_Lon_LEU, ProteinPolymerization_LEU	
LeuLeu				3303-31-9	8198360							L-leucyl-L-leucine	leu-leu	2-(2-amino-4-methylpentanamido)-4-methylpentanoic acid	dipeptide		C12H24N2O3	CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N	0	N	244	252		6.4	-1.3	-1.3			Apts_Leu, ProteinDegradation_FtsH_LEU, ProteinDegradation_Lon_LEU, ProteinPolymerization_LEU, TX_OppB_Leu	
lincomycin			C06812 	154-21-2	46506668		6472					lincomycin			antibiotic	lincosamide	C18H34N2O6S1	[H][C@@]1(O[C@]([H])([C@H](NC(=O)C2C[C@@H](CCC)CN2C)[C@@H](C)O)[C@H](O)[C@H](O)[C@H]1O)SC	0	N	407									Binds 50S ribosomal subunit and prevents peptide bond formation [PUB_0847].
LIPOATE	LIPOIC-ACID		C00725	62-46-4	3990	B00160	30314		C00000754			lipoate	lipoate	5-(1,2-dithiolan-3-yl)pentanoate			C8H13O2S2	C1(CC(SS1)CCCCC(=O)[O-])	-1	N	205	182			2.1	-0.5			LIPOYLLYSHs, LplA, TX_LIPOATE	
LIPOYLAMP	LIPOYL-AMP		C16238 		47205546			LAQ				lipoyl-AMP	[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[5-(1,2-dithiolan-3-yl)pentanoyl]oxy}phosphonate	[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[5-(1,2-dithiolan-3-yl)pentanoyl]oxy}phosphonate	modified amino acid		C18H25N5O8P1S2	C(C3(C(C(C(N2(C1(=C(C(=NC=N1)N)N=C2)))O3)O)O))OP(OC(CCCCC4(SSCC4))=O)([O-])=O	-1	N	535	424		3.9	-2.8	-2.1			LplA, MG_272_MONOMER_MODIFICATION_001	
LIPOYLLYS				20902-53-8	8680122							N(6)-(lipoyl)lysine	2-amino-6-[5-(1,2-dithiolan-3-yl)pentanamido]hexanoic acid	2-amino-6-[5-(1,2-dithiolan-3-yl)pentanamido]hexanoic acid			C14H26N2O3S2	NC(CCCCNC(=O)CCCCC1CCSS1)C(O)=O	0	N	334	312		5.9	-0.9	-1.0			LIPOYLLYSHs, MG_272_MONOMER_MODIFICATION_001	
lomefloxacin			C07078		9289		116278					Lomefloxacin	lomefloxacin	1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid	antibiotic	fluoroquinolone	C17H19F2N3O3	CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O	0	N	351	299		7.3	-1.1	-1.1			TX_NormM_lomefloxacin	Inhibits topoisomerase II/DNA gyrase and topoisomerase IV [PUB_0847].
LYS	LYS	lys-L	C00047	56-87-1	3349	B00013	18019	LYS	C00001378			L-Lysine	5-amino-5-carboxypentan-1-aminium	5-amino-5-carboxypentan-1-aminium	amino acid		C6H15N2O2	NC(CCCC[NH3+])C(O)=O	1	N	147	150	2.2, 8.9, 10.28	9.8	-3.8	-5.6			Apts_Lys, HinT_AMP_Lysine_MG132, HinT_GMP_Lysine_MG132, LIPOYLLYSHs, MG486_MODIFICATION_002, MG501_Aminoacylation, MG509_Aminoacylation, MG_272_MONOMER_MODIFICATION_001, PeptidylTRNAHs_LYS, ProteinDegradation_FtsH_LYS, ProteinDegradation_Lon_LYS, ProteinPolymerization_LYS	
LysLys				13184-13-9	10242166							L-lysyl-L-lysine	5-(6-aminio-2-aminohexanamido)-5-carboxypentan-1-aminium	5-(2-amino-6-azaniumylhexanamido)-5-carboxypentan-1-aminium	dipeptide		C12H28N4O3	NC(CCCC[NH3+])C(=O)NC(CCCC[NH3+])C(O)=O	2	N	276	280		10.2	-4.9	-8.4			Apts_Lys, ProteinDegradation_FtsH_LYS, ProteinDegradation_Lon_LYS, ProteinPolymerization_LYS, TX_OppB_Lys	
m1AD					85510505		318410					1-methyladenine	6-amino-1-methyl-9H-purin-1-ium	6-amino-1-methyl-9H-purin-1-ium	modified nucleobase	methylation	C6H8N5	C[N+]1=C(N)C2=C(NC=N2)N=C1	1	N	150	127		6.6	-5.5	-5.5			DNADamage_AD_m1AD_MMS, DNADamage_AD_m1AD_MMSO4, DNADamage_AD_m1AD_MNNG, DNADamage_AD_m1AD_MNU	
m1dA												1-methyl-2'-deoxyadenosine	6-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-methylpurin-1-ium	6-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-methyl-9H-purin-1-ium	modified deoxyribonucleoside	methylation	C11H16N5O3	C[N+]1=C(N)C2=C(N=C1)N(C=N2)C1CC(O)C(CO)O1	1	N	266	227		8.5	-6.1	-6.1			TX_m1dA, UshA_m1dAMP	
m1dAMP												1-methyl-2'-deoxyadenosine monophosphate	6-amino-9-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-1-methylpurin-1-ium	6-amino-9-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-1-methyl-9H-purin-1-ium	modified deoxyribonucleotide monophosphate	methylation	C11H15N5O6P1	C[N+]1=C(N)C2=C(N=C1)N(C=N2)C1CC(O)C(COP([O-])([O-])=O)O1	-1	N	344	268		2.2	-7.8	-9.3			UshA_m1dAMP	
m1dG												1-methyl-2'-deoxyguanosine	2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-methylpurin-6-one	2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-methyl-6,9-dihydro-1H-purin-6-one	modified deoxyribonucleoside	methylation	C11H15N5O4	CN1C(=O)C2=C(N=C1N)N(C=N2)C1CC(O)C(CO)O1	0	N	281	233		7.9	-1.6	-1.6			TX_m1dG, UshA_m1dGMP	
m1dGMP												1-methyl-2'-deoxyguanosine monophosphate	[5-(2-amino-1-methyl-6-oxopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2-amino-1-methyl-6-oxo-6,9-dihydro-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	methylation	C11H14N5O7P1	CN1C(=O)C2=C(N=C1N)N(C=N2)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	359	273		1.5	-2.5	-5.1			UshA_m1dGMP	
m1G	CPD0-1043			2140-65-0	57394402							1-methylguanosine	2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-methylpurin-6-one	2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-methyl-6,9-dihydro-1H-purin-6-one	modified ribonucleoside		C11H15N5O5	C3(OC(CO)C(O)C(O)3)N2C=NC1=C2N=C(N)N(C)C1=O	0	N	297	241		7.1	-2.5	-2.5			TX_m1G, UshA_m1GMP	
m1GMP												1-methylguanosine monophosphate	[5-(2-amino-1-methyl-6-oxopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	[5-(2-amino-1-methyl-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	modified ribonucleotide monophosphate		C11H14N5O8P1	CN1C(N)=NC2=C(N=CN2C2OC(COP([O-])([O-])=O)C(O)C2O)C1=O	-2	N	375	282		1.5	-3.4	-6.0			MG484_MODIFICATION_001, MG487_MODIFICATION_001, MG508_MODIFICATION_001, MG519_MODIFICATION_001, UshA_m1GMP	
m1GN												1-methylguanine	2-amino-1-methyl-9H-purin-6-one	2-amino-1-methyl-6,9-dihydro-1H-purin-6-one	modified nucleobase	methylation	C6H7N5O1	CN1C(=O)C2=C(NC=N2)N=C1N	0	N	165	132		6.3	-0.9	-0.9			DNADamage_GN_m1GN_MMS, DNADamage_GN_m1GN_MNU	
m2G				2140-77-4	53801189		19702					N(2)-methylguanosine	9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-(methylamino)-1H-purin-6-one	9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-(methylamino)-6,9-dihydro-1H-purin-6-one	modified ribonucleoside		C11H15N5O5	C3(OC(CO)C(O)C(O)3)N2C=NC1=C2N=C(N(C))NC1=O	0	N	297	241		6.0	-2.4	-2.4			TX_m2G, UshA_m2GMP	
m2GMP												N(2)-methylguanosine monophosphate	{3,4-dihydroxy-5-[2-(methylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl}methyl phosphate	{3,4-dihydroxy-5-[2-(methylamino)-6-oxo-6,9-dihydro-1H-purin-9-yl]oxolan-2-yl}methyl phosphate	modified ribonucleotide monophosphate		C11H14N5O8P1	CNC1=NC2=C(N=CN2C2OC(COP([O-])([O-])=O)C(O)C2O)C(=O)N1	-2	N	375	281		1.5	-3.5	-5.9			MGrrnA16S_MODIFICATION_001, UshA_m2GMP	
m3AD	3-Methyl-Adenines		C00913		26744165		38635					3-methyladenine	3-methyl-9H-purin-6-imine	3-methyl-6,9-dihydro-3H-purin-6-imine	modified nucleobase	methylation	C6H7N5	CN1C=NC(=N)C2=C1NC=N2	0	N	149	124		8.3	-0.9	-0.9			DNADamage_AD_m3AD_MMS, DNADamage_AD_m3AD_MMSO4, DNADamage_AD_m3AD_MNNG, DNADamage_AD_m3AD_MNU	
m3CSN				6220-47-9	24505895							3-methylcytosine	4-(methylamino)-1H-pyrimidin-2-one	4-(methylamino)-1,2-dihydropyrimidin-2-one	modified nucleobase	methylation	C5H7N3O1	CNC1=NC(=O)NC=C1	0	N	125	110		12.5	-1.0	-1.0			DNADamage_CSN_m3CSN_MMS, DNADamage_CSN_m3CSN_MMSO4, DNADamage_CSN_m3CSN_MNNG, DNADamage_CSN_m3CSN_MNU, DNADamage_m3CSN_hm3CSN_hydroxyl_radical	
m3dA				76227-25-3	78075938							3-methyl-2'-deoxyadenosine	2-(hydroxymethyl)-5-(6-imino-3-methylpurin-9-yl)oxolan-3-ol	2-(hydroxymethyl)-5-(6-imino-3-methyl-6,9-dihydro-3H-purin-9-yl)oxolan-3-ol	modified deoxyribonucleoside	methylation	C11H15N5O3	CN1C=NC(=N)C2=C1N(C=N2)C3CC(C(O3)CO)O	0	N	265	224		8.9	-1.6	-1.6			TX_m3dA, UshA_m3dAMP	
m3dAMP												3-methyl-2'-deoxyadenosine monophosphate	[3-hydroxy-5-(6-imino-3-methylpurin-9-yl)oxolan-2-yl]methyl phosphate	[3-hydroxy-5-(6-imino-3-methyl-6,9-dihydro-3H-purin-9-yl)oxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	methylation	C11H14N5O6P1	CN1C=NC(=N)C2=C1N(C=N2)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	343	264		2.7	-4.5	-5.1			UshA_m3dAMP	
m3dC				22882-02-6	9471134							3-methyl-2'-deoxycytidine	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(methylamino)pyrimidin-2-one	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(methylamino)-1,2-dihydropyrimidin-2-one	modified deoxyribonucleoside	methylation	C10H15N3O4	CNC1=NC(=O)N(C=C1)C2CC(C(O2)CO)O	0	N	241	210		7.5	-1.6	-1.6			TX_m3dC, UshA_m3dCMP	
m3dCMP												3-methyl-2'-deoxycytidine monophosphate	{3-hydroxy-5-[4-(methylamino)-2-oxopyrimidin-1-yl]oxolan-2-yl}methyl phosphate	{3-hydroxy-5-[4-(methylamino)-2-oxo-1,2-dihydropyrimidin-1-yl]oxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate	methylation	C10H14N3O7P1	CNC1=NC(=O)N(C=C1)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	319	250		1.1	-2.3	-5.1			UshA_m3dCMP	
m3dG				92754-66-0	701646							3-methyl-2'-deoxyguanosine	2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-methylpurin-6-one	2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-methyl-6,9-dihydro-3H-purin-6-one	modified deoxyribonucleoside	methylation	C11H15N5O4	CN1C2=C(N=CN2C2CC(O)C(CO)O2)C(=O)N=C1N	0	N	281	233		7.2	-1.9	-1.9			TX_m3dG, UshA_m3dGMP	
m3dGMP												3-methyl-2'-deoxyguanosine monophosphate	[5-(2-amino-3-methyl-6-oxopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2-amino-3-methyl-6-oxo-6,9-dihydro-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	methylation	C11H14N5O7P1	CN1C2=C(N=CN2C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)N=C1N	-2	N	359	273		1.4	-2.4	-5.4			UshA_m3dGMP	
m3dT					85555353		363760					3'-methyl-2'-deoxythymidine	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,5-dimethylpyrimidine-2,4-dione	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,5-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified deoxyribonucleoside	methylation	C11H16N2O5	CC1=CN(C(=O)N(C1=O)C)C2CC(C(O2)CO)O	0	N	256	224		5.5	-0.9	-0.9			TX_m3dT, UshA_m3dTMP	
m3dTMP												3'-methyl-2'-deoxythymidine monophosphate	[5-(3,5-dimethyl-2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(3,5-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	methylation	C11H15N2O8P1	CN1C(=O)N(C=C(C)C1=O)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	334	264			-1.0	-4.4			UshA_m3dTMP	
m3GN												3-methylguanine	2-amino-3-methyl-9H-purin-6-one	2-amino-3-methyl-6,9-dihydro-3H-purin-6-one	modified nucleobase	methylation	C6H7N5O1	CN1C2=C(N=CN2)C(=O)N=C1N	0	N	165	132		6.0	-1.3	-1.3			DNADamage_GN_m3GN_MMS, DNADamage_GN_m3GN_MMSO4, DNADamage_GN_m3GN_MNNG, DNADamage_GN_m3GN_MNU	
m3THY	CPD0-1930			4160-77-4	10240482							3'-methylthymine	3,5-dimethyl-1H-pyrimidine-2,4-dione	3,5-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified nucleobase	methylation	C6H8N2O2	CC1=CNC(=O)N(C1=O)C	0	N	140	123		3.2	-0.2	-0.2			DNADamage_THY_m3THY_MMS, DNADamage_THY_m3THY_MNU	
m4CSN					55832386							4-methylcytosine	4-amino-4-methyl-1,3-dihydropyrimidin-2-one	4-amino-4-methyl-1,2,3,4-tetrahydropyrimidin-2-one	modified nucleobase	methylation	C5H9N3O1	N1C=CC(NC1=O)(N)C	1	N	127	115		10.5	-1.0	-1.8			DNADamage_CSN_m4CSN_CH3	majority of m4dC in bacteria is due to action of restriction-modification systems [PUB_0478]; 0.5-2% cytidine replacement in bacteria [PUB_0478];
m4dC												4-methyl-2'-deoxycytidine	4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-methyl-3H-pyrimidin-2-one	4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-methyl-1,2,3,4-tetrahydropyrimidin-2-one	modified deoxyribonucleoside	methylation	C10H17N3O4	C1C(C(OC1N2C=CC(NC2=O)(N)C)CO)O	1	N	243	215		10.4	-1.7	-2.5			TX_m4dC, UshA_m4dCMP	majority of m4dC in bacteria is due to action of restriction-modification systems [PUB_0478]; 0.5-2% cytidine replacement in bacteria [PUB_0478];
m4dCMP												4-methyl-2'-deoxycytidine monophosphate	[5-(4-amino-4-methyl-2-oxo-3H-pyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(4-amino-4-methyl-2-oxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	methylation	C10H16N3O7P1	CC1(N)NC(=O)N(C=C1)C1CC(O)C(COP([O-])([O-])=O)O1	-1	N	321	256		3.6	-6.0	-5.9			UshA_m4dCMP	
m5C				2140-61-6	29214844		20607					5-methylcytidine	5-methylcytidine	4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2-dihydropyrimidin-2-one	modified ribonucleoside		C10H15N3O5	CC1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O	0	N	257	218		6.9	-2.4	-2.4			TX_m5C, UshA_m5CMP	
m5CMP					85415893		217465					5-methylcytidine monophosphate	[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	[5-(4-amino-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	modified ribonucleotide monophosphate		C10H14N3O8P1	CC1=CN(C2OC(COP([O-])([O-])=O)C(O)C2O)C(=O)N=C1N	-2	N	335	258		1.1	-3.1	-5.9			UshA_m5CMP	
m5CSN			C02376		5418							5-methylcytosine	5-methylcytosine	4-amino-5-methyl-1,2-dihydropyrimidin-2-one	modified nucleobase	methylation	C5H7N3O1	CC1=CNC(=O)N=C1N	0	N	125	109		12.6	-0.8	-0.9			DNADamage_CSN_m5CSN_CH3, DNADamage_m5CSN_hm5CSN_hydroxyl_radical, DNADamage_SpontaneousBaseDeamination_m5C	occurs in bacteriophage DNA [PUB_0477]; 100% cytidine replacement in phage XP12 [PUB_0478]; 0.3-2% cytidine replacement in bacteria [PUB_0478];
m5dC			C03592	838-07-3	6383							5-methyl-2'-deoxycytidine	4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one	4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2-dihydropyrimidin-2-one	modified deoxyribonucleoside	methylation	C10H15N3O4	CC1=CN(C(=O)N=C1N)C2CC(C(O2)CO)O	0	N	241	209		7.8	-1.5	-1.5			TX_m5dC, UshA_m5dCMP	occurs in bacteriophage DNA [PUB_0477]; 100% cytidine replacement in phage XP12 [PUB_0478]; 0.3-2% cytidine replacement in bacteria [PUB_0478];
m5dCMP												5-methyl-2'-deoxycytidine monophosphate	[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(4-amino-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	methylation	C10H14N3O7P1	CC1=CN(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)N=C1N	-2	N	319	250		1.5	-2.6	-5.0			UshA_m5dCMP	
m62A			C03416		85164663		28284					N6,N6-dimethyladenosine	2-[6-(dimethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol	2-[6-(dimethylamino)-9H-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol	modified ribonucleoside		C12H17N5O4	CN(C)C1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)O)O	0	N	295	251		8.7	-1.1	-1.2			TX_m62A, UshA_m62AMP	
m62AMP												N6,N6-dimethyladenosine monophosphate	{5-[6-(dimethylamino)purin-9-yl]-3,4-dihydroxyoxolan-2-yl}methyl phosphate	{5-[6-(dimethylamino)-9H-purin-9-yl]-3,4-dihydroxyoxolan-2-yl}methyl phosphate	modified ribonucleotide monophosphate		C12H16N5O7P1	CN(C)C1=NC=NC2=C1N=CN2C1OC(COP([O-])([O-])=O)C(O)C1O	-2	N	373	292		3.8	-4.2	-4.6			MGrrnA16S_MODIFICATION_004, MGrrnA16S_MODIFICATION_006, UshA_m62AMP	
m6A				1867-73-8	10232449							N(6)-methyladenine	2-(hydroxymethyl)-5-[6-(methylamino)purin-9-yl]oxolane-3,4-diol	2-(hydroxymethyl)-5-[6-(methylamino)-9H-purin-9-yl]oxolane-3,4-diol	modified ribonucleoside		C11H15N5O4	CNC1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)O)O	0	N	281	233		8.7	-1.8	-1.8			TX_m6A, UshA_m6AMP	
m6AD				22387-37-7	85399901		201188					6-methyladenine	N-methyl-9H-purin-6-amine	6-map	modified nucleobase	methylation	C6H7N5	CNC1=NC=NC2=C1N=CN2	0	N	149	125		7.6	-0.2	-0.2			DNADamage_AD_m6AD_CH3, DNA_RM_EcoD_Methylation, DNA_RM_MunI_Methylation	majority of m6dA in bacteria is due to action of restriction-modification systems [PUB_0478]; 0.3-3% adenosine replacement in bacteria [PUB_0478];
m6AMP												N(6)-methyladenine monophosphate	{3,4-dihydroxy-5-[6-(methylamino)purin-9-yl]oxolan-2-yl}methyl phosphate	{3,4-dihydroxy-5-[6-(methylamino)-9H-purin-9-yl]oxolan-2-yl}methyl phosphate	modified ribonucleotide monophosphate		C11H14N5O7P1	CNC1=NC=NC2=C1N=CN2C1OC(COP([O-])([O-])=O)C(O)C1O	-2	N	359	274		3.8	-4.9	-5.3			MGrrnA16S_MODIFICATION_003, MGrrnA16S_MODIFICATION_004, MGrrnA16S_MODIFICATION_005, MGrrnA16S_MODIFICATION_006, UshA_m6AMP	
m6dA												6-methyl-2'-deoxyadenosine	2-(hydroxymethyl)-5-[6-(methylamino)-9H-purin-9-yl]oxolan-3-ol	2-(hydroxymethyl)-5-[6-(methylamino)purin-9-yl]oxolan-3-ol	modified deoxyribonucleoside	methylation	C11H15N5O3	CNC1=NC=NC2=C1N=CN2C1CC(O)C(CO)O1	0	N	265	225		9.4	-0.9	-0.9			TX_m6dA, UshA_m6dAMP	majority of m6dA in bacteria is due to action of restriction-modification systems [PUB_0478]; 0.3-3% adenosine replacement in bacteria [PUB_0478];
m6dAMP												6-methyl-2'-deoxyadenosine monophosphate	{3-hydroxy-5-[6-(methylamino)-9H-purin-9-yl]oxolan-2-yl}methyl phosphate	{3-hydroxy-5-[6-(methylamino)purin-9-yl]oxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate	methylation	C11H14N5O6P1	CNC1=NC=NC2=C1N=CN2C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	343	265		3.8	-4.0	-4.4			UshA_m6dAMP	
m7AD					85510215		318119					7-methyladenine	7-methylpurin-6-amine	7-methyl-7H-purin-6-amine	modified nucleobase	methylation	C6H7N5	CN1C=NC2=C1C(N)=NC=N2	0	N	149	125		13.1	-0.3	-0.4			DNADamage_AD_m7AD_MMS, DNADamage_AD_m7AD_MMSO4, DNADamage_AD_m7AD_MNNG, DNADamage_AD_m7AD_MNU	
m7dA												7-methyl-2'-deoxyadenosine	6-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methyl-1,3,7,9$l^{5}-purin-9-ylium	6-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methyl-7H-1,3,7,9$l^{5}-purin-9-ylium	modified deoxyribonucleoside	methylation	C11H16N5O3	CN1C=[N+](C2CC(O)C(CO)O2)C2=C1C(N)=NC=N2	1	N	266	227		5.8	-5.1	-5.1			TX_m7dA, UshA_m7dAMP	
m7dAMP												7-methyl-2'-deoxyadenosine monophosphate	6-amino-9-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-7-methyl-1,3,7,9$l^{5}-purin-9-ylium	6-amino-9-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-7-methyl-7H-1,3,7,9$l^{5}-purin-9-ylium	modified deoxyribonucleotide monophosphate	methylation	C11H15N5O6P1	CN1C=[N+](C2CC(O)C(COP([O-])([O-])=O)O2)C2=C1C(N)=NC=N2	-1	N	344	267			-5.2	-7.7			UshA_m7dAMP	
m7dG				28074-91-1	75344968							7-methyl-2'-deoxyguanosine	2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methyl-6-oxo-3,9-dihydropurine-7,9-diium	2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methyl-6-oxo-6,9-dihydro-3H-purine-7,9-diium	modified deoxyribonucleoside	methylation	C11H17N5O4	C[N+]1=C[NH+](C2CC(O)C(CO)O2)C2=C1C(=O)N=C(N)N2	0	N	283	237		7.4	-5.3	-3.6			TX_m7dG, UshA_m7dGMP	
m7dGMP												7-methyl-2'-deoxyguanosine monophosphate	2-amino-9-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-7-methyl-6-oxo-3,9-dihydropurine-7,9-diium	2-amino-9-{4-hydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-7-methyl-6-oxo-6,9-dihydro-3H-purine-7,9-diium	modified deoxyribonucleotide monophosphate	methylation	C11H16N5O7P1	C[N+]1=C[NH+](C2CC(O)C(COP([O-])([O-])=O)O2)C2=C1C(=O)N=C(N)N2	-2	N	361	277		3.5	-5.4	-6.4			UshA_m7dGMP	
m7G	CPD0-1041			20244-86-4	57393133							7-methylguanosine	2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-hydroxy-7-methylpurin-7-ium	2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-hydroxy-7-methyl-9H-purin-7-ium	modified ribonucleoside		C11H16N5O5	C[N+]1=CN(C2OC(CO)C(O)C2O)C2=C1C(O)=NC(N)=N2	1	N	298	244		5.7	-5.6	-5.6			TX_m7G, UshA_m7GMP	
m7GMP												7-methylguanosine monophosphate	2-amino-9-{3,4-dihydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-7-methyl-6-oxo-1H-purin-7-ium	2-amino-9-{3,4-dihydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-7-methyl-6-oxo-6,9-dihydro-1H-purin-7-ium	modified ribonucleotide monophosphate		C11H15N5O8P1	C[N+]1=CN(C2OC(COP([O-])([O-])=O)C(O)C2O)C2=C1C(=O)NC(N)=N2	-1	N	376	283		2.2	-8.7	-9.6			MG471_MODIFICATION_001, MG472_MODIFICATION_001, MG484_MODIFICATION_002, MG485_MODIFICATION_001, MG486_MODIFICATION_001, MG488_MODIFICATION_001, MG490_MODIFICATION_001, MG492_MODIFICATION_001, MG497_MODIFICATION_001, MG501_MODIFICATION_001, MG504_MODIFICATION_001, MG509_MODIFICATION_001, MG510_MODIFICATION_001, MG511_MODIFICATION_001, MG512_MODIFICATION_001, MG514_MODIFICATION_001, MG519_MODIFICATION_002, MG523_MODIFICATION_001, UshA_m7GMP	
m7GN					46168677							7-methylguanine	2-amino-7-methyl-6-oxo-3,9-dihydropurin-7-ium	2-amino-7-methyl-6-oxo-6,9-dihydro-3H-purin-7-ium	modified nucleobase	methylation	C6H8N5O1	C[N+]1=CNC2=C1C(=O)N=C(N)N2	0	N	166	134		6.1	-4.6	-5.6			DNADamage_GN_m7GN_MMS, DNADamage_GN_m7GN_MMSO4, DNADamage_GN_m7GN_MNNG, DNADamage_GN_m7GN_MNU	
m8dG					41028575							8-methyl-2'-deoxyguanosine	2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-methyl-7,8-dihydro-3H-purin-6-one	2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-methyl-6,7,8,9-tetrahydro-3H-purin-6-one	modified deoxyribonucleoside	methylation	C11H17N5O4	N1C(N(C2=C1C(=O)N=C(N2)N)C3CC(C(O3)CO)O)C	0	N	283	238		11.8	-2.0	-2.0			TX_m8dG, UshA_m8dGMP	
m8dGMP												8-methyl-2'-deoxyguanosine monophosphate	[5-(2-amino-8-methyl-6-oxo-7,8-dihydro-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2-amino-8-methyl-6-oxo-6,7,8,9-tetrahydro-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	methylation	C11H16N5O7P1	CC1NC2=C(NC(N)=NC2=O)N1C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	361	278		6.1	-5.8	-5.5			UshA_m8dGMP	
m8GN												8-methylguanine	2-amino-8-methyl-3,7,8,9-tetrahydropurin-6-one	2-amino-8-methyl-6,7,8,9-tetrahydro-3H-purin-6-one	modified nucleobase	methylation	C6H9N5O1	N1C(NC2=C1C(=O)N=C(N2)N)C	0	N	167	137		12.5	-1.5	-1.5			DNADamage_GN_m8GN_CH3	
MAL	MAL	mal-L	C00149	97-67-6	3449	B00042	30797	LMR	C00001192			L-Malate	mal	2-hydroxybutanedioate	carboxy acid		C4H4O5	OC(CC([O-])=O)C([O-])=O	-2	N	132	104			-1.1	-6.6			Mdh	
MAN	MANNOSE	man	C00159	3458-28-4	37675		37675					D-Mannose	glucose	2,3,4,5,6-pentahydroxyhexanal	carbohydrate	sugar	C6H12O6	C(C(C(C(C(C=O)O)O)O)O)O	0	N	180	159		4.4	-3.6	-3.6			YbiV_MAN6P	
MAN1P	MANNOSE-1P	man1p	C03812	27251-84-9								D-Mannose 1-phosphate	[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate	[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate	carbohydrate	sugar phosphate	C6H11O9P1	OCC1OC(OP([O-])([O-])=O)C(O)C(O)C1O	-2	N	258	194			-3.1	-6.4			CpsG	
MAN6P	MANNOSE-6P	man6p	C00275		3572	B01204	17369	M6D	C00007307			D-Mannose 6-phosphate	(3,4,5,6-tetrahydroxyoxan-2-yl)methyl phosphate	(3,4,5,6-tetrahydroxyoxan-2-yl)methyl phosphate	carbohydrate	sugar phosphate	C6H11O9P1	OC1OC(COP([O-])([O-])=O)C(O)C(O)C1O	-2	N	258	194			-3.1	-6.4			CpsG, TX_UHPT3, YbiV_MAN6P	
MET	MET	met-L	C00073	63-68-3	3373	B01148	16643	MET	C00001379			L-Methionine	methionine	2-amino-4-(methylsulfanyl)butanoic acid	amino acid		C5H11N1O2S1	C(=O)(O)C(N)CCSC	0	N	149	138		6.0	-2.3	-2.3			Apts_Met, FMETHs, HCYSMT, MetK, MetS, MG485_Aminoacylation, MG488_Aminoacylation, MG488_Formyltransferase, MsrA, MsrB, NTerminalMethionineClevage, PeptidylTRNAHs_MET, ProteinDegradation_FtsH_MET, ProteinDegradation_Lon_MET, ProteinPolymerization_MET	
METHF	5-10-METHENYL-THF	methf	C00445		3733	B04682	15638		C00019687			5,10-methyltetrahydrofolate	3-amino-8-{4-[(1,3-dicarboxylatopropyl)carbamoyl]phenyl}-1-oxo-4H,5H,6H,6aH,7H-2,4,5,8,10000000$l^{5}-imidazo[1,5-f]pteridin-10-ylium	3-amino-8-{4-[(1,3-dicarboxylatopropyl)carbamoyl]phenyl}-1-oxo-1H,4H,5H,6H,6aH,7H,8H-2,4,5,8,10000000$l^{5}-imidazo[1,5-f]pteridin-10-ylium	vitamin	folate	C20H20N7O6	NC1=NC(=O)C2=C(NCC3CN(C=[N+]23)C2=CC=C(C=C2)C(=O)NC(CCC([O-])=O)C([O-])=O)N1	-2	N	454	372		3.6	-5.1	-10.3			FolD1, FolD2, METHFHYD	
methylRed	CPD0-1147			845-10-3	24579432							4′-dimethylaminoazobenzene-2-carboxylic acid	2-{2-[4-(dimethylamino)phenyl]diazen-1-yl}benzoate	2-{2-[4-(dimethylamino)phenyl]diazen-1-yl}benzoate	antibiotic		C15H14N3O2	CN(C)C1=CC=C(C=C1)N=NC2=CC=CC=C2C(=O)[O-]	-1	N	268	242		3.6	3.3	0.8			AzoR	
methyl_nitrosamine					10234588							methyl nitrosamine	methyl(nitroso)amine	methyl(nitroso)amine	alkylating byproduct	methylation	C1H4N2O1	CNN=O	0	N	60	55		0.3	-0.2	-1.2				byproduct of DNA methylation by DMN
METHYL_OCDCEA					24592556							methyl oleate	methyl (8E)-octadec-8-enoate	methyl (8E)-octadec-8-enoate			C19H36O2	CCCCCCCCC\C=C\CCCCCCC(=O)OC	0	Y	296	337			6.9	6.9			LIPASE_METHYL_OCDCEA_MG310, LIPASE_METHYL_OCDCEA_MG327, LIPASE_METHYL_OCDCEA_MG344	
MetMet					10233351							L-methionyl-L-methionine	2-[2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid	2-[2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid	dipeptide		C10H20N2O3S2	CSCCC(C(=O)NC(CCSC)C(=O)O)N	0	N	280	255		6.3	-2.5	-2.5			Apts_Met, Deformylation, NTerminalMethionineClevage, ProteinDegradation_FtsH_MET, ProteinDegradation_Lon_MET, ProteinPolymerization_MET, TX_OppB_Met	
METSOXRL	CPD-8990	metsox-R-L					49032					L-Methionine-R-Sulfoxide	2-aminio-4-methanesulfinylbutanoate	2-azaniumyl-4-methanesulfinylbutanoate			C5H11N1O3S1	CS(=O)CCC([NH3+])C([O-])=O	0	N	165	146		5.4	-4.7	-4.7			MsrB	
METSOXSL	L-Methionine-sulfoxides	metsox-S-L	C02989	454-41-1	5898	B04873	17016					L-Methionine-S-Sulfoxide	2-aminio-4-methanesulfinylbutanoate	2-azaniumyl-4-methanesulfinylbutanoate			C5H11N1O3S1	CS(=O)CCC([NH3+])C([O-])=O	0	N	165	146		5.4	-4.7	-4.7			MsrA	
METTHF	METHYLENE-THF	mlthf	C00143	3432-99-3	3443	B04640	1989	MHF	C00007250			5,10-Methylenetetrahydrofolate	2-[(4-{3-amino-1-oxo-4H,5H,6H,6aH,7H,9H-imidazolidino[1,5-f]pteridin-8-yl}phenyl)formamido]pentanedioic acid	2-[(4-{3-amino-1-oxo-1H,4H,5H,6H,6aH,7H,8H,9H-imidazolidino[1,5-f]pteridin-8-yl}phenyl)formamido]pentanedioic acid	vitamin	folate	C20H23N7O6	C(C1(=CC=C(C=C1)N3(CC2(CNC4(=C(N2C3)C(N=C(N)N4)=O)))))(=O)NC(C(=O)O)CCC(O)=O	-2	N	457	381		4.7	-3.4	-7.4			FolD1, FthC, GlyA3, MetF, ThyA	
MG	MG+2	mg2	C00305	7439-95-4	3599		18420	MG				magnesium ion	magnesium	magnesium(2+) ion	ion		Mg1	[Mg+2]	2	N	24	22			-0.6	-0.6			TX_MGTA_MG	
MMS	CPD-7038			66-27-3	8146818		25255					methyl methanesulphonate	MMS	methyl methanesulfonate	alkylating agent	methylation	C2H6O3S1	COS(=O)(=O)C	0	N	110	90			-0.6	-0.6			DNADamage_AD_m1AD_MMS, DNADamage_AD_m3AD_MMS, DNADamage_AD_m7AD_MMS, DNADamage_CSN_m3CSN_MMS, DNADamage_GN_m1GN_MMS, DNADamage_GN_m3GN_MMS, DNADamage_GN_m7GN_MMS, DNADamage_GN_O6mGN_MMS, DNADamage_THY_m3THY_MMS	SN2 DNA methylating agent [PUB_0465]
MMSO4					85563059		371544					dimethyl sulfate	dimethylsulfate	dimethyl sulfate	alkylating agent	methylation	C2H6O4S1	COS(=O)(=O)OC	0	N	126	99			-0.1	-0.1			DNADamage_AD_m1AD_MMSO4, DNADamage_AD_m3AD_MMSO4, DNADamage_AD_m7AD_MMSO4, DNADamage_CSN_m3CSN_MMSO4, DNADamage_GN_m3GN_MMSO4, DNADamage_GN_m7GN_MMSO4, DNADamage_GN_O6mGN_MMSO4	SN2 DNA methylating agent [PUB_0465]
MN	MN+2	mn2	C00034	7439-96-5	3336		18291	MN				manganese ion	mn(2+)	manganese(2+) ion	ion		Mn1	[Mn+2]	2	N	55	34			-0.2	-0.2			TX_MGTA_MN	
MNNG			C14592		85240171		21759					N-methyl-N'-nitro-N-nitrosoguanidine	1-methyl-2-nitro-1-nitrosoguanidine	1-methyl-2-nitro-1-nitrosoguanidine	alkylating agent	methylation	C2H5N5O3	CN(C(=N[N+](=O)[O-])N)N=O	0	N	147	110			-0.4	-0.4			DNADamage_AD_m1AD_MNNG, DNADamage_AD_m3AD_MNNG, DNADamage_AD_m7AD_MNNG, DNADamage_CSN_m3CSN_MNNG, DNADamage_CSN_O2mCSN_MNNG, DNADamage_GN_m3GN_MNNG, DNADamage_GN_m7GN_MNNG, DNADamage_GN_O6mGN_MNNG, DNADamage_THY_O2mTHY_MNNG, DNADamage_THY_O4mTHY_MNNG	SN1 DNA methylating agent [PUB_0465]
MNU			C14595		17395595		50102					N-methyl-N-nitrosourea	1-methyl-1-nitrosourea	1-methyl-1-nitrosourea	alkylating agent	methylation	C2H5N3O2	CN(C(=O)N)N=O	0	N	103	85			-0.5	-0.5			DNADamage_AD_m1AD_MNU, DNADamage_AD_m3AD_MNU, DNADamage_AD_m7AD_MNU, DNADamage_CSN_m3CSN_MNU, DNADamage_CSN_O2mCSN_MNU, DNADamage_GN_m1GN_MNU, DNADamage_GN_m3GN_MNU, DNADamage_GN_m7GN_MNU, DNADamage_GN_O6mGN_MNU, DNADamage_THY_m3THY_MNU, DNADamage_THY_O2mTHY_MNU, DNADamage_THY_O4mTHY_MNU	SN1 DNA methylating agent [PUB_0465]
MO	MO+2	mobd	C00150	7439-98-7	185498		28685					molybdenum ion	molybdenum(2+) ion	molybdenum(2+) ion	ion		Mo1	[Mo++]	2	N	96	34							MOrx	
MOBD	CPD-3	mobd	C06232		8475		25371					Molybdate	molybdate	dioxomolybdenumbis(olate)	ion		Mo1O4	O=[Mo](=O)([O-])[O-]	-2	N	160	74			-1.8	-1.8			MOrx, TX_MGTA_MOBD	
MONOBUTYRIN					11446213							1-monobutyrin	1-monobutyrin	2,3-dihydroxypropyl butanoate			C7H14O4	CCCC(=O)OCC(O)CO	0	Y	162	158		5.3	-0.3	-0.3			LIPASE_MONOBUTYRIN_MG310, LIPASE_MONOBUTYRIN_MG327, LIPASE_MONOBUTYRIN_MG344	
MOR			C14452		17395452		34856					morpholine	morpholine	morpholine			C4H9N1O1	C1COCCN1	1	N	87	90			-0.4	-1.7			HinT_AMP_Mor_MG132, HinT_GMP_Mor_MG132	
MQL7	CPD-12125		C05819		8114		18151					Menaquinol 7		2-[(2E)-3,7-dimethylocta-2,6-dienyl]-3-methylnaphthalene-1,4-diol	vitamin		C46H66O2	CC1=C(C2=CC=CC=C2C(=C1CC=C(C)CCC=C(C)C)O)O	0	Y	310									
MQN7	CPD-9718		C00828	11032-49-8	4086							Menaquinone 7		2-[(2E)-3,7-dimethylocta-2,6-dienyl]-3-methylnaphthalene-1,4-dione	vitamin		C46H64O2	CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCC=C(C)C	0	Y	308									
MS			C11145		8144523		27376					methanesulfonic acid	methanesulfonic acid	methanesulfonic acid	alkylating byproduct	methylation	C1H4O3S1	CS(=O)(=O)O	-1	N	96	73			-1.0	-3.3			DNADamage_AD_e1AD_EMS, DNADamage_AD_e3AD_EMS, DNADamage_AD_e6AD_EMS, DNADamage_AD_e7AD_EMS, DNADamage_AD_m1AD_MMS, DNADamage_AD_m3AD_MMS, DNADamage_AD_m7AD_MMS, DNADamage_CSN_e3CSN_EMS, DNADamage_CSN_m3CSN_MMS, DNADamage_CSN_O2eCSN_EMS, DNADamage_GN_e1GN_EMS, DNADamage_GN_e3GN_EMS, DNADamage_GN_e7GN_EMS, DNADamage_GN_m1GN_MMS, DNADamage_GN_m3GN_MMS, DNADamage_GN_m7GN_MMS, DNADamage_GN_O6eGN_EMS, DNADamage_GN_O6mGN_MMS, DNADamage_THY_e3THY_EMS, DNADamage_THY_m3THY_MMS, DNADamage_THY_O2eTHY_EMS, DNADamage_THY_O4eTHY_EMS	byproduct of DNA methylation by MMS
MSO4			C02704		5667		17760					Methyl sulfate	methyl sulfate	methoxysulfonic acid	alkylating byproduct	methylation	C1H4O4S1	COS(=O)(=O)O	-1	N	112	82			-0.5	-2.8			DNADamage_AD_m1AD_MMSO4, DNADamage_AD_m3AD_MMSO4, DNADamage_AD_m7AD_MMSO4, DNADamage_CSN_m3CSN_MMSO4, DNADamage_GN_m3GN_MMSO4, DNADamage_GN_m7GN_MMSO4, DNADamage_GN_O6mGN_MMSO4	byproduct of DNA methylation by MMSO4
MTHF	5-METHYL-THF	5mthf	C00440	134-35-0	3729	B04681	15641		C00007252			5-Methyltetrahydrofolate	2-[(4-{[(2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methyl]amino}phenyl)formamido]-4-carboxybutanoate	2-[(4-{[(2-amino-5-methyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]-4-carboxybutanoate	vitamin	folate	C20H24N7O6	CN1C(CNC2=CC=C(C=C2)C(=O)NC(CCC(O)=O)C([O-])=O)CNC2=C1C(=O)N=C(N)N2	-2	N	458	390		4.9	-4.4	-8.0			MetF, MetS	
n2AD					87351544		479075					2-amino-adenine	9H-purine-2,6-diamine	9H-purine-2,6-diamine	modified nucleobase		C5H6N6	NC1=NC2=C(N=CN2)C(N)=N1	0	N	150	118		8.1	-0.7	-1.0			DNADamage_AD_n2AD_NH3	occurs in bacteriophage DNA [PUB_0477]; 100% adenosine replacement in phage S-2L [PUB_0478];
n2dA					85408687		210129					2-amino-2'-deoxyadenosine	5-(2,6-diaminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol	5-(2,6-diamino-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol	modified deoxyribonucleoside		C10H14N6O3	C1C(C(OC1N2C=NC3=C2N=C(N=C3N)N)CO)O	0	N	266	218		10.0	-1.3	-1.4			TX_n2dA, UshA_n2dAMP	occurs in bacteriophage DNA [PUB_0477]; 100% adenosine replacement in phage S-2L [PUB_0478];
n2dAMP												2-amino-2'-deoxyadenosine monophosphate	[5-(2,6-diaminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2,6-diamino-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C10H13N6O6P1	NC1=NC2=C(N=CN2C2CC(O)C(COP([O-])([O-])=O)O2)C(N)=N1	-2	N	344	258		4.7	-4.3	-4.8			UshA_n2dAMP	
NA	NA+	na1	C01330	7440-23-5	4541		29101	NA				sodium ion	na(+)	sodium	ion		Na1	[Na+]	1	N	23	49			-0.8	-0.8			TX_NAUP2, TX_NormM_acriflavine, TX_NormM_benzalkonium, TX_NormM_berberine, TX_NormM_ciprofloxacin, TX_NormM_crystalViolet, TX_NormM_doxorubicin, TX_NormM_enoxacin, TX_NormM_ethidium, TX_NormM_lomefloxacin, TX_NormM_norfloxacin, TX_NormM_novobiocin, TX_NormM_proflavine, TX_NormM_rhodamine6G, TX_NormM_tetraphenylphosphonium	
NAAD			C13051	5502-96-5	583440				C00007537			nicotinic acid adenine dinucleotide	1-{5-[({[({[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl}-3-carboxy-1$l^{5}-pyridin-1-ylium	1-{5-[({[({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl}-3-carboxy-1$l^{5}-pyridin-1-ylium			C21H27N6O15P2	C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C4N=CN=C5N)O)O)O)O)C(=O)O	-2	N	665	503		2.4	-10.1	-12.4			NADD1, NadE	
NAC	NIACINE	nac	C00253	59-67-6	3552	B00073	15940	NIO	C00000208			nicotinate	nicotinate	pyridine-3-carboxylate	vitamin		C6H4N1O2	[O-]C(=O)C1=CN=CC=C1	-1	N	122	103		4.0	-0.2	-2.8			PncB, TX_NAC	
NAD	NAD	nad	C00003	53-84-9	3305	B01126	15846	NAD	C00007256			nicotinamide adenine dinucleotide, oxidized	1-[5-({[({[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphinato]oxy}methyl)-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1$l^{5}-pyridin-1-ylium	1-[5-({[({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphinato]oxy}methyl)-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1$l^{5}-pyridin-1-ylium	vitamin	redox electron carrier	C21H26N7O14P2	NC(=O)C1=CC=C[N+](=C1)C1OC(COP([O-])(=O)OP([O-])(=O)OCC2OC(C(O)C2O)N2C=NC3=C2N=CN=C3N)C(O)C1O	-1	N	662	503		2.9	-10.6	-11.7			AceE, AzoR, DNALigation, DNA_ligation_repair, Fre1, Fre4, Fre5, GapA, LdhA, Mdh, MetF, NADD2, NadE, NadK, NADR1, NOX	
NADH	NADH	nadh	C00004		3306	B01127	16908	NAI				nicotinamide adenine dinucleotide, reduced	[5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl ({[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	[5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl ({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	vitamin	redox electron carrier	C21H27N7O14P2	C(OP(=O)([O-])OP(=O)(OCC1(C(O)C(O)C(O1)N3(C2(C(=C(N)N=CN=2)N=C3))))[O-])C4(C(O)C(C(O4)N5(C=C(C(N)=O)CC=C5))O)	-2	N	663	504		3.6	-6.7	-8.6			AceE, AzoR, Fre1, Fre4, Fre5, GapA, LdhA, Mdh, MetF, NOX	
NADP	NADP	nadph	C00005	2646-71-1	3307	B01128	16474	NDP	C00019545			nicotinamide adenine dinucleotide phosphate, oxidized	1-[5-({[({[5-(6-aminopurin-9-yl)-4-(hydrogen phosphonatooxy)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphinato]oxy}methyl)-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1$l^{5}-pyridin-1-ylium	1-[5-({[({[5-(6-amino-9H-purin-9-yl)-4-(hydrogen phosphonatooxy)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphinato]oxy}methyl)-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1$l^{5}-pyridin-1-ylium	vitamin	redox electron carrier	C21H26N7O17P3	NC(=O)C1=CC=C[N+](=C1)C1OC(COP([O-])(=O)OP([O-])(=O)OCC2OC(C(OP(O)([O-])=O)C2O)N2C=NC3=C2N=CN=C3N)C(O)C1O	-3	N	741	546		2.1	-11.7	-15.7			DhfR1, FolD1, Fre3, Fre6, NadK, SNGLYPOr, TrxB	
NADPH	NADPH	nadph	C00005	2646-71-1	3307	B01128	16474	NDP	C00019545			nicotinamide adenine dinucleotide phosphate, reduced	[5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl ({[5-(6-aminopurin-9-yl)-4-(hydrogen phosphonatooxy)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	[5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl ({[5-(6-amino-9H-purin-9-yl)-4-(hydrogen phosphonatooxy)-3-hydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	vitamin	redox electron carrier	C21H27N7O17P3	NC(=O)C1=CN(C=CC1)C1OC(COP([O-])(=O)OP([O-])(=O)OCC2OC(C(OP(O)([O-])=O)C2O)N2C=NC3=C2N=CN=C3N)C(O)C1O	-4	N	742	547		2.8	-7.6	-12.5			DhfR1, FolD1, Fre3, Fre6, SNGLYPOr, TrxB	
nalidixic_acid			C05079 	389-08-2	46507401		100147					nalidixic acid			antibiotic	quinolone	C12H12N2O3	CCN1C=C(C(O)=O)C(=O)C2=C1N=C(C)C=C2	0	N	232									Binds DNA and inhibits RNA synthesis [PUB_0847].
NAMN	NICOTINATE_NUCLEOTIDE		C01185		4411	B01404	15763	NCN	C00007447			nicotinate/nicotinic acid mononucleotide	3-carboxy-1-{3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl}-1$l^{5}-pyridin-1-ylium	3-carboxy-1-{3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl}-1$l^{5}-pyridin-1-ylium			C11H15N1O9P1	OC1C(COP(O)(O)=O)OC(C1O)[N+]1=CC=CC(=C1)C(O)=O	-2	N	336	262			-5.4	-9.4			NADD1, PncB	
NH3	AMMONIA		C00014	7664-41-7	3316	B00004	16134	NH3	C00007267			ammonia	ammonia	ammonia	gas		H3N1	[NH3]	1	N	17	23			-1.2	-2.8			Adi, ArcC, Cdd1, Cdd2, DNADamage_AD_n2AD_NH3, DNADamage_SpontaneousBaseDeamination_adenine, DNADamage_SpontaneousBaseDeamination_cytosine, DNADamage_SpontaneousBaseDeamination_guanine, DNADamage_SpontaneousBaseDeamination_m5C, GLNHs, HinT_AMP_NH2_MG132, NadE, NADR2, NH3eq, PhnW, YicP	
NH4	AMMONIUM	nh4	C01342		223		28938	NH4				ammonium	ammonium	azanium	ion		H4N1	[NH4+]	1	N	18	25			-1.2	-2.8			NH3eq, TX_NH4	
NI	NI+2	ni2	C00291	7440-02-0	3585		49786	NI				nickel	ni(2+)	nickel(2+) ion	ion		Ni1	[Ni++]	2	N	59	18			0.2	0.2			TX_Cbi_Ni	
nisin					87269033		567022					nisin	6-amino-2-(2-{2-[2-(2-{2-[(7-{6-amino-2-[2-(2-{[21-(2-{[10-({15-[2-(2-amino-3-methylpentanamido)but-2-enamido]-9-methylidene-5,8,11,14-tetraoxo-6,12-bis(sec-butyl)-1-thia-4,7,10,13-tetraazacyclohexadecane}amido)-9-methyl-1,4,11-trioxo-decahydro-2H-pyrrolo	6-amino-2-(2-{2-[2-(2-{2-[(7-{6-amino-2-[2-(2-{[21-(2-{[10-({15-[2-(2-amino-3-methylpentanamido)but-2-enamido]-6,12-bis(butan-2-yl)-9-methylidene-5,8,11,14-tetraoxo-1-thia-4,7,10,13-tetraazacyclohexadecane}amido)-9-methyl-1,4,11-trioxo-tetradecahydropyrro			C142H227N43O37S7	CCC(C)C(N)C(=O)NC(=CC)C(=O)NC1CSCC(NC(=O)C(NC(=O)C(=C)NC(=O)C(NC1=O)C(C)CC)C(C)CC)C(=O)NC1C(C)SCC(NC(=O)CNC(=O)C2CCCN2C1=O)C(=O)NC(CCCNN)C(=O)NC1C(C)SCC(NC(=O)CNC(=O)C(CCSC)NC(=O)C(NC(=O)C(C)NC(=O)CNC1=O)C(C)CC)C(=O)NC(CC(N)=O)C(=O)NC(CCSC)C(=O)NC(CCCCN)C(=O)NC1C(C)SCC2NC(=O)C(NC(=O)C(=C)NC1=O)C(C)SCC(NC(=O)C(CC1=CN=CN1)NC2=O)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(CC1=CN=CN1)C(=O)NC(C(C)C)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O	0	N	3353			10.3	-19.5	-22.9			TX_SalX_nisin, TX_SunT_nisin	
NMN	NICOTINAMIDE_NUCLEOTIDE	nmn	C00455	1094-61-7	3741	B01247	16171	NMN	C00019694			nicotinamide mononucleotide	3-carbamoyl-1-{3,4-dihydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-1$l^{5}-pyridin-1-ylium	3-carbamoyl-1-{3,4-dihydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-1$l^{5}-pyridin-1-ylium			C11H14N2O8P1	C(C1(OC(C(C1O)O)[N+]2(=CC=CC(=C2)C(=O)N)))OP(=O)([O-])[O-]	-1	N	333	260			-6.2	-8.7			DNALigation, DNA_ligation_repair, NADD2, NADR1, NADR2	
NNG					37397457							1-nitro-2-nitrosoguanidine	1-nitro-2-nitrosoguanidine	1-nitro-2-nitrosoguanidine	alkylating byproduct	methylation	C1H3N5O3	C(=NN=O)(N)N[N+](=O)[O-]	0	N	133	92		5.4	-0.7	-0.7			DNADamage_AD_m1AD_MNNG, DNADamage_AD_m3AD_MNNG, DNADamage_AD_m7AD_MNNG, DNADamage_CSN_m3CSN_MNNG, DNADamage_CSN_O2mCSN_MNNG, DNADamage_GN_m3GN_MNNG, DNADamage_GN_m7GN_MNNG, DNADamage_GN_O6mGN_MNNG, DNADamage_THY_O2mTHY_MNNG, DNADamage_THY_O4mTHY_MNNG	byproduct of DNA methylation by MNNG
norfloxacin			C06687		85306349		100246					Norfloxacin	norfloxacin	1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid	antibiotic	fluoroquinolone 	C16H18F1N3O3	CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O	0	N	319	277		7.4	-1.5	-1.5			TX_NormM_norfloxacin	Inhibits topoisomerase II/DNA gyrase and topoisomerase IV [PUB_0847].
novobiocin			C05080		7526		148697					Novobiocin	{5-hydroxy-6-[(2-hydroxy-3-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzene]amido}-8-methyl-4-oxochromen-7-yl)oxy]-3-methoxy-2,2-dimethyloxan-4-yl} carbamate	{5-hydroxy-6-[(2-hydroxy-3-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzene]amido}-8-methyl-4-oxo-4H-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyloxan-4-yl} carbamate	antibiotic		C31H36N2O11	CC1=C(C=CC2=C1OC(=C(C2=O)NC(=O)C3=CC(=C(C=C3)O)CC=C(C)C)O)OC4C(C(C(C(O4)(C)C)OC)OC(=O)N)O	0	N	613	539		1.7	4.0	3.7			TX_NormM_novobiocin	Inhibits topoisomerase II/DNA gyrase [PUB_0847].
NR	NICOTINATE_NUCLEOTIDE	nicrnt	C01185		4411	B01404	15763	NCN	C00007447			Nicotinate D-ribonucleotide	3-carbamoyl-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1$l^{5}-pyridin-1-ylium	3-carbamoyl-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1$l^{5}-pyridin-1-ylium			C11H12N1O9P1	C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)O)O)O)C(=O)O	1	N	255	219		4.6	-6.1	-6.1			NADR2	
NU				13010-20-3	10233735							nitrosourea	nitrosourea	nitrosourea	alkylating byproduct	methylation	C1H3N3O2	C(=O)(N)NN=O	0	N	89	67		2.3	-0.8	-0.8			DNADamage_AD_e1AD_ENU, DNADamage_AD_e3AD_ENU, DNADamage_AD_e6AD_ENU, DNADamage_AD_e7AD_ENU, DNADamage_AD_m1AD_MNU, DNADamage_AD_m3AD_MNU, DNADamage_AD_m7AD_MNU, DNADamage_CSN_e3CSN_ENU, DNADamage_CSN_m3CSN_MNU, DNADamage_CSN_O2eCSN_ENU, DNADamage_CSN_O2mCSN_MNU, DNADamage_GN_e1GN_ENU, DNADamage_GN_e3GN_ENU, DNADamage_GN_e7GN_ENU, DNADamage_GN_m1GN_MNU, DNADamage_GN_m3GN_MNU, DNADamage_GN_m7GN_MNU, DNADamage_GN_O6eGN_ENU, DNADamage_GN_O6mGN_MNU, DNADamage_THY_e3THY_ENU, DNADamage_THY_m3THY_MNU, DNADamage_THY_O2eTHY_ENU, DNADamage_THY_O2mTHY_MNU, DNADamage_THY_O4eTHY_ENU, DNADamage_THY_O4mTHY_MNU	byproduct of DNA methylation by MNU
O2		o2	C00007	7782-44-7	3309	B00001	15379	OXY				oxygen	oxygen	oxidanone	gas		O2	O=O	0	N	32	22			-0.3	-0.3			HemG, MOrx, NOX, NrdEF_ADP, NrdEF_CDP, NrdEF_GDP, NrdEF_UDP, TX_O2	
O2eCSN					8230941							2'-O-ethylcytosine	2-ethoxy-1H-pyrimidin-4-imine	2-ethoxy-1,4-dihydropyrimidin-4-imine	modified nucleobase	ethylation	C6H9N3O1	N1C=CC(N=C1OCC)=N	0	N	139	127		8.0	0.2	0.2			DNADamage_CSN_O2eCSN_DES, DNADamage_CSN_O2eCSN_EMS, DNADamage_CSN_O2eCSN_ENU	
O2edC												2'-O-ethyl-2'-deoxycytidine	5-(2-ethoxy-4-iminopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-ol	5-(2-ethoxy-4-imino-1,4-dihydropyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-ol	modified deoxyribonucleoside	ethylation	C11H17N3O4	C1C(C(OC1N2C=CC(N=C2OCC)=N)CO)O	0	N	255	227		9.5	-0.4	-0.4			TX_O2edC, UshA_O2edCMP	
O2edCMP												2'-O-ethyl-2'-deoxycytidine monophosphate	[5-(2-ethoxy-4-iminopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2-ethoxy-4-imino-1,4-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	ethylation	C11H16N3O7P1	CCOC1=NC(=N)C=CN1C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	333	268		3.2	-4.4	-3.9			UshA_O2edCMP	
O2edT				59495-21-5	51255172							2'-O-ethyl-2'-deoxythymidine	2-ethoxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-4-one	2-ethoxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,4-dihydropyrimidin-4-one	modified deoxyribonucleoside	ethylation	C12H18N2O5	CCOC1=NC(=O)C(=CN1C2CC(C(O2)CO)O)C	0	N	270	242		5.5	-0.1	-0.1			TX_O2edT, UshA_O2edTMP	
O2edTMP												2'-O-ethyl-2'-deoxythymidine monophosphate	[5-(2-ethoxy-5-methyl-4-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2-ethoxy-5-methyl-4-oxo-1,4-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	ethylation	C12H17N2O8P1	CCOC1=NC(=O)C(C)=CN1C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	348	281			-0.3	-3.6			UshA_O2edTMP	
O2eTHY					24537991							2'-O-ethylthymine	2-ethoxy-5-methyl-1H-pyrimidin-4-one	2-ethoxy-5-methyl-1,4-dihydropyrimidin-4-one	modified nucleobase	ethylation	C7H10N2O2	CCOC1=NC(=O)C(=CN1)C	0	N	154	141		10.1	0.5	0.4			DNADamage_THY_O2eTHY_DES, DNADamage_THY_O2eTHY_EMS, DNADamage_THY_O2eTHY_ENU	
O2mCSN					11342788							2'-O-methylcytosine	2-methoxy-1H-pyrimidin-4-imine	2-methoxy-1,4-dihydropyrimidin-4-imine	modified nucleobase	methylation	C5H7N3O1	N1C=CC(N=C1OC)=N	0	N	125	110		7.9	-0.2	-0.2			DNADamage_CSN_O2mCSN_MNNG, DNADamage_CSN_O2mCSN_MNU	
O2mdC												2'-O-methyl-2'-deoxycytidine	2-(hydroxymethyl)-5-(4-imino-2-methoxypyrimidin-1-yl)oxolan-3-ol	2-(hydroxymethyl)-5-(4-imino-2-methoxy-1,4-dihydropyrimidin-1-yl)oxolan-3-ol	modified deoxyribonucleoside	methylation	C10H15N3O4	C1C(C(OC1N2C=CC(N=C2OC)=N)CO)O	0	N	241	211		9.5	-0.8	-0.8			TX_O2mdC, UshA_O2mdCMP	
O2mdCMP												2'-O-methyl-2'-deoxycytidine monophosphate	[3-hydroxy-5-(4-imino-2-methoxypyrimidin-1-yl)oxolan-2-yl]methyl phosphate	[3-hydroxy-5-(4-imino-2-methoxy-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	methylation	C10H14N3O7P1	COC1=NC(=N)C=CN1C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	319	250		3.2	-4.7	-4.3			UshA_O2mdCMP	
O2mdT				37085-48-6	10254650							2'-O-methyl-2'-deoxythymidine	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-methoxy-5-methylpyrimidin-4-one	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-methoxy-5-methyl-1,4-dihydropyrimidin-4-one	modified deoxyribonucleoside	methylation	C11H16N2O5	CC1=CN(C(=NC1=O)OC)C2CC(C(O2)CO)O	0	N	256	224		5.5	-0.5	-0.5			TX_O2mdT, UshA_O2mdTMP	
O2mdTMP												2'-O-methyl-2'-deoxythymidine monophosphate	[3-hydroxy-5-(2-methoxy-5-methyl-4-oxopyrimidin-1-yl)oxolan-2-yl]methyl phosphate	[3-hydroxy-5-(2-methoxy-5-methyl-4-oxo-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	methylation	C11H15N2O8P1	COC1=NC(=O)C(C)=CN1C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	334	264			-0.6	-4.0			UshA_O2mdTMP	
O2mTHY				25902-91-4	24518692							2'-O-methylthymine	2-methoxy-5-methyl-1H-pyrimidin-4-one	2-methoxy-5-methyl-1,4-dihydropyrimidin-4-one	modified nucleobase	methylation	C6H8N2O2	CC1=CNC(=NC1=O)OC	0	N	140	124		10.0	0.1	0.1			DNADamage_THY_O2mTHY_MNNG, DNADamage_THY_O2mTHY_MNU	
O4edT				59495-22-6	10627357							4'-O-ethyl-2'-deoxythymidine	4-ethoxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one	4-ethoxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2-dihydropyrimidin-2-one	modified deoxyribonucleoside	ethylation	C12H18N2O5	CCOC1=NC(=O)N(C=C1C)C2CC(C(O2)CO)O	0	N	270	241		5.5	-0.3	-0.3			TX_O4edT, UshA_O4edTMP	
O4edTMP												4'-O-ethyl-2'-deoxythymidine monophosphate	[5-(4-ethoxy-5-methyl-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(4-ethoxy-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	ethylation	C12H17N2O8P1	CCOC1=NC(=O)N(C=C1C)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	348	281			-0.4	-3.8			UshA_O4edTMP	
O4eTHY					76240798							4'-O-ethylthymine	4-ethoxy-5-methyl-1H-pyrimidin-2-one	4-ethoxy-5-methyl-1,2-dihydropyrimidin-2-one	modified nucleobase	ethylation	C7H10N2O2	CCOC1=NC(=O)NC=C1C	0	N	154	141		10.9	0.4	0.4			DNADamage_THY_O4eTHY_DES, DNADamage_THY_O4eTHY_EMS, DNADamage_THY_O4eTHY_ENU	
O4mdT					52843966							4'-O-methyl-2'-deoxythymidine	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-methoxy-5-methylpyrimidin-2-one	1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-methoxy-5-methyl-1,2-dihydropyrimidin-2-one	modified deoxyribonucleoside	methylation	C11H16N2O5	CC1=CN(C(=O)N=C1OC)C2CC(C(O2)CO)O	0	N	256	224		5.5	-0.6	-0.6			TX_O4mdT, UshA_O4mdTMP	
O4mdTMP												4'-O-methyl-2'-deoxythymidine monophosphate	[3-hydroxy-5-(4-methoxy-5-methyl-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl phosphate	[3-hydroxy-5-(4-methoxy-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	methylation	C11H15N2O8P1	COC1=NC(=O)N(C=C1C)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	334	265			-0.8	-4.1			UshA_O4mdTMP	
O4mTHY				25902-89-0	51624590							4'-O-methylthymine	4-methoxy-5-methyl-1H-pyrimidin-2-one	4-methoxy-5-methyl-1,2-dihydropyrimidin-2-one	modified nucleobase	methylation	C6H8N2O2	CC1=CNC(=O)N=C1OC	0	N	140	124		10.9	0.0	0.0			DNADamage_THY_O4mTHY_MNNG, DNADamage_THY_O4mTHY_MNU	
O6edG				50704-46-6	24696419							6'-O-ethyl-2'-deoxyguanosine	5-(2-amino-6-ethoxypurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol	5-(2-amino-6-ethoxy-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol	modified deoxyribonucleoside	ethylation	C12H17N5O4	CCOC1=NC(=NC2=C1N=CN2C3CC(C(O3)CO)O)N	0	N	295	250		9.3	-0.3	-0.3			TX_O6edG, UshA_O6edGMP	
O6edGMP												6'-O-ethyl-2'-deoxyguanosine monophosphate	[5-(2-amino-6-ethoxypurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2-amino-6-ethoxy-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	ethylation	C12H16N5O7P1	CCOC1=NC(N)=NC2=C1N=CN2C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	373	290		3.4	-2.9	-3.8			UshA_O6edGMP	
O6eGN					540739		540739					6'-O-ethylguanine	6-ethoxy-9H-purin-2-amine	6-ethoxy-9H-purin-2-amine	modified nucleobase	ethylation	C7H9N5O1	CCOC1=NC(N)=NC2=C1N=CN2	0	N	179	150		7.1	0.3	0.3			DNADamage_GN_O6eGN_DES, DNADamage_GN_O6eGN_EMS, DNADamage_GN_O6eGN_ENU	
O6mdG				964-21-6	215561							6'-O-methyl-2'-deoxyguanosine	5-(2-amino-6-methoxypurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol	5-(2-amino-6-methoxy-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol	modified deoxyribonucleoside	methylation	C11H15N5O4	COC1=NC(=NC2=C1N=CN2C3CC(C(O3)CO)O)N	0	N	281	233		9.4	-0.7	-0.7			TX_O6mdG, UshA_O6mdGMP	
O6mdGMP												6'-O-methyl-2'-deoxyguanosine monophosphate	[5-(2-amino-6-methoxypurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2-amino-6-methoxy-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate	methylation	C11H14N5O7P1	COC1=NC(N)=NC2=C1N=CN2C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	359	274		3.4	-3.2	-4.1			UshA_O6mdGMP	
O6mGN					85668184		479073					6'-O-methylguanine	6-methoxy-9H-purin-2-amine	6-methoxy-9H-purin-2-amine	modified nucleobase	methylation	C6H7N5O1	COC1=NC(N)=NC2=C1N=CN2	0	N	165	133		7.1	0.0	-0.1			DNADamage_GN_O6mGN_MMS, DNADamage_GN_O6mGN_MMSO4, DNADamage_GN_O6mGN_MNNG, DNADamage_GN_O6mGN_MNU	
OA	OXALACETIC_ACID	oaa	C00036	328-42-7	3338	B00010	30744	OAA	C00001197			oxaloacetate	oxaloacetate(2-)	2-oxobutanedioate	carboxy acid		C4H2O5	C([O-])(CC(=O)C([O-])=O)=O	-2	N	130	98			0.0	-5.9			AspC1, Mdh, PcbX, Ppc, TX_OA	
OCDCA		ocdca	C01530	57-11-4	4692	B01462	25629	STE	C00001238	LMFA01010018	DFA0018	octadecanoate (n-C18:0)	stearate	octadecanoate	fatty acyl		C18H35O2	CCCCCCCCCCCCCCCCCC(=O)[O-]	-1	N	283	325			7.2	4.9			Aas6, LIPASE_TRISTEARIN_MG310, LIPASE_TRISTEARIN_MG327, LIPASE_TRISTEARIN_MG344, TX_OCDCA	
OCDCEA		ocdcea	C00712		4265936		16196			LMFA01030002	DFA0111	octadecenoate (n-C18:1)	octadec-9-enoate	octadec-9-enoate	fatty acyl		C18H33O2	CCCCCCCCC=CCCCCCCCC([O-])=O	-1	N	281	318			6.8	4.6			Aas7, LIPASE_METHYL_OCDCEA_MG310, LIPASE_METHYL_OCDCEA_MG327, LIPASE_METHYL_OCDCEA_MG344, LIPASE_TRIOLEIN_MG310, LIPASE_TRIOLEIN_MG327, LIPASE_TRIOLEIN_MG344, LIPASE_TWEEN80_MG310, LIPASE_TWEEN80_MG327, LIPASE_TWEEN80_MG344, TX_OCDCEA	
ODEC11GP		1odec11eg3p								LMGP10050000		1-octadec-11-enoyl-sn-glycerol 3-phosphate	[3-(octadec-9-enoyloxy)-2-oxopropoxy]phosphonic acid	[3-(octadec-9-enoyloxy)-2-oxopropoxy]phosphonic acid	lipid	glycerophospholipid	C21H39O7P1	CCCCCCCCC=CCCCCCCCC(=O)OCC(=O)COP(=O)(O)O	-2	N	435	428			5.8	2.4			PlsC7, PlsX7	
ODECG3P		1odecg3p	C00681		3950		16975			LMGP10050000		1-octadecanoyl-sn-glycerol 3-phosphate	[3-(octadecanoyloxy)-2-oxopropoxy]phosphonic acid	[3-(octadecanoyloxy)-2-oxopropoxy]phosphonic acid	lipid	glycerophospholipid	C21H41O7P1	CCCCCCCCCCCCCCCCCC(=O)OCC(=O)COP(=O)(O)O	-2	N	437	434			6.2	2.8			PlsC6, PlsX6	
OH	OH		C01328		8145681		16234					hydoxide anion	OH(-)	oxidanide	reactive oxygen species		H1O1	[OH-]	0	N	17	17		7.0	-0.9	-0.9			DNADamage_AD_epsilon1N6AD_chloroethylene_oxide, DNADamage_CSN_epsilon3N4CSN_chloroethylene_oxide, DNADamage_GN_epsilon1N2GN_chloroethylene_oxide, DNADamage_GN_epsilonN23GN_chloroethylene_oxide, hydroxyl_radical_generation_1	
ORN	L-ORNITHINE	orn	C01602	70-26-8	4756	B00331	18257		C00001384			ornithine	4-amino-1-carboxybutan-1-aminium	4-amino-1-carboxybutan-1-aminium	non-standard amino acid		C5H13N2O2	NCCCC([NH3+])C(O)=O	1	N	133	133		9.8	-4.0	-5.9			ArgF	
oxo2AD					87285430		584591					2-hydroxyadenine	6-amino-1,9-dihydropurin-2-one	6-amino-2,9-dihydro-1H-purin-2-one	modified nucleobase		C5H5N5O1	N1C=NC2=C(NC(=O)N=C12)N	0	N	151	115		9.6	-1.8	-1.9			DNADamage_AD_oxo2AD_hydroxyl_radical	
oxo2dA				106449-56-3	10262979							2-hydroxy-2'-deoxyadenosine	6-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-2-one	6-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,9-dihydro-1H-purin-2-one	modified deoxyribonucleoside		C10H13N5O4	C1C(C(OC1N2C=NC3=C(NC(=O)N=C32)N)CO)O	0	N	267	215		9.2	-2.4	-2.5			TX_oxo2dA, UshA_oxo2dAMP	
oxo2dAMP												2-hydroxy-2'-deoxyadenosine monophosphate	[5-(6-amino-2-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(6-amino-2-oxo-2,9-dihydro-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C10H12N5O7P1	NC1=C2N=CN(C3CC(O)C(COP([O-])([O-])=O)O3)C2=NC(=O)N1	-2	N	345	255		3.6	-2.9	-6.0			UshA_oxo2dAMP	
oxo8AD					85543195		351476					8-hydroxyadenine	6-amino-7,9-dihydropurin-8-one	6-amino-8,9-dihydro-7H-purin-8-one	modified nucleobase		C5H5N5O1	N2C1=C(C(=NC=N1)N)NC2=O	0	N	151	115		6.8	-0.4	-0.4			DNADamage_AD_oxo8AD_hydroxyl_radical, MutM_oxo8AD	103-320 per 10^7 bases [PUB_0479];
oxo8dA				62471-63-0	78413756							8-hydroxy-2'-deoxyadenosine	6-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7H-purin-8-one	6-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-8,9-dihydro-7H-purin-8-one	modified deoxyribonucleoside		C10H13N5O4	C1C(C(OC1N2C3=C(C(=NC=N3)N)NC2=O)CO)O	0	N	267	215		7.1	-1.3	-1.3			TX_oxo8dA, UshA_oxo8dAMP	103-320 per 10^7 bases [PUB_0479];
oxo8dAMP												8-hydroxy-2'-deoxyadenosine monophosphate	[5-(6-amino-8-oxo-7H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(6-amino-8-oxo-8,9-dihydro-7H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C10H12N5O7P1	NC1=NC=NC2=C1NC(=O)N2C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	345	255		1.9	-2.9	-4.7			MutM_oxo8AD, UshA_oxo8dAMP	
oxo8dG					24671802		121726					8-Oxo-2'-deoxyguanosine; 8-hydroxy-2'-deoxyguanosine	2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,7-dihydropurine-6,8-dione	2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,7,8,9-tetrahydro-3H-purine-6,8-dione	modified deoxyribonucleoside		C10H13N5O5	C1C(C(OC1N2C3=C(C(=O)N=C(N3)N)NC2=O)CO)O	0	N	283	223		5.0	-2.5	-2.7			TX_oxo8dG, UshA_oxo8dGMP	most common DNA base lesion [PUB_0479]; 92-520 lesions per 10^7 bases [PUB_0479]; recognized by endonuclease III, FPG, UNG [PUB_0473]
oxo8dGMP												8-Oxo-2'-deoxyguanosine monophosphate; 8-hydroxy-2'-deoxyguanosine monophosphate	[5-(2-amino-6,8-dioxo-3,7-dihydropurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(2-amino-6,8-dioxo-6,7,8,9-tetrahydro-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C10H12N5O8P1	NC1=NC(=O)C2=C(N1)N(C1CC(O)C(COP([O-])([O-])=O)O1)C(=O)N2	-2	N	361	263		1.9	-4.3	-6.1			MutM_oxo8GN, UshA_oxo8dGMP	
oxo8GN					81058842		52617					8-Oxo-guanine; 8-hydroxyguanine	2-amino-7,9-dihydro-3H-purine-6,8-dione	2-amino-6,7,8,9-tetrahydro-3H-purine-6,8-dione	modified nucleobase		C5H5N5O2	N2C1=C(C(=O)N=C(N1)N)NC2=O	0	N	167	122		5.2	-1.8	-2.0			DNADamage_GN_oxo8GN_hydroxyl_radical, MutM_oxo8GN	most common DNA base lesion [PUB_0479]; 92-520 lesions per 10^7 bases [PUB_0479]; recognized by endonuclease III, FPG, UNG [PUB_0473]
oxoethyl7dG												7-(2'-oxoethyl)-2'-deoxyguanosine	2-{2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-1,3,7$l^{5},9-purin-7-yl}acetaldehyde	2-{2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-6,9-dihydro-3H-1,3,7$l^{5},9-purin-7-yl}acetaldehyde	modified deoxyribonucleoside		C12H16N5O5	C1C(C(OC1[N]2C=[N](C3=C2NC(=NC3=O)N)CC=O)CO)O	0	N	310	254		11.2	-1.2	-1.2			TX_oxoethyl7dG, UshA_oxoethyl7dGMP	
oxoethyl7dGMP												7-(2'-oxoethyl)-2'-deoxyguanosine monophosphate	{5-[2-amino-6-oxo-7-(2-oxoethyl)-3H-1,3,7$l^{5},9-purin-9-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	{5-[2-amino-6-oxo-7-(2-oxoethyl)-6,9-dihydro-3H-1,3,7$l^{5},9-purin-9-yl]-3-hydroxyoxolan-2-yl}methyl phosphate	modified deoxyribonucleotide monophosphate		C12H15N5O8P1	NC1=NC(=O)C2=C(N1)N(C=[N]2CC=O)C1CC(O)C(COP([O-])([O-])=O)O1	-2	N	388	294		3.6	-3.4	-4.7			UshA_oxoethyl7dGMP	
oxoethyl7GN												7-(2'-oxoethyl)-guanine	2-amino-6-oxo-7-(2-oxoethyl)-3,9-dihydropurin-7-ium	2-amino-6-oxo-7-(2-oxoethyl)-6,9-dihydro-3H-purin-7-ium	modified nucleobase		C7H8N5O2	[N]1C=[N](C2=C1NC(=NC2=O)N)CC=O	-1	N	194	154		4.4	-5.3	-7.5			DNADamage_GN_oxoethyl7GN_chloroethylene_oxide	
PA120		pa120	C00416		3706		16337			LMGP10010000		1,2-didodecanoyl-sn-glycerol 3-phosphate	1-(dodecanoyloxy)-3-(phosphonatooxy)propan-2-yl dodecanoate	1-(dodecanoyloxy)-3-(phosphonatooxy)propan-2-yl dodecanoate	lipid	glycerophospholipid, phosphatidyl inositol	C27H51O8P1	CCCCCCCCCCCC(=O)OCC(COP([O-])([O-])=O)OC(=O)CCCCCCCCCCC	-2	Y	535	543			8.3	5.1			CdsA1, PlsC1	
PA140		pa140	C00416		3706		16337			LMGP10010000		1,2-ditetradecanoyl-sn-glycerol 3-phosphate	1-(phosphonatooxy)-3-(tetradecanoyloxy)propan-2-yl tetradecanoate	1-(phosphonatooxy)-3-(tetradecanoyloxy)propan-2-yl tetradecanoate	lipid	glycerophospholipid, phosphatidyl inositol	C31H59O8P1	CCCCCCCCCCCCCC(=O)OCC(COP([O-])([O-])=O)OC(=O)CCCCCCCCCCCCC	-2	Y	591	611			10.1	6.8			CdsA2, PlsC2	
PA141		pa141	C00416		3706		16337			LMGP10010000		1,2-ditetradec-7-enoyl-sn-glycerol 3-phosphate	1-(phosphonatooxy)-3-(tetradec-7-enoyloxy)propan-2-yl tetradec-7-enoate	1-(phosphonatooxy)-3-(tetradec-7-enoyloxy)propan-2-yl tetradec-7-enoate	lipid	glycerophospholipid, phosphatidyl inositol	C31H55O8P1	CCCCCCC=CCCCCCC(=O)OCC(COP([O-])([O-])=O)OC(=O)CCCCCC=CCCCCCC	-2	Y	587	595			9.4	6.1			CdsA3, PlsC3	
PA160		pa160	C00416		3706		16337			LMGP10010000		1,2-dihexadecanoyl-sn-glycerol 3-phosphate	[2-(octadec-9-enoyloxy)-3-(tetradecanoyloxy)propoxy]phosphonic acid	[2-(octadec-9-enoyloxy)-3-(tetradecanoyloxy)propoxy]phosphonic acid	lipid	glycerophospholipid, phosphatidyl inositol	C35H67O8P1	CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)O)OC(=O)CCCCCCCC=CCCCCCCCC	-2	Y	647	675			11.5	8.2			CdsA4, PlsC4	
PA161		pa161	C00416		3706		16337			LMGP10010000		1,2-dihexadec-9-enoyl-sn-glycerol 3-phosphate	1-(hexadec-9-enoyloxy)-3-(phosphonatooxy)propan-2-yl hexadec-9-enoate	1-(hexadec-9-enoyloxy)-3-(phosphonatooxy)propan-2-yl hexadec-9-enoate	lipid	glycerophospholipid, phosphatidyl inositol	C35H63O8P1	CCCCCCC=CCCCCCCCC(=O)OCC(COP([O-])([O-])=O)OC(=O)CCCCCCCC=CCCCCCC	-2	Y	643	663			11.2	7.9			CdsA5, PlsC5	
PA180		pa180	C00416		3706		16337			LMGP10010000		1,2-dioctadecanoyl-sn-glycerol 3-phosphate	[2-(octadec-9-enoyloxy)-3-(octadecanoyloxy)propoxy]phosphonic acid	[2-(octadec-9-enoyloxy)-3-(octadecanoyloxy)propoxy]phosphonic acid	lipid	glycerophospholipid, phosphatidyl inositol	C39H75O8P1	CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)O)OC(=O)CCCCCCCC=CCCCCCCCC	-2	Y	703	742			13.3	10.0			CdsA6, PlsC6	
PA181		pa181	C00416		3706		16337			LMGP10010000		1,2-dioctadec-11-enoyl-sn-glycerol 3-phosphate	1-(octadec-11-enoyloxy)-3-(phosphonatooxy)propan-2-yl octadec-11-enoate	1-(octadec-11-enoyloxy)-3-(phosphonatooxy)propan-2-yl octadec-11-enoate	lipid	glycerophospholipid, phosphatidyl inositol	C39H71O8P1	CCCCCCC=CCCCCCCCCCC(=O)OCC(COP([O-])([O-])=O)OC(=O)CCCCCCCCCC=CCCCCCC	-2	Y	699	731			12.9	9.7			CdsA7, PlsC7	
PAP	PAP	pap	C00054	1053-73-2	3356	B01140	17985	A3P	C00019352			Adenosine 3',5'-bisphosphate	[5-(6-aminopurin-9-yl)-4-hydroxy-3-(phosphonatooxy)oxolan-2-yl]methyl phosphate	[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonatooxy)oxolan-2-yl]methyl phosphate			C10H11N5O10P2	C1(N=CN=C2(C=1N=CN2C3(OC(C(C3O)OP([O-])([O-])=O)COP([O-])(=O)[O-])))N	-4	N	423	296		2.0	-6.3	-9.4			AcpS, BPNT	
pCHOL	PHOSPHORYL-CHOLINE		C00588		3081		295975					phosphoryl-choline	[2-(trimethylaminio)ethyl] phosphate	[2-(trimethylazaniumyl)ethyl] phosphate			C5H13N1O4P1	C([N+](C)(C)C)COP([O-])([O-])=O	-1	N	182	162			-4.8	-2.8			CholK	
PDLA5P		pyam5p	C00647	529-96-4	3919	B00154	18335	PMP	C00007506			Pyridoxamine 5'-phosphate	[4-(aminomethyl)-5-hydroxy-6-methylpyridin-3-yl]methyl hydrogen phosphate	[4-(aminomethyl)-5-hydroxy-6-methylpyridin-3-yl]methyl hydrogen phosphate			C8H12N2O5P1	CC1=NC=C(COP(O)([O-])=O)C(CN)=C1O	-1	N	247	200		5.2	-3.1	-3.2			GlyA1, GlyA2	
penicillin_G			C05551	61-33-6	46506778		18208					penicillin G			antibiotic	penicillin	C16H18N2O4S1	[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O	0	N	334									Inhibits cell wall synthesis [PUB_0847].
PEP	PHOSPHO-ENOL-PYRUVATE	pep	C00074	138-08-9	3374	B00019	18021	PEP	C00000798			phosphoenolpyruvate	2-(phosphonatooxy)prop-2-enoate	2-(phosphonatooxy)prop-2-enoate			C3H2O6P1	[O-]C(=O)C(=C)OP([O-])([O-])=O	-3	N	165	112			-0.6	-7.5			DhaK, Eno, Ppc, Pyk_ADP, Pyk_CDP, Pyk_DADP, Pyk_DCDP, Pyk_DGDP, Pyk_DTDP, Pyk_DUDP, Pyk_GDP, Pyk_IDP, Pyk_TDP, Pyk_UDP, TX_FRUPTS, TX_GLCPTS	
PG160		pg160	C00344		3637					LMGP04010000		Phosphatidylglycerol (dihexadecanoyl, n-C16:0)	1-{[(2,3-dihydroxypropyl) phosphonato]oxy}-3-(hexadecanoyloxy)propan-2-yl hexadecanoate	1-{[(2,3-dihydroxypropyl) phosphonato]oxy}-3-(hexadecanoyloxy)propan-2-yl hexadecanoate	lipid	glycerophospholipid, phosphatidylglycerol	C38H74O10P1	CCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC	-1	Y	722	749			10.9	8.6			Cls1, glycosyltransferase_PG160_DAG160, PgpA1, ProLipoproteinDiacylglycerylTransferase	
PG161		pg161	C00344		3637					LMGP04010000		Phosphatidylglycerol (dihexadec-9-enoyl, n-C16:1)	1-{[(2,3-dihydroxypropyl) phosphonato]oxy}-3-(hexadec-9-enoyloxy)propan-2-yl hexadec-9-enoate	1-{[(2,3-dihydroxypropyl) phosphonato]oxy}-3-(hexadec-9-enoyloxy)propan-2-yl hexadec-9-enoate	lipid	glycerophospholipid, phosphatidylglycerol	C38H70O10P1	CCCCCCC=CCCCCCCCC(=O)OCC(COP([O-])(=O)OCC(O)CO)OC(=O)CCCCCCCC=CCCCCCC	-1	Y	718	734			10.2	7.8			Cls2, glycosyltransferase_PG161_DAG161, PgpA2	
PG181		pg181	C00344		3637					LMGP04010000		Phosphatidylglycerol (dioctadec-11-enoyl, n-C18:1)	1-{[(2,3-dihydroxypropyl) phosphonato]oxy}-3-(octadec-11-enoyloxy)propan-2-yl octadec-11-enoate	1-{[(2,3-dihydroxypropyl) phosphonato]oxy}-3-(octadec-11-enoyloxy)propan-2-yl octadec-11-enoate	lipid	glycerophospholipid, phosphatidylglycerol	C42H78O10P1	CCCCCCC=CCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC(O)CO)OC(=O)CCCCCCCCCC=CCCCCCC	-1	Y	774	802			12.0	9.6			Cls3, glycosyltransferase_PG181_DAG181, PgpA3	
PGP160		pgp160	C03892		6624					LMGP05010000		Phosphatidylglycerophosphate (dihexadecanoyl, n-C16:0)	1-(hexadecanoyloxy)-3-({[2-hydroxy-3-(phosphonatooxy)propyl] phosphonato}oxy)propan-2-yl hexadecanoate	1-(hexadecanoyloxy)-3-({[2-hydroxy-3-(phosphonatooxy)propyl] phosphonato}oxy)propan-2-yl hexadecanoate	lipid	glycerophospholipid, phosphatidylglycerol phosphate	C38H73O13P2	CCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC(O)COP([O-])([O-])=O)OC(=O)CCCCCCCCCCCCCCC	-3	Y	800	789			10.8	5.3			PgpA1, PgsA1	
PGP161		pgp161	C03892		6624					LMGP05010000		Phosphatidylglycerophosphate (dihexadec-9-enoyl, n-C16:1)	1-(hexadec-9-enoyloxy)-3-({[2-hydroxy-3-(phosphonatooxy)propyl] phosphonato}oxy)propan-2-yl hexadec-9-enoate	1-(hexadec-9-enoyloxy)-3-({[2-hydroxy-3-(phosphonatooxy)propyl] phosphonato}oxy)propan-2-yl hexadec-9-enoate	lipid	glycerophospholipid, phosphatidylglycerol phosphate	C38H69O13P2	CCCCCCC=CCCCCCCCC(=O)OCC(COP([O-])(=O)OCC(O)COP([O-])([O-])=O)OC(=O)CCCCCCCC=CCCCCCC	-3	Y	796	774			10.1	4.6			PgpA2, PgsA2	
PGP181		pgp181	C03892		6624					LMGP05010000		Phosphatidylglycerophosphate (dioctadec-11-enoyl, n-C18:1)	1-({[2-hydroxy-3-(phosphonatooxy)propyl] phosphonato}oxy)-3-(octadec-11-enoyloxy)propan-2-yl octadec-11-enoate	1-({[2-hydroxy-3-(phosphonatooxy)propyl] phosphonato}oxy)-3-(octadec-11-enoyloxy)propan-2-yl octadec-11-enoate	lipid	glycerophospholipid, phosphatidylglycerol phosphate	C42H77O13P2	CCCCCCC=CCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC(O)COP([O-])([O-])=O)OC(=O)CCCCCCCCCC=CCCCCCC	-3	Y	852	842			11.9	6.4			PgpA3, PgsA3	
PHE	PHE	phe-L	C00079	63-91-2	3379	B01151	17295	PHE	C00001386			L-phenylalanine	phenylalanine	2-amino-3-phenylpropanoic acid	amino acid		C9H11N1O2	NC(CC1=CC=CC=C1)C(O)=O	0	N	165	156		6.0	-1.3	-1.3			Apts_Phe, AspC3, MG490_Aminoacylation, PeptidylTRNAHs_PHE, ProteinDegradation_FtsH_PHE, ProteinDegradation_Lon_PHE, ProteinPolymerization_PHE, TX_AROP12, TX_AROP22	
PhePhe					8189514							L-phenylalanyl-L-phenylalanine	phe-phe	2-(2-amino-3-phenylpropanamido)-3-phenylpropanoic acid	dipeptide		C18H20N2O3	C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)N	0	N	312	291		6.0	-0.5	-0.6			Apts_Phe, ProteinDegradation_FtsH_PHE, ProteinDegradation_Lon_PHE, ProteinPolymerization_PHE, TX_OppB_Phe	
PHPYR		phpyr	C00166	156-06-9	3466	B00048	30851	PPY	C00000751			phenylpyruvate	keto-phenylpyruvate	2-oxo-3-phenylpropanoate			C9H7O3	[O-]C(=O)C(=O)CC1=CC=CC=C1	-1	N	163	143			1.9	-1.5			AspC3	
PI	Pi	pi	C00009	7664-38-2	3311	B00002	18367	2HP	C00007408			phosphate	hydrogen phosphate	hydrogen phosphate	ion		H1O4P1	OP([O-])([O-])=O	-2	N	96	59			-1.0	-3.8			ArgF, AtpA, ATPHs_ChromosomeCondensation_SMC, ATPHs_DNAReplication_Helicase, ATPHs_DNASupercoiling_gyrase, ATPHs_DNASupercoiling_topoisomeraseIV, ATPHs_ProteinTranslocation_SecA, ATPHs_ProteinTranslocation_SRP, BPNT, DeoD1, DeoD2, DeoD3, DeoD4, DeoD5, DeoD6, DeoD7, DeoD8, DnaA_inactivation, DNA_RM_EcoD_Restriction, FthC, FTHFS, FtsZ_deactivation, GapA, GTPHs_ChromosomeSegregation_CobQ, GTPHs_ChromosomeSegregation_Era, GTPHs_ChromosomeSegregation_MraZ, GTPHs_ChromosomeSegregation_Obg, GTPHs_Cytokinesis_FtsZ, GTPHs_RibosomeAssembly_EngA, GTPHs_RibosomeAssembly_EngB, GTPHs_RibosomeAssembly_Era, GTPHs_RibosomeAssembly_Obg, GTPHs_RibosomeAssembly_RbfA, GTPHs_RibosomeAssembly_RbgA, HR_junctionMigration, HR_strandExchange, MetK, MG502_Amidotransferase, MG_166_MONOMER_MODIFICATION_001, NADR2, NER_DNAExcision, NER_DNAIncision, PcbX, Pdp1, Pdp2, Pdp3, PgpA1, PgpA2, PgpA3, PhnX, PncB, Ppa, Ppc, ProteinDegradation_FtsH_ALA, ProteinDegradation_FtsH_ARG, ProteinDegradation_FtsH_ASN, ProteinDegradation_FtsH_ASP, ProteinDegradation_FtsH_CYS, ProteinDegradation_FtsH_GLN, ProteinDegradation_FtsH_GLU, ProteinDegradation_FtsH_GLY, ProteinDegradation_FtsH_HIS, ProteinDegradation_FtsH_ILE, ProteinDegradation_FtsH_LEU, ProteinDegradation_FtsH_LYS, ProteinDegradation_FtsH_MET, ProteinDegradation_FtsH_PHE, ProteinDegradation_FtsH_PRO, ProteinDegradation_FtsH_SER, ProteinDegradation_FtsH_THR, ProteinDegradation_FtsH_TRP, ProteinDegradation_FtsH_TYR, ProteinDegradation_FtsH_VAL, ProteinDegradation_Lon_ALA, ProteinDegradation_Lon_ARG, ProteinDegradation_Lon_ASN, ProteinDegradation_Lon_ASP, ProteinDegradation_Lon_CYS, ProteinDegradation_Lon_GLN, ProteinDegradation_Lon_GLU, ProteinDegradation_Lon_GLY, ProteinDegradation_Lon_HIS, ProteinDegradation_Lon_ILE, ProteinDegradation_Lon_LEU, ProteinDegradation_Lon_LYS, ProteinDegradation_Lon_MET, ProteinDegradation_Lon_PHE, ProteinDegradation_Lon_PRO, ProteinDegradation_Lon_SER, ProteinDegradation_Lon_THR, ProteinDegradation_Lon_TRP, ProteinDegradation_Lon_TYR, ProteinDegradation_Lon_VAL, pSERpp, Pta, pTHRpp, pTYRpp, RNACleavage_DeaD_AMP, RNACleavage_DeaD_CMP, RNACleavage_DeaD_GMP, RNACleavage_DeaD_UMP, RNACleavage_RsgA_AMP, RNACleavage_RsgA_CMP, RNACleavage_RsgA_GMP, RNACleavage_RsgA_UMP, TX_Cbi_Co, TX_Cbi_Ni, TX_GL, TX_GL3P, TX_GLNHPQ, TX_MdlB_doxorubicin, TX_MGTA_CA, TX_MGTA_CU, TX_MGTA_FE2, TX_MGTA_FE3, TX_MGTA_MG, TX_MGTA_MN, TX_MGTA_MOBD, TX_MGTA_ZN, TX_OppB_Ala, TX_OppB_Arg, TX_OppB_Asn, TX_OppB_Asp, TX_OppB_Cys, TX_OppB_Gln, TX_OppB_Glu, TX_OppB_Gly, TX_OppB_His, TX_OppB_Ile, TX_OppB_Leu, TX_OppB_Lys, TX_OppB_Met, TX_OppB_Phe, TX_OppB_Pro, TX_OppB_Ser, TX_OppB_Thr, TX_OppB_Trp, TX_OppB_Tyr, TX_OppB_Val, TX_PHNT, TX_PIUP1, TX_RIBUP, TX_SalX_nisin, TX_SO4, TX_SPMDUP1, TX_SPRDUP2, TX_SunT_nisin, TX_UHPT1, TX_UHPT2, TX_UHPT3, UshA_AMP, UshA_aza6dTMP, UshA_aza8dAMP, UshA_c5dUMP, UshA_carbamoylmethyl6dAMP, UshA_cmnm5s2UMP, UshA_cyclobutane_dCMPdCMP, UshA_cyclobutane_dCMPdTMP, UshA_cyclobutane_dTMPdCMP, UshA_cyclobutane_dTMPdTMP, UshA_cyclodAMP, UshA_cyclodGMP, UshA_dCMP, UshA_dCMP64dCMP, UshA_dCMP64dCMP_dewar, UshA_dCMP64dTMP, UshA_dCMP64dTMP_dewar, UshA_dCMP_GLYC, UshA_DHdTMP, UshA_DHdUMP, UshA_dhpdUMP, UshA_dINSMP, UshA_dTMP, UshA_dTMP64dCMP, UshA_dTMP64dCMP_dewar, UshA_dTMP64dTMP, UshA_dTMP64dTMP_dewar, UshA_dTMP_GLY, UshA_dUMP, UshA_dXANMP, UshA_e1dAMP, UshA_e1dGMP, UshA_e3dAMP, UshA_e3dCMP, UshA_e3dGMP, UshA_e3dTMP, UshA_e4dCMP, UshA_e5dCMP, UshA_e6dAMP, UshA_e7dAMP, UshA_e7dGMP, UshA_e8dGMP, UshA_epsilon1N2dGMP, UshA_epsilon1N6dAMP, UshA_epsilon3N4dCMP, UshA_epsilonN23dGMP, UshA_f5dUMP, UshA_FAPydAMP, UshA_FAPydGMP, UshA_glchm5dCMP, UshA_glchm5dUMP, UshA_gludTMP, UshA_GmMP, UshA_GMP, UshA_hm3dCMP, UshA_hm5dCMP, UshA_hm5dUMP, UshA_hm5hydantoin_dRiboseMP, UshA_ho5dCMP, UshA_ho5dUMP, UshA_ho5ho6dTMP, UshA_ho5ho6dUMP, UshA_ho5hydantoin_dRiboseMP, UshA_IMP, UshA_k2CMP, UshA_m1dAMP, UshA_m1dGMP, UshA_m1GMP, UshA_m2GMP, UshA_m3dAMP, UshA_m3dCMP, UshA_m3dGMP, UshA_m3dTMP, UshA_m4dCMP, UshA_m5CMP, UshA_m5dCMP, UshA_m62AMP, UshA_m6AMP, UshA_m6dAMP, UshA_m7dAMP, UshA_m7dGMP, UshA_m7GMP, UshA_m8dGMP, UshA_n2dAMP, UshA_O2edCMP, UshA_O2edTMP, UshA_O2mdCMP, UshA_O2mdTMP, UshA_O4edTMP, UshA_O4mdTMP, UshA_O6edGMP, UshA_O6mdGMP, UshA_oxo2dAMP, UshA_oxo8dAMP, UshA_oxo8dGMP, UshA_oxoethyl7dGMP, UshA_PSIURIMP, UshA_putdTMP, UshA_s2UMP, UshA_s4UMP, UshA_UmMP, YbiV_deoxyG6P, YbiV_F6P, YbiV_G6P, YbiV_GL2P, YbiV_MAN6P, YbiV_R5P, YbiV_SBT6P, YbiV_SNGLYP	
PL5P		pydx5p	C00018	54-47-7	3320	B00005	18405	PLP	C00007503			Pyridoxal 5'-phosphate	(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate	(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate	vitamin		C8H8N1O6P1	CC1=NC=C(COP([O-])([O-])=O)C(C=O)=C1O	-2	N	245	188		2.9	-2.1	-3.0			GlyA1, GlyA2, PYDXK	
POE_SORBITAN												Polyoxyethylene (20) sorbitan	16-{3,4-bis[(14-hydroxy-3,6,9,12-tetraoxatetradecan-1-yl)oxy]oxolan-2-yl}-3,6,9,12,15,18,21,24,27,30-decaoxadotriacontane-1,32-diol	16-{3,4-bis[(14-hydroxy-3,6,9,12-tetraoxatetradecan-1-yl)oxy]oxolan-2-yl}-3,6,9,12,15,18,21,24,27,30-decaoxadotriacontane-1,32-diol			C46H92O25	OCCOCCOCCOCCOCCOCC(OCCOCCOCCOCCOCCO)C1OCC(OCCOCCOCCOCCOCCO)C1OCCOCCOCCOCCOCCO	0	N	1045	1008		6.2	-3.5	-3.5			LIPASE_TWEEN80_MG310, LIPASE_TWEEN80_MG327, LIPASE_TWEEN80_MG344	
PPAA			C03167		6050	B00552	18124	POA	C00000799			Phosphonoacetaldehyde	(2-oxoethyl)phosphonic acid	(2-oxoethyl)phosphonic acid			C2H5O4P1	C(C=O)P(=O)(O)O	-1	N	124	92			-1.9	-4.2			PhnW, PhnX	
PPGPP	GUANOSINE-5DP-3DP	ppgpp	C01228		4450	B01416		G4P				Guanosine 3',5'-bis(diphosphate)	[5-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-2-({[(phosphonatooxy)phosphinato]oxy}methyl)oxolan-3-yl] (phosphonatooxy)phosphonate	[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-4-hydroxy-2-({[(phosphonatooxy)phosphinato]oxy}methyl)oxolan-3-yl] (phosphonatooxy)phosphonate	carbohydrate	modified ribonucleotide diphosphate	C10H11N5O17P4	C(OP(=O)([O-])OP(=O)([O-])[O-])C1(OC(C(O)C(OP(=O)([O-])OP(=O)([O-])[O-])1)N3(C=NC2(C(=O)NC(N)=NC=23)))	-4	N	597	389		0.8	-4.4	-11.7			RelA1	
PPHG		pppg9	C01079		4317	B00236	15435		C00007371			protoporphyrinogen IX	3-[20-(2-carboxylatoethyl)-10,15-diethenyl-5,9,14,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1(20),3,5,8,10,13,15,18-octaen-4-yl]propanoate	3-[20-(2-carboxylatoethyl)-10,15-diethenyl-5,9,14,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1(20),3,5,8,10,13,15,18-octaen-4-yl]propanoate			C34H38N4O4	CC1=C2CC3=C(C)C(C=C)=C(CC4=C(C)C(C=C)=C(CC5=C(C)C(CCC([O-])=O)=C(CC(N2)=C1CCC([O-])=O)N5)N4)N3	-2	N	567	522			6.2	0.7			HemG	
PPI	PPI	ppi	C00013	2466-09-3	3315	B00003	18361	PPV	C00019561			diphosphate	diphosphate(3-)	(hydrogen phosphonatooxy)phosphonate	ion		H1O7P2	OP([O-])(=O)OP([O-])([O-])=O	-3	N	175	102			-1.4	-6.7			Aas1, Aas2, Aas3, Aas4, Aas5, Aas6, Aas7, Apt, CdsA1, CdsA2, CdsA3, CdsA4, CdsA5, CdsA6, CdsA7, diadenylate_cyclase, DNAPolymerization_dATP, DNAPolymerization_dCTP, DNAPolymerization_dGTP, DNAPolymerization_dTTP, DNAPrimerPolymerization_ATP, DNAPrimerPolymerization_CTP, DNAPrimerPolymerization_GTP, DNAPrimerPolymerization_UTP, DNA_polymerization_dATP_repair, DNA_polymerization_dCTP_repair, DNA_polymerization_dGTP_repair, DNA_polymerization_dTTP_repair, GalU1, Hpt1, Hpt2, LplA, MetK, MG471_Aminoacylation, MG471_MODIFICATION_003, MG472_Aminoacylation, MG472_MODIFICATION_002, MG475_Aminoacylation, MG475_MODIFICATION_001, MG479_Aminoacylation, MG479_MODIFICATION_001, MG483_Aminoacylation, MG483_MODIFICATION_002, MG484_Aminoacylation, MG484_MODIFICATION_003, MG485_Aminoacylation, MG485_MODIFICATION_002, MG486_Aminoacylation, MG486_MODIFICATION_002, MG486_MODIFICATION_004, MG487_Aminoacylation, MG487_MODIFICATION_002, MG488_Aminoacylation, MG488_MODIFICATION_003, MG489_Aminoacylation, MG489_MODIFICATION_001, MG490_Aminoacylation, MG490_MODIFICATION_002, MG492_Aminoacylation, MG492_MODIFICATION_002, MG493_Aminoacylation, MG493_MODIFICATION_001, MG495_Aminoacylation, MG495_MODIFICATION_002, MG496_Aminoacylation, MG496_MODIFICATION_001, MG497_Aminoacylation, MG497_MODIFICATION_002, MG499_Aminoacylation, MG499_MODIFICATION_001, MG500_Aminoacylation, MG500_MODIFICATION_002, MG501_Aminoacylation, MG501_MODIFICATION_002, MG501_MODIFICATION_005, MG502_Aminoacylation, MG502_MODIFICATION_001, MG502_MODIFICATION_004, MG503_Aminoacylation, MG503_MODIFICATION_002, MG504_Aminoacylation, MG504_MODIFICATION_003, MG506_Aminoacylation, MG506_MODIFICATION_001, MG507_Aminoacylation, MG507_MODIFICATION_001, MG508_Aminoacylation, MG508_MODIFICATION_003, MG509_Aminoacylation, MG509_MODIFICATION_003, MG510_Aminoacylation, MG510_MODIFICATION_003, MG511_Aminoacylation, MG511_MODIFICATION_002, MG512_Aminoacylation, MG512_MODIFICATION_003, MG513_Aminoacylation, MG513_MODIFICATION_001, MG513_MODIFICATION_003, MG514_Aminoacylation, MG514_MODIFICATION_002, MG518_Aminoacylation, MG518_MODIFICATION_002, MG519_Aminoacylation, MG519_MODIFICATION_003, MG520_Aminoacylation, MG520_MODIFICATION_001, MG523_Aminoacylation, MG523_MODIFICATION_002, MG_0004_Aminoacylation, NADD1, NADD2, NadE, NADR1, PncB, Ppa, RibF2, RnaPolymerization_ATP, RnaPolymerization_CTP, RnaPolymerization_GTP, RnaPolymerization_UTP, Upp	
PPIX		ppp9	C02191	553-12-8	5261	B00399	15430		C00007370			protoporphyrin IX	3-[20-(2-carboxylatoethyl)-9,14-diethenyl-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-4-yl]propanoate	3-[20-(2-carboxylatoethyl)-9,14-diethenyl-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-4-yl]propanoate			C34H32N4O4	CC1=C2NC(C=C3N=C(C=C4N=C(C=C5NC(=C2)C(C=C)=C5C)C(C)=C4CCC([O-])=O)C(CCC([O-])=O)=C3C)=C1C=C	-2	N	561	507		4.2	6.8	2.4			HemG	
pristinamycin			C11299 	21411-53-0	46506471							pristinamycin			antibiotic	macrolide	C28H35N3O7	CC(C)[C@@H]1OC(=O)C2=CCCN2C(=O)C2=COC(CC(=O)C[C@H](O)\C=C(C)/C=C\CNC(=O)\C=C/[C@H]1C)=N2	0	N	526									Binds 23S rRNA of the 50S ribosomal subunit [PUB_0847].
PRO	PRO	pro-L	C00148	147-85-3	3448	B01173	17203	PRO	C00001388			L-Proline	proline	pyrrolidine-2-carboxylic acid	amino acid		C5H9N1O2	C(=O)(O)C1(CCCN1)	0	N	115	108	1.99, 10.6	7.1	-2.7	-2.7			Apts_Pro, MG484_Aminoacylation, PeptidylTRNAHs_PRO, ProteinDegradation_FtsH_PRO, ProteinDegradation_Lon_PRO, ProteinPolymerization_PRO	
proflavine			C11181		13362		8452					Proflavine	proflavine	acridine-3,6-diamine	antibiotic	acridine	C13H11N3	C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N	1	N	209	186			1.9	0.8			TX_NormM_proflavine	DNA intercalator [PUB_0847].
ProPro												L-prolyl-L-proline	1-[(pyrrolidin-2-yl)carbonyl]pyrrolidine-2-carboxylic acid	1-[(pyrrolidin-2-yl)carbonyl]pyrrolidine-2-carboxylic acid	dipeptide		C10H16N2O3	OC(=O)C1CCCN1C(=O)C1CCCN1	0	N	212	196		6.7	-3.3	-3.3			Apts_Pro, ProteinDegradation_FtsH_PRO, ProteinDegradation_Lon_PRO, ProteinPolymerization_PRO, TX_OppB_Pro	
PRPP	PRPP	prpp	C00119		3419	B01164	17111	PRP	C00007296			5-Phospho-alpha-D-ribose 1-diphosphate	{3,4-dihydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl} (phosphonatooxy)phosphonate	{3,4-dihydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl} (phosphonatooxy)phosphonate	carbohydrate	sugar phosphate	C5H8O14P3	OC1C(O)C(OP([O-])(=O)OP([O-])([O-])=O)OC1COP([O-])([O-])=O	-5	N	385	251			-3.0	-11.3			Apt, Hpt1, Hpt2, PncB, PrsA, Upp	
pSER	3-P-SERINE	pser-L	C01005	407-41-0	2014		37712					phosphoserine	2-aminio-3-(phosphonatooxy)propanoate	2-azaniumyl-3-(phosphonatooxy)propanoate	modified amino acid		C3H6N1O6P1	C(C(C(=O)[O-])[NH3+])OP(=O)([O-])[O-]	-3	N	183	134		1.5	-3.5	-7.5			MG_070_MONOMER_MODIFICATION_003, MG_070_MONOMER_MODIFICATION_005, MG_273_MONOMER_MODIFICATION_001, MG_305_MONOMER_MODIFICATION_001, MG_317_MONOMER_MODIFICATION_004, MG_342_MONOMER_MODIFICATION_001, MG_377_MONOMER_MODIFICATION_002, MG_377_MONOMER_MODIFICATION_004, MG_377_MONOMER_MODIFICATION_008, MG_401_MONOMER_MODIFICATION_002, MG_401_MONOMER_MODIFICATION_003, MG_401_MONOMER_MODIFICATION_008, MG_401_MONOMER_MODIFICATION_009, MG_407_MONOMER_MODIFICATION_001, MG_427_MONOMER_MODIFICATION_002, MG_438_MONOMER_MODIFICATION_004, MG_438_MONOMER_MODIFICATION_006, MG_451_MONOMER_MODIFICATION_002, MG_451_MONOMER_MODIFICATION_003, MG_460_MONOMER_MODIFICATION_001, MG_460_MONOMER_MODIFICATION_002, MG_491_MONOMER_MODIFICATION_001, pSERpp	
PSIURI	CPD-497		C02067 	1445-07-4	5155	B01529	17802		C00001508			pseudouridine	5-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-dihydropyrimidine-2,4-dione	5-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified ribonucleoside		C9H12N2O6	C1(=C(C(=O)NC(=O)N1)C2(OC(CO)C(O)C(O)2))	0	N	244	197		3.3	-3.1	-3.1			TX_PSIURI, UshA_PSIURIMP	
PSIURIMP												pseudouridine monophoshate	[5-(2,4-dioxo-1,3-dihydropyrimidin-5-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	modified ribonucleotide monophosphate		C9H11N2O9P1	OC1C(COP([O-])([O-])=O)OC(C1O)C1=CNC(=O)NC1=O	-2	N	322	237			-3.2	-6.6			MG471_MODIFICATION_002, MG483_MODIFICATION_001, MG486_MODIFICATION_003, MG488_MODIFICATION_002, MG495_MODIFICATION_001, MG500_MODIFICATION_001, MG501_MODIFICATION_004, MG502_MODIFICATION_003, MG503_MODIFICATION_001, MG504_MODIFICATION_002, MG508_MODIFICATION_002, MG509_MODIFICATION_002, MG510_MODIFICATION_002, MG512_MODIFICATION_002, MG518_MODIFICATION_001, MGrrnA23S_MODIFICATION_002, MGrrnA23S_MODIFICATION_003, MGrrnA23S_MODIFICATION_005, MGrrnA23S_MODIFICATION_007, UshA_PSIURIMP	
pTHR	L-THREONINE-O-3-PHOSPHATE	thrp	C12147	1114-81-4	14294		37525					phosphothreonine	2-amino-3-(phosphonatooxy)butanoic acid	2-amino-3-(phosphonatooxy)butanoic acid	modified amino acid		C4H8N1O6P1	CC(OP([O-])([O-])=O)C(N)C(O)=O	-2	N	197	151		1.5	-3.0	-7.0			MG_070_MONOMER_MODIFICATION_001, MG_070_MONOMER_MODIFICATION_002, MG_070_MONOMER_MODIFICATION_004, MG_217_MONOMER_MODIFICATION_001, MG_317_MONOMER_MODIFICATION_002, MG_317_MONOMER_MODIFICATION_003, MG_377_MONOMER_MODIFICATION_001, MG_377_MONOMER_MODIFICATION_006, MG_377_MONOMER_MODIFICATION_007, MG_392_MONOMER_MODIFICATION_001, MG_392_MONOMER_MODIFICATION_002, MG_401_MONOMER_MODIFICATION_004, MG_401_MONOMER_MODIFICATION_005, MG_401_MONOMER_MODIFICATION_006, MG_427_MONOMER_MODIFICATION_001, MG_438_MONOMER_MODIFICATION_003, MG_438_MONOMER_MODIFICATION_007, MG_438_MONOMER_MODIFICATION_008, MG_438_MONOMER_MODIFICATION_009, MG_451_MONOMER_MODIFICATION_001, MG_460_MONOMER_MODIFICATION_003, pTHRpp	
PTRC	PUTRESCINE	ptrc	C00134	110-60-1	3434	B00037	17148	PUT	C00001428			putrescine	butane-1,4-bis(aminium)	butane-1,4-bis(aminium)	polyamine		C4H14N2	[NH3+]CCCC[NH3+]	2	N	90	108			-0.9	-6.3			DNADamage_hm5U_putTHY_PTRC, TX_SPRDUP2	
pTYR		tyrp	C06501		8732							Phosphotyrosine	[4-(2-amino-2-carboxyethyl)phenyl] phosphate	[4-(2-amino-2-carboxyethyl)phenyl] phosphate	modified amino acid		C9H10N1O6P1	NC(CC1=CC=C(OP([O-])([O-])=O)C=C1)C(O)=O	-2	N	259	204		1.8	-2.7	-5.1			MG_274_MONOMER_MODIFICATION_001, MG_282_MONOMER_MODIFICATION_001, MG_305_MONOMER_MODIFICATION_002, MG_317_MONOMER_MODIFICATION_001, MG_317_MONOMER_MODIFICATION_005, MG_328_MONOMER_MODIFICATION_001, MG_377_MONOMER_MODIFICATION_003, MG_377_MONOMER_MODIFICATION_005, MG_377_MONOMER_MODIFICATION_009, MG_377_MONOMER_MODIFICATION_010, MG_377_MONOMER_MODIFICATION_011, MG_401_MONOMER_MODIFICATION_001, MG_401_MONOMER_MODIFICATION_007, MG_407_MONOMER_MODIFICATION_002, MG_407_MONOMER_MODIFICATION_003, MG_438_MONOMER_MODIFICATION_001, MG_438_MONOMER_MODIFICATION_002, MG_438_MONOMER_MODIFICATION_005, pTYRpp	
putdT												alpha-putrescinyl-2'-deoxythymidine	5-{[(4-aminobutyl)amino]methyl}-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrimidine-2,4-dione	5-{[(4-aminobutyl)amino]methyl}-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified deoxyribonucleoside		C14H24N4O5	C1(=CN(C(=O)NC1=O)C2CC(C(O2)CO)O)CNCCCCN	2	N	328	298		10.0	-3.3	-6.9			TX_putdT, UshA_putdTMP	occurs in bacteriophage DNA [PUB_0477]; in bacteriophage PhiW-14 up to 50% thymidine replaced by putdT [PUB_0478];
putdTMP												alpha-putrescinyl-2'-deoxythymidine monophosphate	[5-(5-{[(4-aminobutyl)amino]methyl}-2,4-dioxo-3H-pyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	[5-(5-{[(4-aminobutyl)amino]methyl}-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate	modified deoxyribonucleotide monophosphate		C14H23N4O8P1	NCCCCNCC1=CN(C2CC(O)C(COP([O-])([O-])=O)O2)C(=O)NC1=O	0	N	406	338		7.4	-9.7	-9.9			UshA_putdTMP	
putTHY				40451-54-5	24523142							alpha-putrescinylthymine	5-{[(4-aminobutyl)amino]methyl}-1,3-dihydropyrimidine-2,4-dione	5-{[(4-aminobutyl)amino]methyl}-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified nucleobase		C9H16N4O2	C1(=CNC(=O)NC1=O)CNCCCCN	2	N	212	198		10.0	-2.6	-6.3			DNADamage_hm5U_putTHY_PTRC	occurs in bacteriophage DNA [PUB_0477]; in bacteriophage PhiW-14 up to 50% thymidine replaced by putdT [PUB_0478];
PYDX	PYRIDOXAL	pydx	C00250	66-72-8	3549	B00072	17310	PXL	C00007509			Pyridoxal		3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carbaldehyde	vitamin		C8H9N1O3	CC1=NC=C(C(=C1O)C=O)CO	0	N	167								PYDXK, TXPYDX	
PYR	PYRUVATE	pyr	C00022	127-17-3	3324	B00006	32816	PYR	C00001200		DFA0385	pyruvate	pyruvate	2-oxopropanoate	carboxy acid		C3H3O3	CC(=O)C([O-])=O	-1	N	87	73			0.1	-3.4			AceE, DhaK, GlyA1, GlyA2, LdhA, PcbX, Pyk_ADP, Pyk_CDP, Pyk_DADP, Pyk_DCDP, Pyk_DGDP, Pyk_DTDP, Pyk_DUDP, Pyk_GDP, Pyk_IDP, Pyk_TDP, Pyk_UDP, TX_FRUPTS, TX_GLCPTS	
R1P	RIBOSE-1P	r1p	C00442	58459-37-3								alpha-D-Ribose 1-phosphate	{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}phosphonic acid	{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}phosphonic acid	carbohydrate	sugar phosphate	C5H11O8P1	C(O)[CH]1(O[CH](OP(O)(O)=O)[CH](O)[CH](O)1)	-2	N	230	173			-2.4	-5.8			DeoD4, DeoD5, DeoD6, DeoD7, Pdp3	
R5P	RIBOSE-5P	r5p	C00117	4151-19-3	3417	B04635	17797		C00007473			alpha-D-Ribose 5-phosphate	2,3,4-trihydroxy-5-(phosphonatooxy)pentanal	2,3,4-trihydroxy-5-(phosphonatooxy)pentanal	carbohydrate	sugar phosphate	C5H9O8P1	OC(COP([O-])([O-])=O)C(O)C(O)C=O	-2	N	228	173			-3.1	-6.2			PrsA, RpiB, Tkt1, YbiV_R5P	
RBFLVRD	CPD-316	rbflvrd	C01007		4252		8798					riboflavin, reduced	7,8-dimethyl-10-(2,3,4,5-tetrahydroxypentyl)-3H,4aH,5H-benzo[g]pteridine-2,4-dione	7,8-dimethyl-10-(2,3,4,5-tetrahydroxypentyl)-2H,3H,4H,4aH,5H,10H-benzo[g]pteridine-2,4-dione	vitamin	redox electron carrier	C17H22N4O6	C3(C2(NC1(=CC(=C(C=C1N(C2=NC(N3)=O)CC(C(C(CO)O)O)O)C)C)))=O	0	N	378	326		5.2	-1.6	-1.6			Fre3, Fre4	
rhodamine6G			C11177		85164765		52895					Rhodamine 6G	rhodamine 6g	9-[2-(ethoxycarbonyl)phenyl]-N-ethyl-6-(ethylamino)-2,7-dimethyl-3H-xanthen-3-iminium	antibiotic		C28H31N2O3	CCNC1=C(C=C2C(=C1)OC3=CC(=[NH+]CC)C(=CC3=C2C4=CC=CC=C4C(=O)OCC)C)C	0	N	444	420			5.3	5.3			TX_NormM_rhodamine6G	
RIB		rib-D	C00121	50-69-1	3421	B04636	47013					D-ribose	ribose	5-(hydroxymethyl)oxolane-2,3,4-triol	carbohydrate	sugar	C5H10O5	C(C1C(C(C(O1)O)O)O)O	0	N	150	128		4.2	-2.3	-2.3			TX_RIBUP, YbiV_R5P	
RIBFLV	RIBOFLAVIN	ribflv	C00255	83-88-5	3554	B01201	17015	RBF	C00001552			riboflavin, oxidized	riboflavin	7,8-dimethyl-10-(2,3,4,5-tetrahydroxypentyl)-2H,3H,4H,10H-benzo[g]pteridine-2,4-dione	vitamin	redox electron carrier	C17H20N4O6	CC1=C(C)C=C2N(CC(O)C(O)C(O)CO)C3=NC(=O)NC(=O)C3=NC2=C1	-1	N	376	321		3.9	-0.9	-1.3			Fre3, Fre4, RibF1, TX_RIBFLV	
ribothymidine					8147972		30821					ribothymidine	ara-T	1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified nucleoside		C10H14N2O6	CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O	0	N	258	215		3.5	-2.0	-2.0				
rifampicin			C06688	13292-46-1	8913		28077					rifampicin			antibiotic	rifamycin	C43H58N4O12	CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C	0	N	823									Inhibits DNA-dependent RNA polymerase [PUB_0847].
RL5P	RIBULOSE-5P	ru5p-D	C00199	4151-19-3	3499	B01187	17363	5RP				D-Ribulose 5-phosphate	1,3,4-trihydroxy-5-(phosphonatooxy)pentan-2-one	1,3,4-trihydroxy-5-(phosphonatooxy)pentan-2-one	carbohydrate	sugar phosphate	C5H9O8P1	OCC(=O)C(O)C(O)COP([O-])([O-])=O	-2	N	228	173			-2.8	-5.9			Rpe, RpiB	
s2U	2-THIOURIDINE			20235-78-3	1968							2-thiouridine	1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-sulfanylidene-3H-pyrimidin-4-one	1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-4-one	modified ribonucleoside		C9H12N2O5S1	C3(OC(CO)C(O)C(O)3)N1C=CC(=O)NC1(=S)	0	N	260	208		2.8	-1.5	-1.6			TX_s2U, UshA_s2UMP	
s2UMP												2-thiouridine monophosphate	[3,4-dihydroxy-5-(4-oxo-2-sulfanylidene-3H-pyrimidin-1-yl)oxolan-2-yl]methyl phosphate	[3,4-dihydroxy-5-(4-oxo-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methyl phosphate	modified ribonucleotide monophosphate		C9H11N2O8P1S1	OC1C(COP([O-])([O-])=O)OC(C1O)N1C=CC(=O)NC1=S	-2	N	338	248			-1.6	-5.1			MG501_MODIFICATION_002, MG501_MODIFICATION_003, MG502_MODIFICATION_001, MG502_MODIFICATION_002, MG513_MODIFICATION_001, MG513_MODIFICATION_002, UshA_s2UMP	
s4U				13957-31-8	9419244							4-thiouridine	1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-sulfanylidene-3H-pyrimidin-2-one	1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-sulfanylidene-1,2,3,4-tetrahydropyrimidin-2-one	modified ribonucleoside		C9H12N2O5S1	C3(OC(CO)C(O)C(O)3)N1C=CC(=S)NC1(=O)	0	N	260	208		2.7	-1.5	-1.6			TX_s4U, UshA_s4UMP	
s4UMP												4-thiouridine monophosphate	[3,4-dihydroxy-5-(2-oxo-4-sulfanylidene-3H-pyrimidin-1-yl)oxolan-2-yl]methyl phosphate	[3,4-dihydroxy-5-(2-oxo-4-sulfanylidene-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methyl phosphate	modified ribonucleotide monophosphate		C9H11N2O8P1S1	OC1C(COP([O-])([O-])=O)OC(C1O)N1C=CC(=S)NC1=O	-2	N	338	248			-1.6	-5.1			MG471_MODIFICATION_003, MG472_MODIFICATION_002, MG475_MODIFICATION_001, MG479_MODIFICATION_001, MG483_MODIFICATION_002, MG484_MODIFICATION_003, MG485_MODIFICATION_002, MG486_MODIFICATION_004, MG487_MODIFICATION_002, MG488_MODIFICATION_003, MG489_MODIFICATION_001, MG490_MODIFICATION_002, MG492_MODIFICATION_002, MG493_MODIFICATION_001, MG495_MODIFICATION_002, MG496_MODIFICATION_001, MG497_MODIFICATION_002, MG499_MODIFICATION_001, MG500_MODIFICATION_002, MG501_MODIFICATION_005, MG502_MODIFICATION_004, MG503_MODIFICATION_002, MG504_MODIFICATION_003, MG506_MODIFICATION_001, MG507_MODIFICATION_001, MG508_MODIFICATION_003, MG509_MODIFICATION_003, MG510_MODIFICATION_003, MG511_MODIFICATION_002, MG512_MODIFICATION_003, MG513_MODIFICATION_003, MG514_MODIFICATION_002, MG518_MODIFICATION_002, MG519_MODIFICATION_003, MG520_MODIFICATION_001, MG523_MODIFICATION_002, UshA_s4UMP	
S7P	D-SEDOHEPTULOSE-7-P	s7p	C00281		3576	B04661	15721					D-sedoheptulose-7-phosphate	1,3,4,5,6-pentahydroxy-7-(phosphonatooxy)heptan-2-one	1,3,4,5,6-pentahydroxy-7-(phosphonatooxy)heptan-2-one	carbohydrate	sugar phosphate	C7H13O10P1	OCC(=O)C(O)C(O)C(O)C(O)COP([O-])([O-])=O	-2	N	288	224			-4.0	-7.2			TalA, Tkt1	
SALA	3-SULFINOALANINE	3sala	C00606	1115-65-7	3881	B01293		CSD				3-Sulfino-L-alanine	2-amino-3-sulfinatopropanoate	2-amino-3-sulfinatopropanoate			C3H5N1O4S1	C(C([N+])CS([O-])=O)(=O)[O-]	-1	N	151	116		0.2	-2.6	-6.2			CsdA	"3-sulfino-L-alanine is an intermediate in cysteine biosynthesis and degradation [PUB_0006].
"
SBT	SORBITOL	sbt-D	C00794	50-70-4	8145605		17924					D-Sorbitol	sorbitol	hexane-1,2,3,4,5,6-hexol	carbohydrate	sugar alcohol	C6H14O6	C(C(C(C(C(CO)O)O)O)O)O	0	N	182	165		5.0	-3.7	-3.7			YbiV_SBT6P	
SBT6P	D-SORBITOL-6-P	sbt6p	C01096 	108392-12-7	2594		370698					D-Sorbitol 6-phosphate	6-(hydrogen phosphonatooxy)hexane-1,2,3,4,5-pentol	6-(hydrogen phosphonatooxy)hexane-1,2,3,4,5-pentol	carbohydrate	sugar phosphate	C6H14O9P1	OCC(O)C(O)C(O)C(O)COP(O)([O-])=O	-2	N	261	208			-3.8	-7.0			YbiV_SBT6P	
SER	SER	ser-L	C00065	56-45-1	3365	B01145	17115	SER	C00001393			L-Serine	serine	2-amino-3-hydroxypropanoic acid	amino acid		C3H7N1O3	C(=O)(O)C(N)CO	0	N	105	93		5.7	-4.0	-4.0			Apts_Ser, GlpQ3, GlyA3, MG385r3, MG471_MODIFICATION_003, MG472_MODIFICATION_002, MG475_Aminoacylation, MG475_MODIFICATION_001, MG479_MODIFICATION_001, MG483_MODIFICATION_002, MG484_MODIFICATION_003, MG485_MODIFICATION_002, MG486_MODIFICATION_004, MG487_Aminoacylation, MG487_MODIFICATION_002, MG488_MODIFICATION_003, MG489_MODIFICATION_001, MG490_MODIFICATION_002, MG492_MODIFICATION_002, MG493_MODIFICATION_001, MG495_MODIFICATION_002, MG496_MODIFICATION_001, MG497_MODIFICATION_002, MG499_MODIFICATION_001, MG500_MODIFICATION_002, MG501_MODIFICATION_002, MG501_MODIFICATION_005, MG502_MODIFICATION_001, MG502_MODIFICATION_004, MG503_MODIFICATION_002, MG504_MODIFICATION_003, MG506_Aminoacylation, MG506_MODIFICATION_001, MG507_Aminoacylation, MG507_MODIFICATION_001, MG508_MODIFICATION_003, MG509_MODIFICATION_003, MG510_MODIFICATION_003, MG511_MODIFICATION_002, MG512_MODIFICATION_003, MG513_MODIFICATION_001, MG513_MODIFICATION_003, MG514_MODIFICATION_002, MG518_MODIFICATION_002, MG519_MODIFICATION_003, MG520_MODIFICATION_001, MG523_MODIFICATION_002, MG_070_MONOMER_MODIFICATION_003, MG_070_MONOMER_MODIFICATION_005, MG_273_MONOMER_MODIFICATION_001, MG_305_MONOMER_MODIFICATION_001, MG_317_MONOMER_MODIFICATION_004, MG_342_MONOMER_MODIFICATION_001, MG_377_MONOMER_MODIFICATION_002, MG_377_MONOMER_MODIFICATION_004, MG_377_MONOMER_MODIFICATION_008, MG_401_MONOMER_MODIFICATION_002, MG_401_MONOMER_MODIFICATION_003, MG_401_MONOMER_MODIFICATION_008, MG_401_MONOMER_MODIFICATION_009, MG_407_MONOMER_MODIFICATION_001, MG_427_MONOMER_MODIFICATION_002, MG_438_MONOMER_MODIFICATION_004, MG_438_MONOMER_MODIFICATION_006, MG_451_MONOMER_MODIFICATION_002, MG_451_MONOMER_MODIFICATION_003, MG_460_MONOMER_MODIFICATION_001, MG_460_MONOMER_MODIFICATION_002, MG_491_MONOMER_MODIFICATION_001, PeptidylTRNAHs_SER, ProteinDegradation_FtsH_SER, ProteinDegradation_Lon_SER, ProteinPolymerization_SER, pSERpp	
SerSer				6620-95-7	10246126							L-seryl-L-serine	L-serine, N-L-seryl-	2-(2-amino-3-hydroxypropanamido)-3-hydroxypropanoic acid	dipeptide		C6H12N2O5	C(C(C(=O)NC(CO)C(=O)O)N)O	0	N	192	167		5.7	-5.9	-6.0			Apts_Ser, ProteinDegradation_FtsH_SER, ProteinDegradation_Lon_SER, ProteinPolymerization_SER, TX_OppB_Ser	
singlet_oxygen					11533410		29194					singlet oxygen	oxygen	oxidanylidene	reactive oxygen species		O1	[O]	0	N	16	15			0.2	0.2				as ROS of DNA bases selectively interacts with guanine [PUB_0479];
SNGLYP	SN-GLYCEROL-1-PHOSPHATE		C00623 	5746-57-6	3896		16221	1GP				sn-glycerol-1-phosphate	3-(phosphonatooxy)propane-1,2-diol	3-(phosphonatooxy)propane-1,2-diol			C3H7O6P1	C(O)C(O)COP(=O)([O-])[O-]	-2	N	170	128			-2.0	-5.1			ProLipoproteinDiacylglycerylTransferase, SNGLYPOr, YbiV_SNGLYP	
SO2	SULFUR-DIOXIDE	so2	C09306	7446-09-5	11497	B01113	18422	SO2				sulfur dioxide	sulfur dioxide	(oxo-$l^{4}-sulfanylidene)oxidane	gas		O2S1	S(=O)=O	0	N	64	41			0.3	0.3			CsdA	
SO4	SULFATE	so4			1117		16189	SUL				sulphate	sulfate	sulfate	ion		O4S1	O=S(=O)([O-])[O-]	-2	N	96	60			-0.8	-5.6			TX_SO4	
sparfloxacin			C07662	110871-86-8	46506453		9212					sparfloxacin			antibiotic	fluoroquinolone	C19H22F2N4O3	C[C@H]1CN(C[C@@H](C)N1)C1=C(F)C2=C(C(=O)C(=CN2C2CC2)C(O)=O)C(N)=C1F	0	N	392									Inhibits topoisomerase II/DNA gyrase and topoisomerase IV [PUB_0847].
spectinomycin			C02078                      	1695-77-8	46505032							spectinomycin			antibiotic	aminoglycoside	C14H24N2O7	[H][C@@]12O[C@H](C)CC(=O)[C@]1(O)O[C@]1([H])[C@@H](NC)[C@@H](O)[C@@H](NC)[C@H](O)[C@@]1([H])O2	0	N	332									Inhibits 30S ribosomal subunit [PUB_0847].
SPMD	SPERMIDINE	spmd	C00315	124-20-9	3609	B01214	16610	SPD	C00001431			spermidine	(4-aminiobutyl)(3-aminiopropyl)azanium	(4-azaniumylbutyl)(3-azaniumylpropyl)azanium	polyamine		C7H22N3	[NH3+]CCCC[NH2+]CCC[NH3+]	3	N	148	174			-1.1	-8.2			TX_SPMDUP1	
STEROL			C00187	57-88-5	3487	B01181	16113	CLR	C00003648	LMST01010001	SST0005	cholesterol	cholesterol	2,15-dimethyl-14-(6-methylheptan-2-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol	lipid	sterol	C27H46O1	CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C	0	Y	387	428		8.4	7.1	7.1			TX_STEROL	
streptomycin			C00413	57-92-1	46506845		17076					streptomycin			antibiotic	aminoglycoside	C21H39N7O12	CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O	0	N	582									Irreversibly binds 30S ribosomal subunit and 16S rRNA. Interferes with decoding site and initiation leading to mRNA misreading [PUB_0847].
superoxide					8143763		18421					superoxide	O2(-)	oxidanidyloxidanyl	reactive oxygen species		O2	[O-][O]	-1	N	32	24			-0.4	-1.7				insufficiently reactive to modify DNA [PUB_0479];
T3P1	GAP	g3p	C00661	591-59-3	3930		17138		C00007285			D-glyceraldehdye-3-phosphate	2-hydroxy-3-(phosphonatooxy)propanal	2-hydroxy-3-(phosphonatooxy)propanal			C3H5O6P1	OC(COP([O-])([O-])=O)C=O	-2	N	168	122			-1.8	-5.0			DeoC, Fba, GapA, TalA, Tkt1, Tkt2, TpiA	
T3P2	DIHYDROXY-ACETONE-PHOSPHATE	dhap	C00111		3411	B00029	16108	13P	C00007560			Dihydroxyacetone phosphate	1-hydroxy-3-(phosphonatooxy)propan-2-one	1-hydroxy-3-(phosphonatooxy)propan-2-one			C3H5O6P1	OCC(=O)COP([O-])([O-])=O	-2	N	168	122			-1.6	-5.0			DhaK, Fba, GpsA, SNGLYPOr, TpiA	
TAG16P		tagdp-D	C03785		6535	B04913	4250					D-Tagatose 1,6-biphosphate	{3,4,5-trihydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}methyl phosphate	{3,4,5-trihydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}methyl phosphate	carbohydrate	sugar phosphate	C6H10O12P2	OC1C(COP([O-])([O-])=O)OC(O)(COP([O-])([O-])=O)C1O	-4	N	336	234			-3.0	-9.8			FruK2	
TAG6P		tag6p-D	C01097		4332	B04767	4251	TA6	C00019683			D-Tagatose 6-phosphate	[3,4,5-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl phosphate	[3,4,5-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl phosphate	carbohydrate	sugar phosphate	C6H11O9P1	OCC1(O)OC(COP([O-])([O-])=O)C(O)C1O	-2	N	258	194			-2.9	-6.2			FruK2	
tBHP	BUTYL-HYDROPEROXIDE				53787189		365419					tert-butylhydroperoxide	2-methylpropane-2-peroxol	2-methylpropane-2-peroxol			C4H10O2	CC(C)(C)OO	0	N	90	97		3.7	1.0	1.0			Ohr_tBHP, OsmC_tBHP	
tBOH					17425442		26878					tert-Butanol	tert-butyl alcohol	2-methylpropan-2-ol	alcohol		C4H10O1	CC(C)(C)O	0	N	74	88		8.3	0.5	0.5			Ohr_tBHP, OsmC_tBHP	
TDECEG3P		1tdec7eg3p	C00681		3950		16975			LMGP10050000		1-tetradec-7-enoyl-sn-glycerol 3-phosphate	(2-hydroxy-2,3-dioxo-1,4,2$l^{5}-dioxaphosphinan-5-yl)methyl tridecanoate	(2-hydroxy-2,3-dioxo-1,4,2$l^{5}-dioxaphosphinan-5-yl)methyl tridecanoate	lipid	glycerophospholipid	C17H31O7P1	CCCCCCCCCCCCC(=O)OCC1COP(=O)(C(=O)O1)O	-1	N	378	357			4.3	2.0			PlsC3, PlsX3	
TDECG3P		1tdecg3p	C00681		3950		16975			LMGP10050000		1-tetradecanoyl-sn-glycerol 3-phosphate	2-hydroxy-3-(phosphonatooxy)propyl tetradecanoate	2-hydroxy-3-(phosphonatooxy)propyl tetradecanoate	lipid	glycerophospholipid	C17H33O7P1	CCCCCCCCCCCCCC(=O)OCC(O)COP([O-])([O-])=O	-2	N	380	369			4.1	0.9			PlsC2, PlsX2	
TDP												TDP					C10H13N2O12P2		-3	N	415								Pyk_TDP	
tetracycline			C06570	60-54-8	46506693		27902					tetracycline			antibiotic	tetracycline	C22H24N2O8	[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C	0	N	444									Inhibits 30S ribosomal subunit and prevents amino-acyl tRNA from binding to the A site fo the ribosome [PUB_0847].
tetraphenylphosphonium			C11152		26697143		44880					tetraphenylphosphonium	pph4(+)	tetraphenylphosphanium	antibiotic		C24H20P1	C1=CC=C(C=C1)[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4	1	N	339	317			6.1	6.1			TX_NormM_tetraphenylphosphonium	
THF	THF	thf	C00101	135-16-0	3401	B04633	15635	THG	C00007249			5,6,7,8-Tetrahydrofolate	2-[(4-{[(2-amino-4-oxo-5,6,7,8-tetrahydro-1H-pteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioate	2-[(4-{[(2-amino-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioate	vitamin	folate	C19H21N7O6	NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)NC(CCC([O-])=O)C([O-])=O)N2)N1	-2	N	443	369		4.9	-4.8	-8.4	0		DhfR1, FTHFS, GlyA3, MetS, MG488_Formyltransferase, MG501_MODIFICATION_003, MG502_MODIFICATION_002, MG513_MODIFICATION_002, TX_THF	
THM	THIAMINE	thm	C00378	59-43-8	3668	B00096	18385	VIB	C00000775			thiamine		2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1, 3-thiazol-3-ium-5-yl]ethanol	vitamin		C12H17N4O1S1	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO	1	N	265								TMDPK, TXTHM	
THMP		thmmp	C01081	532-40-1	4319	B00237	9533	TPS	C00019628			Thiamin monophosphate	3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-5-[2-(phosphonatooxy)ethyl]-1,3-thiazol-3-ium	3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-5-[2-(phosphonatooxy)ethyl]-1,3-thiazol-3-ium			C12H16N4O4P1S1	CC1=C(CCOP([O-])([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N	-1	N	343	279		3.5	-5.9	-5.2			ThiL	
THR	THR	thr-L	C00188	72-19-5	3488	B01182	16857	THR	C00001394			L-Threonine	threonine(L)	2-amino-3-hydroxybutanoic acid	amino acid		C4H9N1O3	C(=O)(O)C(N)C(C)O	0	N	119	111	2.15, 9.12	5.6	-3.6	-3.6			Apts_Thr, GlyA4, MG479_Aminoacylation, MG510_Aminoacylation, MG512_Aminoacylation, MG_070_MONOMER_MODIFICATION_001, MG_070_MONOMER_MODIFICATION_002, MG_070_MONOMER_MODIFICATION_004, MG_217_MONOMER_MODIFICATION_001, MG_317_MONOMER_MODIFICATION_002, MG_317_MONOMER_MODIFICATION_003, MG_377_MONOMER_MODIFICATION_001, MG_377_MONOMER_MODIFICATION_006, MG_377_MONOMER_MODIFICATION_007, MG_392_MONOMER_MODIFICATION_001, MG_392_MONOMER_MODIFICATION_002, MG_401_MONOMER_MODIFICATION_004, MG_401_MONOMER_MODIFICATION_005, MG_401_MONOMER_MODIFICATION_006, MG_427_MONOMER_MODIFICATION_001, MG_438_MONOMER_MODIFICATION_003, MG_438_MONOMER_MODIFICATION_007, MG_438_MONOMER_MODIFICATION_008, MG_438_MONOMER_MODIFICATION_009, MG_451_MONOMER_MODIFICATION_001, MG_460_MONOMER_MODIFICATION_003, PeptidylTRNAHs_THR, ProteinDegradation_FtsH_THR, ProteinDegradation_Lon_THR, ProteinPolymerization_THR, pTHRpp	
ThrThr												L-threonyl-L-threonine	2-(2-amino-3-hydroxybutanamido)-3-hydroxybutanoic acid	2-(2-amino-3-hydroxybutanamido)-3-hydroxybutanoic acid	dipeptide		C8H16N2O5	CC(O)C(N)C(=O)NC(C(C)O)C(O)=O	0	N	220	201		5.9	-5.1	-5.1			Apts_Thr, ProteinDegradation_FtsH_THR, ProteinDegradation_Lon_THR, ProteinPolymerization_THR, TX_OppB_Thr	
THY	THYMINE	thym	C00178	65-71-4	3478	B00051	17821	TDR	C00001511			thymine	Thy	5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione	nucleobase		C5H6N2O2	CC1=CNC(=O)NC1=O	0	N	126	106	9.9	2.5	-0.5	-0.5			DNADamage_CSNTHY_CSN64THY_UVB_radiation, DNADamage_CSNTHY_cyclobutane_CSNTHY_UVB_radiation, DNADamage_SpontaneousBaseDeamination_m5C, DNADamage_SpontaneousBaseLoss_thymine, DNADamage_THYCSN_cyclobutane_THYCSN_UVB_radiation, DNADamage_THYCSN_THY64CSN_UVB_radiation, DNADamage_THYTHY_cyclobutane_THYTHY_UVB_radiation, DNADamage_THYTHY_THY64THY_UVB_radiation, DNADamage_THY_DHTHY_hydrogen_radical, DNADamage_THY_e3THY_DES, DNADamage_THY_e3THY_EMS, DNADamage_THY_e3THY_ENU, DNADamage_THY_hm5URA_hydroxyl_radical, DNADamage_THY_ho5ho6THY_hydroxyl_radical, DNADamage_THY_m3THY_MMS, DNADamage_THY_m3THY_MNU, DNADamage_THY_O2eTHY_DES, DNADamage_THY_O2eTHY_EMS, DNADamage_THY_O2eTHY_ENU, DNADamage_THY_O2mTHY_MNNG, DNADamage_THY_O2mTHY_MNU, DNADamage_THY_O4eTHY_DES, DNADamage_THY_O4eTHY_EMS, DNADamage_THY_O4eTHY_ENU, DNADamage_THY_O4mTHY_MNNG, DNADamage_THY_O4mTHY_MNU, DNADamage_THY_THY_GLYC_hydroxyl_radical, Pdp2, TX_THY	
THY64CSN												thymine-[6,4]-cytosine	5-amino-5-methyl-6-(2-oxo-1H-pyrimidin-4-yl)-1,3-diazinane-2,4-dione	5-amino-5-methyl-6-(2-oxo-1,2-dihydropyrimidin-4-yl)-1,3-diazinane-2,4-dione	modified nucleobase		C9H11N5O3	N1C=CC(=NC1=O)C2C(C)(C(NC(N2)=O)=O)N	0	N	237	195		9.1	-2.1	-2.1			DNADamage_THY64CSN_THY64CSN_dewar_UVB_radiation, DNADamage_THYCSN_THY64CSN_UVB_radiation	
THY64CSN_dewar												thymine-[6,4]-cytosine dewar product	5-amino-5-methyl-6-{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-1,3-diazinane-2,4-dione	5-amino-5-methyl-6-{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-1,3-diazinane-2,4-dione	modified nucleobase		C9H11N5O3	N2C1=CC(N1C2=O)C3C(C)(C(NC(N3)=O)=O)N	0	N	237	187		7.5	-2.0	-2.0			DNADamage_THY64CSN_THY64CSN_dewar_UVB_radiation	
THY64THY					24519484							thymine-[6,4]-thymine	5-hydroxy-5-methyl-6-(5-methyl-2-oxo-1H-pyrimidin-4-yl)-1,3-diazinane-2,4-dione	5-hydroxy-5-methyl-6-(5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)-1,3-diazinane-2,4-dione	modified nucleobase		C10H12N4O4	CC1(C(NC(=O)NC1=O)C2=NC(=O)NC=C2C)O	0	N	252	208		9.1	-1.6	-1.6			DNADamage_THY64THY_THY64THY_dewar_UVB_radiation, DNADamage_THYTHY_THY64THY_UVB_radiation	
THY64THY_dewar												thymine-[6,4]-thymine dewar product	5-hydroxy-5-methyl-6-{5-methyl-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-1,3-diazinane-2,4-dione	5-hydroxy-5-methyl-6-{5-methyl-2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-1,3-diazinane-2,4-dione	modified nucleobase		C10H12N4O4	CC2=C1NC(=O)N1C2C3C(C)(C(NC(N3)=O)=O)O	0	N	252	201		2.4	-1.6	-1.6			DNADamage_THY64THY_THY64THY_dewar_UVB_radiation	
THY_GLYC					8146714		29128					thymine glycol	thymine glycol	5,6-dihydroxy-5-methyl-1,3-diazinane-2,4-dione	modified nucleobase		C5H8N2O4	CC1(C(NC(=O)NC1=O)O)O	0	N	160	130		1.9	-1.9	-2.0			DNADamage_THY_THY_GLYC_hydroxyl_radical	recognized by endonuclease III, FPG, UNG [PUB_0473]
TPP		thmpp	C00068		3368	B01146	9532	TPP	C00019627			thiamine diphosphate	3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-5-(2-{[(phosphonatooxy)phosphinato]oxy}ethyl)-1,3-thiazol-3-ium	3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-5-(2-{[(phosphonatooxy)phosphinato]oxy}ethyl)-1,3-thiazol-3-ium	vitamin		C12H16N4O7P2S1	CC1=C(CCOP([O-])(=O)OP([O-])([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N	-2	N	422	321		2.3	-5.8	-7.3			ThiL, TMDPK	
TRIBUTYRIN			C13870	60-01-5	85488912		296488					tributyrin; 1,3-Di(butanoyloxy)propan-2-yl butanoate; butyrin	1,3-bis(butanoyloxy)propan-2-yl butanoate	1,3-bis(butanoyloxy)propan-2-yl butanoate	lipid	glycerolipid	C15H26O6	CCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC	0	Y	302	300			2.9	2.9			LIPASE_TRIBUTYRIN_MG310, LIPASE_TRIBUTYRIN_MG327, LIPASE_TRIBUTYRIN_MG344	
TRILAURIN				538-24-9	607174							trilaurin	1,3-bis(dodecanoyloxy)propan-2-yl dodecanoate	1,3-bis(dodecanoyloxy)propan-2-yl dodecanoate	lipid	glycerolipid	C39H74O6	CCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCC	0	Y	639	708			13.6	13.6			LIPASE_TRILAURIN_MG310, LIPASE_TRILAURIN_MG327, LIPASE_TRILAURIN_MG344	
TRIMYRISTIN				555-45-3	607175					LMGL03012616		trimyristin; 1,3-Di(tetradecanoyloxy)propan-2-yl tetradecanoate; glyceryl trimyristate	1,3-bis(tetradecanoyloxy)propan-2-yl tetradecanoate	1,3-bis(tetradecanoyloxy)propan-2-yl tetradecanoate	lipid	glycerolipid	C45H86O6	[H]C(COC(=O)CCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC	0	Y	723	811			16.3	16.3			LIPASE_TRIMYRISTIN_MG310, LIPASE_TRIMYRISTIN_MG327, LIPASE_TRIMYRISTIN_MG344	
TRIOLEIN				41755-78-6	87246614		53753					triolein	1,3-bis(octadec-9-enoyloxy)propan-2-yl octadec-9-enoate	1,3-bis(octadec-9-enoyloxy)propan-2-yl octadec-9-enoate	lipid	glycerolipid	C57H104O6	CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC	0	Y	885	990			20.5	20.5			LIPASE_TRIOLEIN_MG310, LIPASE_TRIOLEIN_MG327, LIPASE_TRIOLEIN_MG344	
TRIPALMITIN				555-44-2	24900325					LMGL03010001		tripalmitin; 1,2,3-Trihexadecanoylglycerol; Glyceryl Tripalmitate; Glycerol Tripalmitate	TG(16:0/16:0/16:0)	1,3-bis(hexadecanoyloxy)propan-2-yl hexadecanoate	lipid	glycerolipid	C51H98O6	CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC	0	Y	807	912			18.9	18.9			LIPASE_TRIPALMITIN_MG310, LIPASE_TRIPALMITIN_MG327, LIPASE_TRIPALMITIN_MG344	
TRISTEARIN				555-43-1	4266246					LMGL03010002		Tristearin	tristearin	1,3-bis(octadecanoyloxy)propan-2-yl octadecanoate	lipid	glycerolipid	C57H110O6	CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC	0	Y	891	1014			21.6	21.6			LIPASE_TRISTEARIN_MG310, LIPASE_TRISTEARIN_MG327, LIPASE_TRISTEARIN_MG344	
TRI_HDCEA_IN					10970491							triacylglycerol of {Hexadecenoate acid}	1,3-bis(hexadec-9-enoyloxy)propan-2-yl hexadec-9-enoate	1,3-bis(hexadec-9-enoyloxy)propan-2-yl hexadec-9-enoate	lipid	glycerolipid	C51H92O6	CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC	0	Y	801	888			17.8	17.8			LIPASE_TRI_HDCEA_IN_MG310, LIPASE_TRI_HDCEA_IN_MG327, LIPASE_TRI_HDCEA_IN_MG344	
TRI_TTDCEA_IN												triacylglycerol of {tetradecenoic acid}	1,3-bis(tetradec-9-enoyloxy)prop-1-en-2-yl tetradec-9-enoate	1,3-bis(tetradec-9-enoyloxy)prop-1-en-2-yl tetradec-9-enoate	lipid	glycerolipid	C45H78O6	CCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCC)=COC(=O)CCCCCCCC=CCCCC	0	Y	715	779			14.9	14.9			LIPASE_TRI_TTDCEA_IN_MG310, LIPASE_TRI_TTDCEA_IN_MG327, LIPASE_TRI_TTDCEA_IN_MG344	
TRP	TRP	trp-L	C00078	73-22-3	3378	B01150	16828	TRP	C00001396			L-tryptophan	trp(.)	2-amino-3-(1H-indol-3-yl)propanoic acid	amino acid		C11H12N2O2	NC(CC1=CNC2=C1C=CC=C2)C(O)=O	0	N	204	182		6.0	-1.2	-1.2			Apts_Trp, MG496_Aminoacylation, MG504_Aminoacylation, PeptidylTRNAHs_TRP, ProteinDegradation_FtsH_TRP, ProteinDegradation_Lon_TRP, ProteinPolymerization_TRP, TX_AROP11, TX_AROP21	
TrpTrp				20696-60-0	8888253							L-trytophanyl-L-trytophan	2-[2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid	2-[2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid	dipeptide		C22H22N4O3	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N	0	N	390	344		6.0	-0.3	-0.4			Apts_Trp, ProteinDegradation_FtsH_TRP, ProteinDegradation_Lon_TRP, ProteinPolymerization_TRP, TX_OppB_Trp	
TTDCA		ttdca	C06424	544-63-8	8659	B02019	28875	MYR	C00001228	LMFA01010014	DFA0014	tetradecanoate (n-C14:0)	myristate	tetradecanoate	fatty acyl		C14H27O2	CCCCCCCCCCCCCC(=O)[O-]	-1	N	227	257			5.4	3.1			Aas2, LIPASE_TRIMYRISTIN_MG310, LIPASE_TRIMYRISTIN_MG327, LIPASE_TRIMYRISTIN_MG344, TX_TTDCA	
TTDCEA		ttdcea	C08322		7849919		27781			LMFA01030051	DFA0090	tetradecenoate (n-C14:1)	tetradec-9-enoate	tetradec-9-enoate	fatty acyl		C14H25O2	CCCCC=CCCCCCCCC([O-])=O	-1	N	225	250			5.0	2.8			Aas3, LIPASE_TRI_TTDCEA_IN_MG310, LIPASE_TRI_TTDCEA_IN_MG327, LIPASE_TRI_TTDCEA_IN_MG344, TX_TTDCEA	
TTP												TTP					C10H13N2O15P3		-4	N	494								Pyk_TDP	
TWEEN80												Tween 80; Polyoxyethylene (20) sorbitan monooleate; polysorbate 80	17-{3,4-bis[(14-hydroxy-3,6,9,12-tetraoxatetradecan-1-yl)oxy]oxolan-2-yl}-32-hydroxy-3,6,9,12,15,18,21,24,27,30-decaoxadotriacontan-1-yl (8E)-octadec-8-enoate	17-{3,4-bis[(14-hydroxy-3,6,9,12-tetraoxatetradecan-1-yl)oxy]oxolan-2-yl}-32-hydroxy-3,6,9,12,15,18,21,24,27,30-decaoxadotriacontan-1-yl (8E)-octadec-8-enoate			C64H124O26	CCCCCCCCC\C=C\CCCCCCC(=O)OCCOCCOCCOCCOCCOCC(OCCOCCOCCOCCOCCO)C1OCC(OCCOCCOCCOCCOCCO)C1OCCOCCOCCOCCOCCO	0	Y	1310	1308		6.2	3.9	3.9			LIPASE_TWEEN80_MG310, LIPASE_TWEEN80_MG327, LIPASE_TWEEN80_MG344	
TYR	TYR	tyr-L	C00082	60-18-4	3382	B01154	17895	TYR	C00001397			L-tyrosine	tyrosine	2-amino-3-(4-hydroxyphenyl)propanoic acid	amino acid		C9H11N1O3	NC(CC1=CC=C(O)C=C1)C(O)=O	0	N	181	164		5.5	-1.6	-1.6			Apts_Tyr, AspC2, MG503_Aminoacylation, MG_274_MONOMER_MODIFICATION_001, MG_282_MONOMER_MODIFICATION_001, MG_305_MONOMER_MODIFICATION_002, MG_317_MONOMER_MODIFICATION_001, MG_317_MONOMER_MODIFICATION_005, MG_328_MONOMER_MODIFICATION_001, MG_377_MONOMER_MODIFICATION_003, MG_377_MONOMER_MODIFICATION_005, MG_377_MONOMER_MODIFICATION_009, MG_377_MONOMER_MODIFICATION_010, MG_377_MONOMER_MODIFICATION_011, MG_401_MONOMER_MODIFICATION_001, MG_401_MONOMER_MODIFICATION_007, MG_407_MONOMER_MODIFICATION_002, MG_407_MONOMER_MODIFICATION_003, MG_438_MONOMER_MODIFICATION_001, MG_438_MONOMER_MODIFICATION_002, MG_438_MONOMER_MODIFICATION_005, PeptidylTRNAHs_TYR, ProteinDegradation_FtsH_TYR, ProteinDegradation_Lon_TYR, ProteinPolymerization_TYR, pTYRpp, TX_AROP13, TX_AROP23	
TyrTyr				1050-28-8 	8546048							L-tyrosyl-L-tyrosine	tyr-tyr	2-[2-amino-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid	dipeptide		C18H20N2O5	C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O	0	N	344	308		5.8	-1.1	-1.2			Apts_Tyr, ProteinDegradation_FtsH_TYR, ProteinDegradation_Lon_TYR, ProteinPolymerization_TYR, TX_OppB_Tyr	
U23CMP	CPD-3725	23cump	C02355		5402	B01566						2',3'-Cyclic UMP	6-(2,4-dioxo-3H-pyrimidin-1-yl)-7-hydroxy-2-oxo-tetrahydro-4H-1,3,5,2$l^{5}-furo[3,2-d][1,3,2$l^{5}]dioxaphosphinin-2-olate	6-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-7-hydroxy-2-oxo-hexahydro-1,3,5,2$l^{5}-furo[3,2-d][1,3,2$l^{5}]dioxaphosphinin-2-olate	cyclic ribonucleotide monophosphate		C9H10N2O8P1	OC1C2OP([O-])(=O)OCC2OC1N1C=CC(=O)NC1=O	-1	N	305	221			-1.6	-4.0			CpdB1	
U3MP	CPD-3724	3ump	C01368	35170-03-7	4567	B01443	28895	U3P				3'-UMP	[5-(2,4-dioxo-3H-pyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] phosphate	[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] phosphate	nucleoside 3'-phosphate 		C9H11N2O9P1	OCC1OC(C(O)C1OP([O-])([O-])=O)N1C=CC(=O)NC1=O	-2	N	322	238		0.9	-2.5	-6.2			CpdB1	
UDP	UDP	udp	C00015	58-98-0	3317	B01132	17659	UDP	C00007313			UDP	[5-(2,4-dioxo-3H-pyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (phosphonatooxy)phosphonate	[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (phosphonatooxy)phosphonate	ribonucleotide diphosphate		C9H11N2O12P2	OC1C(COP([O-])(=O)OP([O-])([O-])=O)OC(C1O)N1C=CC(=O)NC1=O	-3	N	401	280			-3.0	-7.9			CmkB3, glycosyltransferase_Ceramide16_GalCer16, glycosyltransferase_Ceramide16_GlcCer16, glycosyltransferase_DAG160_GalDAG160, glycosyltransferase_DAG160_GlcDAG160, glycosyltransferase_DAG161_GalDAG161, glycosyltransferase_DAG161_GlcDAG161, glycosyltransferase_DAG181_GalDAG181, glycosyltransferase_DAG181_GlcDAG181, glycosyltransferase_GalCer16_GalGalCer16, glycosyltransferase_GalCer16_GlcGalCer16, glycosyltransferase_GalDAG160_GalGalDAG160, glycosyltransferase_GalDAG160_GlcGalDAG160, glycosyltransferase_GalDAG161_GalGalDAG161, glycosyltransferase_GalDAG161_GlcGalDAG161, glycosyltransferase_GalDAG181_GalGalDAG181, glycosyltransferase_GalDAG181_GlcGalDAG181, glycosyltransferase_GalGalDAG160_GalGalGalDAG160, glycosyltransferase_GalGalDAG160_GlcGalGalDAG160, glycosyltransferase_GalGalDAG161_GalGalGalDAG161, glycosyltransferase_GalGalDAG161_GlcGalGalDAG161, glycosyltransferase_GalGalDAG181_GalGalGalDAG181, glycosyltransferase_GalGalDAG181_GlcGalGalDAG181, glycosyltransferase_GalGlcCer16_GalGalGlcCer16, glycosyltransferase_GalGlcDAG160_GalGalGlcDAG160, glycosyltransferase_GalGlcDAG160_GlcGalGlcDAG160, glycosyltransferase_GalGlcDAG161_GalGalGlcDAG161, glycosyltransferase_GalGlcDAG161_GlcGalGlcDAG161, glycosyltransferase_GalGlcDAG181_GalGalGlcDAG181, glycosyltransferase_GalGlcDAG181_GlcGalGlcDAG181, glycosyltransferase_GlcCer16_GalGlcCer16, glycosyltransferase_GlcDAG160_GalGlcDAG160, glycosyltransferase_GlcDAG160_GlcGlcDAG160, glycosyltransferase_GlcDAG161_GalGlcDAG161, glycosyltransferase_GlcDAG161_GlcGlcDAG161, glycosyltransferase_GlcDAG181_GalGlcDAG181, glycosyltransferase_GlcDAG181_GlcGlcDAG181, glycosyltransferase_GlcGlcDAG160_GlcGlcGlcDAG160, glycosyltransferase_GlcGlcDAG161_GlcGlcGlcDAG161, glycosyltransferase_GlcGlcDAG181_GlcGlcGlcDAG181, NrdEF_UDP, PfkA5, Pyk_UDP	
UDPG	UDP-GLUCOSE	udpg	C00029	133-89-1	3331	B04622	18066	GUD	C00001514			UDP-glucose	[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] ({[5-(2,4-dioxo-3H-pyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] ({[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	carbohydrate	nucleotide sugar	C15H22N2O17P2	OCC1OC(OP([O-])(=O)OP([O-])(=O)OCC2OC(C(O)C2O)N2C=CC(=O)NC2=O)C(O)C(O)C1O	-2	N	564	418			-5.0	-9.7			GalE, GalU1, glycosyltransferase_Ceramide16_GlcCer16, glycosyltransferase_DAG160_GlcDAG160, glycosyltransferase_DAG161_GlcDAG161, glycosyltransferase_DAG181_GlcDAG181, glycosyltransferase_GalCer16_GlcGalCer16, glycosyltransferase_GalDAG160_GlcGalDAG160, glycosyltransferase_GalDAG161_GlcGalDAG161, glycosyltransferase_GalDAG181_GlcGalDAG181, glycosyltransferase_GalGalDAG160_GlcGalGalDAG160, glycosyltransferase_GalGalDAG161_GlcGalGalDAG161, glycosyltransferase_GalGalDAG181_GlcGalGalDAG181, glycosyltransferase_GalGlcDAG160_GlcGalGlcDAG160, glycosyltransferase_GalGlcDAG161_GlcGalGlcDAG161, glycosyltransferase_GalGlcDAG181_GlcGalGlcDAG181, glycosyltransferase_GlcDAG160_GlcGlcDAG160, glycosyltransferase_GlcDAG161_GlcGlcDAG161, glycosyltransferase_GlcDAG181_GlcGlcDAG181, glycosyltransferase_GlcGlcDAG160_GlcGlcGlcDAG160, glycosyltransferase_GlcGlcDAG161_GlcGlcGlcDAG161, glycosyltransferase_GlcGlcDAG181_GlcGlcGlcDAG181	
UDPGAL	UDP-GALACTOSE	udpgal	C00052		3354	B04625	18307	GDU	C00007390			UDP-galactose	[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] ({[5-(2,4-dioxo-3H-pyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] ({[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	carbohydrate	nucleotide sugar	C15H22N2O17P2	OCC1OC(OP([O-])(=O)OP([O-])(=O)OCC2OC(C(O)C2O)N2C=CC(=O)NC2=O)C(O)C(O)C1O	-2	N	564	418			-5.0	-9.7			GalE, Glf, glycosyltransferase_Ceramide16_GalCer16, glycosyltransferase_DAG160_GalDAG160, glycosyltransferase_DAG161_GalDAG161, glycosyltransferase_DAG181_GalDAG181, glycosyltransferase_GalCer16_GalGalCer16, glycosyltransferase_GalDAG160_GalGalDAG160, glycosyltransferase_GalDAG161_GalGalDAG161, glycosyltransferase_GalDAG181_GalGalDAG181, glycosyltransferase_GalGalDAG160_GalGalGalDAG160, glycosyltransferase_GalGalDAG161_GalGalGalDAG161, glycosyltransferase_GalGalDAG181_GalGalGalDAG181, glycosyltransferase_GalGlcCer16_GalGalGlcCer16, glycosyltransferase_GalGlcDAG160_GalGalGlcDAG160, glycosyltransferase_GalGlcDAG161_GalGalGlcDAG161, glycosyltransferase_GalGlcDAG181_GalGalGlcDAG181, glycosyltransferase_GlcCer16_GalGlcCer16, glycosyltransferase_GlcDAG160_GalGlcDAG160, glycosyltransferase_GlcDAG161_GalGlcDAG161, glycosyltransferase_GlcDAG181_GalGlcDAG181	
UDPGALF	UDP-D-GALACTO-14-FURANOSE	udpgalfur	C03733		6496		18251					UDP-D-galacto-1,4-furanose	[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl] ({[5-(2,4-dioxo-3H-pyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl] ({[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate	carbohydrate	nucleotide sugar	C15H22N2O17P2	OCC(O)C1OC(OP([O-])(=O)OP([O-])(=O)OCC2OC(C(O)C2O)N2C=CC(=O)NC2=O)C(O)C1O	-2	N	564	417			-5.0	-9.7			Glf	
Um				2140-76-3	10232469							2'-O-methyluridine	1-[4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-3H-pyrimidine-2,4-dione	1-[4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione	modified ribonucleoside		C10H14N2O6	C3(OC(CO)C(O)C(O(C))3)N1C=CC(=O)NC1(=O)	0	N	258	216		3.4	-1.8	-1.8			TX_Um, UshA_UmMP	
UmMP												2'-O-methyluridine monophosphate	[5-(2,4-dioxo-3H-pyrimidin-1-yl)-3-hydroxy-4-methoxyoxolan-2-yl]methyl phosphate	[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxy-4-methoxyoxolan-2-yl]methyl phosphate	modified ribonucleotide monophosphate		C10H13N2O9P1	COC1C(O)C(COP([O-])([O-])=O)OC1N1C=CC(=O)NC1=O	-2	N	336	256			-1.9	-5.3			MGrrnA23S_MODIFICATION_006, UshA_UmMP	
UMP	UMP	ump	C00105	58-97-9	3405	B01161	16695	U	C00007311			UMP	[5-(2,4-dioxo-3H-pyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate	ribonucleotide monophosphate		C9H11N2O9P1	C1(=CC(=O)NC(=O)N1C2(OC(COP(=O)([O-])[O-])C(O)C(O)2))	-2	N	322	238			-2.5	-5.9			CmkB3, DNAPrimerPolymerization_UTP, MG471_MODIFICATION_002, MG471_MODIFICATION_003, MG472_MODIFICATION_002, MG475_MODIFICATION_001, MG479_MODIFICATION_001, MG483_MODIFICATION_001, MG483_MODIFICATION_002, MG484_MODIFICATION_003, MG485_MODIFICATION_002, MG486_MODIFICATION_003, MG486_MODIFICATION_004, MG487_MODIFICATION_002, MG488_MODIFICATION_002, MG488_MODIFICATION_003, MG489_MODIFICATION_001, MG490_MODIFICATION_002, MG492_MODIFICATION_002, MG493_MODIFICATION_001, MG495_MODIFICATION_001, MG495_MODIFICATION_002, MG496_MODIFICATION_001, MG497_MODIFICATION_002, MG499_MODIFICATION_001, MG500_MODIFICATION_001, MG500_MODIFICATION_002, MG501_MODIFICATION_002, MG501_MODIFICATION_004, MG501_MODIFICATION_005, MG502_MODIFICATION_001, MG502_MODIFICATION_003, MG502_MODIFICATION_004, MG503_MODIFICATION_001, MG503_MODIFICATION_002, MG504_MODIFICATION_002, MG504_MODIFICATION_003, MG506_MODIFICATION_001, MG507_MODIFICATION_001, MG508_MODIFICATION_002, MG508_MODIFICATION_003, MG509_MODIFICATION_002, MG509_MODIFICATION_003, MG510_MODIFICATION_002, MG510_MODIFICATION_003, MG511_MODIFICATION_002, MG512_MODIFICATION_002, MG512_MODIFICATION_003, MG513_MODIFICATION_001, MG513_MODIFICATION_003, MG514_MODIFICATION_002, MG518_MODIFICATION_001, MG518_MODIFICATION_002, MG519_MODIFICATION_003, MG520_MODIFICATION_001, MG523_MODIFICATION_002, MGrrnA23S_MODIFICATION_002, MGrrnA23S_MODIFICATION_003, MGrrnA23S_MODIFICATION_005, MGrrnA23S_MODIFICATION_006, MGrrnA23S_MODIFICATION_007, RNACleavage_DeaD_UMP, RNACleavage_RNAseIII_UMP, RNACleavage_RNAseJ_UMP, RNACleavage_RNAseP_UMP, RNACleavage_RNAseR_UMP, RNACleavage_RsgA_UMP, RnaPolymerization_UTP, Udk1, Upp	
UpUp												Up-Up	[5-(2,4-dioxo-3H-pyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl 5-(2,4-dioxo-3H-pyrimidin-1-yl)-4-hydroxy-2-[(phosphonatooxy)methyl]oxolan-3-yl phosphate	[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl 5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-4-hydroxy-2-[(phosphonatooxy)methyl]oxolan-3-yl phosphate			C18H21N4O17P2	OC1C(O)C(OC1COP([O-])(=O)OC1C(O)C(OC1COP([O-])([O-])=O)N1C=CC(=O)NC1=O)N1C=CC(=O)NC1=O	-3	N	627								DNAPrimerPolymerization_UTP, RNACleavage_DeaD_UMP, RNACleavage_RNAseIII_UMP, RNACleavage_RNAseJ_UMP, RNACleavage_RNAseP_UMP, RNACleavage_RNAseR_UMP, RNACleavage_RsgA_UMP, RnaPolymerization_UTP	
URA	URACIL	ura	C00106	66-22-8	3406	B00026	17568	URA	C00001513			uracil	uracil	1,2,3,4-tetrahydropyrimidine-2,4-dione	nucleobase		C4H4N2O2	O=C1NC=CC(=O)N1	0	N	112	89			-0.9	-0.9			DeoD8, DNADamage_SpontaneousBaseDeamination_cytosine, DNADamage_URA_DHURA_hydroxyl_radical, DNADamage_URA_ho5ho6URA_hydroxyl_radical, DNADamage_URA_ho5URA_hydroxyl_radical, Pdp1, Pdp3, TX_URA, Ung_URA, Upp	
URI	URIDINE	uri	C00299	58-96-8	3593	B01210	16704	URI	C00019674			uridine	uridine	1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione	ribonucleoside		C9H12N2O6	OCC1OC(C(O)C1O)N1C=CC(=O)NC1=O	0	N	244	198		3.4	-2.4	-2.4			Cdd1, Pdp3, Udk1	
UTP	UTP	utp	C00075	63-39-8	3375	B01149	15713	UTP				UTP	({[5-(2,4-dioxo-3H-pyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	({[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate	ribonucleotide triphosphate		C9H11N2O15P3	C1(=CC(=O)NC(=O)N1C2(OC(COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])C(O)C(O)2))	-4	N	480	323			-3.4	-10.7			DNAPrimerPolymerization_UTP, GalU1, PfkA5, Pyk_UDP, RnaPolymerization_UTP	
VAL	VAL	val-L	C00183	72-18-4	3483	B00054	16414	VAL	C00001398			L-Valine	valine	2-amino-3-methylbutanoic acid	amino acid		C5H11N1O2	CC(C)C(N)C(=O)O	0	N	117	119		6.2	-2.1	-2.1			Apts_Val, MG511_Aminoacylation, PeptidylTRNAHs_VAL, ProteinDegradation_FtsH_VAL, ProteinDegradation_Lon_VAL, ProteinPolymerization_VAL	
ValVal				3918-94-3	10285797							L-valyl-L-valine	val-val	2-(2-amino-3-methylbutanamido)-3-methylbutanoic acid	dipeptide		C10H20N2O3	CC(C)C(C(=O)NC(C(C)C)C(=O)O)N	0	N	216	218		6.4	-2.0	-2.1			Apts_Val, ProteinDegradation_FtsH_VAL, ProteinDegradation_Lon_VAL, ProteinPolymerization_VAL, TX_OppB_Val	
vinyl_chloride	VINYL-CHLORIDE		C06793		8144334		28509					Vinylchloride	vinylchloride	chloroethene	reactive oxygen species		C2H3Cl1	C=CCl	0	N	62	52			1.4	1.4			vinyl_chloride_activation_1	
X5P	XYLULOSE-5-PHOSPHATE	xu5p-D	C00231		3530	B01195	16332		C00019693			D-Xylulose 5-phosphate	1,3,4-trihydroxy-5-(phosphonatooxy)pentan-2-one	1,3,4-trihydroxy-5-(phosphonatooxy)pentan-2-one	carbohydrate	sugar phosphate	C5H9O8P1	OCC(=O)C(O)C(O)COP([O-])([O-])=O	-2	N	228	173			-2.8	-5.9			Rpe, Tkt1, Tkt2	
XAN	XANTHINE	xan	C00385	69-89-6	3675	B00099	17712	XAN	C00019660			xanthine	Xan	2,3,6,9-tetrahydro-1H-purine-2,6-dione	modified nucleobase		C5H4N4O2	O=C1NC2=C(N=CN2)C(=O)N1	0	N	152	111		3.8	-0.3	-0.3			DeoD7, DNADamage_HYXN_XAN_hydroxyl_radical, DNADamage_SpontaneousBaseDeamination_guanine	
XTSN	XANTHOSINE	xtsn	C01762	146-80-5	4895	B01495	18107		C00007222			xanthosine	xanthosine	9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,3,6,9-tetrahydro-1H-purine-2,6-dione	modified ribonucleoside		C10H12N4O6	C3(C2(=C(N(C1(OC(CO)C(O)C1O))C=N2)NC(=O)N3))=O	0	N	284	220		3.6	-1.8	-1.8			DeoD7	
ZN	ZN+2	zn2	C00038	7440-66-6	3340		29105	ZN				zinc ion	zn(2+)	zinc(2+) ion	ion		Zn1	[Zn++]	2	N	65	11			0.2	0.2			TX_MGTA_ZN	

